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Summary 
University of Sussex 
Dominic Johnson 
Ph.D. Biochemistry 
 
Investigating DNA double-strand break formation and repair in meiosis 
Meiotic recombination is a complex process that requires tight regulation to ensure accurate 
chromosomal segregation and to prevent DNA double-strand breaks (DSBs), introduced to 
initiate meiotic recombination, from becoming damaging. Spo11 introduces DSBs via a 
topoisomerase-like reaction during meiosis. In this thesis I present work investigating the 
mechanisms that regulate the formation and repair of the protein-linked DSBs created by 
Spo11 and topoisomerase II (Top2). 
Initiation of Spo11-DSB resection is conducted by the Mre11-Rad50-Xrs2 (MRX) complex 
and Sae2 protein, which nucleolytically removes Spo11 covalently bound to oligonucleotides 
via a phosphotyrosine bond. Sae2 activity is controlled by post-translational modifications and 
regulation of its oligomeric state. Here I present data characterising the phenotype of Sae2 
proteins mutated at putative Mec1/Tel1 phosphorylation sites (Chapter 3). 
The human TDP2 protein, hydrolytically removes proteolysed topoisomerase II (Top2) from 
the 5ʹ′ end of Top2-DSBs. Here I show that TDP2 is also active upon the phosphotyrosine bond 
between Spo11 and DNA in vitro (Chapter 4). Removal of Spo11 from the 5ʹ′ end of double-
stranded DNA by TDP2 permits resection by lambda exonuclease but no resection is observed 
by the primary meiotic 5ʹ′ to 3ʹ′ exonuclease, Exo1, in vitro. This suggests an evolutionary 
benefit of Spo11-DSB processing by the MRX complex and Sae2 at generating a substrate that 
permits Exo1 resection instead of the hydrolytic Spo11 removal mechanism by TDP2 
(Chapter 4). 
Utilising TDP2 activity, I have developed a novel method to map Spo11-DSBs genome-wide 
with single nucleotide resolution (Chapter 5). 
The spatial patterning of meiotic DSBs is controlled in yeast by the ATM/ATR homologs 
Tel1/Mec1. Results from this new genome-wide DSB mapping method suggest that the kinase 
activity of Tel1 regulates hyper-local repression of coincident Spo11-DSBs (Chapter 6). 
  v 
Utilising TDP2 and the nucleotide resolution mapping procedure for Spo11, Saccharomyces 
cerevisiae topoisomerase II (Top2) was also mapped genome-wide, which indicated that there 
are preferential sites for Top2 cleavage in vivo (Chapter 7). In the future this procedure can be 
adapted to map other protein-DNA complexes in vivo in a wide range of organisms. 
Collectively the work presented in this thesis further elucidates the mechanisms underpinning 
the spatial patterning of Spo11-DSBs in meiosis, the subsequent repair of meiotic DSBs, and 
also contributes to our understanding of the location of Top2 cleavage sites in vivo.  
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Chapter 1: Introduction 
 2 
Chapter 1: Introduction 
2.1 Mitosis and meiosis 
Cells need to divide to enable an organism to grow as well as to replace dying or damaged 
cells. They do this via a process known as mitosis, which, consists of DNA replication 
followed by one round of chromosome segregation resulting in two daughter cells identical to 
the parent cell. The actual mitotic divisional phase is relatively short, with the preceding 
interphase taking up the majority of the cycle. During interphase the cell initially grows and 
prepares for DNA replication through expression of proteins and replicating organelles (G1 
phase). This is followed by replication of the cell’s DNA to produce sister chromatids (S 
phase), and finally more growth and preparation for division (G2) before mitosis begins. The 
mitotic pathway condenses the chromosomes (prophase), aligns them at the metaphase plate 
(metaphase), separates sister chromatids (anaphase), with the chromatids arriving at opposite 
poles of the cell and decondensing (telophase), before the cell physically divides in two, 
generating the two identical daughter cells (cytokinesis) (see Figure 1.1 for schematic). During 
the creation of gametes a specialised mode of cell division occurs known as meiosis. A diploid 
cell undergoes one round of DNA replication (in pre-meiotic S phase) followed by two rounds 
of chromosome segregation to produce cells with half the chromosome complement. The first 
round of chromosomal segregation is a reductional division (meiosis I), where homologous 
chromosomes segregate. The second round is an equational division (meiosis II), where sister 
chromatids segregate, similar to mitotic sister chromatid segregation. This specialised cell 
division of meiosis is controlled by regulation of the cell cycle proteins, cyclin-dependent 
kinases (CDKs).  
2.1.1 Cell cycle regulation in mitosis and meiosis 
In mitotic cells, CDKs control the tight regulation required to ensure a cell cycle stage has 
been completed correctly before progressing to the next. CDKs are present in all known 
eukaryotes and are characterised by the need for a cyclin subunit for their enzymatic activities. 
In mammals CDKs evolved into three cell cycle-related subfamilies and five transcriptional 
subfamilies, whereas in S. cerevisiae there are five CDKs with the master regulator being 
Cdc28, an ortholog of mammalian Cdk1 (reviewed in Mendenhall & Hodge 1998; Malumbres 
2014). In S. cerevisiae, Cdc28 levels are consistent and in excess throughout the cell cycle. 
The binding of inactivating proteins, as well as activating/inactivating phosphorylation events, 
control CDK activity to some degree but mainly it is the pairing of particular cyclins, of which  
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Figure 1.1: Mitotic and meiotic cell division.  
A. In mitosis, DNA replication occurs during S phase to produce sister chromatids. Sister chromatids 
then condense, align and separate during the mitotic (M) phase of the cell cycle generating diploid 
daughter cells. B. Meiosis consists of one round of DNA replication in S phase (pre-meiotic S phase) 
followed by two rounds of segregation (meiosis I and II). During prophase I homologs combine 
physically via the formation of chiasmata before being segregated to opposite poles (reductional 
division). During meiosis II sister chromatids then segregate to opposite poles resulting in the 
formation of non-identical haploid gametes. Lengths of the cell-cycle stages are not drawn to scale.  
Adapted from Marston & Amon, 2004 
B!
A!
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there are nine in S. cerevisiae, whose levels and binding to CDKs determine the cell cycle 
stage and its progression (Barral et al., 1995; Suryadinata et al., 2010). These cyclins consist 
of: Cln1-3 that sequentially interact with Cdc28 in G1 phase, Clb5 and Clb6 in S phase and 
Clb1-4 in mitosis (Nasmyth, 1996).  
CDKs are serine/threonine kinases, and analysis of a large number of their substrates has 
revealed that CDK phosphorylation requires a proline residue immediately adjacent (C-
terminally) to the serine or threonine site to be phosphorylated (S/T-P). This event can be 
promoted by, but is not dependent on, a positively charged arginine or lysine three amino acids 
downstream (S/T-P-X-R/K) (Songyang et al., 1994, 1996; Srinivasan et al., 1995). This 
consensus sequence is conserved for CDKs, but substrate specificity can be regulated via the 
activating cyclin-subunit, which also has specific residues that they recognise and interact with 
(cyclin-binding motif). Mutation of this cyclin-binding motif on the substrate can prevent 
phosphorylation by CDK (Adams et al., 1996; Furstenthal et al., 2001; Schulman et al., 1998).  
The mitotic cycle consists of one round of DNA replication followed by one round of 
segregation in order to produce two identical daughter cells. This process is coordinated by a 
two-step regulation of CDK activity (Tanaka and Araki, 2010). First, in the G1 stage, CDK 
activity is kept low, which allows licensing to occur. This is where the pre-replicative complex 
assembles at origins of replication, a process essential for DNA replication to occur but is 
inhibited by CDK activity. Then, in late G1, CDK activity increases, triggering DNA 
replication from the origins. These origins of replication cannot be licensed again until exit 
from the mitotic cycle when CDK levels drop (Ohkura, 2015). This control of DNA replication 
is manipulated during the specialised cell division of meiosis.  
One round of DNA replication followed by two rounds of segregation with no intervening S 
phase is essential for a reduction in ploidy. The inhibition of S phase is carried out in a meiotic 
cell by maintaining high CDK activity levels between the two divisions (Ohkura, 2015). 
Meiosis utilises many of the same cyclins from mitosis to control CDK activity. However in 
contrast, it has an essential requirement for Clb5 for pre-meiotic S phase and meiotic initiation, 
with the Clb2 cyclin not required. Therefore, CLB2 expression is switched off at the start of 
meiosis. This natural silencing of the CLB2 gene in meiosis, by suppression of its promoter, 
can be used to create meiotic nulls of proteins. Placing a gene under control of the CLB2 
promoter switches off expression of the protein during meiosis, with expression during the rest 
of the cell cycle unaffected. This allows the study and manipulation of meiotic proteins that 
may be essential for normal cycling cells (Jessop et al., 2006). 
In diploid Saccharomyces cerevisiae cells the absence of a nitrogen source combined with a 
non-fermentable carbon source causes diploid cells to enter meiosis (Freese et al., 1982). This 
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entry into meiosis is initiated by the expression of the Ime1 transcription factor, which 
irreversibly directs the cell to undertake meiosis. Activation of Ime1 leads to the transcription 
of the ‘early’ meiotic genes, which play roles in entry into pre-meiotic S phase, recombination 
and chromosomal pairing in meiotic prophase (Primig et al., 2000). ImeI and another kinase, 
Ime2, also promotes suppression of replication between divisions and primes the cell for entry 
into the meiotic divisions (Guttmann-Raviv et al., 2001). Ime1 and Ime2 activate CDK and 
also initiate expression of the transcription factor Ndt80 (Holt et al., 2007; Shin et al., 2010). 
Ndt80 activation induces genes required for the exit from prophase (Tung et al., 2000).  
Reductional division in meiosis I requires the homologs to pair in order to be segregated, a 
unique situation to meiosis. This process takes place in the first meiotic prophase whereby 
homologs recombine and generate a physical connection to each other to aid orientation and 
division. Accurate segregation of homologs is critical to prevent nondisjunction, a situation 
where gametes contain extra or missing chromosomes, which can, in humans, lead to genetic 
diseases such as Down’s syndrome (three copies of chromosome 21). The process of 
recombining the homologs is achieved by utilising the homologous recombination repair 
pathway of DNA double-strand breaks (DSBs).  
2.2 Double-strand breaks 
External and internal forces continuously damage the genome of a cell with as many as 
1 million individual lesions per cell per day (Lodish and Berk, 2003). There are many types of 
DNA damage with the most critical type being a DSB whereby both strands of the DNA 
duplex are broken. DSBs are formed from external sources such as ionising radiation (IR). 
Internally, DSBs can be generated by reactive oxygen species (from cellular metabolism) and 
during DNA replication when replication forks collide with a lesion (Bosco et al., 2004; 
Limoli et al., 2002). DSBs are also programmed by the cell during processes such as mating-
type switching in yeast (Pueyo et al., 1993), V(D)J recombination (Franco et al., 2006) and 
during meiosis (Keeney and Neale, 2006). If left unrepaired DSBs can lead to cell death, and if 
not repaired correctly DSBs can cause translocations, loss of heterozygosity and deletions in 
the DNA, as well as chromosome loss. All these factors are associated with cancerous cells 
(Aplan, 2006). Therefore, the cell has evolved groups of proteins that sense DSBs and act as a 
checkpoint to arrest the cell and activate DNA repair pathways (more detail in later sections) 
(Su, 2006). Primarily the two pathways that repair DSBs are non-homologous end joining 
(NHEJ) and homologous recombination (HR). The differences between NHEJ and HR are 
described in more detail below and are represented as a schematic in Figure 1.2.  
  
Chapter 1: Introduction 
 6 
  
Figure 1.2: DSB repair pathways: Non-homologous end joining and homologous recombination. 
DSBs can be repaired by non-homologous end joining (NHEJ) or homologous recombination (HR) 
depending on the cell cycle stage. In G1, the Ku heterodimer binds DSBs and promotes NHEJ 
alongside Dnl4 and Lif1 with MRX tethering the ends. When Cdc28 is active, such as in G2/S or 
during meiotic prophase, Sae2 gets phosphorylated and activates the nuclease activity of Mre11 
resulting in resection of the 5! strand. Exo1 and/or Sgs1-Dna2 resection machinery performs long-
range resection to generate long ssDNA tails capable of strand invasion, a step necessary for efficient 
homology search and repair of the DSB.  
Adapted from Langerak & Russell 2011 
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The balance between DSB repair pathway choice differs between species, cell type and cell 
cycle phase. For example, in S. cerevisiae, unlike in mammalian cells, HR predominates over 
NHEJ as the DSB pathway of choice outside of G1 (Friedl et al., 1998). NHEJ does play a 
role, and predominates in G0 and G1, whereas HR predominates after DNA replication when 
an undamaged sister chromatid is present to use as a template (Veuger et al., 2003). The main 
process that shifts repair from NHEJ to HR is the 5ʹ′ resection of the DSB. The primary cyclin-
dependent kinase in S. cerevisiae, Cdc28, is a major regulator of this pathway choice, and its 
activity is required for the 5ʹ′ resection of the DSB, thus shifting repair towards HR. Cdc28 is 
active in all cell cycle stages except G0/G1, the stage where NHEJ predominates. This 
therefore provides the link between DSB repair pathway choice and the cell cycle stage (Aylon 
et al., 2004). Corroborating this, CDK is active in meiosis and DSBs repair exclusively via HR 
(Huertas et al., 2008).  
2.2.1 NHEJ 
NHEJ is classically known as an error-prone method of DSB repair. However, in the case of 
clean-ended DSBs, such as those created by nucleases leaving complementary overhangs, 
NHEJ can repair accurately (Rassin, 2003). When DSBs are formed with non-complementary 
ends, or with complex adducts or structures, NHEJ cannot precisely re-join the ends. In this 
situation NHEJ involves micro-homology to direct repair whereby some complementary bases 
align and flaps are removed. This leads to the occurrence of insertions and deletions giving rise 
to its error-prone reputation.  
S. cerevisiae NHEJ initiates with the binding of the highly conserved Mre11-Rad50-Xrs2 
(MRX) complex (MRN (Nbs1) in mammalian cells), which tethers the DSB (Lisby et al., 
2004). The MRX complex is also involved in HR, described later. The current mechanism is 
still unclear but either prior to, or following MRX binding, the Ku complex binds the DSB end 
(Mari et al., 2006). Ku is conserved from bacteria to humans and in S. cerevisiae is a 
heterodimer of Yku70 and Yku80. Ku binds using its ring structure to slide onto the DSB end 
and it orients itself with the Yku80 C-terminus positioned towards the DSB end to allow 
contact with Dln4 (Daley et al., 2005).  
Dnl4 and Lif1 (mammalian DNA ligase IV and XRCC4) bind to Yku80 and Xrs2 respectively, 
permitting the recruitment of DNA ligase IV (Chen et al., 2001). The Nej1 protein also 
promotes NHEJ through controlling the subcellular localisation of Lif1 (Valencia et al., 2001). 
Alignment and complementary base pairing at the DSB now occurs and ligation is attempted. 
Failure to ligate the DSB results in processing of the end in some manner before attempting 
ligation again. This processing is done by a variety of different proteins such as Pol4, which 
Chapter 1: Introduction 
 8 
fills in ends (Wilson and Lieber, 1999), and Rad27 (mammalian FEN-1), which cleaves 5ʹ′ 
flaps (Liou et al., 2001).  
2.2.2 An overview of homologous recombination  
Homologous recombination (HR, Figure 1.3) utilises homologous sequences elsewhere in the 
genome as a template for repair. These sequences can include the sister chromatid, 
homologous chromosome or repeated regions either close by or on different chromosomes 
(Stahl, 1996; Szostak et al., 1983). However, in order for error-free repair, the homologous 
sequence must be a perfect complement, a situation only found on the sister chromatid after 
DNA replication (Figure 1.1A). Repair from a non-perfect homolog can lead to loss of 
heterozygosity. This is due to gene conversion, a process where the unbroken template 
sequence is copied non-reciprocally to the broken locus (Luo et al., 2000). Additionally, when 
HR repairs from a non-allelic/ectopic region, often due to repetitive sequences, damaging 
genomic rearrangements can occur (Stankiewicz and Lupski, 2002). 
Briefly, in mitotic cells, with more detail on specific topics and meiotic events in later sections, 
the double-strand break repair (DSBR) model describes HR initiating from DSBs, which are 
recognised by the MRX complex. Nucleolytic end-processing of the 5ʹ′ strand occurs by MRX 
and Sae2 (CtIP in mammalian cells), generating short 3ʹ′ ssDNA tails (Mimitou and 
Symington, 2009; Pueyo et al., 1993).  In mitotic cells the resection of the 5ʹ′ strand is 
continued by exonuclease 1 (Exo1), and/or the Sgs1-Top3-Rmi1 (STR)-Dna2 complex, to 
generate long 3ʹ′ ssDNA tails (Krogh and Symington, 2004). These ssDNA tails are bound by 
replication protein A (RPA), minimising the formation of secondary structures and facilitating 
loading of the recombinase Rad51 by the mediator protein Rad52 or human BRCA2 (New et 
al., 1998). Rad51 forms a nucleoprotein filament on ssDNA, which is capable of homology 
search, strand invasion and pairing with an undamaged homologous duplex (San Filippo et al., 
2008). Here the invading strand generates a displacement loop (D-loop) and is used to prime 
DNA synthesis from the template strand. The 3ʹ′ ending strand from the other side of the DSB 
anneals to the displaced strand from the donor duplex and primes a second round of leading 
strand synthesis. A double Holliday junction (dHJ) intermediate is formed after ligation of the 
newly synthesised strand to the resected 5ʹ′ strand. These branched structures can be resolved 
in different ways resulting in different outcomes of HR. A process known as dissolution 
involves helicases and topoisomerases, which migrate the branched HJ structures towards each 
other and cleave the inner strands (decatenate) resulting in non-crossovers (NCOs) (Cejka et 
al., 2010; Ellis et al., 1995; Wu and Hickson, 2003). In contrast, cleavage of the outer strands 
of one HJ and the inner strands of the other HJ generates crossover (CO) products (reviewed in 
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Symington et al., 2014). Mitotic DSBs repairing via HR generally do not resolve via the CO 
pathway, unlike in meiosis where half of DSBs repair as COs in S. cerevisiae (Chen et al., 
2008; Mancera et al., 2008). Another model, alongside the DSBR model, has been proposed 
known as the synthesis-dependent strand annealing (SDSA) model (Nassif et al., 1994; Pâques 
et al., 1998). The SDSA model states that one 3ʹ′ end of the DSB invades the homologous 
template duplex, which is displaced by helicases after limited DNA synthesis. The nascent 
complementary strand anneals and, following filling-in synthesis and ligation, NCO products 
are formed (Nassif et al., 1994; Symington et al., 2014).  
2.3 The DNA damage response checkpoint  
DSBs are critical lesions to the cell, therefore there are checkpoint pathways in place to ensure 
that they are dealt with in the correct manner before cell cycle progression can continue. The 
DNA damage response (DDR) signal transduction pathway, as the name suggests, detects 
DNA damage and couples the prevention of cell cycle progression to the activation of DNA 
repair pathways. It has at its heart two main players: Ataxia-telangiectasia mutated (ATM), 
and Ataxia-telangiectasia and RAD3-related (ATR) proteins (reviewed in Ciccia & Elledge 
2010). ATM and ATR are members of the phosphoinositide 3-kinase-related protein kinase 
(PIKK) family and are highly conserved through all eukaryotes, with the S. cerevisiae 
homologs being Tel1 (Greenwell et al., 1995; Morrow et al., 1995) and Mec1 (Kato and 
Ogawa, 1994; Weinert et al., 1994) respectively.  
To invoke their DDR checkpoint functions they phosphorylate a known consensus sequence 
on proteins, hydrophobic-X-hydrophobic-[S/T]-Q sites, also named S/T-Q or SQ/TQ sites 
(Kim et al., 1999). Some of these S/T-Q sites have been found to cluster within 100 amino 
acids, with these regions named S/T-Q cluster domains (SCD), and are considered to be a 
structural hallmark for DNA damage response proteins (Traven and Heierhorst, 2005).  
To give time for DNA repair to occur before replication or mitosis begins, ATM and ATR 
phosphorylate CHK1 and CHK2, which all act together to reduce CDK activity. This 
inhibition of CDK arrests cell-cycle progression at G1/S and G2/M checkpoints (Bartek and 
Lukas, 2007; Kastan and Bartek, 2004). There are numerous other phosphorylation substrates 
of Mec1ATR and Tel1ATM, including DNA repair proteins, which have been identified in yeast 
and mammalian systems using different techniques (Chen et al., 2010; Matsuoka et al., 2007; 
Smolka et al., 2007; Stokes et al., 2007).  
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Figure 1.3: Models for homologous recombination resolution.  
DSBs undergo 5! to 3! resection as detailed in the main text. The long ssDNA 3! end invades a 
homologous sequence and primes leading strand synthesis. The SDSA pathway involves the invading 
strand being displaced after some limited synthesis, which then reanneals with the 3!ssDNA end of 
the other side of the DSB. Fill-in synthesis and ligation then always results in NCO products forming. 
The DSBR pathway involves the 3! ssDNA tail from the other side of the break annealing to the 
displaced strand from the donor duplex (known as second-end capture), priming a second round of 
leading strand synthesis. A double-Holliday junction is formed after ligation of the newly synthesised 
DNA to the resected 5! strands. Two resolution pathways are possible. The dHJ can branch migrate 
into a hemicatenane (HC) and be dissolved or they can cleaved by endonuclease at positions 1, 2, 3 
and 4, both leading to NCO products. CO products form when the joint molecules are resolved by 
cleavage of the junctions at positions 1, 2, 5 and 6.  
Adapted from Symington et al., 2014 
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Tel1ATM 
Mec1 and Tel1 are activated in different ways in response to DNA damage. ATM (Tel1) is 
mutated in ataxia-telangiectasia (A-T) disease, a disease characterised by cancer 
predisposition, defective cell cycle checkpoint and neurodegeneration (Anheim et al., 2012). 
These characteristics are similar to those seen in diseases linked to mutations in the individual 
members of the MRN complex (Shiloh, 2014), suggesting an overlap in the functions of ATM 
and the MRN complex. The MRN complex recruits ATM to the site of DNA damage, and they 
interact via the Nbs1/Xrs2 subunit (Nakada et al., 2003; You et al., 2005). Once localised to 
the DSB by MRN, ATM is activated by monomerisation and autophosphorylation (Bakkenist 
and Kastan, 2003). If any component of the MRX complex is defective, Tel1 activation is 
prevented, although the mechanism behind this is still relatively unknown (Berkovich et al., 
2007; Falck et al., 2005; Lee and Paull, 2005; Nakada et al., 2003; You et al., 2005). Once the 
ends of DSBs are subjected to 5ʹ′ to 3ʹ′ resection, Tel1 signalling activity is disrupted (Mantiero 
et al., 2007), but the long ssDNA tails produced from extensive 5ʹ′ to 3ʹ′ resection go on to 
active the Mec1 kinase (Gobbini et al., 2013).  
Mec1ATR 
Mec1 is also promoted by DSBs but its recruitment is reliant on single-stranded DNA 
(ssDNA), specifically RPA-coated ssDNA 3ʹ′overhangs via an ATR/Mec1 interacting protein, 
ATRIP (Ddc2 in S. cerevisiae). When situated at these ssDNA sites, the 9-1-1 complex 
(RAD9-RAD1-HUS1 in mammals and Ddc1-Rad17-Mec3 in S. cerevisiae), which was loaded 
at the ds-ssDNA junction by the RFC-like clamp loader (Rad24-Rfc2-5 in S. cerevisiae), 
directly stimulates Mec1 kinase activity (Chen et al., 2007; Cortez, 2001; Mains et al., 1990; 
Paciotti et al., 2000; Zou and Elledge, 2003). Therefore, early DSB formation (or unresected 
breaks) recruit and activate Tel1 through the MRX complex, and after end processing, 
resection and binding of RPA to the 3ʹ′ ssDNA produced, Mec1 is recruited and activated.  
Many studies on these two proteins have concerned mitotic DSBs. However, as meiotic HR is 
reliant on DSB formation by Spo11, it is unsurprising that Mec1 and Tel1 are also active and 
even have unique roles in meiotic DSB repair (discussed in later sections).   
2.4 Meiosis and HR 
Meiosis in most organisms utilises the strand invasion ability of HR for the pairing of 
homologs and for the crossing over of genetic material, resulting in the production of 
genetically diverse haploids (Page, 2003; Petronczki et al., 2003). As previously stated, mitotic 
DSBs repaired by HR preferentially utilise the sister chromatid to minimize genome 
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rearrangements and loss of heterozygosity (Johnson and Jasin, 2001; Kadyk and Hartwell, 
1992). Meiotic recombination shares similarities with mitotic recombination at the early 
stages; however, there are many differences between the two. More detail on meiotic DSB 
formation, end processing and resection will be discussed in later sections. The following 
sections outline briefly some other differences between meiotic HR and mitotic HR.  
2.4.1 RPA 
In both meiotic and mitotic cells the 3ʹ′ ssDNA tails generated from the action of MRX/Sae2 
and Exo1 are bound by the abundant ssDNA binding protein, RPA (Lisby et al., 2004; Wang 
and Haber, 2004). RPA is composed of three subunits: RPA1, RPA2 and RPA3, and prevents 
formation of secondary structures, whilst protecting ssDNA from nucleolytic degradation. 
RPA is essential for mitotic growth and meiotic recombination, with mutants defective in the 
repair of Spo11-DSBs (Soustelle et al., 2002). However, recently, meiosis-specific RPA 
homologs have been shown to be involved. Studies in metazoans identified a paralog of RPA1, 
known as MEIOB, which interacts with RPA2 and is essential for proper meiotic 
recombination in mice (Luo et al., 2013; Souquet et al., 2013).  
2.4.2 Inter-homolog bias 
The aim for meiotic recombination is to join homologs and exchange genetic material. Recent 
studies indicate that 70-90% of meiotic DSBs are repaired via the homolog and the rest via the 
sister chromatid (Goldfarb and Lichten, 2010), a process known as inter-homolog bias (Haber 
et al., 1984; Jackson and Fink, 1985; Schwacha and Kleckner, 1994, 1997). This bias is driven 
by a number of factors. During meiosis the Mec1/Tel1 kinases are activated and phosphorylate 
the Hop1 protein (Carballo et al., 2008), which in turn promotes activation of Mek1, a protein 
required to promote this inter-homolog bias (Kim et al., 2010).  
In mitosis, the Rad51 protein conducts homology search to direct repair from the sister 
chromatid. Rad51 is still expressed in meiosis but another meiosis-specific nucleofilament-
producing protein is also expressed, Dmc1 (Bishop et al., 1992).  Rad51 cannot substitute for 
the loss of Dmc1 in meiosis and cells accumulate resected DSBs (Bishop et al., 1992; Usui et 
al., 2001; Xu et al., 1997). However, Rad51 is still required for inter-homolog bias (Schwacha 
and Kleckner, 1997). Experiments looking at a separation-of-function mutant of Rad51 
(rad51-I13A) revealed that Rad51 joint molecule activity is dispensable in meiosis with its 
important function being to act as an accessory factor to Dmc1 (Cloud et al., 2012).  
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2.4.3 Non-crossovers vs. crossovers 
Like mitotic HR, meiotic DSBs can repair via either a NCO or CO pathway. However, COs 
are of critical importance to meiosis as they establish chiasmata, physical links between 
homologs tethering them together. Approximately half of DSBs repair as COs in S. cerevisiae 
meiosis with 5-6 COs per chromosome (Chen et al., 2008; Mancera et al., 2008). In other 
species, however, CO numbers can be lower with only a single ‘obligate’ crossover per 
chromosome (Jones, 1967) being essential for correct segregation (reviewed in Jones and 
Franklin, 2006).  
The differentiation between a NCO and a CO is thought to be conducted at the formation of 
the D-loop stage by the proteinacious Rad51-Dmc1 filament (Bishop and Zickler, 2004; 
Börner et al., 2004; Hunter and Kleckner, 2001; Zickler and Kleckner, 1999). The subsequent 
dHJ formation via the DSBR pathway has the potential to produce either a CO or NCO; 
however it was reported that these joint molecules are predominantly resolved as COs (Allers 
and Lichten, 2001). Instead, NCOs are predominantly formed via the SDSA pathway (Pueyo et 
al., 1993). One way in which NCOs are promoted is via the Sgs1-Top3-Rmi1 complex. Even 
though Sgs1 (Dna2) does not seem to play a role in the resection of the DSB during meiosis 
(Zakharyevich et al., 2010), it is still a key player at the later stages of recombination by 
disrupting nascent D-loops and preventing multi-chromatid joint molecules, promoting NCOs 
(Oh et al., 2007).  
2.4.4 Synaptonemal complex 
In meiosis, the axis of homologous chromosomes are synapsed via a proteinacious structure 
known as the synaptonemal complex (SC). Assembly of this meiosis-specific scaffold, which 
stretches the entire length of the paired chromosomes, is essential for the formation of meiotic 
COs. The homologs initially pair via the process of homology search and strand invasion, 
mediated by Dmc1/Rad51 nucleoprotein filaments. Synapsis is then initiated and a tripartite 
structure consisting of Zip1, Hop1 and Red1 begins to form, with Zip1 polymerising the length 
of the chromosomes (Sym et al., 1993). Zip1 is part of a group of proteins known as ZMMs 
(Zip1-4, Msh4/5, Mer3, Spo16, Pph3), which have various roles in the formation and 
regulation of the SC. These proteins are key for the final stages of recombination. Their 
absence results in accumulation of DSBs and dHJs, and the homologs fail to synapse. 
Unsynapsed homologs results in checkpoint activation and defects in meiotic progression 
(Börner et al., 2004; Shinohara et al., 2008; Sym et al., 1993).   
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2.4.5 Meiotic phases 
Compared to mitosis, meiosis has a prolonged prophase I that can be divided cytologically into 
five distinct stages: (i) Leptonema, chromosomes condense and axial elements begin to form 
on sister chromatids. (ii) Zygonema, homologs pair and begin to synapse along the axis via the 
SC. (iii) Pachynema, homologs align and synapse along the entire axis. (iv) Diplonema, 
dissolution of synapsis occurs but homologs remain linked via chiasmata. (v) Diakinesis, the 
majority of SC is lost and chromosomes begin to condense. The prolonged prophase I enables 
accumulation of DSBs to allow for the increased chance of chiasmata forming (Merino et al., 
2000; Møens and Pearlman, 1988; Zickler and Kleckner, 1998, 1999). The pre-meiotic S phase 
is also prolonged compared to mitotic S phase and it is thought that during this extended 
period of replication other meiosis-specific events take place. This rationale is due to deletion 
of the SPO11 gene (essential for meiotic recombination) reducing the length of S phase by a 
quarter, suggesting that the recombination machinery assembles alongside DNA replication 
(Cha et al., 2000). Additionally, the time that a DSB is made at a certain site is rigidly 
connected to the time of DNA replication at the same locus (Borde, 2000). A recent study 
showed that the replisome-associated components Tof1 and Csm3 associate and recruit Dbf4-
dependent Cdc7 kinase (DDK) to the replication fork. Here DDK phosphorylates chromatin-
bound Mer2 in replicating regions (Murakami and Keeney, 2014). Phosphorylation of Mer2 
promotes recruitment of other DSB-forming proteins thus linking DNA replication timing and 
DSB formation (Henderson et al., 2006; Panizza et al., 2011; Sasanuma et al., 2008).  
2.5 Meiotic DSB formation 
Even though numerous spontaneous DSBs occur in a cell, during meiosis a consistent and 
efficient way to utilise HR to form COs is required and is achieved by the generation of DSBs 
via the Spo11 protein in prophase I (Szostak et al. 1983; Sun et al. 1989; Cao et al. 1990; 
Bergerat et al. 1997; Keeney et al. 1997). To ensure accurate homolog segregation, each cell 
forms numerous DSBs to ensure the formation of at least one chiasmata/CO per chromosome, 
as well as the numerous DSBs promoting homologue pairing and alignment (Henderson and 
Keeney, 2004; Kauppi et al., 2013; Tessé et al., 2003). It is estimated that 160 DSBs are 
formed per cell in S. cerevisiae (Pan et al., 2011), 15-30 in Caenorhabditis elegans and more 
than 200 in mammalian cells (Martinez-Perez and Colaiácovo, 2009; Rosu et al., 2011). 
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2.5.1 Spo11  
Spo11 was first seen to be essential for meiotic recombination in S. cerevisiae in 1985 
(Klapholz et al., 1985), but its precise role was unknown until 1997. Initial studies into meiotic 
recombination observed that in a background where DSBs accumulated (sae2∆, mre11S and 
rad50S), a covalent protein linkage to the 5ʹ′ end either side of the DSB was present (de Massy 
et al., 1995; Keeney and Kleckner, 1995; Liu et al., 1995). This sort of covalent linkage is 
reminiscent of topoisomerase-like transesterification reactions where the protein forms a 
transient covalent bond with the DNA at an intermediary step (reviewed in Champoux, 2001).  
Genetic and sequencing studies on the archaeal TopoVIA subunit described similarities with 
four proteins of unknown function, one being the S. cerevisiae protein Spo11 (Bergerat et al., 
1997). Topoisomerases cleave DNA by attacking the phosphodiester bond with a catalytic 
tyrosine residue, forming a covalent bond. Spo11 contains such a tyrosine at Tyr135. Upon 
mutating this residue to a phenylalanine, preventing any catalytic activity, DSBs in meiosis 
were no longer formed and no meiotic recombination took place (Bergerat et al., 1997). 
Spo11-DNA species were isolated using a biochemical method in rad50s meiotic cells. Nuclei 
were isolated from meiotic cells and gDNA extracted using guanidine-HCl plus ionic detergent 
at 65 °C, with the bulk protein removed using a caesium chloride gradient. These harsh 
conditions isolate gDNA away from all weakly bound proteins but still retain any covalently 
bound protein on the DNA. Protein-bound DNA was isolated away from free DNA using a 
glass fibre filter to which proteins specifically adsorb to and protein-DNA species eluted using 
SDS. Non-specific nucleases were used to remove any bound DNA and the sample analysed 
by mass spectrometry. A 45 kDa protein, Spo11, was enriched in the rad50s strains and 
proceeding experiments immunoprecipitated the Spo11-HA protein, which coprecipitated with 
DNA from the known strong HIS4::LEU2 DSB hotspot (Keeney et al. 1997). These studies 
indicated that Spo11 was the responsible protein for creating DSBs in meiosis and accumulates 
covalently bound to the end in rad50S and sae2∆ cells (de Massy et al., 1995; Keeney et al., 
1997; Keeney and Kleckner, 1995; Liu et al., 1995).  
The essential function of Spo11 in S. cerevisiae extends to its orthologs in other species. The 
Spo11 protein itself is highly conserved and studies in C. elegans, Drosophila melanogaster 
and Mus musculus have all demonstrated its ability to initiate meiotic recombination (Baudat 
et al., 2000; Dernburg et al., 1998; Hayashi-Hagihara, 1998; Romanienko and Camerini-Otero, 
2000). Interestingly, in C. elegans, ionising radiation-induced DSBs alleviated the dependence 
on Spo11 for meiotic recombination. This indicates that whilst cells are dependent on Spo11 
for meiotic recombination, it is primarily the DSB-forming ability of Spo11 that is required for 
this function (Dernburg et al., 1998).  
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2.5.2 The Spo11 complex 
Topoisomerase II (Top2), which cleaves DNA in a similar manner to Spo11, acts as a dimer 
(Shelton et al., 1983). Experiments where Spo11 was tagged with two different affinity tags, 
the two tagged Spo11 forms coprecipitated suggesting dimeric assembly or a larger oligomeric 
structure. This dimerisation of Spo11 is essential for DSB formation and dependent on two 
other proteins, Rec102 and Rec104 (Sasanuma et al., 2007). The Rec102-Rec104 complex is 
also required for the nuclear localisation and activity of Spo11 (Kee et al., 2004). These two 
proteins are not the only proteins essential for Spo11 DSB formation. In fact there are at least 
nine proteins required for DSB formation in meiosis. Of these nine proteins, yeast two-hybrid 
experiments identified four sub-complexes (Rec102-Rec104, Spo11-Ski8, Rec114-Mei4-Mer2 
and Mre11-Rad50-Xrs2), which also interact between themselves and are all required for DSB 
formation (Arora et al., 2004; Maleki et al., 2007; Petrini, 1999; Uetz et al., 2000).  
Ski8 plays a role in RNA metabolism in vegetative cells (Masison et al., 1995), but it is also 
essential for meiotic DSB formation (Gardiner et al., 1997). It has been described as a scaffold 
protein that aids in the nuclear localisation of Spo11 and in the recruitment of other DSB 
proteins to the chromosome. Yeast two-hybrid assays also indicated Ski8 is required for the 
interaction of Spo11 and Rec104 (Arora et al., 2004). Mer2 interacts with itself, Mei4, Xrs2 
and Rec114 (Arora et al., 2004; Henderson et al., 2006; Li et al., 2006; Maleki et al., 2007). Its 
phosphorylation by CDK in meiosis is essential for meiotic recombination (Henderson et al., 
2006). The Rec114-Mei4-Mer2 sub-complex binds axial sites which anti-correlate with DSB 
sites. Mer2 is recruited to these axial sites by Red1 and Hop1 (Panizza et al., 2011). The role 
of Rec114 itself is relatively unknown but phosphorylation by Mec1/Tel1 is important for its 
function. Mutating the S/T-Q motifs of Rec114 to alanines resulted in a subtle increase in DSB 
formation, whereas a phosphomimetic mutation, and over-expression of the wild type protein, 
decreased DSB formation (Bishop et al., 1999; Carballo et al., 2013). The evolutionarily 
conserved MRX complex, as described earlier and in more detail later, has a role in the 
nucleolytic processing of DSBs in HR. However, it is also required for DSB formation in S. 
cerevisiae (reviewed in Keeney 2001) and in C. elegans (Chin and Villeneuve, 2001), but not 
for DSB formation in Schizosaccharomyces pombe or Arabidopsis thaliana (Bleuyard et al., 
2004; Puizina, 2004; Young et al., 2004). In S. cerevisiae Mre11 requires all the components 
of the Spo11 complex, except Rad50, for localisation to the DSB site. However, the binding of 
Mre11 does not require DSB formation itself and Mre11 still transiently associates with the 
DNA in a spo11-Y135F (catalytic-dead) mutant, indicating that MRX plays a role in the pre-
DSB complex. This tightly couples DSB formation with the end-processing of Spo11-DSBs 
(Borde et al., 2004). However, in mammalian cells these DSB-forming proteins are essential 
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during early development, preventing a determination of their role in mammalian meiosis 
(Cole et al., 2010).  
2.5.3 Interference & spatial patterning of DSBs 
When and where DSBs are made in the genome during meiosis is under tight control by 
numerous different pathways. As previously stated, DSBs only form in a narrow time window 
of prophase I (Padmore et al., 1991). DSB formation is tightly coupled to pre-meiotic 
replication, occurring 1.5-2 hours after, presumably ensuring that DSBs achieve their correct 
function and are not toxic lesions at inappropriate times. It was first seen that blocking DNA 
replication prevented DSB formation in a replication checkpoint-independent manner (Borde, 
2000), but later it was documented that pre-meiotic replication is not a prerequisite for DSB 
formation. Rather, the coordination of the two processes is regulated by CDK and Dbf4-
dependent kinase Cdc7 (DDK) phosphorylation of Mer2  (Blitzblau et al., 2012; Murakami 
and Keeney, 2008, 2014).  
Spo11 has some bias towards DNA sequence (Murakami and Nicolas, 2009; Pan et al., 2011), 
yet the sites of the genome where Spo11 creates DSBs are not driven towards this weak site 
preference. Instead DSBs are spread non-randomly throughout the genome and are often 
clustered at, what are designated, recombination hotspots, a region of approximately 70-250 bp 
(reviewed in Lichten & Goldman 1995). In S. cerevisiae there doesn’t seem to be one 
responsible pathway for designating hotspot usage, instead numerous pathways affect DSB 
position, as discussed below.  
One well-recognised factor in the location of DSB hotspots is that they always form in 
micrococcal nuclease (MNase)-sensitive/nucleosome-depleted regions (NDRs), a feature 
commonly linked with promoter regions (Fan and Petes, 1996; Kaplan et al., 2009; Pan et al., 
2011) (Figure 1.4C). However, even though the majority of DSBs occur in NDRs, not all 
NDRs contain DSBs, which therefore suggests a further level of control in Spo11 recruitment 
and/or activation at these sites (Pan et al., 2011). DSB hotspots may be targeted in different 
ways between organisms. In S. cerevisiae it has been published that methylation of histone H3 
on lysine 4 (H3K4) correlates with Spo11 hotspots, with the methyltransferase Set1 required 
for this modification. In the absence of Set1, the frequency of DSBs at 84% of meiotic sites 
was severely reduced, correlating with a reduction of local levels of H3K4 methylation (Borde 
et al., 2009; Sollier et al., 2004). Similarly, in mammalian cells a H3K4 methyltransferase 
known as PRDM9 mediates hotspot selection.  The DNA binding zinc finger domain of 
PRDM9 contains a variable amino acid sequence thereby giving rise to unique hotspot maps  
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Figure 1.4: Spo11-DSB hotspot distribution.  
A. Spo11 creates DSBs non-randomly throughout the genome, enriched at what are designated 
recombination hotspots. Telomere-proximal and pericentric regions are suppressed for DSB 
formation. B. Meiotic chromosomes are organised into protruding loops, attached to a proteinaceous 
axis with DSBs predominantly occuring on these loops. C. Within these loops Spo11-oligos 
(processed Spo11-DSBs) cluster in promoter nucleosome-depleted regions adjacent to the +1 
nucleosome containing the transcription start site (TSS).  
Adapted from Pan et al., 2011 
B!
A!
C!
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within individuals bearing differing PRDM9 alleles (Baudat et al., 2010; Parvanov et al., 
2010).  
In meiosis, sister chromatids condense by being organised into protruding loops, attached to a 
proteinaceous axis (as shown in Figure 1.4B), a feature distinct from mitotic chromosomes. 
The axis comprises of axial elements; the cohesin complex containing the meiosis-specific 
subunit, Rec8, and the meiosis-specific Hop1 and Red1 proteins (Blat and Kleckner, 1999; 
Hollingsworth et al., 1990; Klein et al., 1999; Panizza et al., 2011; Smith and Roeder, 1997; 
Zickler and Kleckner, 2015). DSB hotspots predominantly occur within these loops, however 
many of the proteins responsible for the activation and regulation of Spo11-induced DSBs 
reside at the axis (Blat et al., 2002; Borde and de Massy, 2013; Kleckner, 2006). A model 
known as the tethered-loop axis model (as depicted in Figure 1.5) has been proposed to 
counteract this discrepancy. This model states that the Spp1 subunit of the Set1 complex 
simultaneously associates with axis-associated protein Mer2 and with H3K4me3 sites, which 
are enriched at hotspots on the loop. Spp1 therefore acts as a bridge to tether the protruding 
loop to the axis where the DSB can occur (Sommermeyer et al., 2013).  
In S. cerevisiae, in principle any base pair can be a site of a DSB in meiosis. However, there 
are approximately 3600 regions, termed hotspots, where DSBs more frequently occur (Lichten 
and Goldman, 1995).  However, in a single cell only 150-200 DSBs are made (Pan et al., 
2011). Therefore, mechanisms must be in place that limit and evenly distribute DSBs 
throughout the genome (reviewed in Keeney et al. 2014; Cooper et al. 2014). As DSBs in 
meiosis repair off a homologous chromatid, it would seem unwise to break the homologous 
sequence after the first DSB has been made. A DSB on one chromosome prevents a DSB 
forming in the same location on the sister chromatid, and has been seen to decrease the 
frequency of a DSB forming on its homolog. This is known as trans inhibition and is 
dependent on the DNA damage response (DDR) kinases Mec1ATR and Tel1ATM (Fukuda et al., 
2008; Rocco and Nicolas, 1996; Xu and Kleckner, 1995; Zhang et al., 2011). Inhibition of 
further DSB formation in close proximity to an initial DSB on the same molecule (cis 
inhibition) was previously reported (Fan et al., 1997; Fukuda et al., 2008; Wu and Lichten, 
1995; Xu and Kleckner, 1995), with a recent study finding this inhibition on the same 
chromatid, dubbed DSB interference, is regulated by Tel1 (Garcia et al., 2015). Tel1 has a 
localised, suppressive effect, which spans over ~70-100 kb on the same chromatid, reducing 
the frequency of coincident DSB formation below that expected by chance. As well as DSBs 
now forming independently of one another, DSBs also group within ~7.5 kb at a greater 
coincidence than random independent DSBs would. This indicates that the DSBs are somehow 
being formed in a concerted manner, with the authors explaining this phenomenon by stating 
that these local DSBs form together due to them being on the same loop of chromatin with  
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Figure 1.5: Meiotic loops and axis and the tethered-loop axis model.  
Spo11-DSBs predominantly within the protruding loops that are formed in meiosis. The PHD domain 
of Spp1, which is located on the axis with Mer2, identifies the H3K4me3 on the protruding loop and 
bridges the site down to the axis where DSB forming proteins are found. Due to this sporadic long-
range interaction, as assessed by ChIP, Spo11 may appear to be located at either the hotspot site or the 
axis. 
Adapted from Sommermeyer et al., 2013 
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pre-tethering of the loop, upstream of DSB formation, ‘activating’ it and allowing DSBs to 
form close by on the same loop (Garcia et al., 2015).  
2.5.4 Genome-wide mapping of Spo11 DSBs 
Genome-wide mapping of Spo11-DSBs has given us vast amounts of information on where 
Spo11 creates breaks. Initially, DNA samples enriched for meiosis-specific DSBs from rad50S 
strains were used as hybridisation probes on DNA microarrays and it was observed that 
hotspots were nonrandomly associated in G/C rich regions and certain transcriptional profiles, 
whilst coldspots were more associated with telomeres and centromeres (Gerton et al., 2000). 
Later studies observed that in a dmc1∆ background, more DSBs were formed than observed in 
rad50S mapping data and that some DSBs were artificially lower in some regions in rad50S 
(Blitzblau et al., 2007; Buhler et al., 2007). In these studies the ssDNA produced from 
resection of Spo11-DSBs was used to map hotspots in the dmc1∆ background. Here, Spo11-
DSBs had been processed and formed in a wild type scenario but ssDNA accumulates due to 
dmc1∆ cells lacking strand invasion and thus completion of HR. Double the number of 
hotspots was observed compared to the rad50S mapping data and a lot of the previously 
described cold-regions now had detectable ssDNA from DSBs (Blitzblau et al., 2007; Buhler 
et al., 2007). However, these studies still had limited quantitative and spatial resolution due to 
the design of the microarrays, large sizes of DNA used as probes and low dynamic range of 
hybridisation signal. They were also performed in mutant backgrounds where DSBs are not 
fully repaired, which may influence later forming DSBs due to various checkpoint signals 
from the large amounts of ssDNA present. Therefore, the Keeney lab designed a method to 
map the Spo11-oligonucleotides produced in wild type cells (more details on Spo11-oligos 
later) (Pan et al., 2011c). Their map confirmed DSBs form in nucleosome-depleted regions, 
mainly in intergenic regions, but a significant number within ORFs. Their DSB sites correlated 
with the previous mapping work done in rad50S and dmc1∆ cells but gave much higher 
resolution. For example, suppressed regions for formation of DSBs, such as telomeres and 
pericentric regions (see Figure 1.4A), were shortened compared to previous studies. Spo11-
oligos were also observed to negatively correlate with Rec8 sites, a meiosis-specific cohesin 
subunit at the axis (Pan et al., 2011). However, due to the G-tailing required for preparing the 
Spo11-oligonucleotides for sequencing there is still a potential discrepancy for any Spo11 
cleavage sites where there is a 5ʹ′ C present. Additionally, the short oligonucleotide could not 
be mapped due to potential multi-mapping that would occur with reads this short. This issue 
also arises for S. pombe when trying to map the short (13-14 nt) Rec12 (Spo11)-oligos (Fowler 
et al., 2014). This leaves a requirement for further high-resolution methods for mapping of 
Spo11 (Rec12)-DSBs.  
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2.6 DSB end-processing 
2.6.1 Spo11-oligonucleotide formation 
In order for Spo11-DSBs to be repaired by HR, the Spo11 moiety has to be removed to allow 
proper homology search and strand invasion. Two mechanisms of Spo11 removal from the 5ʹ′ 
ends of the DSB are possible: (i) direct hydrolysis of the covalent bond between Spo11 and the 
5ʹ′ end or (ii) single-stranded nucleolytic cleavage of Spo11 bound to a short oligonucleotide 
(Keeney 2001; Keeney et al. 1997). Radioactive end-labelling of DNA in an 
immunoprecipitated Spo11-HA protein sample, with species resolved on an SDS-PAGE gel, 
revealed two bands, specific for Spo11-HA. These species were not present in the catalytic-
dead Spo11 mutant (spo11-Y135F) or in rad50S or sae2∆ mutants, indicating that these 
species were Spo11-formation and DSB processing dependent (Neale et al., 2005). Protease 
digestion of Spo11 and the resolution of the attached oligonucleotides on a urea-PAGE gel 
revealed an upper band ~24-40 nt in length and a lower band at ~10-15 nt (Neale et al., 2005). 
These two discrete sizes of Spo11-oligonucleotide species have been observed in a variety of 
other species, including mouse, which indicates this mechanism for processing of Spo11-DSBs 
is evolutionarily conserved (Neale et al., 2005). However, in S. pombe, Rec12 (Spo11) is 
endonucleolytically released by Rad32 (Mre11) nuclease activity, in cooperation with Ctp1 
(Sae2/CtIP), attached to only one length of oligonucleotide (~13-29 nt), suggesting a different 
nucleolytical regulatory mechanism to that seen in mammalian and S. cerevisiae cells (Milman 
et al., 2009).  
As the size of these Spo11-oligos are shorter than the average length of the ssDNA tails 
produced via resection, this indicates that there is an initial clipping off of Spo11 attached to 
the oligonucleotide prior to extensive resection of the 5ʹ′ strand. However, the reason behind 
the production of two sizes of Spo11-oligo rather than one is still unknown, but it has been 
postulated to be due to asymmetric processing of the DSB with one side endonucleolytically 
cleaved further away than the other by Mre11 endonuclease activity (Neale et al., 2005). In 
support of this model a large number of hotspots were observed with the long oligonucleotides 
predominantly mapping to the Crick strand and not to the Watson strand (presumably the 
missing Spo11-oligos from the Watson strand consisted of the shorter length oligonucleotides 
which were not mapped in this study) (Pan et al., 2011). Additionally, Spo11-oligonucleotides 
are resistant to degradation by DNase, which may be explained by the multi-protein Spo11 
complex forming an asymmetric barrier to resection and complete degradation of Spo11-oligos 
(Garcia et al., 2011). 
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2.6.2 The Mre11-Rad50-Xrs2 complex 
The components of the MRX complex, whose structure can be seen in Figure 1.6, have been 
subject to numerous studies.  The MRX complex has been implicated in multiple roles in the 
cell including DSB formation in meiosis (reviewed in Lam and Keeney, 2015), DSB resection 
at mitotic and meiotic breaks (Mimitou and Symington, 2008; Zhu et al., 2008), and Tel1ATM 
signalling through the Xrs2/Nbs1 subunit (Nakada et al., 2003). Its role in DSB formation, 
NHEJ and Tel1 signalling has been discussed in earlier sections. This section will delve into 
the DSB end processing activity of the MRX complex and its interplay between NHEJ and 
HR. 
The MRX complex is composed of Mre11, Rad50 and Xrs2 proteins (Johzuka and Ogawa, 
1995; Usui et al., 1998). The Mre11 and Rad50 subunits are highly conserved through all 
domains of life. Mre11 contains five conserved phosphodiesterase motifs, all of which are 
essential for both the exo- and endonuclease functions (Bressan et al., 1999; Moreau et al., 
1999; Paull and Gellert, 1998; Trujillo et al., 1998; Usui et al., 1998). Rad50 is a large 153kDa 
protein which contains ATP-dependent binding to DNA (Alani et al., 1989; Raymond and 
Kleckner, 1993; Sharples and Leach, 1995). The MRX complex structure contains a head 
domain that consists of a dimer of Mre11 interacting with two Rad50 ATP-binding cassettes. 
This domain is responsible for the DNA-binding and the ATP-dependent nuclease activity of 
Mre11. MR complexes can interact inter-molecularly via the coiled-coil domain of Rad50, 
which emanates from this head domain and allows tethering of the DSB ends (Chen et al., 
2001; De Jager et al., 2001; Hopfner et al., 2002), a process essential for meiotic DSB 
formation (Wiltzius et al., 2005). Loss of any component of the MRX complex, as well as 
Rad50 zinc hook mutants, exhibit an increase in separation of the two ends of an induced I-
SceI break, whereas Mre11 nuclease mutants did not, indicating these functions are separable 
(Lobachev et al., 2004).   
As stated, Mre11 and Rad50 are conserved from bacteria to humans, however the third 
component of this complex (Xrs2) is more diverged in eukaryotes and doesn’t exist in 
prokaryotic bacteria, archaea and the T4 bacteriophage. Yeast Mre11 and Rad50 proteins 
complex with Xrs2 whilst the mammalian component is Nbs1. Xrs2 and Nbs1 are less well 
conserved, with similarity limited to two regions of the proteins: the N-terminal fork-head 
associated (FHA) domain, and a conserved region in the C-terminus (Chahwan et al., 2003). 
Xrs2 displays some DNA binding activity (Trujillo et al., 2003), interacts with Mre11 via a C-
terminal region but not Rad50 (Usui et al., 1998), and translocates Mre11 into the nucleus 
(Tsukamoto, 2004). All the components of the MRX complex, and these activities of Xrs2, are 
essential for all functions of the MRX/N complex in vivo (Tsukamoto, 2004). However, it  
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Figure 1.6: Structural organisation of the MRX complex and its DSB end tethering ability.  
The MRX complex consists of a dimer of Mre11 interacting with two Rad50 ATP-binding cassettes 
forming a head domain. When ATP (purple dots) is bound to Rad50, it alters the conformational shape 
of the complex into a closed state that allows DNA binding and end-tethering but occludes the Mre11 
nuclease domains (stars) (top left). Upon ATP hydrolysis to ADP (pink dots), the Rad50 
conformational is altered leading to disengagement of the Rad50 dimer and an exposure of the Mre11 
nuclease domains, promoting end-resection. In the closed state, the coiled-coil domain of Rad50 that 
emanates from the head domain allows tethering of two MRX complexes via the zinc hook of Rad50 
thus tethering two DNA ends together.  
Adapted from Gobbini et al 2016 
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seems that the translocation of Mre11 into the nucleus by Xrs2, as well as its Tel1 interaction, 
are the major roles of the Xrs2 protein. Mutating the Mre11 interaction motif of Xrs2 resulted 
in an xrs2∆ phenotype (Tsukamoto, 2004). A recent study demonstrated that tethering a 
nuclear localisation signal (NLS) to Mre11 rescued xrs2∆ defects in DNA end resection, 
meiosis and hairpin resolution. This strain did however retain defects in Tel1ATM signalling and 
repair of DSBs by NHEJ (Oh et al.,, 2016). Mutations in the conserved regions of the XRS2 
gene elucidated various functional domains of the Xrs2 protein: (i) an Mre11 interaction 
domain, essential for the roles of the MRX complex (Falck et al., 2005; Nakada et al., 2003; 
Tsukamoto, 2004), (ii) a Tel1-interaction domain, which when mutated resulted in a tel1∆-like 
phenotype of defective DNA damage signalling and shortened telomeres (Nakada et al., 2003; 
Shima et al., 2005), and (iii) an FHA domain, which in contrast to the mammalian Nbs1 
protein was not essential for any of the major roles of the MRX complex (Shima et al., 2005), 
but binds phosphorylated Sae2 (CtIP) (Liang et al., 2015). In mammalian cells the Xrs2/Nbs1 
subunit is a critical component as mutations within the NBS1 gene are responsible for the rare 
autosomal recessive disease, Nijmegen breakage syndrome, which increases cancer 
predisposition (Tauchi et al., 2002; Williams et al., 2002; Zhu et al., 2001).  
2.6.3 MRX nuclease functions 
It was first seen that meiotic recombination and DSB resection is inhibited by rad50S and 
mre11 nuclease mutants, so it was suggested that the MRX complex is involved in the 
processing of Spo11-DSBs (Ajimura et al., 1993; Alani et al., 1990; Keeney and Kleckner, 
1995; Liu et al., 1995; Moreau et al., 1999). Indeed, in the rad50S background, Spo11-oligo 
species are not generated. Moreover, in wild type cells the Spo11-oligos generated contained a 
free 3ʹ′ hydroxyl group indicative of endonuclease cleavage (Neale et al., 2005). Mre11 
contains endonuclease activity as well as 3ʹ′ to 5ʹ′ exonuclease activity, and in a nuclease-dead 
mutant of Mre11 (mre11-H125N/mre11-nd), although DNA binding of the Mre11 mutant was 
unaffected (Nicolette et al., 2011), Spo11-oligos were no longer generated (Garcia et al., 2011; 
Moreau et al., 1999; Stracker and Petrini, 2011). Likewise, in S. pombe the nuclease activity of 
Rad32 (Mre11) is essential for the removal of Rec12 (Spo11) (Hartsuiker et al., 2009). In these 
mre11-nuclease and rad50S mutants, DSBs were still present; indicating the role MRN plays 
in promoting DSB formation is distinct from its nuclease activities.  
The nuclease activity of Mre11 was first postulated because Mre11 has sequence homology 
with the bacterial SbcD nuclease (Moreau et al., 1999). The 3ʹ′-5ʹ′ exonuclease activity of 
recombinant Mre11 is stimulated by Rad50 and is dependent on the divalent manganese 
cation, whilst being inhibited by magnesium (Paull and Gellert, 1998). A weak endonuclease 
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activity was also seen on 5ʹ′-terminated DNA strands and other structures (Hopkins and Paull, 
2008; Trujillo and Sung, 2001). Through structural studies it was seen that the catalytic 
domain of the protein could be disrupted through mutation of D56N and/or H125N, resulting 
in a separation of function mutant (Moreau et al., 1999). This mutant, unlike the null mutant, 
was proficient in mating-type switching, telomere maintenance, classical NHEJ, DSB 
formation in meiosis and repair of HO-DSBs (Krogh et al., 2005; Moreau et al., 1999). 
However, the mre11-nuclease mutant accumulates DSBs in meiosis (like the rad50S allele), is 
sensitive to topoisomerase poisons and is mildly sensitive to methyl methane sulfonate (MMS) 
(Krogh et al., 2005).  
For many years there was an inherent contradiction in models for DSB repair and the observed 
exonuclease activity of Mre11. Upon repair of a DSB, long ssDNA tails are generated which 
are 3ʹ′ ending. This means that 5ʹ′ to 3ʹ′ resection had occurred from the DSB but Mre11 
possesses 3ʹ′ to 5ʹ′ exonuclease activity.  This contradiction was solved from work in the Neale 
lab using a mutant of Mre11 that was deficient in exonuclease activity but proficient in 
endonuclease activity (mre11-H59S), a mutant discovered in Pyrococcus furiosus (Williams et 
al., 2008). This mutant still generated Spo11-oligonucleotides and seemed to have no obvious 
resection defect of its own. However, combining the mre11-H59S mutant with deletion of 
Exo1, the major 5ʹ′ to 3ʹ′ resector of DSBs in meiosis (Hodgson et al., 2011; Keelagher et al., 
2011; Manfrini et al., 2010; Tsubouchi and Ogawa, 2000; Zakharyevich et al., 2010), caused 
DSBs to accumulate for longer than in either of the single mutants and resection was reduced 
and delayed. Spo11-oligonucleotides, which still formed in mre11-H59S cells, had altered size 
distribution with an increase in the levels of longer Spo11-oligonucleotides up to 300 nt in 
length. These observations supported a hypothesis that Mre11 creates a nick via its 
endonuclease activity then the 5ʹ′ strand is resected bidirectionally with the inherent 3ʹ′ to 5ʹ′ 
Mre11 exonuclease resecting towards the DSB and Exo1 in a 5ʹ′ to 3ʹ′ direction to extend the 3ʹ′ 
ssDNA tail required for meiotic recombination (Garcia et al., 2011) (see Figure 1.7).  
A similar bidirectional model has been proposed in mammalian cells for DSBs generated from 
IR (Shibata et al., 2014). In this study it was found that the endonuclease function of Mre11 
was a control point for the choice between HR repair and NHEJ repair. Inhibition of Mre11 
endonuclease function, with specific inhibitors, increased repair of DSBs via NHEJ, 
suggesting that activation of Mre11 endonuclease, potentially through Sae2 (CtIP) (discussed 
later), begins resection of the 5ʹ′ strand, inhibiting NHEJ repair and promoting repair by HR 
(Shibata et al., 2014).  
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Figure 1.7: The dependency on MRX nuclease activity at free or blocked DSB ends.  
Even though the MRX complex is recruited to most DSB ends the requirement for MRX nuclease 
activity differs depending on the complexity of the DSB ends. A. When the DSB end is free (clean) 
MRX is rapidly recruited but its nuclease activity is not essential. However, it does speed up the 
process of resection, potentially through creating a more efficient DNA substrate for binding of Exo1. 
B. When the end of a DSB is complex (blocked), such as those containing a chemical modification, 
stalled topoisomerase protein or covalently bound Spo11, the nuclease activity of MRX is essential. 
MRX and Sae2 are rapidly recruited, Sae2 is phosphorylated (in G2/M or meiosis) and Mre11 
endonuclease activity is stimulated. The 5! strand is cleaved and from this nick bidirectional resection 
occurs through the 3! to 5!  exonuclease activity of Mre11 and 5!  to 3! exonuclease activity of Exo1 
or Sgs1-Dna2.  
Figure taken from Cejka, 2015 
A! B!
Chapter 1: Introduction 
 28 
All these experiments indicate that the nuclease function of Mre11 is essential for blocked or 
complex DSB ends like those created by Spo11 in meiosis and by stalled Top2 proteins. These 
ends need to be nucleolytically processed by Mre11 before other DSB repair machinery, such 
as long range 5ʹ′ to 3ʹ′ exonucleases, can access the DSB. However, at ‘clean’ ended DSBs, 
such as at those created by the I-SceI endonuclease or the HO endonuclease (an unrepairable 
single DSB generated by the HO-endonuclease at the MAT locus of JKM139 derivative (Lee 
et al., 1998)), Mre11 nuclease function is not as important with initiation of resection being 
simply delayed in mre11∆, rad50∆ and xrs2∆ mutants (Mimitou and Symington, 2009). This 
suggests these ends lacking chemical modifications are more liable/accessible to 5ʹ′ to 3ʹ′ 
exonucleases to allow repair (Llorente and Symington, 2004; Moreau et al., 1999). Therefore, 
the necessity for Mre11 nuclease action is dependent on how well the long-range resection 
machinery, Exo1 or Sgs1-Dna2, can access the DNA (see Figure 1.7 for a schematic 
comparison between MRX activity on ‘complex’ and ‘clean’ ends). The nuclease functions of 
Mre11 are not dependent on Rad50 or Nbs1/Xrs2 but they are enhanced when in a 
holocomplex (Williams et al., 2007).  
At clean-ended breaks, the interplay between MRX and Ku can also control the choice of DSB 
repair down either the NHEJ or HR route. Both MRX and Ku display almost simultaneous, but 
independent, binding to the DSB end (Wu et al., 2008). Ku can only bind to free DNA ends 
and, once there, protects them from degradation and promotes repair by NHEJ. Ku has been 
shown to block free ends from resection by Exo1 when the MRX complex is defective, 
suggesting the importance of MRX in promoting HR. Likewise, MRX was shown to dissociate 
Ku from the end of the DSB (Shim et al., 2010; Wu et al., 2008). Deletion of YKU70 led to 
increased resection, even in the absence of functional MRX (Mimitou and Symington, 2010). 
Similarly, over-expression of EXO1 suppressed sensitivity to end-processing mutants (sae2∆ 
sgs1∆) (Lewis et al., 2002; Moreau et al., 2001). These results suggest that Ku inhibits HR by 
blocking access of Exo1 to the DSB and that MRX is required to remove Ku to allow HR to 
occur (Bressan et al., 1999; Clerici et al., 2008; Mimitou and Symington, 2010).  
2.6.4 Rad50 roles 
Rad50 activity, and its ability to regulate MRX activity in DNA damage signalling and 
resection, are dependent on ATP binding and hydrolysis, which induces conformational 
changes (see Figure 1.6) (Deshpande et al., 2014; Lammens et al., 2011). The ATPase activity 
of Rad50 is essential for its function, as mutations in the conserved Walker A-type ATPase 
domain results in a rad50∆ phenotype (Chen et al., 2005). Similarly, the rad50S mutant, 
whose phenotype was identical to mre11-nd and sae2∆, has a mutation close to this ATPase 
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domain; however, the exact biochemistry of the rad50S mutation has not been characterised 
(Cao et al., 1990). Recent work on the MRX complex has shown Rad50 to be essential for 
Mre11 endonuclease activity and that the rad50S mutant lacks the capacity to stimulate this 
activity in vitro (Cannavo and Cejka, 2014). This endonuclease activity is also dependent on 
ATP suggesting that the rad50S allele may be defective in ATP hydrolysis and/or at 
stimulating the Mre11 endonuclease activity, potentially via modulating Sae2 interaction with 
the rest of the MRX complex (Cannavo and Cejka, 2014). Similarly, in S. pombe the 
equivalent rad50S mutant is also defective in removing Rec12 (Spo11) (Hartsuiker et al., 
2009).  
2.6.5 Mre11 association at the DSB 
MRX localises first to the site of damage, tethers the ends and acts as a sensor, enabling 
recruitment and activation of the DNA damage checkpoint through Tel1ATM (D’Amours and 
Jackson, 2002; Dolganov et al., 1996; Hopfner et al., 2000; Petrini et al., 1995). Preventing 
end-processing of DSB ends by disrupting MRX function through either rad50S or sae2∆ 
mutations resulted in a delay in the disassembly of Mre11 foci. In meiosis, Mre11 foci 
accumulate in the rad50S background but are not dependent on Tel1, suggesting that this 
accumulation of Mre11 at the DSB is Tel1-independent (Usui et al., 2001). Interestingly, the 
nuclease-deficient mre11-58 (His213Tyr) mutant and mre11-58 rad50S double-mutant are 
capable of forming DSBs in meiosis but do not have persistent Mre11 foci, unlike wild type 
and other nuclease mutants (Usui et al., 1998, 2001). The phenotypes associated with the 
mre11-58 mutant has been linked to the loss of interaction with Rad50 (Moreau et al., 1999), 
but, as DSBs still form, a loss of this interaction is unlikely (Usui et al., 2001).  
The absence of Sae2 also causes prolonged binding of MRX at DSB sites leading to persistent 
DNA-damage checkpoint activation by Tel1 and Rad53 (Clerici et al., 2006; Lisby et al., 
2004). MRE11 nuclease-dead and sae2∆ mutants are defective in dissociation of Mre11 from 
unprocessed DSBs in meiosis (Borde et al., 2004), as well as DSBs from IR (Lisby et al., 
2004). This prolonged binding and accumulation of Mre11 (MRX) at the DSB site is thus 
thought to be due to the lack of Mre11 nuclease activity itself and also lack of its stimulation 
by Sae2. However, Mre11 persists for longer at DSBs in sae2∆ cells compared to mre11 
nuclease-deficient cells, as well as the DNA damage checkpoint being hyperactivated in 
sae2∆. (Clerici et al., 2006; Lisby et al., 2004; Mimitou and Symington, 2011). Prolonged 
retention of Mre11 in sae2∆ mutants, as well as the defective checkpoint deactivation in sae2∆ 
cells, can be rescued by some Mre11 mutations in its N-terminal region. For example, two 
separate Mre11 mutants, H37R and P110L, decrease both DNA binding and retention to DSBs 
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in a sae2∆ background. These mutants retain their meiotic DSB-forming and nuclease abilities, 
indicating these activities are separable (Chen et al., 2015; Puddu et al., 2015). These studies 
suggest that it is the accumulation of Mre11 (MRX) at the DSB sites, in a sae2∆ background 
where ends are not processed, that cause activation of the DNA damage checkpoint and 
sensitivity to DNA damaging agents. Alongside this, over-expression of SAE2 results in a 
faster turnover of Mre11 at DSBs and correlates with a reduction in Rad53 phosphorylation 
(Clerici et al., 2006). These results suggest that a major function of Sae2 is to remove the 
MRX complex from break ends, an independent function from its MRX nuclease-stimulating 
ability.  
TEL1 inactivation does not suppress the DNA damage hypersensitivity of sae2∆ (Puddu et al., 
2015). It does, however, reduce the ability of the mre11-H37R mutant to suppress sae2∆ CPT 
hypersensitivity. Furthermore, the mre11-H37R mutant, which does not accumulate at the 
DSB, now forms foci in TEL1-deficient cells suggesting Tel1 cooperates with Sae2 to promote 
the removal of Mre11 from DSBs (Puddu et al., 2015). A recent genetic screen for mutants 
that require Tel1 for survival to DNA damaging agents isolated the rad50-V1269M mutant 
(Cassani et al., 2016). This mutation resulted in hypersensitivity in tel1∆ cells to phleomycin 
and CPT, and impaired MRX association at the DSB, which is further reduced in the absence 
of Tel1. These results suggest that loss of MRX, and the repair defect, are due to loss of end-
tethering and that this tethering effect is necessary for repair of DSBs by either NHEJ or HR. 
Thus, Tel1 may promote/stabilise the MRX complex at the DSB in a positive feedback loop. 
Intriguingly, this role of Tel1 was independent of its kinase activity (Cassani et al., 2016).  
The MRX complex also plays a role alongside Tel1 in maintenance of telomere length (Hirano 
et al., 2009; Martina et al., 2012), whereas the protein Rif2 negatively regulates telomere 
length (Wotton and Shore, 1997). Rif2 appears to compete with Tel1 for binding the Xrs2 
subunit in vitro, and Rif2 interferes with MRX-Tel1 interaction, preventing Tel1-dependent 
lengthening of telomeres (Hirano et al., 2009). Rif2 also interacts with Xrs2 at DSBs in vivo 
(Hirano et al., 2009), preventing the promotion of MRX retention at the break site by Tel1, 
and, similar to a tel1∆, impedes on the MRX ability to end-tether and repair DSBs (Cassani et 
al., 2016). Rif2 also enhances ATP hydrolysis by Rad50 with rif2∆ cells showing an increase 
in end-tethering and NHEJ (Cassani et al., 2016), indicating that Rif2 counteracts these 
processes and that Rif2 may play a role in the choice between NHEJ and HR by modulating 
the open and closed state of Rad50 (see Figure 1.6). Specifically, it is proposed that an open 
state would increase end resection thereby favouring HR over NHEJ (Cassani et al., 2016). 
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2.6.6 Phosphorylation of the MRX complex by Tel1  
All three members of the MRX/N complex are phosphorylated by ATM/ATR in response to 
DNA damage (D’Amours and Jackson, 2001; Grenon et al., 2001). Phosphorylation of each 
component has different cellular effects. Phosphorylation of Nbs1 at two sites (Ser278 and 
Ser343) in response to DNA damage mediates control of the S phase checkpoint and plays a 
role in maintenance of telomeres (Lavin et al., 2015). Only one site of mammalian Rad50 has 
been observed to be phosphorylated in response to DNA damage, Ser635. Phosphorylation of 
this site doesn’t affect MRN complex formation but it was important for MRN function 
because the S635G phospho-mutant is not able to correct the S phase checkpoint in Rad50-
deficient cells (Gatei et al., 2011). Finally, exposure of cells to IR, and other agents that induce 
DSBs in mammalian cells, identified phosphorylation sites on Mre11 at Ser676 and Ser678, 
which, when mutated, lead to decreased cell survival and increased chromosomal aberrations 
(Kijas et al., 2015). Further investigation found that hyperphosphorylation of Mre11 by ATM 
led to inactivation of the MRN complex via decreasing its association from chromatin, 
enabling down-regulation of the DNA damage checkpoint (Di Virgilio et al., 2009) 
The MRX complex and Sae2 
The idea that Sae2 modulates Mre11 activity and disassembly from the DSB is supported by 
the observation that Sae2 foci form at the precise time Mre11 foci disassemble, and that Mre11 
foci persist similarly in the mre11-H125N (nuclease deficient) mutant as to that seen in sae2∆ 
cells (Lisby et al., 2004). However, Mre11 foci persist longer in sae2∆ and mre11-H125N cells 
at DSBs with apparent ‘dirty/complex’ ends compared to clean-ended I-SceI DSBs, suggesting 
that the nuclease activity of Mre11 is more important for the processing of complex ends, such 
as those generated in meiosis by Spo11. This also suggests that alternative nucleases can 
compensate for Mre11 nuclease activity when the DSB end is clean (Lisby et al., 2004).  
2.7 Sae2 
The screens that identified an accumulation of Spo11-DSBs in meiosis in rad50S and mre11S 
mutants also identified SAE2/COM1 deficient cells with the same phenotype of unresected 
DSBs, deficient HR and homolog synapsis, and weak sensitivity to MMS (McKee and 
Kleckner, 1997; Prinz et al., 1997). This suggested that the role of Sae2 intersected with that of 
the MRX complex.  
The SAE2 gene is not well conserved in eukaryotes but there have been related proteins 
identified in humans (CtIP), S. pombe (Ctp1), A. thaliana (COM1), and C. elegans  (COM-1) 
(Deveaux et al., 2000; Gönczy et al., 1999; Limbo et al., 2007; Penkner et al., 2007). Sae2 
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contains a short, C-terminal region that displays sequence alignment to these functional 
orthologs (reviewed in Tsutsui et al. 2011). This region includes sites for CDK and 
Mec1ATR/Tel1ATM phosphorylation as well as an oligomerisation motif (Kim et al., 2008; 
Sartori et al., 2007; Wang et al., 2012). The essential nature of Sae2 and its orthologs in 
meiosis is replicated through S. pombe to higher eukaryotes (Hartsuiker et al., 2009; Penkner 
et al., 2007; Uanschou et al., 2007). For example, the distantly related S. cerevisiae and 
S. pombe species show functional conservation between Sae2 and Ctp1, as seen by the 
requirement for Ctp1 in Rec12 (Spo11) removal in meiosis (Hartsuiker et al., 2009).  
2.7.1 Sae2 protein domains 
The Sae2 protein C-terminus contains a conserved region, which is essential for the 
stimulation of DSB end-processing by MRX and is where many essential phosphorylation sites 
reside (Cannavo and Cejka, 2014; Kim et al., 2008). The N-terminus seems to be somewhat 
dispensable as overexpression of sae2-ΔN120 or sae2-ΔN170 can support sporulation in sae2Δ 
cells, whereas the overexpression of sae2-ΔC170 cannot. However, the overexpression of sae2-
ΔN170 does not suppress MMS sensitivity, and the self-interacting mutant of Sae2 (L25P-
E171G) confers only partial suppression, suggesting that the N-terminal region has a function 
other than just self-interaction (Kim et al., 2008).  
2.7.2 Interaction with MRX 
The similarity between SAE2 mutants and MRE11 nuclease mutants suggest that Sae2 
functionally integrates with the MRX complex (Keeney and Kleckner, 1995). To investigate 
this in detail the Cejka lab directly demonstrated that recombinant Sae2 stimulates Mre11 
endonuclease activity on in vitro blocked-end DNA substrates, whilst Mre11 exonuclease 
activity was independent of Sae2. This Mre11 endonuclease activity showed a preference for 
the 5ʹ′ blocked end of dsDNA substrates and cleaved 15-25 nt from the end (Cannavo and 
Cejka, 2014). This observation may explain why Spo11-oligonucleotides are the observed 
lengths – due to endonucleolytic clipping of the 5ʹ′ strand flanking the DSB. The 3ʹ′ to 5ʹ′ 
exonuclease function of Mre11 may therefore only be required for further resection of the 5ʹ′ 
strand by multiple nicking, up to 300 nt from the DSB, followed by resection towards the DSB 
(Garcia et al., 2011).  
With mutants of Sae2 and the MRX complex conveying similar phenotypes, it was thought 
that they should interact physically. It was initially reported that via yeast two-hybrid and in 
vitro assays that they did not physically interact in solution unless DNA was present 
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(Lengsfeld et al., 2007; Uetz et al., 2000). More recently it was shown that recombinant Sae2 
is able to pull-down the MRX complex via the Mre11 and Xrs2 components (Cannavo and 
Cejka, 2014). Conversely, in mammalian cells, CtIP interacts with all three members of the 
MRN complex (Chen et al., 2008; Sartori et al., 2007; Yuan and Chen, 2009). Over-expression 
of SAE2 is able to suppress the SSA defect in rad50S cells (Clerici et al., 2005), suggesting 
that the rad50S mutant prevents interaction of Sae2 with the MRX complex, which can be 
overcome with high concentrations of Sae2 (reviewed in Paull, 2010). However, although the 
rad50S mutant has a similar phenotype to sae2∆, the hypothesis that the rad50S mutation 
prevents Sae2 association with the MRX complex and/or the DSB is not supported by 
experiments demonstrating that Sae2 foci are not disrupted in mre11∆ or rad50S mutants 
(Lisby et al., 2004).  
Sae2, although essential for processing of meiotic breaks, is dispensable for some mitotic HR 
processes (Bressan et al., 1999; Ivanov et al., 1994; Malkova et al., 1996; Tsubouchi and 
Ogawa, 1998). Sae2 deficiency, similar to MRX deficiency, causes a delay of approximately 
30 minutes before resection initiates at HO-endonuclease induced DSBs, resulting in an 
increased frequency of NHEJ repair. This indicates that the initial processing by MRX and 
Sae2 is a driving force towards HR rather than NHEJ (Lee et al., 2008; Mimitou and 
Symington, 2008).  Loss of Sae2 activity also confers hypersensitivity to MMS (McKee and 
Kleckner, 1997; Rattray et al., 2001), and enhanced Tel1-mediated Rad53 phosphorylation 
after DNA damage (Usui et al., 2001). By contrast, high levels of Sae2 cause telomere 
lengthening in a Tel1-dependent manner (Perrone,et al., 2003). Sae2 is likely to have 
additional roles in mitotic cells as sae2∆ mutants are more sensitive to DNA damaging agents 
than nuclease-deficient Mre11 mutants (Usui et al., 2001).  
2.7.3 Hairpin processing 
In Sae2-deficient (and also rad50S and mre11 nuclease-deficient) cells, large palindromic 
duplications arise within inverted repeats due to misrepair of DSBs, thought to have arisen 
from fold-back and replication of 3ʹ′ ssDNA intermediates (Rattray et al., 2001; 2005). 
Unprocessed hairpin structures also arise at such inverted repeats in sae2∆ cells (Lobachev et 
al., 2002). Subsequent work demonstrated that Sae2 itself is an endonuclease, responsible for 
cleaving 5ʹ′ flap structures and at single-stranded regions adjacent to hairpin DNA (Lengsfeld 
et al., 2007). However, there is no discernable nuclease domain on the Sae2 protein, and more 
recently other laboratories have not detected this same endonuclease activity (Cannavo and 
Cejka, 2014; Niu et al., 2010).  
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2.7.4 CtIP/Ctp1 
As previously stated, Sae2 and CtIP/Ctp1, although functional orthologs, only have a short 
stretch of sequence conservation found in the C-terminus. Both proteins seemingly play a 
similar role in activation of the Mre11 nuclease and are both required for DSB resection, but 
their biochemical interactions differ. For example, CtIP and Ctp1 require MRN for localisation 
to a DSB (Limbo et al., 2007), whereas Sae2 can localise independently of the MRX complex 
(Lisby et al., 2004). CtIP has also been shown to directly interact with the MRN complex 
(Sartori et al., 2007), and it was not until recently that Sae2 was found to interact weakly with 
the MRX complex (Cannavo and Cejka, 2014). CtIP is also much larger than Sae2 (897 a.a. 
vs. 345 a.a.), with the only defined region of Sae2 being a coiled-coil region in the N-terminus 
that mediates homodimerisation (Dubin et al., 2004).  
2.7.5 Regulation of Sae2 activity 
Even though Sae2 is essential for processing meiotic DSBs and that is has important roles in 
other pathways, its actual mechanistic role is still largely unknown. To elucidate the functional 
role of Sae2, a substantial body of work has investigated the role of post-translational 
modification and the impacts of oligomerisation, with Sae2 being phosphorylated and 
acetylated after MMS treatment on numerous residues (Fu et al., 2014), as discussed below.  
CDK phosphorylation of Sae2  
As previously mentioned, Cdc28, the main CDK in S. cerevisiae, increases in activity in S/G2 
phases of the cell cycle. Such activation leads to a wide range of substrates being 
phosphorylated, one of which is Sae2 (Huertas et al., 2008). HR repair, in contrast to NHEJ 
repair, is the more accurate repair method of DSBs, but it requires the presence of a sister-
chromatid. In S. cerevisiae, HR therefore predominates in S and G2 phases of the cell cycle, 
whereas NHEJ is generally restricted to G1 (as described earlier) (Aylon et al., 2004; Caspari 
et al., 2002; Esashi et al., 2005; Grzegorz et al., 2004). CDK activity governs which repair 
pathway a DSB should take by phosphorylating substrates during S and G2 to favour HR 
repair, with a major control step being at the point of resection initiation. Promotion of 
resection of a DSB drives repair down the HR pathway because resected DNA is refractory to 
repair by NHEJ (Aylon et al., 2004; Grzegorz et al., 2004).  
The Sae2 protein contains three potential CDK phosphorylation sites: Ser134, Ser179 and 
Ser267. Of these, Ser267 maps to the only region on Sae2 that is conserved with mammalian 
CtIP and fission yeast Ctp1 (Huertas et al., 2008). Mutation of the two sites not in this 
conserved region to unphosphorylatable alanines (S134A and S179A) did not alter the 
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sensitivity of strains to the topoisomerase I poison, camptothecin (CPT). By contrast, mutation 
of the conserved S267 site to alanine caused sensitivity almost to sae2∆ levels. Additionally, 
mutation of the cyclin-binding motif (Arg-X-Leu (RXL)) on Sae2, a motif essential for 
phosphorylation of substrates by CDK, also caused CPT sensitivity. In contrast, mutating the 
Ser267 site to glutamic acid to mimic phosphorylation (S267E) showed no sensitivity to CPT, 
and combining this S267E mutant with the cyclin-binding motif mutant reduced the sensitivity 
of the cyclin-binding mutant strains (Huertas et al., 2008). At a HO-DSB, sae2-S267A confers 
sae2∆-like absence of end resection. By contrast, the sae2-S267E mutant displays wild type 
resection kinetics that are only slightly affected by inhibiting cdc28-as1 (an inhibitable form of 
Cdc28), unlike wild type Sae2. However, the sae2-S267E mutant displays sensitivity to IR 
when the cells are in the G1 phase of the cell cycle (something that is not seen in sae2∆ or 
sae2-S267A). One explanation for this observation is that the DSBs generated are resected and 
therefore inhibitory to repair by NHEJ, but the lack a sister chromatid to repair from results in 
aberrant attempts to repair by HR. The analogous CDK site in human CtIP (Thr847) when 
mutated to alanine also displays CPT hypersensitivity, indicating that CDK-dependent control 
of Sae2 activity and resection initiation may be conserved through other eukaryotes (Huertas et 
al., 2008). However, in fission yeast the Sae2 homolog, Ctp1, does not contain a CDK 
phosphorylation site analogous to Ser267. Instead CDK controls protein expression of Ctp1, 
such that it is cell-cycle regulated (Limbo et al., 2007).  
CDK activity in meiosis rises during pre-meiotic S phase and increases through prophase I 
(Marston and Amon, 2004). Sae2 is also phosphorylated by CDK on Ser267 in meiosis, and 
the sae2-S267A mutant fails to repair meiotic DSBs similar to sae2∆ mutants (Manfrini et al., 
2010). Phosphorylation at S134 may also have a role during meiosis because the double sae2-
S134A-S267A mutant has lower spore viability than the sae2-S267A single mutant (Huertas et 
al., 2008; Manfrini et al., 2010). Similarly, a recent study noted a hypomorphic phenotype in 
the S267A mutant compared to a nearly null phenotype in the double S134A-S267A mutant, 
indicating that this S134 site may also be an, albeit minor, CDK phosphorylation site that 
regulates Sae2 activity (Fu et al., 2014). In vitro, phosphorylation of Sae2 on S267 is critical 
for its ability to stimulate MRX endonuclease activity (Cannavo and Cejka, 2014). The S267A 
mutant has no change in its ability to bind DNA, but has impaired interaction with the MRX 
complex, suggesting that the conserved C-terminal region (and S267 site) of Sae2 either 
directly interacts with the MRX complex or that this mutant protein is improperly folded 
(Cannavo and Cejka, 2014).  
Mec1/Tel1 phosphorylation of Sae2 
As discussed, Tel1 is recruited to, and binds to, DSBs via the Xrs2 protein of the MRX 
complex (Nakada et al., 2003), where it (and Mec1) phosphorylate many proteins associated 
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with the DSB including MRX and Sae2 (Baroni et al., 2004). Sae2 contains five S/T-Q sites, 
which are a consensus sequence for Mec1/Tel1 phosphorylation: Ser73, Thr90, S249, Thr279 
and Ser289. Mutation of all five sites to prevent putative phosphorylation eliminated the 
majority of Sae2 phosphorylation when assessed by gel mobility assays (Baroni et al., 2004), 
and conferred phenotypes similar to sae2∆ in respect to MMS sensitivity, mitotic 
recombination at inverted repeats, and restart of cell cycle progression once the checkpoint is 
activated (Baroni et al., 2004). A more recent study noted that mutation of Thr90, Ser249 and 
Thr279 eliminates the bulk of slower migrating species via Western blot upon phleomycin 
treatment (Liang et al., 2015). Whilst S249 mutation had no effect on Sae2 function, the two 
threonine residues appear to act redundantly to regulate Sae2 function. The S. cerevisiae 
Thr279 site (found in the conserved region of Sae2) aligns with CtIP Thr289, a site 
phosphorylated by ATR/ATM and required for HR (Liang et al., 2015; Wang et al., 2013). 
Collectively it is proposed that these residues mediate specific interactions between Sae2/CtIP 
and multiple FHA domain-containing proteins including Xrs2, and that such interactions may 
link Sae2 to its role in regulation of the MRX complex (Liang et al., 2015).   
Sae2 is phosphorylated periodically during the meiotic cycle in a Mec1- and Tel1-dependent 
manner (Cartagena-Lirola et al., 2006). This phosphorylation appears at the onset of pre-
meiotic S phase, increases when DSBs are formed and then decreases upon DSB repair. 
Mutation of these five residues to prevent phosphorylation causes an accumulation of the 
DSBs formed by Spo11 in a similar manner to that of sae2∆ cells, indicating a defect in DSB 
resection (Cartagena-Lirola et al., 2006).  
Oligomerisation 
Although phosphorylation of Sae2 alters its activity in vitro and in vivo, the actual biochemical 
mechanism of Sae2 activity and how these modifications physically affect the protein are still 
relatively unknown. Recent work has focused on the way in which post-translational 
modifications of Sae2 affects its oligomeric state (Cejka lab - personal communication; Fu et 
al., 2014). Sae2 exists as a multimer in vivo (Kim et al., 2008). However, whilst mutation of 
the L25 self-interacting site (L25P) abolishes oligomerisation of Sae2 (Kim et al., 2008), a 
Sae2 mutant lacking the first 169 amino acids can still promote MRX endonuclease activity in 
vitro (Cannavo and Cejka, 2014), suggesting that self-interaction is not essential for Sae2 
activity but instead may regulate its activity in vivo. Mutation of the CDK site to alanine 
(S267A) reduces the active/monomeric fraction of Sae2, whereas mimicking phosphorylation 
at this site, alongside phosphorylation mimics of the Mec1/Tel1 phosphorylation sites, 
increased the active/monomeric fraction (Fu et al., 2014).  
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2.8 DSB resection  
DSB resection in cycling cells is a process that involves three pathways: MRX/Sae2, Exo1 and 
Sgs1/Dna2. Resection of the 5ʹ′ strand can proceed 2000-4000 nt at mitotic DSBs for allelic 
recombination, 3000-6000 nt for ectopic recombination (Chung et al., 2010), and 850 nt at 
meiotic DSBs (Zakharyevich et al. 2010). Mre11 is a 3ʹ′ to 5ʹ′ exonuclease that acts by creating 
a nick and resecting towards the DSB (Garcia et al., 2011). With the length resection proceeds, 
resection by the action of the Mre11 endo- and exonuclease alone would be very inefficient 
and thus, there is a requirement for more proficient, 5ʹ′ to 3ʹ′ exonucleases. However, the MRX 
complex and Sae2 are important for the initiation of resection at DSBs. Resection at both HO-
endonuclease (Llorente and Symington, 2004) or I-SceI DSBs (Clerici et al., 2005) is greatly 
delayed in cells deficient for any component of the MRX complex or Sae2, but resection 
length is unaffected. Therefore other nucleases can substitute for the initial resection, 
performed by the MRX complex alongside Sae2, on clean-ended DSBs (Mimitou and 
Symington, 2009). The 5ʹ′ to 3ʹ′ nucleases involved in DSB resection are the Exo1 protein and 
the Sgs1-Dna2 pathway. Resection tract lengths are reduced to 100-300 nt in mitotic cells and 
270 nt in meiotic cells containing the sgs1∆ exo1∆ mutant (Zakharyevich et al. 2010; Chung et 
al. 2010). The 100-300 nt of resection by the MRX complex can enable the repair of DSBs in 
the sgs1∆ exo1∆ double mutant, but a triple mutant of exo1∆ sgs1∆ sae2∆ (or Mre11 mutation) 
causes cell lethality and no resection occurs (Mimitou and Symington, 2008).  
At clean-ended DSBs in mitotic cells the Exo1 protein and the Sgs1-Dna2 pathway act as 
redundant nucleases required for this extensive resection (Zhu et al., 2008). However, the 
resection length of DSBs in meiosis is not affected in SGS1 mutants, suggesting that Exo1 is 
the sole long range resection mechanism in meiosis (Zakharyevich et al. 2010). In exo1∆ 
meiotic cells, resection proceeds ~270 nt compared to ~850 nt in wild type meiotic cells. In a 
sgs1∆ mutant the length of wild type resection is unchanged, and in the sgs1∆ exo1∆ double 
mutant the resection length is still 270 nt (Zakharyevich et al., 2010), consistent with findings 
that Mre11 and Sae2 cooperate to initially cleave the 5ʹ′ strand up to ~270 nt from the DSB and 
resect 3ʹ′ to 5ʹ′ (Garcia et al., 2011). Despite this consensus view, it has been reported that Sgs1 
may function at late stages of meiosis, but only in the absence of Exo1 (Manfrini et al., 2010).  
Quite why Exo1 is the sole 5ʹ′ to 3ʹ′ resector in meiosis, unlike mitotic cells, is still unknown. 
However, unpublished work in the Neale laboratory has determined that in a checkpoint-
deficient background (rad24∆), Sgs1-Dna2 and Mre11/MRX both perform substantial 
resection. This suggests that the Mre11 and Sgs1/Dna2 pathways are usually suppressed in a 
Rad24-dependent manner in meiosis. In mitosis and meiosis the limited resection, dependent 
on MRX and Sae2 activity, is enough for homology search and efficient joint molecule 
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formation (Chung et al., 2010; Zhu et al., 2008), suggesting long range resection by Exo1 and 
Sgs1-Dna2 might only be important for the activation of the DNA-damage checkpoint via 
ssDNA/RPA stimulation of Mec1ATR (reviewed in Cejka 2015).  
2.8.1 MRX and Sae2 interactions with Exo1 
Over-expression of EXO1 can partially suppress the resection initiation defect of Mre11 and 
Sae2 mutants, but only at clean-ended breaks (Tsubouchi and Ogawa, 2000). This indicates 
that the nucleolytic action of Mre11 and Sae2 are important for the repair of blocked (protein 
bound/chemically modified) DSB ends, but are not essential for clean-ended ones. Instead it is 
thought that MRX simply increases the efficiency of the long-range resection enzymes at 
clean-ended DSBs (Moreau et al., 2001; Tsubouchi and Ogawa, 2000). As previously 
discussed, Ku may play a role in preventing Exo1 recruitment or access to the DSB, as 
deletion of Yku70/80 in Mre11 mutant or sae2∆ background suppresses the initiation of 
resection defect seen in these mutants (Langerak and Russell, 2011; Limbo et al., 2007; 
Mimitou and Symington, 2011; Shim et al., 2010).  
In vitro the favoured substrate for Exo1 is a 3ʹ′ overhang duplex DNA substrate (Cannavo et 
al., 2013). Thus, the nick and 3ʹ′ ending ssDNA tail created by MRX/Sae2 in vivo creates a 
more efficient substrate for Exo1 to act upon. MRX/N stimulates Exo1 resection in vitro but is 
not required for its activity as long as Ku is absent, corroborating the in vivo data (Cannavo et 
al., 2013). Stimulation of resection by Exo1 by MRX/Sae2 is not dependent on Mre11 
nuclease activity (Nicolette et al., 2010). However, to date, no direct physical interaction 
between Exo1 and MRX has been detected. Because MRX and Exo1 only interact in the 
presence of DNA it has been postulated that MRX and Sae2 may alter the conformation of the 
DNA, rendering it more accessible to Exo1 through unwinding (Nicolette et al., 2010).  
MRX also stimulates the Sgs1-Dna2 pathway, as demonstrated by the observation that exo1∆ 
rad50∆ cells have decreased resection compared to exo1∆ cells alone (Zhu et al., 2008). 
Additionally, the nuclease-deficient mutant of Mre11 confers sensitivity to IR, which is 
heightened in the absence of Dna2 nuclease function despite Exo1 still being present (Budd 
and Campbell, 2009). Thus, the function of Dna2 is partially redundant with MRX with 
respect to processing of IR-induced damage, and this function is distinct from that of Exo1. 
Expression of a helicase-proficient, nuclease-deficient form of Dna2 is lethal in cells 
expressing an Mre11 nuclease-deficient allele, suggesting that structures generated by Dna2 
specifically require Mre11-dependent processing in the presence of a helicase+/nuclease- form 
of Dna2 (Budd and Campbell, 2009; reviewed in Paull, 2010).  
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2.8.2 Regulation of Exo1 
The ssDNA binding protein, RPA, is not required for Exo1 binding to DNA, but is required to 
promote its extensive resection potentially by preventing the formation of secondary DNA 
structures and non-specific binding of Exo1 (Chen et al., 2013; Myler et al., 2016). In mitotic 
cells, Exo1 is phosphorylated in a Rad53-dependent manner, which has been proposed to 
inhibit its resection activity, a process thought to limit the amount of ssDNA produced and 
subsequently limit the DNA damage checkpoint (Morin et al., 2008). Conversely, human 
EXO1 is phosphorylated by CDK, which is required for its activity. Phosphorylation of 
S. cerevisiae Exo1 by CDK has not been demonstrated and may not be conserved. In meiosis, 
resection is limited to ~850 nt, much less than the ~2000 nt seen at mitotic DSBs even though 
EXO1 is upregulated in meiosis in multiple organisms (reviewed in Symington, 2016). This 
suggests that Exo1 may be subject to negative regulation, possibly similar to the Rad53-
dependent regulation proposed in mitotic cells (Morin et al., 2008). The upregulation of Exo1 
may contribute as to why resection is so limited in an exo1∆ mutant, with Exo1 normally out-
competing any alternative resection machinery in wild type cells.  
2.9 Meiotic recombination checkpoint 
Creation of Spo11-DSBs in meiosis activates the DDR checkpoint, transiently pausing 
progression to the first meiotic nuclear division (reviewed in Ciccia and Elledge, 2010). This 
allows time for the induced DSBs to be repaired before the cell attempts to segregate 
chromosomes. As in mitotic cells, Mec1ATR and Tel1ATM are the main players in the DDR 
pathway (Morrow et al., 1995; Weinert et al., 1994). The MRX complex, which, as previously 
discussed, is essential for DSB formation, is responsible for the initial activation of this 
pathway (Lisby et al., 2004). The MRX complex, through its Xrs2 subunit, recruits and 
interacts with Tel1ATM at the DSB through a motif in its C-terminus. Deletion of this motif in 
XRS2 results in a defect in DNA damage signalling, similar to that of a tel1∆ mutant (Nakada 
et al. 2003). The presence of MRX at a DSB site with a covalently bound protein, such as 
Spo11, stimulates Tel1 activity (Fukunaga et al., 2011), and this stimulation is hyperactivated 
when Spo11-DSBs accumulate, such as in a nuclease deficient Mre11 mutant or in a sae2∆ 
background (which are unable to nucleolytically remove Spo11 from the DSB ends). Tel1 
recruitment to the DSB site leads to phosphorylation of Mre11, Xrs2 and Sae2, which, as 
previously described, is essential for Sae2 activity (Cartagena-Lirola et al., 2006; Usui et al., 
2001).  
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In wild type cells, Spo11 removal and resection generates ~1500 nt of ssDNA around each 
DSB, activating Mec1ATR via Rad24 (reviewed in Navadgi-Patil and Burgers, 2011). 
Activation of Mec1 results in phosphorylation of the axial element protein Hop1 (Carballo et 
al., 2008). This in turn results in recruitment and autophosphorylation of the meiosis-specific 
kinase, Mek1. Activation of Hop1 and Mek1 promotes repair of the DSB via the intact 
homologous non-sister chromatid rather than the sister chromatid, thus aiding in homolog 
pairing and preventing Dmc1-independent repair of meiotic DSBs (Carballo et al., 2008). In 
the case of defective recombination and repair, Mec1 phosphorylation of Mek1 prevents exit 
of cells from meiotic prophase. In S. cerevisiae, this meiotic prophase arrest also requires 
members of the 9-1-1 checkpoint clamp and loader, Rad17 and Rad24 (Lydall et al., 1996), in 
a situation similar to the mitotic DDR (Weinert, 1998). Checkpoint activation triggers Mek1 
hyperphosphorylation of Swe1 (the S. cerevisiae homolog of Wee1), which in turn 
phosphorylates Cdc28. This phosphorylation inactivates Cdc28 causing the observed delay in 
meiotic prophase, referred to as pachytene arrest (Leu and Roeder, 1999; Pérez-Hidalgo et al., 
2002). 
Another downstream target of the DDR is the Ndt80 transcription factor (reviewed in Winter, 
2012). Ndt80 is activated by phosphorylation in wild type cells, which triggers a positive 
autoregulatory loop that leads to the induction of genes required for exit from prophase. An 
unknown target of the DDR causes Ndt80 hypophosphorylation preventing exit from meiotic 
prophase (Tung et al., 2000).  
2.10 Topoisomerases 
DNA undergoes a lot of conformational changes throughout its metabolism. It is densely 
packaged into the nucleus but requires relaxation and alteration for processes such as 
transcription, replication and proper chromosomal segregation. Torsional stress in the form of 
supercoiling is generated from these processes, and therefore the cell requires a mechanism to 
relieve this tension. This mechanism comes in the form of topoisomerases with genetic and 
cell biological studies providing the essential nature of these proteins in various cellular 
processes (Almouzni and Méchali, 1988; Mondal et al., 2003).  
Topoisomerases essentially cut and religate DNA, allowing DNA strand passage, strand 
decatenation and unwinding, and are able to do this unassisted (see Figure 1.8 for schematic). 
Topoisomerases work by utilising a reversible transesterification reaction (Champoux, 1977). 
The active site of these enzymes contains a catalytic tyrosine, which acts as a nucleophile to 
the phosphate backbone of the DNA (Tse-Dinh et al., 1984). This first transesterification 
reaction breaks the DNA backbone, creating a covalently bound protein adduct. This transient  
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Figure 1.8: A model for the mechanism of strand passage for yeast Top2.  
Top2 binds to the G segment of DNA and cleaves it through a transesterification reaction, generating 
a covalent bond to the  5! end of the scissle phosphate on both strands. This creates a double-strand 
break in the G segment. A second DNA segment  known as the T segment can now pass through the 
DSB. It is first captured by the Top2 dimer in an ATP-dependent manner whereby the N-terminal 
(ATPase) domains of the two Top2 monomers form a clamp around the T segment. Strand passage of 
the T segment enables it to exit through the bottom of the dimer. ATP hydrolysis releases the clamp 
and allows the Top2 enzyme to reset.  
Figure taken from Cozzarelli et al., 2006 
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break allows for the various transformations of the DNA structure by the topoisomerases. The 
second transesterification reaction reseals the DNA backbone and regenerates the catalytic 
tyrosine of the topoisomerase (Wang, 2002).  
In mammalian cells there are six genes coding for topoisomerases. The equivalent proteins are 
split into two categories, type I and type II topoisomerases, depending on their mechanism of 
action (Champoux, 2001). Type II topoisomerases are classified into two distinct families IIA 
and IIB, with IIA family members including eukaryotic Top2, bacterial DNA gyrase and 
topoIV. The six genes are also categorised into three groups, each containing two isoforms: 
Top1 and Top1mt, Top2α and Top2β, and finally Top3α and Top3β (reviewed in Wang, 
2002). Topoisomerases differ by their structure and mechanism of this cleaving and religating.  
Topoisomerase I (Top1) and Topoisomerase III (Top3) cleave and religate a single strand of 
DNA, whereas Topoisomerase II (Top2) cleaves both strands generating a four base pair 
overhang before religating (reviewed in Pommier et al. 2014). 
Top1 first creates a single-stranded break through creation of a covalent link to the 3ʹ′ strand of 
the DNA phosphate backbone, that permits dissipation of supercoiling through rotation of the 
broken strand around the intact one (Chen et al. 2013). Top2 can also reduce supercoiling but, 
as well as Top3, can also work through strand passage, allowing a single or double strand of 
DNA through the cleavage complex of another DNA strand (Soret et al., 2003). Both create 
covalent adducts with opposite polarity to Top1, thus creating a bond with the 5ʹ′ phosphate. 
(Pommier et al., 2010, 2014; Schoeffler and Berger, 2008). Top3α allows passage of DNA 
molecules such as those formed in double Holliday junctions (Plank et al., 2006; Pommier, 
2012; Wu et al., 2000), whereas with Top3β the substrate can be a single-stranded RNA 
molecule (Stoll et al., 2013; Xu et al., 2013).  
2.10.1 Topoisomerase II 
Eukaryotic topoisomerase II proteins are largely homodimers, and whereas S. cerevisiae has 
only one type of type II topoisomerase (Top2), vertebrates have two isoforms, Top2α and 
Top2β. S. cerevisiae Top1 is not essential (but is essential in multicellular eukaryotes for early 
development), thought to be due to Top2 being able to substitute Top1 function (Champoux, 
2001; Soret et al., 2003; Uemura and Yanagida, 1984).  
A study in fission yeast using ChIP-chip showed that Top1 and Top2 sites map to intergenic 
regions, with 65% of sites mapping both Top1 and Top2 (Salceda et al., 2006). However, Top1 
sites positively correlated with mRNA levels, whereas in highly transcribed ORFs they noted 
reduced Top2 binding. This indicates that Top1 activity is linked to transcriptionally active 
regions (Durand-Dubief et al., 2010). Top2 localises more than Top1 to the coding 
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(nucleosomal) regions, consistent with Top2 being the main modulator of DNA topology on 
nucleosomal DNA (Salceda et al., 2006).  
2.10.2 Stalled/poisoned Top2 
There are many anti-cancer drugs that target topoisomerases, with two most commonly used in 
the laboratory setting being camptothecin (CPT) and etoposide. These drugs bind to Top1 and 
Top2 respectively and increase the half-life of the covalently bound protein (Top1 and Top2 
cleavable complex – Top1cc/Top2cc) to the DNA end (Baldwin and Osheroff, 2005). The two 
subunits of Top2cc can religate their broken DNA strand independently of one another, which 
means that etoposide exposure, which prevents religation, can trap Top2ccs as a single-
stranded nick (etoposide only affects one monomer) or double-stranded break (etoposide 
affects both monomers) (Bromberg et al., 2003), in a concentration dependent manner. 
However, the Top2 lesions are not directly sensed as damage because the bound, intact Top2 
has a strong interaction between the two Top2 subunits, holding either side of the break 
together (Tennyson and Lindsley, 1997). True DSBs can arise when a DNA replication fork 
collides with a nick or a DSB at the Top2cc (Kuzminov, 1999). Alternatively, collision with 
the transcription machinery can disrupt the Top2cc, or it can stimulate proteolysis of the 
Top2cc by the 26S proteasome (Mao et al., 2001; Tammaro et al., 2013).  
Genome-wide mapping of topoisomerase II cleavage following etoposide treatment of 
mammalian cells has recently been reported (Baranello et al., 2014). Single-stranded DNA 
breaks (SSBs) were labelled by nick translation using DNA polymerase I and digoxigenin-
modified nucleotides, whilst DSBs were 3ʹ′ end tailed with biotin labelled nucleotides. 
Labelled DNA molecules were enriched for after shearing. Etoposide was found to generate 
mostly SSBs compared to DSBs, potentially due to etoposide inhibiting the religation of each 
broken strand by the two Top2 monomers independently (Bromberg et al., 2003). Top2 lesions 
were enriched at promoter regions at the transcriptional start site (TSS) compared to the rest of 
the genome, and this was positively correlated with the levels of transcription (weakly 
expressed genes had lower Top2 breaks and higher expressed genes had more). One 
explanation for this possible correlation may be that the increase in gene expression increased 
the level of transcription-generated torsional stress, which required increased action of Top2 
(Baranello et al., 2014).  
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2.10.3 Repairing stalled topoisomerase complexes 
Top2-DNA complexes, formed after inhibition by drugs such as etoposide (described above), 
are very similar to DSBs formed by Spo11, in that both generate 5ʹ′ covalent phosphotyrosyl 
bonds on both sides of the DSB. MRN null mutants and rad50S or mre11 nuclease-dead 
mutants in S. pombe are hypersensitive to both Top1 and Top2 poisons, suggesting a role for 
the MRX/N complex in processing topoisomerase lesions (Hartsuiker et al., 2009; Malik and 
Nitiss, 2004). The mechanism for repairing DSBs generated by Top2 is still far from clear. 
MRX/Sae2-dependent release of Spo11 generates Spo11-oligos (Neale et al., 2005). For Top2, 
a similar mechanism has been proposed, yet the apparent size of Top2-oligo complexes was 
much shorter (Hartsuiker et al., 2009; Neale et al., 2005). However, in S. pombe, Ctp1 (Sae2) 
is only directly required for processing Top2 lesions and not Top1 ones (Hartsuiker et al., 
2009), correlating with recent studies on Sae2 demonstrating that it promotes Mre11 
endonuclease activity on the 5ʹ′ strand adjacent to 5ʹ′ blocked DNA ends (Cannavo and Cejka, 
2014). 
In mammalian cells, Top2-DSBs can also be repaired via the action of tyrosyl-DNA 
phosphodiesterase 2 (TDP2), a protein that contains 5ʹ′ phosphodiesterase activity capable of 
directly hydrolysing the phosphotyrosyl bond between proteolysed Top2 and the 5ʹ′ end of the 
DSB allowing repair. As such, TDP2-defective cells are highly sensitive to etoposide (Cortes-
Ledesma et al., 2009). TDP2 has since been characterised to be specific for hydrolysing an 
array of 5ʹ′ phosphotyrosyl bonds as well as an, albeit weak, activity for 3ʹ′ phosphotyrosyl 
bonds, only in the absence of Tdp1 (Zeng et al., 2012). The mechanism of repairing Top2 
DSBs via the MRX complex results in ssDNA generation, which is refractory to NHEJ and 
instead drives repair of DSBs down the HR pathways (Shibata et al., 2014). With NHEJ being 
the predominant repair pathway in higher eukaryotes, it would suggest that TDP2 is the main 
mechanism of repair at Top2-DSBs (Mårtensson et al., 2003).  
In S. cerevisiae, there is no obvious TDP2 ortholog. Tdp1, a protein that specifically 
hydrolyses 3ʹ′ phosphotyrosyl bonds, is present and orthologs are found in all organisms. Tdp1 
activity against 3ʹ′-tyrosyl substrates correspond to Top1 lesions and not 5ʹ′ linked Top2 or 
Top3 substrates (Pouliot et al., 1999, 2001). However, deletion of TDP1 in S. cerevisiae results 
in hypersensitivity to both Top2 targeting agents and over-expression of TOP2 (Nitiss et al., 
2006), suggesting that Tdp1 does play a role in processing Top2-5ʹ′ lesions. Consistent with 
this, recombinant Tdp1 was able to hydrolyse a covalently bound, Top2 derived, peptide from 
the 5ʹ′ end of a DNA substrate in vitro (Nitiss et al., 2006). Therefore, it is possible that, in 
S. cerevisiae, Tdp1 acts on both types of phosphotyrosyl bonds, whereas in humans two 
proteins have evolved to tackle the two different types of lesion. Alternatively, in S. cerevisiae, 
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Tdp1 plays a minor role in processing Top2 lesions with other pathways, such as the 
MRX/Sae2 pathway, responsible for the processing of these lesions. This latter hypothesis may 
indicate why HR is favoured over NHEJ in S. cerevisiae for the repair of DSBs, as the 
increased activity of MRX/Sae2 would generate ssDNA tails, which are inhibitory to repair by 
NHEJ.  
2.11 Questions to answer 
DSBs are critical lesions that occur frequently in cells of all organisms. Pathways have 
evolved to repair DSBs to prevent deletions, translocations and fusions in the DNA. The HR 
and NHEJ pathways are the two main mechanisms by which DSBs can be repaired. The choice 
between the two pathways depends on a variety of factors, including the cell-cycle stage, 
coordinated by CDKs. The proteins that have been proposed to play a role at the critical 
decision point between the two pathways are the MRX and Sae2 complex. Activation of Sae2 
by CDKs, which stimulates the Mre11 endonuclease, drives repair of DSBs down the HR 
route. Therefore, study into the role of Sae2 is of importance to understand how Sae2 and the 
MRX complex are regulated, as aberrant repair by NHEJ or HR can lead to genomic 
instability. The balance between NHEJ and HR also differs between species, with mammalian 
cells predominantly repairing DSBs via NHEJ, in contrast to S. cerevisiae. The presence or 
absence of specific repair pathways may be responsible for this difference. For example, 
mammalian cells contain the TDP2 protein, which hydrolyses covalently bound TOP2 from 
DSBs. This process generates a clean-ended DSB, which is easily repaired by NHEJ. In 
S. cerevisiae a TDP2 ortholog does not exist. An ortholog of mammalian TDP1 protein, which 
hydrolyses 3ʹ′ bound TOP1 from DNA, does exist (Tdp1) and may have dual polarity of 
removing 3ʹ′ and 5ʹ′ bound proteins from DNA. However, as HR predominates in S. cerevisiae, 
it is more likely that other repair pathways, such as the MRX/Sae2 pathway, act instead and 
repair DSBs in a manner that promotes HR. It is therefore of interest as to how DSBs in 
S. cerevisiae repair if a pathway such as the mammalian TDP2 repair pathway could be 
simulated. This is of particular interest at meiotic Spo11-DSBs, which always repair via HR 
due to the action of MRX/Sae2, for accurate chromosome alignment and pairing. Spo11-DSBs 
can occur anywhere in the genome but appear more frequently at defined hotspots. The 
mechanism and regulation of where Spo11 creates DSBs has been studied, but there is still a 
requirement for further mapping of Spo11-DSB sites. Development of a method for mapping 
Spo11 may also be applicable for mapping Top2-DSBs genome-wide because Spo11 and Top2 
generate similar DSBs. Therefore, there are numerous questions in the field that still need 
answering. Some specific questions that will be looked at in this thesis are as follows: 
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• How is Sae2 regulated in meiosis in direct respect to processing the ends of Spo11-
DSBs?  
• As TDP2 has been shown to be able to remove proteolysed Top2 and other covalently 
bound substrates, can it also act on Spo11-bound DSBs? If so is there any role for 
TDP2 in meiosis? 
• If Spo11-DSBs are processed in a non-nucleolytical manner, does this affect how the 
resection machinery and HR proteins act upon the break? 
• How does Tel1 regulate interference of DSBs during meiosis? Are the effects Tel1 has 
on DSB formation dependent on its kinase activity? 
• Can we develop a way to map, with single nucleotide resolution, where Spo11 creates 
DSBs during meiosis in a sae2∆ background where DSBs accumulate?  
• If we can develop a method for this, can we extrapolate this method to look into other 
DNA-protein adducts and where they form? 
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Chapter 2: Materials and Methods 
2.1  Materials 
2.1.1 Strains 
Table 2.1: S. cerevisiae strains used in this study. Note for the SAE2 mutagenesis strains see plasmid table for 
corresponding strain numbers and genotypes 
Parent: VG296 lys2/”, ura3/”, arg4-nsp or bgl?/”, leu2::hisG or leu2∆?/”, his4X::LEU2,/” nuc1::LEU2/”, SPO11-
His6-FLAG3-loxP-KanMX-loxP/” 
Strain # Name Genotype Notes 
VG303 sae2∆ sae2∆::KanMX6/” Constructed by VG 
DJ14 SAE2 
+HYG 
pVG19 (CEN)::HYG Empty CEN plasmid expressing 
hygromycin resistance as a control 
DJ15 sae2∆        
+ HYG 
sae2∆::KanMX6/”, pVG19 (CEN)::HYG Empty CEN plasmid expressing 
hygromycin resistance as a control 
DJ20 CEN:SAE2 sae2∆::KanMX6/”, pDJ8: 0.5kb+-Sae2 (HYG) CEN plasmid: Untagged Sae2 
DJ21 CEN:SAE2-
His10 
sae2∆::KanMX6/”, pDJ11: 0.5kb+-Sae2-His10 
(HYG) 
CEN plasmid: Sae2-His10 
DJ22 CEN:SAE2-
3HA 
sae2∆::KanMX6/”, pDJ10: 0.5kb+-Sae2-HA 
(HYG) 
CEN plasmid: Sae2-3HA 
DJ160 CEN: 
pADH1-
TDP2-His6 
sae2∆::KanMX6/”, pDJ85: pADH1-TDP2-His6 
(HYG) 
CEN plasmid: Tdp2-His6 
constitutively expressed 
DJ70 CEN:GAL1
-TDP2 
sae2∆::KanMX6/”, pDJ62: pGAL1-TDP2 (HYG) CEN plasmid: Tdp2 induced 
expression 
 
Table 2.2: Strains for SAE2 over-expression 
Parent: MJ548xMJ555 (ho::LYS2/’, lys2/’, arg4-bgl/’, leu2/’, ura3::PGPD1GAL4(848)-ER::URA3, SPO11-His6-
FLAG3-loxP-KanMX-loxP/’, HIS4::LEU2-(BamHI;+ori)/his4X::LEU2-(NgoMIV;+ori)--URA3, SAE2/ 
sae2∆::KanMX6) – MJ548 was transformed with integrating plasmid as stated before being crossed with MJ555 
Strain Construction Genotype Notes 
DJ74 MJ548+pMN118 sae2_5’UTR::natNT2::P_GAL1::SAE2[+1 to GAL1-SAE2 (cryptic SK1 ATG) 
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x MJ555 +1192]/sae2∆::KanMX6 
DJ75 MJ548+pMN119 
x MJ555 
sae2_5’UTR::natNT2::P_GAL1::SAE2[+1 to 
+1192]/sae2∆::KanMX6 
GAL1-SAE2 (cryptic S288C ATG) 
DJ132 MJ552+pDJ79     
x MJ555 
sae2_5’UTR::natNT2::P_GAL1::SAE2(S267A)[+
1 to +1192]/sae2∆::KanMX6 
GAL1-SAE2 (S267A) (cryptic SK1 
ATG) 
DJ134 MJ552+pDJ80     
x MJ555 
sae2_5’UTR::natNT2::P_GAL1::SAE2(S278A-
T279A)[+1 to +1192]/sae2∆::KanMX6 
GAL1-SAE2 (S278A-T279A)  
(cryptic SK1 ATG) 
DJ157 MJ552+pDJ84     
x MJ555 
sae2_5’UTR::natNT2::P_GAL1::SAE2(L25P)[+1 
to +1192]/sae2∆::KanMX6 
GAL1-SAE2 (L25P) (cryptic SK1 
ATG) 
 
Table 2.3: Strains for Spo11-DSB Mapping  
Parent: MJ6 (ho::LYS2/”, lys2/”, ura3/”, arg4-nsp/”, leu2::hisG/”, his4X::LEU2/”, nuc1::LEU2/”) 
Strain Name Genotype Notes 
VG377 exo1∆ dmc1∆ dmc1∆::HphMX4/”, exo1∆::KanMX4/” Alias: KW1 
MJ315 Untagged sae2∆::KanMX6/’ ‘Wild type’ for Spo11 Mapping 
but actually sae2∆ 
MJ319 Spo11-YF sae2∆::KanMX6/’,  
spo11(Y135F)-HA3His6::KanMX4/’ 
Spo11-catalytic dead (Y135F), 
sae2∆ 
VG402 tel1∆ sae2∆::KanMX4/”, tel1∆::HphMX4/”  
VG431 tel1kd sae2∆::KanMX6/”,  
tel1-D2612A, N2617A, D2631A/” 
tel1-kinase dead (tel1kd), sae2∆ 
 
Table 2.4: Strains for topoisomerase mapping 
Parent:  MJ429 (ura3∆0, leu2∆0, his3∆1, met15∆0, pdr1∆::PDR1-DBD-CYC8::LEU2) - haploid 
Strain Name Genotype Notes 
MJ429 Wild type As above Wild type with sensitivity cassette 
MJ475 sae2∆ sae2∆::KanMX6 sae2∆ with sensitivity cassette 
MJ551 mre11∆ mre11∆::KanMX4 mre11∆ with sensitivity cassette 
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2.1.2 Plasmids 
Centromeric plasmids 
Table 2.2: Centromeric plasmids (all containing hygromycin (HYG) drug-resistance marker) 
Plasmid# Name Construction Strain # 
pVG19 Empty HYG 
resistance 
Constructed by VG. Used as a control for HYG resistance DJ15 
pVG24 Sae2 Constructed by VG. Untagged wild type Sae2 DJ20 
pDJ9 pVG24+NheI Mutagenesis of pVG24 using primers DJ#63&64 to incorporate NheI 
site at C-terminal of SAE2 
N/A 
pDJ10 Sae2-HA/Wild 
type 
Ligated in –HA3 tag in frame to C-terminal of SAE2 DJ22 
pDJ16 SAE2 (S267A) Mutagenesis of pDJ10 with primers VG#22&23 DJ23 
pDJ17 SAE2 (S267E) Mutagenesis of pDJ10 with primers VG#24&25 DJ24 
pDJ18 SAE2 (S73A) Mutagenesis of pDJ10 with primers DJ#24&26 DJ25 
pDJ19 SAE2 (S73E) Mutagenesis of pDJ10 with primers DJ#25&27 DJ26 
pDJ20 SAE2 (T90A) Mutagenesis of pDJ10 with primers DJ#28&30 DJ27 
pDJ21 SAE2 (T90E) Mutagenesis of pDJ10 with primers DJ#29&31 DJ28 
pDJ22 SAE2 (S249A) Mutagenesis of pDJ10 with primers DJ#32&34 DJ29 
pDJ23 SAE2 (S249E) Mutagenesis of pDJ10 with primers DJ#33&35 DJ30 
pDJ26 SAE2 (S289A) Mutagenesis of pDJ10 with primers DJ#44&45 DJ33 
pDJ27 SAE2 (S289E) Mutagenesis of pDJ10 with primers DJ#46&49 DJ34 
pDJ32 SAE2 (S73A-
T90A) 
Mutagenesis of pDJ18 with primers DJ#28&30 DJ41 
pDJ33 SAE2 (S73E-
T90E) 
Mutagenesis of pDJ19 with primers DJ#29&31 DJ42 
pDJ34 SAE2 (S249A-
S289A) 
Mutagenesis of pDJ22 with primers DJ#44&45 DJ43 
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pDJ40 SAE2 (K239R-
K266R) 
Mutagenesis of pDJ28 with primers DJ#60&62 DJ39 
pDJ41 SAE2 (K239Q-
K266Q) 
Mutagenesis of pDJ29 with primers DJ#59&61 DJ40 
pDJ43 SAE2 (S73E-
T90E-S249E) 
Mutagenesis of pDJ33 with primers DJ#33&35 DJ80 
pDJ48 SAE2 (S134A) Mutagenesis of pDJ10 with primers DJ#71&72 DJ78 
pDJ49 SAE2 (S134E) Mutagenesis of pDJ10 with primers DJ#73&74 DJ79 
pDJ53 SAE2 (T279A) Mutagenesis of pDJ10 with primers DJ#79&80 DJ54 
pDJ57 SAE2 (N123A-
R127A) 
Mutagenesis of pDJ55 with primers DJ#81&82 DJ56 
pDJ58 SAE2 (T279E) Mutagenesis of pDJ10 with primers DJ#77&78 DJ76 
pDJ59 SAE2 (E24Q-
L25P) 
Mutagenesis of pDJ10 with primers RA#1&2 DJ82 
pDJ63 TDP2 Sub-cloned in TDP2 in place of SAE2  on GAL1-SAE2 plasmid DJ70 
pDJ64 SAE2 (E131V) Mutagenesis of pDJ10 with primers RA#7&8 DJ83 
pDJ65 SAE2 (T90S) Mutagenesis of pDJ10 with primers DJ#150&151 DJ97 
pDJ66 SAE2 (T279S) Mutagenesis of pDJ10 with primers DJ#172&173 DJ98 
pDJ69 SAE2 (S289D) Mutagenesis of pDJ10 with primers DJ#174&175 DJ99 
pDJ75 EXO1 pVG25 digested with XhoI and NotI to remove SAE2+-0.5kb. EXO1+-
0.5kb amplified with XhoI and NotI flanking ends. Insert and vector 
digested and EXO1 ligated into centromeric plasmid. 
DJ110 
pDJ78 SAE2 (S179A) Mutagenesis of pDJ10 with primers DJ#160&161 DJ126 
pDJ83 SAE2 (L25P) Mutagenesis of pDJ10 with primers DJ#224&225 DJ82 
pDJ86 SAE2 (S249E-
S267E) 
Mutagenesis of pDJ23 with primers VG#24&25 DJ176 
pDJ87 SAE2 (T279E-
S267E) 
Mutagenesis of pDJ58 with primers VG#24&25 DJ177 
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pDJ88 SAE2 (S289E-
S267E) 
Mutagenesis of pDJ27 with primers VG#24&25 DJ178 
pDJ89 SAE2 (S73E-
T90E-S249E-
T279E) 
Mutagenesis of pDJ43 with primers DJ#77&78 
Alias: 4E 
DJ174 
pDJ91 SAE2 (S179E) Mutagenesis of pDJ10 with primers DJ#162&163 DJ172 
pDJ92 SAE2 (S73E-
T90E-S249E-
T279E-S267E) 
Mutagenesis of pDJ89 with primers VG#24&25 
Alias: 4E+S267E 
DJ175 
pDJ94 SAE2 (S73A-
T90A-S249A-
T279A) 
Mutagenesis of pDJ93 with primers DJ#28&30 
Alias: 4A 
DJ173 
pDJ85 pADH1-TDP2-
His6 
Subcloned in hygromycin resistance marker in place of URA3 marker 
on pMN110  
DJ160 
pMN118 GAL1-SAE2 (SK1 
ATG) 
SAE2 under control of GAL1 promoter with SK1 cryptic ATG 
(constructed by NL) 
DJ74 
pMN119 GAL1-SAE2 
(S288C ATG) 
SAE2 under control of GAL1 promoter with S288C cryptic ATG 
(constructed by NL) 
DJ75 
pDJ79 GAL1-SAE2 
(S267A) (SK1 
ATG) 
pMN118 mutagenised using primers VG22+23 DJ132 
pDJ80 GAL1-SAE2 
(S278A-T279A) 
(SK1 ATG) 
pMN118 mutagenised using primers DJ36+38 DJ134 
pDJ84 GAL1-SAE2 
(L25P) (SK1 
ATG) 
pMN118 mutagenised using primers DJ224+225 DJ157 
All SAE2 plasmids listed here are Sae2-HA unless otherwise stated. 
The base SAE2-HA centromeric plasmid (pDJ10) was created as depicted in Figure 2.1. 
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Figure 2.1: Schematic of cloning steps to generate centromeric SAE2-HA plasmid for 
mutagenesis.  
A. pVG24, a centromeric plasmid cloned by Valerie Garcia containing the SAE2 open reading frame 
(ORF) +/- 0.5 kb placing SAE2 under it’s natural promoter and terminator. The plasmid also contains 
the hygromycin drug-resistance marker for transformed yeast selection. B. Overlapping primers 
(DJ#63&#64) were designed and site-directed mutagenesis performed to incorporate a NheI site a the 
C-terminal of SAE2. C. Insertion of the NheI site at the C-terminal of SAE2, removing the stop codon 
and permitting ligation of a HA3 tag in frame with the SAE2 ORF. D. HA3 tag was amplified with 
NheI flanking ends using colony PCR of MJ552 using primers DJ#65&#66. E. Schematic of final 
plasmid for mutagenesis, pDJ10. pDJ9 and the amplified HA3 insert were digested with NheI at 37 ° 
C for 1 hour, PCR clean-up performed and the insert ligated using T4 ligase. Zoomed in region shows 
SAE2 ORF in frame with the HA3 tag. 
A!
C!
E!
B!
D!
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2.1.3 Oligonucleotides 
Oligonucleotide Synthesis 
All oligonucleotides were synthesised by Fisher Scientific UK Ltd. or Integrated DNA 
Technologies (IDT, *) 
Table 2.3: Oligonucleotides used in this study 
Oligo # Name Sequence 5ʹ′- 3ʹ′ 
24 SAE2-S73A-F CTCCTCAACAATCCGCCCAGACGTCTGCGG 
25 SAE2-S73E-F CTCCTCAACAATCCGAACAGACGTCTGCGG 
26 SAE2-S73A-R CCGCAGACGTCTGGGCGGATTGTTGAGGAG 
27 SAE2-S73E-R CCGCAGACGTCTGTTCGGATTGTTGAGGAG 
28 SAE2-T90A-F GAAGATTTCATCCTTGCCCAGTTTGATGAG 
29 SAE2-T90E-F GAAGATTTCATCCTTGAACAGTTTGATGAG 
30 SAE2-T90A-R CTCATCAAACTGGGCAAGGATGAAATCTTC 
31 SAE2-T90E-R CTCATCAAACTGTTCAAGGATGAAATCTTC 
32 SAE2-S249A-F CAGTAGTTATAGAAGCCCAAAATTCGGACT 
33 SAE2-S249E-F CAGTAGTTATAGAAGAACAAAATTCGGACT 
34 SAE2-S249A-R AGTCCGAATTTTGGGCTTCTATAACTACTG 
35 SAE2-S249E-R AGTCCGAATTTTGTTCTTCTATAACTACTG 
44 SAE2-S289A-F GAGGACAAAAAGAAAGCCCAGGAAATCATC 
45 SAE2-S289A-R GATGATTTCCTGGGCTTTCTTTTTGTCCTC 
46 SAE2-S289E-R GATGATTTCCTGTTCTTTCTTTTTGTCCTC 
49 SAE2-S289E-F GAGGACAAAAAGAAAGAACAGGAAATCATC 
55 SAE2 K239-acetyl-mimic_F GCCAGAGGATTCTCAACACAGATCATTGTC 
56 SAE2 K239-acetyl-mimic_R GACAATGATCTGTGTTGAGAATCCTCTGGC 
57 SAE2 K239-acetyl-mutant_F GCCAGAGGATTCTAGACACAGATCATTGTC 
58 SAE2 K239-acetyl-mutant_R CAAAACCTGGGGGGGATCTTGATCTATTCCTC 
59 SAE2 K266-acetyl-mimic_R CAAAACCTGGGGGGGATTGTGATCTATTCCTC 
60 SAE2 K266-acetyl-mutant_F GAGGAATAGATCAAGATCCCCCCCAGGTTTTG 
61 SAE2 K266-acetyl-mimic_F GAGGAATAGATCACAATCCCCCCCAGGTTTTG 
62 SAE2 K239-acetyl-mutant_R GACAATGATCTGTGTCTAGAATCCTCTGGC 
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63 SAE2-CTERM-NHEI-F GCAGATATATGCTAGATGTGCTAGCACGCCAGCGATCATCATTC 
64 SAE2-CTERM-NHEI-R GAATGATGATCGCTGGCGTGCTAGCACATCTAGCATATATCTGC 
71 CDK S134A F CGGAGTTTAGTGCCCCTTTAAATGGCC 
72 CDK S134A R GGCCATTTAAAGGGGCACTAAACTCCG 
73 CDK S134E F CGGAGTTTAGTGAACCTTTAAATGGCC 
74 CDK S134E R GGCCATTTAAAGGTTCACTAAACTCCG 
75 N123A R CGTTTATGCCTGGCAGGTGGCATAGTAAC 
76 N123A F GTTACTATGCCACCTGCCAGGCATAAACG 
77 T279E F GGATTTTCCCTCCGAACAGGAAGGGAACG 
78 T279E R CGTTCCCTTCCTGTTCGGAGGGAAAATCC 
79 T279A R CGTTCCCTTCCTGGGCGGAGGGAAAATCC 
80 T279A F GGATTTTCCCTCCGCCCAGGAAGGGAACG 
81 R127A R ACTCCGAAATTTTGGCTTTATGCCTATTAG 
82 R127A F CTAATAGGCATAAAGCCAAAATTTCGGAGT 
148 EXO1-0.5KB (XHOI)_F AAGTCTCGAGGTGACAAATCACTGGAAGA 
149 EXO1+0.5KB (NOTI)_R CCGTGCGGCCGCTTTGATTAACAAAATTCTCG 
150 SAE2-T90S_F GATTTCATCCTTTCTCAGTTTGATG 
151 SAE2-T90S_R CATCAAACTGAGAAAGGATGAAATC 
160 SAE2-S179A_F CTGAATCTACAGCGCCAAATTTATAC 
161 SAE2-S179A_R GTATAAATTTGGCGCTGTAGATTCAG 
162 SAE2-S179E_F CTGAATCTACAGAGCCAAATTTATAC 
163 SAE2-S179E_R GTATAAATTTGGCTCTGTAGATTCAG 
172 SAE2-T279S_F GATTTTCCCTCCTCTCAGGAAGGGAAC 
173 SAE2-T279S_R GTTCCCTTCCTGAGAGGAGGGAAAATC 
174 SAE2-S279D_F CAAAAAGAAAGACCAGGAAATCATC 
175 SAE2-S279D_R GATGATTTCCTGGTCTTTCTTTTTG 
220* ADAPTOR_P5_(1)_TOP ACACTCTTTCCCTACACGACGCTCTTCCGATCT 
221* ADAPTOR_P5_(1)_BOTTOM /5PHOS/GATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT/INVDT/ 
222* ADAPTOR_P7_(2)_TOP /5PHOS/GATCGGAAGAGCACACGTCTGAACTCCAGTCAC/INVDT/ 
223* ADAPTOR_P7_(2)_BOTTOM GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
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224 SAE2: L25P_F CAGTCTCGATGAACCACTAAATGTGCA 
225 SAE2: L25P_R TGCACATTTAGTGGTTCATCGAGACTG 
 
2.1.4 Reagents 
Any specific chemicals, buffers and solutions used are detailed in the appropriate method. All 
chemicals were purchased from Sigma Aldrich and all enzymes from New England Biolabs 
(NEB), unless otherwise stated. 
2.1.5 Media 
Bacteria Media 
Luria Broth (LB): 1% Bacto-tryptone, 0.5% Yeast Extract, 1% NaCl pH 7.0 .  
For LB plates, 2% Bacto Agar is added and solution microwaved to dissolve the agar.   
LB-Amp plates: Ampicillin is added to a final concentration of 100 µg ml-1 after microwaving 
when solution has cooled to holding temperature.  
 
Yeast Media 
YPDAU: 1% BD Bacto Yeast Extract, 2% BD Bacto Peptone, 0.5 mM Adenine, 0.4 mM 
Uracil, 20% D-Glucose. Yeast extract, peptone, adenine and uracil are added to 90% volume 
double distilled water and autoclaved. D-Glucose is added to a final concentration of 2% 
bringing the total final volume to 100%.  
For YPDAU plates, 2% Bacto Agar is added before autoclaving. 
For drug selection, YPDAU is prepared as documented and drugs are added to the final 
concentration as listed below: 
Table 2.4: Drug concentrations in yeast media 
Drug Final Concentration 
G418-200 200 µg ml-1 
G418-400 400 µg ml-1 
Hygromycin (HYG) 300 µg ml-1 
Nourseothricin-Dihydrogen	  Sulfate (Nat)	   
 
100 µg ml-1 
Methyl Methanesulfonate (MMS) 0.025% 
Camptothecin (CPT) 20-60 µM 
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YPA: 1% BD Bacto Yeast Extract, 2% BD Bacto Peptone, 1% Potassium Acetate, 0.001% 
Antifoam 204. Antifoam 204 added after autoclaving. 
Sporulating media (SPM): 2% Potassium Acetate, 5 µg ml-1 Adenine, 5 µg ml-1 Arginine, 5 
µg ml-1 Histidine, 15 µg ml-1 Leucine, 5 µg ml-1 Tryptophan, 5 µg ml-1 Uracil, 0.001% Sigma 
Antifoam 204. Antifoam 204 and amino acid supplements added after autoclaving.  
2.2 Methods 
2.2.1 Nucleic Acid Manipulation 
PCR Amplification 
A solution was made containing 10.5 µl water, 0.5 µl DNA template, 1 µl 10 µM mix of 
forward and reverse primers, and 12.5 µl 2× Phusion High-Fidelity PCR Master Mix 
(#M0531L; NEB). A PCR program was run consisting of: 95 °C for 5 minutes initial 
denaturation; 30 cycles of denaturation at 95 °C for 30 seconds, primer annealing at 56 °C (as 
standard, but was altered depending on primer annealing Tm °C) for 1 minute, extension at 
72 °C (1 minute per kb of mutating plasmid); final extension at 72 °C for 15 minutes. 
 
Colony PCR 
1-2 mm of a yeast colony was taken using a p200 tip and mixed into 50 µl of double distilled 
water. The mix was boiled at 100 °C for 5 minutes, left to cool to room temperature for 
10 minutes then spun at 20,000 × g for 1 minute to pellet cellular debris. 0.5-1 µl of 
supernatant was taken as DNA template for PCR amplification. 
 
Restriction Digests 
DNA was restriction digested as per NEB restriction enzyme guidelines. As standard, 1 µg 
DNA in 1× NEBuffer with 1 µl restriction enzyme was placed at 37 °C for 1-2 hours. 
 
Annealing Oligonucleotides 
Complementary oligonucleotides were mixed together in a 1× TE annealing solution (15 µM 
top primer, 15 µM bottom primer, 50 mM NaCl) and placed at 100 °C for 5 minutes in a hot 
block. The metal block was then removed and placed on the bench for 3-4 hours to cool the 
sample slowly to room temperature allowing efficient annealing of the oligonucleotides. 
Annealed oligonucleotides were stored at -20 °C. 
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Dephosphorylation of Vector DNA 
Desphosphorylation of DNA after digestion using restriction enzymes was conducted by 
adding 1 µl of Alkaline Phosphatase or Calf Intestinal Phosphatase (CIP) directly to the 
digestion mix and placing at 37 °C for 1 hour.  
 
Ligation of DNA 
As per NEB’s guidelines the following reaction was set up on ice: 2 µl 10× T4 DNA Ligase 
Buffer, 50 ng (0.020 pmol), Vector DNA (4 kb), 37.5 ng (0.060 pmol), Insert DNA (1 kb), 1 µl 
T4 DNA Ligase, double distilled water to 20 µl. The sample was mixed and incubated at 16 °C 
overnight. The sample was heat inactivated at 65 °C for 10 minutes.  
 
PCR Clean-up 
DNA was cleaned after PCR using a QIAquick PCR Purification Kit (#28106, QIAGEN). The 
manufacturer’s guidelines were followed.  
 
Gel-electrophoresis 
Typically a 1% agarose 1× TAE (40 mM Tris Base·HCl, 20 mM glacial acetic acid, 1 mM 
EDTA pH 8.0) gel  containing 50 µg ml-1 ethidium bromide was cast. DNA was mixed with 
NEB purple loading dye to 1× (2.5% Ficoll, 10 mM EDTA, 3.3 mM Tris Base·HCl pH 8.0, 
0.08% SDS, 0.02% Dye 1, 0.001% Dye 2) and DNA was fractionated in 1× TAE at 100 V for 
40 minutes. Gels were imaged using a Syngene InGenius bioimaging system. 
 
Gel Extraction and Purification of DNA 
Gel extraction was conducted using QIAquick Gel Extraction Kits (QIAGEN) as per the 
manufacturer’s guidelines. A supplied buffer (QG) solubilises the agarose gel slice when 
heated at 50 °C for 10 minutes. Isopropanol is added to increase the yield of fragments less 
than 500 bp and greater than 4 kb. The solution is then bound to the silica membrane on the 
column as detailed in Plasmid Extraction from Escherichia coli. DNA is eluted from the 
column in 20-50 µl 1× TE. 
 
DNA Sequencing 
DNA sequencing up to 1 kb was performed by GATC Biotech. 
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Nucleic Acid Quantification 
Nucleic acid quantification was performed using a Nanodrop 1000 Spectrophotometer 
(Thermo Scientific) or by a Qubit 2.0 Fluorometer (Thermo Scientific) as per manufacturer’s 
guidelines.  
 
Site-directed mutagenesis 
Overlapping forward and reverse primers of approximately 30 bp were designed containing the 
desired sequence mutation (see Table 2.3 for strain specific primers). A solution was made 
containing 10.5 µl water, 0.5 µl plasmid to be mutagenised, 0.5 µl 25 µM forward mutating 
primer, 0.5 µl 25 µM reverse mutating primer and 12.5 µl 2× Phusion High-Fidelity PCR 
Master Mix (#M0531L; NEB). A PCR program was run consisting of: 95 °C for 5 minutes 
initial denaturation; 18 cycles of 95 °C for 30 seconds, 45 °C for 1 minute, 72 °C (1 minute per 
kb of mutating plasmid); 72 °C for 15 minutes. To remove unmutagenised template plasmid 
samples were incubated with 1 µl DpnI restriction enzyme at 37 °C for 1 hour. To increase 
efficiency of bacterial transformation, excess reagents and primers were removed using a 
Nucleospin Gel and PCR Clean-up kit (#740609.50; Macherey-Nagel) as per the 
manufacturer’s guidelines. The DNA binding buffer NT1, containing chaotropic salts to allow 
DNA to bind the silica column, was diluted 1 in 7 with water (a ratio which prevents DNA less 
than approximately 300 bp form binding the column) and 2 volumes added to size-select away 
from unwanted primers. Samples were washed using buffer NT3 (ethanol containing solution 
to wash away non-DNA molecules) and the DNA eluted off the column using 25 µl 70 °C pre-
heated elution NE buffer (Tris·HCl pH 7.5) which was left incubating on the column for 
5 minutes before spinning through at 11,000 × g for 1 minute. Samples were transformed into 
High Efficiency DH5α E. coli (#2987, NEB) as detailed in section Bacterial Transformation.  
2.2.2 Bacterial transformation 
An aliquot of bacterial DH5α cells (#C2987H, NEB) or homemade competent DH5α was 
removed from -80 °C storage and put on ice to defrost for 10 minutes. Between 5 and 50 µl of 
cells were transferred to a 1.5 ml tube and the transforming plasmid added to the tube at no 
more than 10% of the final volume. Mixing is done carefully using the pipette tip to swirl the 
cells. The cells were put on ice for 30 minutes, heat shocked at 42 °C for 40 seconds and then 
put back on ice for 5 minutes. 300 µl of 37 °C pre-warmed LB was added, the solution mixed 
and incubated at 37 °C for 30-60 minutes. The mix was then plated onto LB-Amp plates for 
selection of transformants.   
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2.2.3 Plasmid Extraction from Escherichia coli 
Bacterial colonies were picked off LB-Amp plates using a p200 pipette tip and the tip placed 
inside a 50 ml centrifuge tube containing 5 ml LB with 100 µg ml-1 ampicillin. Tubes were 
incubated at 30 °C overnight in a shaking incubator. Tubes were centrifuged at 6,800 × g for 
3 minutes and the supernatant aspirated off. 
To obtain plasmid DNA from E. coli, QIAprep Spin Miniprep Kits (#27106; QIAGEN) were 
used. The protocol was used as described in the manufacturer’s guidelines. Bacteria are lysed 
under alkaline conditions and the lysate is subsequently neutralized and adjusted to high-salt 
binding conditions. The lysate is cleared and applied to the silica membrane where the DNA is 
adsorbed, while RNA, cellular proteins and metabolites are not. DNA is washed using an 
ethanol containing solution to remove salts and eluted in 50 µl 1× TE. The eluate is frozen at   
-20 °C until use with 2 µl loaded onto a 1% agarose gel in × TAE buffer to check the plasmid 
size and purity.  
2.2.4 Meiotic culture 
Yeast strains were woken up from -80 °C storage, streaked onto YPD plates or YPD-HYG (for 
centromeric plasmid containing strains) plates and incubated at 30 °C for 3 days. A single 
colony was inoculated into 4 ml liquid YPD and incubated at 30 °C at 250 rpm for 24 hours. 
Cell density (OD600) was measured and 50-250 ml YPA was inoculated to a starting density of 
0.2 OD600 and the culture incubated at 30 °C at 250 rpm for 14 hours 30 minutes. The culture 
was spun at 4 °C at 6,000 × g for 5 minutes, resuspended in an equal volume (to the initial 
YPA volume) of double distilled water, re-spun and then resuspended in and equal volume of 
30 °C pre-warmed sporulation media (SPM). The culture was incubated at 30 °C at 250 rpm 
for the duration of the time course with samples taken at relevant time points. 
2.2.5 Protein induction during meiosis 
Strains containing the GAL4-ER fusion-protein expression cassette and a gene under the 
expression of a galactose promoter had protein expression induced by addition of 1.5 µM β-
estradiol (in 100% ethanol) into the sporulating media. 
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2.2.6 Tetrad dissection 
50 µl of sporulated cells in sporulation media was added to 150 µl 200 mM sodium phosphate 
buffer in a 1.5 ml tube. 1 µl of 1 mg ml-1 zymolyase 100T solution (10 mM Sucrose, 0.7% 
Glucose, 1 mM HEPES pH 7.5, 1 mg Zymolyase 100T) is added, the tube flicked to resuspend 
and incubated at 37 °C for 15 minutes. 10 µl is pipetted onto a YPD plate and left to dry before 
tetrads are dissected.  
2.2.7 Yeast transformation 
5 ml of YPD per transformation was inoculated to a cell density of 0.4 OD600 with overnight 
YPD culture and grown at 30 °C at 250 rpm for 4 hours to a cell density of approximately 
1.5 OD600. Cells were spun down at 1,200 × g for 3 minutes, 4 °C. The supernatant was poured 
off and the pellet resuspended in 1 ml of ice-cold 100 mM lithium acetate, transferred to 
1.5 ml tubes and spun at 2,600 × g for 1 minute. The lithium acetate was removed and this 
process was repeated. The pellet was resuspended in 30 µl 100 mM lithium acetate per 
transformation with 40 µl of the mix then transferred into 1.5 ml tubes. A transformation mix 
(33.3% PEG, 100 mM lithium acetate, 0.28 mg ml-1 single stranded DNA (salmon sperm), 
between 0.1-10 µg transformation DNA fragment) was added to each tube. Tubes are vortexed 
until pellet is fully resuspended then incubated at 30 °C for 30 minutes. Cells are heat shocked 
at 42 °C for 30 minutes then 1 ml double distilled water is added. Cells are spun down at 
25 × g for 1 minute, supernatant aspirated and pellet resuspended in 300 µl YPD. Cells are 
then plated onto a YPD plate, grown for 12 hours and replica plated onto drug-containing YPD 
plates using velvet. These replica-plated cells are then grown for 2-3 days before transformants 
are selected.  
2.2.8 Spot tests 
YPD cultures were diluted 40-fold into fresh YPD and grown vigorously at 30 °C for 4 hours. 
Cultures were then diluted to 0.2 OD600 in distilled water and a 10-fold dilutions series down to 
0.00002 was made. 7 µl of each dilution was spotted in series onto the stated drug-containing 
YPD plates which were incubated at 30 °C for 4 days.  
2.2.9 Genomic DNA preparation  
Non-proteolysing gDNA extraction 
Spheroplasts were prepared from frozen meiotic cell culture aliquots. Cell pellets were 
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resuspended in 300 µl spheroplasting buffer for every 10 ml of cells (1 M sorbitol, 50 mM 
NaHPO4 pH 7.5, 10 mM EDTA, 1% β-mercaptoethanol, 200 µg ml-1 zymolyase 100T) and 
incubated at 37 °C for 20 minutes. Samples were mixed by inversion every 5 minutes during 
this incubation. Samples were immediately placed on ice and Sigma P8215 protease inhibitor 
cocktail and Pefabloc-SC (Roche) were added at 1× concentration. Samples containing greater 
than 10 ml of cells were split into eppendorfs to contain 10 ml of cells each. Spheroplasts were 
fixed with 1 ml ice-cold 100% ethanol, inverted to mix and placed on ice for 10 minutes. Fixed 
spheroplasts were spun down at 1,000 × g for 1 minute, ethanol aspirated off, spun again and 
residual ethanol completely removed. Pelleted material was resuspended in STE lysis buffer 
(2% SDS, 0.5 M Tris pH 8.1, 10 mM EDTA, 0.05% bromophenol blue) using a pestle, 
incubated on ice for 5 minutes then lysed at 65 °C for 10 minutes. After, samples were left to 
reach room temperature for 15 minutes before proceeding. Non-covalently bound proteins 
were removed with an equal volume (or smaller volumes detailed for specific experiments) of 
phenol:chloroform:isoamyl alcohol (25:24:1), mixing vigorously and left to settle for 
5 minutes. Samples were vigorously mixed again and then spun at 20,000 × g for 5 minutes. 
500 µl of the top aqueous phase was taken using a cut P1000 tip and added to a new eppendorf 
tube containing 500 µl of 100% ice-cold ethanol and mixed by inversion to precipitate the 
nucleic acids. Precipitates were pelleted by centrifugation for 1 minute at 16,000 × g, washed 
in 1 ml 70% ethanol and left to air dry for 15 minute before being dissolved in 400 µl 1× TE 
(10 mM Tris Base·HCl pH 8.0, 1 mM EDTA) overnight at 4 °C. RNase was added at 
100 µg ml-1, incubated at 37 °C for 1 hour and reprecipitated with ice-cold 100% ethanol. 
DNA pellets were left to dissolve in 200 µl 1× TE overnight at 4 °C. 
 
Proteolysing gDNA Extraction 
The proteolysing form of genomic DNA extraction mirrors the non-proteolysing method 
except for the following changes: No protease inhibitors were added after spheroplasting; cells 
were not fixed in ethanol; cells were lysed by addition of lysis solution (3% SDS, 100 mM 
EDTA, 1 mg ml-1 Proteinase K) to the spheroplasting solution and placed overnight at 65 °C. 
2.2.10 Southern blot 
Approximately 2 µg of genomic DNA was digested at 37 °C overnight using PstI restriction 
enzyme in NEBuffer 3.1 (100 mM NaCl, 50 mM Tris Base·HCl pH 7.9, 10 mM MgCl2, 
100 µg ml-1 BSA). Additional PstI was added for 4 hours before the addition of NEB purple 
loading dye to 1×. Digested samples were proteolysed using 1 mg ml-1 Proteinase K at 60 °C 
for 30 minutes (unless the proteolysing gDNA extraction method was used), left to reach room 
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temperature before was 10 µg loaded on a 0.7% 1× TAE agarose gel (40 mM Tris Base·HCl, 
20 mM glacial acetic acid, 1 mM EDTA pH 8.0)  containing 50 µg ml-1 ethidium bromide. 
DNA was fractionated in 1× TAE at 60 V for 18 hours. The gel was imaged using Syngene 
InGenius bioimaging system to check migration and then exposed to 1800 J/m2 UV in the 
Stratalinker. The gel was then soaked in three times its volume of denaturation solution (0.5 M 
NaOH, 1.5 M NaCl) for 30 minutes and then transferred to Bio-rad zetaprobe membrane by 
means of a vacuum at 55 mBar for 2 hours. After transfer the membrane was washed in water 
ten times and then cross-linked by exposing the membrane to 1880 J/m2 UV in the 
Stratalinker. The membrane was incubated in 30 ml of hybridisation buffer (0.5 M NaHPO4 
pH 7.5, 7% SDS, 1 mM EDTA, 1% BSA) at 65 °C for 1 hour. The MXR2 probe for looking at 
the HIS4::LEU2 locus was created from 50 ng of template DNA, 0.1 ng of NEB Lambda DNA 
digested with BstEII, and water. The mix was denatured at 100 °C for 5 minutes then put on 
ice. Roche High Prime was added in addition to 0.5-3 mBq of α-32P dCTP and incubated at 
37 °C for 15 minutes. 30 µl 1× TE was added and the probe spun through a GE Healthcare G-
50 spin column at 400 × g for 2 minutes. The probe was then denatured by incubating at 
100 °C for 5 minutes and then put on ice before being added to 20 ml hybridisation mixture. 
The original 30 ml hybridisation buffer was discarded and the 20 ml containing the probe was 
added to the membrane and incubated overnight at 65 °C. After incubation, the membrane was 
washed five times with 100 ml pre-warmed southern wash buffer (1% SDS, 40 mM NaHPO4 
pH 7.5, 1 mM EDTA) and exposed to phosphor screen overnight.  
2.2.11 Covalently linked protein-DNA molecule enrichment 
This protocol describes the final procedure that was created after optimisations were carried 
out as detailed in Chapter 5: Genome-wide mapping Spo11-DSBs. Genomic DNA was purified 
as detailed in section Genomic DNA preparation (non-proteolysing) with 
phenol:chloroform:isoamyl alcohol volumes sometimes altered as stated in specific figures. 
DNA was fragmented using two different schemes. Firstly, sonication using a Covaris M220 
machine (Settings: target BP range 200-700 bp, duty cycle 10%, intensity/peak power 
incidence 75W, cycles/burst 200, bath temperature 7 °C, time 24 minutes (time length of 
sonication varied between experiments as detailed in figures). Secondly, restriction enzyme 
digestion made with a mix of 125 µg DNA, 16 µl NEBuffer, 56 µl double distilled water, and 8 
µl restriction enzyme of choice. The mix was placed at 37 °C for 4 hours. To either the 
sonicated or the digestion mix a column binding buffer was added (0.1% sarkosyl, 0.2% 
Triton-X100, 0.3 M NaCl) and samples pipetted onto QIAprep 2.0 Spin Columns (QIAGEN) 
at 20 µg of approximated starting genomic DNA per column. Under these conditions protein 
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molecules (and protein molecules with DNA covalently attached (Spo11-DNA)) bind to the 
silica membrane of these columns whereas DNA molecules do not. DNA was incubated at 
room temperature on the column for 5 minutes before being centrifuged at 16,000 × g for 1 
minute. Flow-through was put back onto the column, incubated for 5 minutes and spun 
through again. Flow-through was discarded and wash buffer (10 mM Tris Base·HCl pH 8.0, 
1 mM EDTA, 0.3 M NaCl) was applied to the column and left to incubate for 1 minute. 
Columns were then either spun as before or applied to a QIAvac 24 Plus manifold and the 
vacuum switched on. These washes were repeated six times before all the columns were spun 
at 16,000 × g for 1 minute to remove any residual wash buffer. Protein-linked DNA was eluted 
from the column by applying 50 µl TES (10 mM Tris Base·HCl pH 8.0, 1 mM EDTA, 0.5% 
SDS) directly to the silica membrane, incubating it for 5 minutes at room temperature and 
eluting the solution through centrifugation at 16,000 × g for 1 minute. Another 50 µl was 
added and eluted to increase yield of protein-DNA molecules. Protein-DNA molecules were 
then proteolysed using 1 mg ml-1 Proteinase K at 60 °C for 1 hour before being precipitated 
overnight (200 mM NaOAc, 20 µg glycogen, 2.5 volumes ice-cold ethanol) at -80 °C. Samples 
were centrifuged at 4 °C, 21,000 × g for 60 minutes, ethanol aspirated, 1 ml 70% ethanol 
added to wash samples, span at 21,000 × g for 10 minutes, 70% ethanol aspirated and left to 
air dry for 15 minutes. Pellets were resuspended in specific buffer for subsequent experiments.  
2.2.12 Spo11-DNA mapping 
This mapping protocol describes the final version used for mapping single-cut Spo11 and 
Top2 molecules. The optimisation experiments used to get to this final version can be found in 
Chapter 5.  
Precipitated, column-enriched DNA fragments from a 50 ml starting cell volume were 
resuspended in 55 µl Tris Base·HCl pH 8.0 with 5 µl used to measure DNA concentration on a 
Qubit 2.0 machine. The majority of steps now follow the NEBNext Ultra II DNA Library Prep 
Kit for Illumina with a few alterations (Figure 2.2 – Library preparation workflow).  
 
NEBNext End Prep 
50 µl  Fragmented DNA was mixed with 7 µl NEBNext Ultra II End Prep Reaction Buffer and 
3 µl NEBNext Ultra II End Prep Enzyme Mix. The sample was placed in a thermocycler, with 
heated lid set to ≥75 °C, and run with the following program: 20 °C for 30 minutes, 65 °C for 
30 minutes, hold at 4 °C. The sample should then be processed for adaptor ligation 
immediately. 
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  Fragmented DNA in 10 mM Tris!
(Total volume 50 μl)!
NEBNext Ultra II End Prep #1!
(Total volume 60 μl)!
NEBNext Ultra II Custom Adaptor Ligation #1(P7 Adaptor)!
(Total volume 93.5 μl) !
AMPure XP Bead Clean up #1 (B1)!
Add 87  μl beads!
Elute into 53  μl, take 50 μl !
!
Tdp2 Treatment!
50 μl 2x Tdp2 buffer added!
3 μl 10 μM Tdp2 added!
(Total volume 103 μl)!
AMPure XP Bead Clean up #2 (B2)!
Add 150  μl beads!
Elute into 53  μl, take 50 μl !
NEBNext Ultra II End Prep!
(Total volume 60 μl)!
NEBNext Ultra II Custom Adaptor Ligation #2 (P5 Adaptor)!
 (Total volume 93.5 μl) !
AMPure XP Bead Clean up #3 (B3)!
Add 87  μl beads!
Elute into 17  μl, take 15 μl!
PCR Amplification (13-15 cycles)!
(Total volume 50 μl)!
AMPure XP Bead Size-selection (B4)!
Top up volume to 100 μl with 10 mM Tris!
Add 55  μl beads, take supernatant!
Add 25 μl beads, discard supernantant!
Elute off beads into 33  μl, take 30 μl!
Run Agilent Bioanalyser!
Add 9 μl water, load 1 μl!
Create 4 nM Library!
Denature Library!
Create combined 15 pM library!
Run MiSeq!
Figure 2.2: Workflow of single-cut Spo11 Mapping Protocol. A detailed method for mapping 
Spo11-DSBs is located within the text  
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Adaptor Ligation 
The following components were added directly to the End Prep Reaction Mixture: 30 µl 
NEBNext Ultra II Ligation Master Mix, 1 µl NEBNext Ligation Enhancer, 2.5 µl Custom 
Adaptor P5 or P7*. The sample was placed in a thermocycler at 20 °C for 15 minutes with the 
heated lid off.  
*Adaptors (stock is 15 µM) must be diluted as per Table 2.5 below: 
 
Table 2.5 Working adaptor concentration dilution table  
INPUT Adaptor Dilution (Volume of 
Adaptor:Total Volume) 
Working Adaptor 
Concentration 
1 µg-101 ng No dilution 15 µM 
100 ng-5 ng 10-Fold (1:10) 1.5 µM 
Less than 5 ng 25-Fold (1:25) 0.6 µM 
 
AMPure XP Beads Clean-up of DNA 
Volume/concentration of AMPure XP beads used for clean-up and size-selection varied 
depending on the stage of the protocol. See workflow (Figure 2.1) for volumes used at each 
specific stage. The following method describes a general clean-up (buffer swap) of fragmented 
DNA. 
1.5× volume of AMPure XP beads was added to the sample and pipetted up and down ten 
times to thoroughly mix and incubated at room temperature for 7 minutes. The tube was 
briefly spun down to collect the liquid from the sides of the tube before placing on a magnetic 
stand. After the solution cleared (approximately 5 minutes) the supernatant was removed and 
discarded. 200 µl of 80% freshly prepared ethanol was added to the tube whilst in the magnetic 
stand. The tubes were incubated at room temperature for 30 seconds, and the ethanol removed 
and discarded. This step was repeated for a total of two washes. The beads were air dried for 
3 minutes whilst on the magnetic stand with the lid open. The tube was removed from the 
magnetic stand, the buffer required for the next stage of the protocol added, the tube vortexed 
and pipette up and down until the beads are fully resuspended. The tubes were incubated at 
room temperature for 3 minutes, residual liquid from the sides of the tube spun down and the 
tube placed back onto the magnetic stand for 5 minutes until the solution cleared. The 
supernatant was removed minus 2 µl (to prevent beads being taken) and placed into a fresh 
tube ready for the next stage of the protocol. 
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AMPure XP Beads Size-Selection 
For single-cut Spo11-DNA fragments post-PCR amplification size-selection of 150 to 600 bp 
was required. The volume of the sample was brought up to 100 µl with 10 mM Tris Base·HCl 
pH 8.0. 55 µl AMPure XP beads was added, the sample was mixed thoroughly, incubated at 
room temperature for 7 minutes and residual liquid spun down from the sides of the tube. The 
tubes were placed on a magnetic stand for 5 minutes until the solution cleared. The supernatant 
was transferred to a fresh tube not on the magnetic stand (beads discarded), 25 µl of fresh 
AMPure XP beads added, the tube mixed thoroughly, incubated at room temperature for 
7 minutes and residual liquid from the sides of the tube spun down. The tube was placed back 
onto the magnetic stand for 5 minutes until the solution cleared. The supernatant was removed 
and discarded and beads washed twice with 80% ethanol as for the AMPure XP Beads Clean-
up of DNA method (above). Size-selected, fragmented DNA was eluted in 33 µl 0.1× TE 
(1 mM Tris Base·HCl pH 8.0, 0.1 mM EDTA) and 30 µl transferred to a fresh tube. 1 µl of 
this final library was diluted 10-fold with double-distilled water and 1 µl ran on an Agilent 
Bioanalyser (high sensitivity chip) to check size distribution. The final library was stored at -
20 °C.  
 
TDP2 Treatment of fragmented DNA 
To remove covalently bound 5ʹ′protein/peptide from DNA TDP2 (gift from Keith Caldecott) 
was used. Samples were resuspended and an equal volume of 2× TDP2 buffer (100 mM 
NaOAc, 100 mM TrisOAc, 2 mM MgOAc, 2 mM DTT, 200 µg ml-1 BSA) and TDP2 protein 
to 300 nM added. Samples were incubated in a thermocycler at 37 °C for 1 hour. Samples 
were subsequently cleaned up using AMPure XP beads before proceeding to the next step.  
 
PCR Amplification of Adaptor Ligated DNA 
15 µl of AMPure XP bead cleaned, fragmented, adaptor ligated DNA had the following 
components added: 25 µl NEBNext Ultra II Q5 Master Mix, 5 µl Index Primer/i7 Primer, 5 µl 
Universal PCR Primer/i5 Primer.  
Within a batch of samples a unique Index Primer/i7 Primer was used for each individual 
sample. NEBNext Multiplex Oligos for Illumina Set 1 (NEB #E7335 lot 0091412) or Set 2 
(NEB #E7500 lot 0071412).  
The entire volume was pipetted up and down ten times to mix thoroughly and quickly spun to 
collect liquid from the side of the tube. The tube was placed in a thermo cycler and PCR 
amplification was performed using the following PCR cycling conditions (Table 2.6):  
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Table 2.6 Overview of PCR amplification program 
CYCLE STEP TEMP TIME CYCLES 
Initial Denaturation 98 °C 30 seconds 1 
Denaturation 
Annealing/Extension 
98 °C 
65 °C 
10 seconds 
75 seconds 
13-15* 
Final Extension 65 °C 5 minutes 1 
Hold 4 °C ∞  
*The number of cycles used depended on the input amount of DNA. 5 ng to 1 ng = 13 cycles, 1 ng to 0.5 ng = 14 
cycles, ≤0.5 ng = 15 cycles.  
\ 
Preparing Libraries for Sequencing on the MiSeq 
Libraries were prepared as per the NEBNext manufacturer’s guidelines. 1 ml 1 N NaOH was 
freshly prepared and a 0.2 N dilution made using double-distilled water. The DNA 
concentrations of the libraries were determined from the Bioanalyser trace and from the Qubit 
2.0 machine. Libraries were diluted to 4 nM with double-distilled water. 2 µl of each library 
were pooled together in a fresh tube and an equal volume of 0.2 N NaOH was added. The 
samples were vortexed briefly, centrifuged at 280 × g for 1 minute and incubated at room 
temperature for 5 minutes to denature the DNA into single strands. 10 µl of the denatured 
DNA was added to 990 µl HT1 buffer to create a 20 pM library in 1 mM NaOH. For running 
the library on the MiSeq, the library was further diluted to 15 pM with HT1 buffer. 20 pM 
PhiX control was added to 1% total volume (see below for preparation). 
 
Preparing PhiX Control for MiSeq library 
2 µl of a 10 nM PhiX library was diluted to 4 nM with 3 µl of a solution of 10 mM Tris 
Base·HCl pH 8.5, 0.1% Tween 20. This had an equal volume of 0.2 N NaOH added, was 
vortexed briefly and centrifuged at 280 × g for 1 minute before being incubated at room 
temperature for 5 minutes. 10 µl was added to 990 µl HT1 buffer resulting in a 20 pM PhiX 
library which was stored at -20 °C for up to three weeks.  
 
Sequencing 
Sequencing was conducted on the Illumina MiSeq using the MiSeq Reagent Kit v3 (150 cycle) 
(Illumina MS-102-3001).  
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2.2.13 Western blot 
Polyacrylamide gels were homemade using the following procedure. Usually an 8.75% 
polyacrylamide resolving phase (375 mM Tris Base·HCl pH 8.8, 0.1% SDS, 0.1% ammonium 
persulfate, 0.01% TEMED) was made, poured into a casting kit and 100% isopropanol used to 
level the top of the gel. After the gel had set (approximately 30 minutes), the isopropanol was 
poured off and the kit rinsed in distilled water.  The 4% polyacrylamide stacking gel (125 mM 
Tris Base·HCl pH 6.8, 0.1% SDS, 0.1% ammonium persulfate, 0.02% TEMED) was made and 
poured on top of the set resolving phase gel and a comb placed on top of the stacking phase. 
Once set (approximately 30 minutes), the gel was placed into an SDS-PAGE gel running tank, 
the tank was filled with 1× SDS-PAGE Running buffer (25 mM Tris Base·HCl pH 7.5, 
200 mM glycine, 0.5% SDS) and the comb was removed. Protein samples had 2× Laemmli 
loading buffer (4% SDS, 100 mM Tris pH 6.8, 20% glycerol, 2 mM EDTA, 0.005% 
bromophenol blue) added, boiled at 100 °C for 5 minutes, placed on ice for 5 minutes, spun at 
9,400 × g and 20 µl loaded into the gel wells. The gel was run at a 1500 V until samples have 
migrated to the desired position. The gel apparatus is disassembled and the gel is soaked in 1× 
CAPS buffer (10 mM CAPS·NaOH pH 11, 10% methanol). PVDF membrane (Millipore) is 
activated in 100% methanol for 5 minutes then soaked in 1× CAPS buffer for 10 minutes. The 
gel is captured upon the activated PVDF membrane, placed between Whatmann paper and 
setup within a wet transfer tank. Protein transfer is done in 1× CAPS buffer at 0.65 mA for 
1 hour. The transfer apparatus is dismantled and the PVDF washed in 1× TBST (25 mM Tris 
Base·HCl pH 7.5, 150 mM NaCl, 0.1% Tween-20). The membrane is blocked in 5% non-fat 
dried milk in 1× TBST for 30 minutes on a rocking machine before the blocking solution being 
removed and the primary antibody (which binds the protein of interest) in 1× TBST added 
(antibody concentration and incubation time varies between antibodies). The primary antibody 
was removed and the membrane washed three times in 1× TBST for 5 minutes each. If the 
primary antibody was conjugated to horseradish peroxidase (HRP) protein then the membrane 
had enhanced chemiluminescence (ECL) reagent added and exposed to film (see below). For 
standard Western blots the secondary antibody (concentration and incubation time varies 
between antibodies), conjugated to HRP protein, was added in 1× TBST added (which binds 
the primary antibody). The secondary antibody is removed and the membrane washed three 
times in 1× TBST for 5 minutes. ECL reagent is poured onto the membrane and left to 
incubate for 2 minutes before being poured off. The ECL reacts with the HRP on the 
secondary antibody, emitting low intensity light, which can be detected using the ImageQuant 
LAS4000 machine for varying exposure times.  
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2.2.14 Spo11-oligonucleotide assay 
Spo11-oligonucleotide complexes were detected by immunoprecipitation and end-labelling 
following established methods (Neale et al., 2005). Specifically, 10 ml of sporulating culture 
was lysed in 10% ice-cold TCA using zirconia beads and a BioSpec 24. Precipitated material 
was dissolved in 300 µl STE (2% SDS, 0.5 M Tris pH 8.1, 10 mM EDTA, 0.05% 
bromophenol blue), and boiled at 100 °C for 5 minutes. Extracts were centrifuged at 
16,000 × g for 1 minute at 4 °C, and supernatant was diluted with one volume 2× IP buffer 
(2% Triton X100, 300 mM NaCl, 30 mM Tris Base·HCl pH 8.1, 2 mM EDTA) and further 
two-fold in 1× IP buffer. Anti-FLAG antibody (#F1804; Sigma-Aldrich) was added at 1 in 500 
dilution, protein-G-agarose matrix (Roche) at 1 in 50 dilution, and then incubated with rotation 
overnight at 4 °C. Immune complexes were collected by low speed centrifugation, and washed 
twice with 1× IP buffer. This was followed by two washes in 1× TKAc (20 mM Tris·acetate 
pH 7.9, 50 mM K·acetate) before incubation in 25 µl labelling buffer (10-20 units terminal 
deoxynucleotidyl transferase (TdT) (Fermentas), 0.5-3 mBq of α-32P dCTP or dATP 3`-[a-
32P] (cordycepin) (Perkin Elmer), 1× TdT buffer (500 mM potassium cacodylate pH 7.2, 
10 mM CoCl2, 1 mM DTT)) at 37 °C for 1 hour. 20 µl of the labelling buffer was removed and 
50 µl ice-cold 2× Laemmli loading buffer was added, samples boiled for 7 minutes, chilled on 
ice for 5 minutes and spun at 9,400 × g for 1 minute. 20 µl was loaded onto a 7.5% or 8.75% 
SDS-PAGE gel (detailed in section Western Blot) before fractionation at 150 V for 
110 minutes. The gel was transferred to PVDF membrane in 1× CAPS buffer at 0.65 mA for 
1 hour and exposed to a phosphor screen. 
2.2.15 Oligonucleotide sequencing gel 
For nucleotide resolution analysis of Spo11-oligonucleotide lengths, the Spo11-
oligonucleotide protocol was followed up to the labelling step with TdT. Then, the labelling 
solution was completely removed using a gel loading tip, beads washed in 1 ml 1× IP buffer 
and 50 µl 1× TE added containing 1 mg ml-1 Proteinase K. Samples were proteolysed at 60 °C 
for 1 hour.  1 volume of Laemmli buffer was added and the mixture was boiled at 100 °C for 
5 minutes, left on ice for 5 minutes and spun down at 9,400 × g for 1 minute. All the 
supernatant was taken and DNA precipitated with the addition of 20 µg glycogen (R0561; 
Thermo Scientific) and 10 volumes of 100% ice-cold ethanol and placed at -80 °C overnight. 
Precipitates were collected by centrifugation at 16,000 × g for 15 minutes and the pellet 
dissolved in 20-50 µl 1× TE. The oligonucleotides were mixed with 1 volume of sequencing 
gel loading dye (95% formamide, 10 mM EDTA, 0.01% xylene cyanol), and fractionated 
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through a 28 cm tall, 0.5 mm thick 19% polyacrylamide (19:1)/6 M urea gel (or different 
percentage polyacrylamide gel as stated) in 1× TBE (90 mM Tris Base·HCl pH 8.0, 90 mM 
boric acid, 2 mM EDTA) running buffer at approximately 1200 V for 80 minutes. Gels were 
fixed in fixing buffer (10% methanol, 7% acetic acid, 5% glycerol) and exposed to a phosphor 
screen for imaging. 
2.2.16 Bioinformatics 
All bioinformatics scripts can be found in the Appendix and were developed by either Matt 
Neale or Tim Cooper as stated.  
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Chapter 3: Investigating Sae2 activity in meiotic DSB end 
processing 
3.1 Introduction 
Sae2 physically interacts with the MRX complex and is required for activation of Mre11 
endonuclease activity, an activity essential for processing blocked-ended DSBs (Cannavo and 
Cejka, 2014). At Spo11-DSBs the combined action of Mre11 and Sae2 generates Spo11-
oligonucleotides from nucleolytic end-processing of the DSB (Garcia et al., 2011; Moreau et 
al., 1999). Such clipping of the 5ʹ′ strand adjacent to the DSB followed by bidirectional 
resection generates a long 3ʹ′ ssDNA tail and the release of Spo11-oligonucleotides. Spo11-
oligos are formed with two distinct length distributions and can be detected by 
immunoprecipitation of a tagged form of Spo11, end-labelling the oligonucleotide and 
separating the Spo11 protein-DNA species on an SDS-PAGE gel (as described in Materials 
and Methods) (Neale et al., 2005). This method of detecting Spo11-oligos can be utilised to 
analyse, semi-quantitatively, mutants of the end-processing machinery, such as Sae2, for their 
ability to process Spo11-DSBs in meiosis.  
Mitotic cells deficient in Sae2 (or other members of the HR pathway) are sensitive to methyl 
methanesulfonate (MMS) (McKee and Kleckner, 1997; Rattray et al., 2001), which generates 
single-stranded breaks resulting in DSBs through replication fork collision (Ensminger et al., 
2014; Lundin et al., 2005). MMS can therefore be used in spot tests to study any potential Sae2 
mutant phenotypes in cycling cells. In mitotic cells the activation of Mre11 endonuclease by 
Sae2 is a crucial regulation point for the choice between repairing a DSB via NHEJ or HR, 
with the initial resection refractory to repair by NHEJ (Shibata et al., 2014). The Sae2 protein 
contains various important residues, some of which are phosphorylation sites, which control 
Sae2 activity (Figure 3.1A). Phosphorylation of Sae2 mediated by CDK activity, generates an 
active form of the protein, which promotes this endonuclease activity of Mre11 (Cannavo and 
Cejka, 2014; Huertas et al., 2008). Therefore Sae2 activity is the link between the cell cycle 
stage, CDK activity and the choice between NHEJ or HR repair. Other phosphorylation events 
and post-translational modifications have also been implicated in regulation of Sae2 activity 
(Baroni et al., 2004; Cartagena-Lirola et al., 2006; Fu et al., 2014). However, the role of post-
translational modification state in the regulation of Sae2 activity in meiosis requires further 
elucidation.  
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Figure 3.1: Schematic of Sae2 protein and alignment of SAE2 in S. cerevisiae strains.  
A. Residues discussed in this chapter are annotated. Self-interaction sites are written in red. Putative 
CDK phosphorylation sites (S/T-P) are written in blue. Putative Mec1/Tel1 sites (S/T-Q) are 
underlined. The N-terminal self-interaction domain is highlighted in blue. The yellow box indicates 
the C-terminal conserved region. The three truncation mutants used are displayed. B. The sequence of 
the SAE2 ORF is indicated alongside the natural upstream sequences containing cryptic ORFs 
(highlighted) from both SK1 and S288C strains of S. cerevisiae. The sequence of SAE2 and its 
upstream region from the different GAL1 constructs are indicated. 
L25! Sae2!
sae2!N58"
sae2!N120"
sae2!N170"
S73! T90! S134!
E131! S289!S278!T279!S267!S179! S249!K239!
K266!
S73! T90! S134!
E131! S289!S278!T279!S267!S179! S249!K239!
K266!
S134!
E131! S289!S278!T279!S267!S179! S249!K239!
K266!
S289!S278!T279!S267!S179! S249!K239!
K266!
N-terminal self-interaction domain! C-terminal conserved region!
RED: self-interaction sites!
BLUE: putative CDK phosphorylation sites!
Underlined: putative S/T-Q Mec1/Tel1 
phosphorylation sites!
A!
B!
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3.2 The Spo11-end processing activity of Sae2 and the MRX complex can be 
measured using the high-sensitivity Spo11-oligo assay 
In order to characterise the phenotype of SAE2 point mutants during meiosis, the SAE2 gene 
was placed upon a centromeric plasmid with 500 nt flanking either side of the ORF. The 
benefits of this were: (i) Site-directed mutagenesis was very easy to perform on the gene (as 
described in Materials and Methods section Site-directed mutagenesis). (ii) Sae2 is not 
essential for growth of S. cerevisiae cells so therefore the natural SAE2 locus could be deleted. 
This construct permits for complementation of the sae2∆ strain with the centromeric plasmid 
containing the SAE2 gene and the mutant forms.  Plasmid retention is selected using a drug-
resistance marker (hygromycin) contained on the plasmid. (iii) The 500 nt flanking sequence 
either side of the ORF ensures SAE2 will still be controlled by its natural promoter and 
terminator, keeping transcriptional control of the plasmid-borne gene similar to that of the 
chromosomal locus. (iv) Tagging the Sae2 protein with different affinity tags to monitor its 
expression levels is much easier than attempting to incorporate a tag at the natural SAE2 locus. 
Details of the construction of the centromeric SAE2 plasmid can be found in Materials and 
Methods Figure 2.1. To determine whether expression of wild type SAE2 off the centromeric 
(CEN) plasmid could rescue the sae2∆ meiotic defect (deficient in Spo11-oligo formation), 
sae2∆ cells containing the SPO11-FLAG construct were transformed with the SAE2-CEN 
plasmid. Samples from the SAE2-CEN strain, alongside SPO11-FLAG containing wild type 
and sae2∆ strains, were taken from synchronised meiotic cultures at mid-meiotic prophase and 
Spo11-FLAG immunoprecipitated from cellular extracts. Immunoprecipitated Spo11-
oligonucleotides were radioactively end-labelled and resolved on an SDS-PAGE gel (Figure 
3.2).  
Wild type Spo11-oligos (two discrete bands 24-40 and 10-15 nt in length) are present in the 
wild type strain confirming the results of Neale et al., 2005 that Spo11 is released from DSB 
covalently attached to two oligonucleotide lengths (Figure 3.2A left hand panel). As 
previously reported, in sae2∆ cells these two discrete bands are absent indicating a defect in 
Spo11-DSB end processing (Figure 3.2A middle panel). Larger bands with a periodicity of 10 
nt starting at 45 nt in length were seen in all strains including sae2∆ cells. Longer Spo11-oligo 
species were also observed in Garcia et al., 2011 and presumed to be due to nicking of the 5ʹ′ 
strand up to 300 nt away from the DSB. However, subsequent unpublished experiments have 
determined that these species arise in the mre11-H125N (nuclease dead) and rad50S 
backgrounds (data not shown, Matt Neale and Valerie Garcia). Therefore, because Sae2 is 
thought to be an essential activator of Mre11 endonuclease activity (Cannavo and Cejka, 
2014), and because the rad50S mutation also renders the Mre11 endonuclease inactive, it 
would seem that these molecules are not due to nicking by the Mre11 endonuclease. Instead  
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 Hours:!
Wild type!
  
* 
sae2"!
Figure 3.2: Two discrete lengths of Spo11-oligonucleotides are generated in wild type but not 
sae2! cells. SAE2 expressed from a centromeric plasmid complements the sae2! deficiency.  
A. Spo11-oligonucleotide blot from wild type, sae2! and sae2! cells transformed with a centromeric 
plasmid containing SAE2 under control of its natural promoter and terminator (pVG25). Wild type 
and sae2! strains were also transformed with an empty hygromycin resistant plasmid for control 
purposes. 10 ml of cells were taken at the stated hour from the start of meiosis and Spo11-oligos were 
enriched using the Spo11-oligonucleotide assay as stated in Materials and Methods. Samples were 
resolved on a 7.5% SDS-PAGE gel at 150 V for 1 hour 30 minutes, transferred to a PVDF membrane 
and exposed to a phosphor screen overnight.  Open triangles (   ) mark the long and short Spo11-oligo 
species generated in wild type cells. The open bracket (  ) marks the double-cut Spo11-
oligonucleotide species seen in all strains. Asterisk marks non-specific TdT band. B. Spot tests. Wild 
type and sae2! strains were transformed with an empty hygromycin resistant plasmid for control 
purposes. All plates contained 300 µg ml-1 hygromycin to maintain selection of the plasmid. MMS 
plates contained 0.025% MMS. Cultures were grown overnight in YPD (with 300 µg ml-1 
hygromycin) then transferred to fresh YPD+HYG for 4 hours. Cultures were diluted to 0.2 OD600 and 
a 10-fold dilution series spotted onto the plate down to 0.00002, plates were incubated at 30 °C for 4 
days and images taken using a Syngene InGenius bioimaging system.  
0! 3! 4! 5! 6! 8! 0! 3! 4! 5! 6! 8! 0! 3! 4! 5! 6! 8!
pVG25 (CEN): SAE2!
Control! 0.025% MMS!
  Wild type!
sae2"!
SAE2!
SAE2-HIS10!
SAE2-HA!
SAE2-HA (S267A)!
SAE2-HA (S267E)!
A!
B!
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these species are hypothesised to arise from the coincident formation of adjacent Spo11-DSBs 
on the same DNA molecule (this concept will be discussed in more detail in Chapter 6). SAE2 
expressed from the centromeric plasmid, under its natural promoter and terminator, is able to 
restore DSB end processing, as determined by the production of the two discrete lengths of 
wild type Spo11-oligonucleotides. However, the levels of wild type Spo11-oligos observed are 
less compared to cells expressing SAE2 from its chromosomal locus (Figure 3.2A right hand 
panel).   
To determine if the centromeric SAE2 plasmid would also rescue sae2∆ mitotic DNA repair 
defects, cycling cells were serially diluted onto YPD and 0.025% MMS containing YPD plates 
and grown for four days. Centromeric-borne SAE2 rescues the sae2∆ growth defect on MMS 
plates but, similar to the rescue of the meiotic phenotype, rescue was not to wild type levels 
(Figure 3.2B). Nevertheless, these assays will permit the analysis of mutant alleles of SAE2.  
3.3 Determining the detection limit of wild type Spo11-oligonucleotide species 
Because Sae2 is a critical component for meiotic DSB end processing it is expected that 
mutating the protein may alter its ability to generate Spo11-oligos. Because different mutations 
may have varying levels of effect on this process, the dynamic range of the Spo11-oligo assay 
was determined. To do this, different percentages of wild type meiotic cell extract were mixed 
with sae2∆ meiotic extract prior to Spo11-immunoprecipitation and end labelling to determine 
how little wild type Spo11-oligos can be detected when in the presence of cellular material 
(Figure 3.3). The detection limit was high, with wild type Spo11-oligos readily detected when 
only 10% of the meiotic cell extract volume originated from wild type cells (Figure 3.3 right 
hand panel).  This enables the detection of Spo11-oligos across a range of hypomorphic SAE2 
alleles.  
3.4 Affinity tagging Sae2 enables detection of protein levels from meiotic 
cultures  
Mutating proteins for analytical purposes can often cause improper folding and/or expression 
resulting in a false negative result. To be able to determine expression levels of Sae2 once 
mutagenised, an epitope tagged version was used to monitor protein levels via Western 
blotting. The human influenza hemagglutinin (HA) tag is a commonly used epitope tag that 
facilitates in the detection, isolation and purification of proteins (Field et al., 1988). Combining 
three repeats of this peptide enhances its detectability and this 3HA sequence was cloned in  
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Figure 3.3: Wild type Spo11-oligonucleotide species are detectable down to a starting material 
of 0.1 ml cells.  
Spo11-oligonucleotide blot. Stated amounts of wild type whole cell TCA extract were spiked into 
sae2! cell TCA extract and Spo11-oligonucleotides were enriched using the Spo11-oligonucleotide 
assay as stated in Materials and Methods (reagents were not scaled from the standard 10 ml starting 
material size). Samples were resolved on a 7.5% SDS-PAGE gel at 150 V for 1 hour 30 minutes, 
transferred to a PVDF membrane and exposed to a phosphor screen overnight. Open triangles (   ) 
mark the long and short Spo11-oligo species generated in wild type cells. The open bracket (   ) marks 
the double-cut Spo11-oligonucleotide species seen in wild type and sae2!. Asterisk marks non-
specific TdT band.  
Total cell volume:!
 % WT:!
5"ml cells!
100! 10! 1! 0!
2"ml cells!
100! 10! 1! 0!
1"ml cells!
100! 10! 1! 0!
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frame to the C-terminal end of the SAE2 gene on the centromeric plasmid (Figure 2.1). A 
comparable His10 C-terminal tag was also generated.  
Tagging Spo11 with a 3HA-tag generates a hypomorphic allele of the protein which alters 
DSB formation (Diaz et al., 2002; Gray et al., 2013). In order to determine whether the -3HA 
and -10His-tagged forms of Sae2 displayed hypomorphic phenotypes, meiotic cultures of these 
tagged, wild type forms of Sae2 were assayed for Spo11-oligo formation (Figure 3.4). The two 
wild type Spo11-oligo bands were present in all three strains expressing SAE2 from a 
centromeric plasmid indicating untagged, -His10 and -3HA-tagged Sae2 are all capable of 
processing Spo11-DSBs (Figure 3.4). The levels of Spo11-oligos produced are similar 
between the SAE2-3HA and untagged constructs (Figure 3.4 left and middle panels), with the 
SAE2-HIS10 construct being slightly hypomorphic (Figure 3.4 right hand panel). Cycling cells 
of these strains were also assayed for their sensitivity to MMS via spot testing as before 
(Figure 3.2B). Spo11-3HA is more sensitive to MMS compared to the untagged SAE2 and 
Sae2-His10 constructs (Figure 3.2B). However, the SAE2-HA tagged form of Sae2 can be 
utilised to monitor expression levels of Sae2 mutants whilst having only a minor effect on wild 
type Sae2 activity in vivo.  
To determine the relative expression level of tagged SAE2 constructs, a Western blot was 
performed on extracts from meiotic cultures and probed for Sae2-HA or Sae2-His10 using 
anti-HA or anti-His antibodies. However, Sae2 protein was below the detection limit (data not 
shown). Expression levels of Sae2 from its natural chromosomal locus are only at ~100 
molecules per cell (Fu et al., 2014). Such low level expression from the natural SAE2 
promoter, alongside the mild hypomorphic nature of expressing SAE2 from the centromeric 
plasmid (Figure 3.2), suggests that Sae2 protein levels may be extremely low and therefore 
undetectable via Western blot from whole cell extract. An alternative approach that could be 
conducted on these cells would be to immunoprecipitate the Sae2 protein via their respective 
epitope tags and to repeat the Western, removing the potential inhibitory/masking effect the 
whole cell lysate has on detecting low level proteins. With this in mind, studying Sae2 
function via mutagenesis was all conducted on the Sae2-3HA form of the protein to allow the 
potential to attempt to monitor the expression levels at a later date if required.  
3.5 Over-expression of mutant alleles of SAE2 permits observation of activity 
undetectable at low-level expression 
In vitro work performed in the Cejka laboratory has demonstrated that some mutant forms of 
the Sae2 protein display null-like activity at low concentrations, but retain some residual 
activity when used at higher concentrations 
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 Hours:! 0!
pVG25 (CEN): SAE2!
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Figure 3.4: Spo11-oligonucleotides are generated in sae2! cells transformed with a centromeric 
plasmid expressing SAE2, SAE2-HIS10 or SAE2-HA.  
Spo11-oligonucleotide blot. The stated plasmids were transformed into sae2! cells with 
transformants selected using hygromycin resistance. YPD and YPA cultures were grown in the 
presence of 300 µg ml-1 hygromycin to maintain selection of the plasmid. 10 ml of cells were taken at 
the stated hour from the start of meiosis and Spo11-oligos were enriched using the Spo11-
oligonucleotide assay as stated in Materials and Methods. Samples were resolved on a 7.5% SDS-
PAGE gel at 150 V for 1 hour 30 minutes, transferred to a PVDF membrane and exposed to a 
phosphor screen overnight. Open triangles (   ) mark the long and short Spo11-oligo species generated 
in wild type cells. The open bracket (   ) marks the double-cut Spo11-oligonucleotide species seen in 
wild type and sae2!. Asterisk marks non-specific TdT band.  
3! 4! 5! 6! 8! 0! 3! 4! 5! 6! 8! 0! 3! 4! 5! 6! 8!
pDJ10 (CEN): SAE2-HA!pDJ11 (CEN): SAE2-His10!
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 (Cannavo and Cejka, 2014 - personal communication). To mimic this in vivo, a system 
capable of over-expression of SAE2 alleles in meiosis was created. SAE2-3HA was placed 
under control of the GAL1 promoter and integrated at the SAE2 locus. Because addition of 
galactose inhibits meiosis, the strain contained a chimeric GAL4-ER cassette, which enables 
induction via the addition of β-estradiol to the media (Louvion et al., 1993). However, early 
induction also prevents sporulation, therefore meiosis was allowed to proceed for 4 hours to 
allow accumulation of Spo11-DSBs before induction by β-estradiol. Addition of β-estradiol 
led to an increase in the formation of Spo11-oligos (Figure 3.5A - compare 5, 6 and 8 hours 
with and without induction). This generation of Spo11-oligos correlated with the detectable 
expression of the Sae2-HA protein via Western blot (Figure 3.5B). This β-estradiol-controlled 
expression of SAE2 was however leaky, with Spo11-oligo species visible at 3 and 4 hours 
before any induction of SAE2 had occurred (Figure 3.5A – 3 and 4 hour lanes). These species 
were also present in the uninduced sample from 5 to 12 hours (Figure 3.5A - 5-12 h left hand 
panel).  
To detect expression levels of Sae2-HA protein, Western blotting was used on whole cell 
extract from the meiotic time course (Figure 3.5B). The –HA tag fused to Sae2 was probed 
using anti-HA antibody. There was very little detectable protein from 3 hours onwards 
however, there is a relatively strong band observed at the 1 h period (Figure 3.5B). Expression 
of wild type SAE2-3HA, under control of its natural promoter from the centromeric plasmid, 
generated less Spo11-oligos (Figure 3.4 – right hand panel) compared to Spo11-oligos 
generated through leakiness of the GAL1 promoter (Figure 3.5A – 3-5 h uninduced). 
Undetectable protein levels of Sae2-HA from the CEN plasmid (data not shown) suggest that 
at early time points (Figure 3.5B - 1-3 h) leakiness of expression from the GAL1 promoter 
exceeds the basal expression levels of SAE2 from its natural promoter. This leakiness allows 
for a large proportion of Spo11-DSBs to be processed. Nevertheless, further expression of 
SAE2 did increase the levels of Spo11-oligos detected. This indicates that the leaky Sae2 
protein levels are still somewhat limiting biochemically.  
These results suggest expression of SAE2 from a centromeric plasmid infers a hypomorphic 
phenotype for Spo11-oligo production potentially due to the cells containing a single copy of 
the centromeric plasmid and thus also the SAE2 gene. Over-expression of SAE2 using a GAL4-
ER induction system results in leaky expression of SAE2 prior to induction with β-estradiol 
permitting Spo11-oligo production but upon induction Spo11-oligo production is vastly 
increased.  
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Figure 3.5: Galactose-inducible SAE2 leakiness is decreased with the presence of a natural 
cryptic ATG from both S288C and SK1 strains.  
10 ml of cells were taken at the stated hour from the start of meiosis and Spo11-oligos were enriched 
using the Spo11-oligonucleotide assay as stated in Materials and Methods. SAE2 expression was 
induced with the addition of 2 µM !œstradiol at 4 hours. Samples were resolved on a 7.5% SDS-
PAGE gel at 150 V for 1 hour 30 minutes, transferred to a PVDF membrane and exposed to a 
phosphor screen overnight. Open triangles (   ) mark the long and short Spo11-oligo species generated 
in wild type cells. The open bracket (   ) marks the double-cut Spo11-oligonucleotide species seen in 
wild type and sae2!. Asterisk marks non-specific TdT band. A. SAE2-HA expression was put under 
control of a galactose-inducible promoter with the start site sequence reading ATGgtga. B. Western 
blot performed on the whole cell lysate and Sae2-HA detected using primary antibody anti-HA 
(mouse) at 1 in 5000 and secondary antibody anti-mouse (rabbit)  at 1 in 5000. Chemiluminescence 
was detected using an ImageQuant LAS4000 machine C. SAE2 expression was put under control of a 
galactose-inducible promoter with the natural cryptic ATG from S288C inserted, start site sequence 
reading ATGtgagATGgtga. D. SAE2 expression was put under control of a galactose-inducible 
promoter with the natural cryptic ATG from SK1 inserted, start site sequence reading 
ATGtgggATGgtga. 
A!
1! 4! 5! 6!3! 8! Hours:! 10!12!24! 5! 6! 8! 10!12! 24!
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3.6 A cryptic start site at the SAE2 locus regulates expression of the protein 
The relatively high level of basal (uninduced) expression from the GAL1-SAE2 construct 
hinders the usage of this construct in a regulatable manner. From studying the sequence of the 
GAL1-SAE2 construct used in Figure 3.5A-B and the sequence of the natural SAE2 locus it 
was observed that the natural SAE2 gene in SK1 and S288C variants of S. cerevisiae both 
contain an upstream ORF (cryptic ATG site) six base pairs upstream of the annotated start 
codon (Figure 3.1B). In SAE2, this cryptic start site has the potential to generate a two and a 
seven amino acid peptide in S288C and SK1 strains respectively, that always overlaps with the 
natural start site. Such upstream, overlapping ORFs may suppress expression/translation of the 
main ORF by limiting its access to the ribosome (Morris and Geballe, 2000). The cryptic ATG 
at the SAE2 locus has the sequence ATGtgagATGgtga in S288C strains and 
ATGtgggATGgtga in SK1 strains with the second ATG coding for the annotated start of the 
SAE2 gene. By contrast, the sequence of the GAL1-SAE2 construct does not contain a cryptic 
ATG sequence because only the annotated ORF of the gene, without any upstream sequence, 
was cloned downstream of the GAL1 promoter (Figure 3.1B). To investigate whether the 
inclusion of the cryptic ATG could help to reduce the (leaky) basal level of SAE2 expression, 
constructs were generated with an additional six base pairs, either SK1- or S288C-like, 
between the GAL1 promoter and the annotated SAE2 ORF (Figure 3.1B) (Constructed by Nils 
Lambacher without the -3HA tag). Cells were sporulated as before, with addition of β-estradiol 
at 4 h to induce SAE2 expression, and Spo11-oligos measured via IP, end labelling and 
separation via SDS-PAGE. Spo11-oligo production still occurred before and without induction 
(Figure 3.5C-D - see 3 and 4 hours before induction and 5-8 hours in uninduced cells for both 
strains), however, levels are significantly lower than in the original GAL1-SAE2 expression 
strain (Figure 3.5A). After induction of SAE2, Spo11-oligo signal reached similar levels to 
those observed in the original GAL1-SAE2 construct in both the S288C-like and SK1-like 
constructs indicating the expression system works as effectively as before. Of the two cryptic 
strains, the SK1-like construct had lower levels of Spo11-oligos before induction and in the 
uninduced cells compared to the S288C strain, with the induced signal slightly higher. 
Therefore, the SK1-like construct was utilised for inducible-expression of SAE2 in subsequent 
experiments.  
3.7 Over-expression of N-terminal truncations of Sae2 permits Spo11-end 
processing  
The C-terminal region of Sae2 contains a conserved domain that is essential for most of Sae2 
functions (Lengsfeld et al., 2007). The N-terminal region contains domains required for self-
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interaction and oligomerisation, the function of which, have been studied in mitotic and 
meiotic cells (Kim et al., 2008; Lengsfeld et al., 2007). Deletion of the N-terminal region of 
Sae2, where the self-interaction residues (L25 and E131) reside, infer opposing phenotypes 
between mitotic and meiotic cells. Over-expression of the ∆N170 mutant of Sae2 supports 
sporulation in meiotic cells (Spo11 end processing was not directly assessed), but is unable to 
suppress MMS sensitivity (Kim et al., 2008). In vitro, the N-terminal truncation mutant is able 
to stimulate MRX endonuclease activity, although the concentration of Sae2 required was 
relatively high (Cannavo and Cejka, 2014).  
Because stimulation of the MRX endonuclease for DSB end processing only requires the C-
terminal domain of Sae2, these N-terminal truncations, when over-expressed, are expected to 
generate Spo11-oligos in meiotic cells. To test this prediction, inducible over-expression 
cassettes containing a range of N-terminal truncations were assessed for their ability to support 
Spo11-oligo production in meiotic cultures (Figure 3.6). All three truncation mutants (∆N58, 
∆N120 and ∆N170) are capable of producing Spo11-oligos when over-expressed (Figure 3.6 
MJ Neale – unpublished observations), supporting the conclusion that the N-terminal region is 
not essential for DSB end processing in meiotic cells. However, Spo11-oligo levels were 
progressively reduced the more truncated the Sae2 protein was. This reduction in Sae2 activity 
suggests that the N-terminal region influences the regulation of Sae2 activity. Self-interaction 
of Sae2 is thought to be critical for its activity (Kim et al., 2008), however, Fu et al., 2014 
reported that the monomer form of Sae2 was the active component but did postulate that in 
vivo it was more likely that Sae2 acted as a dimer. Therefore, it may be that, in vivo, efficient 
Sae2 activity is dependent on dimerisation but when self-interacting mutants (N-terminal 
deletions or point mutations) are over-expressed the monomeric form of Sae2 has some 
residual activity capable of stimulating the endonuclease activity of the MRX complex.  
As previously observed (Figure 3.5), expression of wild type SAE2 via the GAL4-ER system 
still results in a leakiness of the promoter prior to induction causing Spo11-oligos to be 
observed before induction and in the uninduced cells (Figure 3.5). This observation suggests 
that even low levels of full-length Sae2 are capable of processing Spo11-DSBs. However, in 
all the N-terminal truncation mutants of Sae2 (∆N58, ∆N120 and ∆N170), there is no 
observable Spo11-oligos produced before induction or in the uninduced cells. This observation 
points towards a hypomorphic phenotype of Sae2 when it is unable to dimerise and/or 
oligomerise. Whilst monomeric Sae2 can still function, its ability to stimulate MRX is 
therefore drastically reduced.  
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Figure 3.6: Increasing the length of an N-terminal truncation of Sae2 decreases Spo11-
oligonucleotide production.  
Sae2 was truncated as stated and placed under control of a galactose-inducible promoter. The strains 
contained the GAL4-ER hybrid cassette allowing for controlled induction of galactose-induced genes 
by addition of 2 µM !œstradiol at 4 hours. 10 ml of cells were taken at the stated hour from the start 
of meiosis and Spo11-oligos were enriched using the Spo11-oligonucleotide assay as stated in 
Materials and Methods. Samples were resolved on a 7.5% SDS-PAGE gel at 150 V for 1 hour 30 
minutes, transferred to a PVDF membrane and exposed to a phosphor screen overnight. Open 
triangles (   ) mark the long and short Spo11-oligo species generated in wild type cells. The open 
bracket (   ) marks the double-cut Spo11-oligonucleotide species seen in wild type and sae2!. 
Asterisk marks non-specific TdT band.  
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3.8 Mutation of the self-interaction residue L25 of Sae2 prevents Spo11-oligo 
formation   
Mutation of L25 and E131 in the N-terminal region of SAE2 causes MMS sensitivity and a 
reduction in sporulation efficiency (Kim et al., 2008). The L25 residue is important for inter-
molecular interaction between itself and E131 (or a domain in the vicinity of E131). E131-
E131 interactions were not observed (Kim et al., 2008). However, over-expression of the N-
terminal truncation mutants (Figure 3.6) would suggest this self-interaction is not essential for 
Sae2 activity in meiosis, or at least the requirement can be overcome by over-expression. To 
test the requirement of these self-interaction residues for the ability of Sae2 to promote Spo11-
oligo formation in meiosis, the L25P or E131V point mutants, that prevent self-interaction, 
were incorporated onto the centromeric plasmid and transformed into sae2∆ strains. Meiotic 
cultures were assessed for Spo11-oligo production as before (Figure 3.7). The E131V mutant 
had little effect on Sae2 activity with Spo11-oligo levels only slightly reduced (Figure 3.7A 
right hand panel). However, Spo11-oligos were completely absent in the L25P mutant - 
identical to the sae2∆ phenotype (Figure 3.7A - compare middle two panels). These 
observations support the conclusion that the loss of leakiness (observed Spo11-oligos) in the 
truncation mutants (Figure 3.6) stems from a reduction in the activity of the truncated protein 
due to loss of self-interaction. Likewise when expressed from the centromeric plasmid, which 
appears to reduce expression relative to the chromosomal locus (Figure 3.2A), the L25P 
mutant is unable to produce Spo11-oligos, therefore the low level of presumably monomeric 
Sae2 in this mutant is unable to activate MRX endonuclease activity.  
If this was the case, then over-expressing the L25P mutant might be expected to result in a 
similar outcome to over-expression of the truncated forms of Sae2. To test this idea, the L25P 
mutant was incorporated into the over-expression cassette (SK1-like ATG) with SAE2 
expression of the meiotic culture induced with β-estradiol at 4 h (Figure 3.7B). However, 
unlike wild type SAE2 (left hand panel), the L25P mutant failed to produce any Spo11-oligos 
after induction. This result suggests that the L25P mutant is deficient for any Spo11 end-
processing ability during meiosis and that it can’t be rescued by over-expression.  
3.9 Phosphorylation of Sae2 at S267 by CDK is essential for Sae2 activity in 
meiosis 
CDK phosphorylation of Sae2 at S267 is important for all of Sae2 cellular functions in vivo 
(Huertas et al., 2008; Manfrini et al., 2010) and in vitro (Cannavo and Cejka, 2014). The S267 
site was identified by looking for putative consensus sequences for CDK phosphorylation 
(S/T-P) (Songyang et al., 1994, 1996; Srinivasan et al., 1995). Sae2 contains three such  
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Figure 3.8: Only phosphorylation at S267 by CDK is essential for Sae2 DSB end-processing 
activity and not the other potential CDK phosphorylation sites.  
A. The stated putative CDK phosphorylation site mutants were created on a centromeric SAE2-HA 
plasmid and transformed into sae2! cells with transformants selected using hygromycin resistance.  
YPD and YPA cultures were grown in the presence of 300 µg ml-1 hygromycin to maintain selection 
of the plasmid. 10 ml of cells were taken at 4 h and 6 h points. B. Western blot of the Spo11-
oligonucleotide membrane. 1:4000 !-FLAG antibody (Santa Cruz) with HRP conjugate was used 
against the FLAG epitope tag of Spo11 and chemiluminescence measured using an ImageQuant LAS 
4000 machine. C. 10 ml of cells were taken at the stated time points. D. The sae2-S267A mutant was 
placed under control of a galactose inducible promoter containing a SK1 cryptic ATG site and 
expression induced with the addition of 2 µM !œstradiol at 4 hours. 10 ml of cells were taken at the 
stated hour from the start of meiosis. A,C&D. Spo11-oligos were enriched using the Spo11-
oligonucleotide assay as stated in Materials and Methods. Samples were resolved on a 8.75% SDS-
PAGE gel at 150 V for 1 hour 30 minutes, transferred to a PVDF membrane and exposed to a 
phosphor screen overnight. Open triangles (   ) mark the long and short Spo11-oligo species generated 
in wild type cells. The open bracket (   ) marks the double-cut Spo11-oligonucleotide species seen in 
wild type and sae2!. Asterisk marks non-specific TdT band.  
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consensus sites at S134, S179 and S267. S267A mutants, that prevent CDK phosphorylation at 
this residue, accumulate DSBs via Southern blotting, indicating a repair defect (Manfrini et al., 
2010). The sae2-S134A-S267A double mutant has a further reduction in spore viability than the 
S267A mutant alone (Manfrini et al., 2010), suggesting that the S134 site is also a target for 
CDK phosphorylation, which also stimulates Sae2 activity.  The S179A mutant had no defect 
in spore viability (Manfrini et al., 2010).  
In order to test these mutants directly for Spo11-DSB processing, meiotic cultures were 
assayed for Spo11-oligo formation in strains containing centromeric plasmid-borne mutant 
alleles of the three putative CDK consensus sites (Figure 3.8). Spo11-oligos were not observed 
at any time point of meiosis (up to 8 h) in the S267A mutant (Figure 3.8A&C). Spo11-oligos in 
the S134A mutant were slightly reduced compared to wild type, whilst the S179A mutant 
observed similar Spo11-oligo levels to wild type (Figure 3.8A). These results suggest that 
phosphorylation of the S267 putative CDK phosphorylation site is essential for Spo11-DSB 
end processing. The S134 site, whilst hypomorphic when mutated to alanine, can still promote 
Spo11-oligo formation in meiosis, suggesting a more minor role compared to the S267 
putative phosphorylation site. In agreement with previous reports, mutating the S179 site infers 
no phenotype, indicating phosphorylation of this residue has no effect on Sae2 activity. 
Cycling sae2-S267A cells were also assessed for sensitivity to MMS via spot testing as before. 
The S267A mutant rendered the cells more sensitive to MMS compared to wild type SAE2 
(Figure 3.2B), in agreement with previous reports (Huertas et al., 2008).  
To determine whether the S267A mutant was active when over-expressed, the mutant allele 
was cloned downstream of the GAL1 (SK1-like) promoter and introduced at the chromosomal 
locus. Meiotic cultures were assayed for Spo11-oligo formation as before, with addition of β-
estradiol at 4 h to induce sae2-S267A. Over-expression of the sae2-S267A mutant 
(Figure 3.8D) resulted in no production of Spo11-oligos, supporting the view that this site is 
the critical phosphorylation site for an active Sae2 protein in meiosis (Huertas et al., 2008; 
Manfrini et al., 2010).  
Mimicking phosphorylation by replacing a serine/threonine residue with glutamic (E) or 
aspartic (D) acid enables the ability to study the effects of having an artificial always-
phosphorylated state of a protein (negatively charged aspartic/glutamic acid residues are 
similar to the negative charge created by phosphorylation). Such mutants also allow us to 
appraise whether mutating a specific residue (e.g. serine to alanine mutation) disrupts protein 
folding rather than affecting its activity by preventing phosphorylation. The putative CDK 
phosphorylation sites of SAE2 were individually mutated to glutamic acid, placed onto a 
centromeric plasmid and transformed into sae2∆ cells. Meiotic cultures were assayed for 
Spo11-oligo production (Figure 3.8A&C). Mimicking phosphorylation at all three putative 
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CDK sites of Sae2 still permitted Spo11-oligo production. However, both the S267 and S134 
sites had slightly lower levels of Spo11-oligos compared to wild type. This suggests that any 
mutation of these residues may slightly reduce Sae2 activity but the protein still effectively 
folds to generate an active protein. To determine the effects of mimicking phosphorylation at 
the S267 site in mitotic cells, cycling cells containing the S267E mutant was assayed for MMS 
sensitivity via spot testing (Figure 3.2B). Consistent with the slightly hypomorphic nature of 
this mutation in meiosis, sae2-S267E cells were slightly more sensitive to MMS compared to 
wild type SAE2 but not as sensitive as the S267A mutant (Figure 3.2B). These results suggest 
phosphorylation of the S267 site is essential for processing of Spo11-DSBs.  
3.10 Phosphorylation of the putative Mec1/Tel1 site at T279 is important for the 
role of Sae2 in meiosis 
Phosphorylation by CDK is not the only phosphorylation event that occurs on Sae2. After 
DNA damage, and during the cell cycle, Sae2 becomes phosphorylated in a Mec1/Tel1 
dependent manner (Baroni et al., 2004). Mec1/Tel1 phosphorylate substrates on SQ or TQ 
residues (Kim et al., 1999). Sae2 contains five putative acceptor sites: S73, T90, S249, T279, 
S289 (Figure 3.1A). Mutation of all five residues to alanine (5A) causes MMS sensitivity, 
defective recombination at inverted repeats and defective meiotic recombination, phenotypes 
that are similar to sae2∆ (Baroni et al., 2004; Cartagena-Lirola et al., 2006). Mutation of the 
putative Mec1/Tel1 phosphorylation sites found at in the C-terminus of Sae2 (S249A, T279A 
and S289A, in combination with a S278A mutant) indicated these putative phosphorylation 
sites are more important for Sae2 function in meiosis than those found in the N-terminal region 
(S73 and T90) (Cartagena-Lirola et al., 2006). Because of the subtle differences in the 
phenotypes of the previously characterised mutants it was of interest to determine which 
residues were important for Spo11-DSB processing in meiosis. Single point mutants of each of 
the putative S/T-Q sites were generated by site-directed mutagenesis and assayed for meiotic 
Spo11-oligo production and for sensitivity to MMS in cycling cells (Figure 3.9). The S278 
residue on Sae2, whilst not a putative S/T-Q site for Mec1/Tel1 phosphorylation, has 
frequently been mutated alongside the actual putative Mec1/Tel1 phosphorylation site T279 
(Baroni et al., 2004; Cartagena-Lirola et al., 2006; Cejka lab - personal communication). 
Therefore, the double sae2-S278A-T279A mutant was also assayed for meiotic and mitotic 
DSB repair defects (Figure 3.9).  
The Spo11-DSB end-processing activity and the sensitivity to MMS had comparable 
outcomes. The sae2-S278A-T279A mutant is defective in Spo11-oligo formation (Figure 3.9A 
– right hand panel), as well as being sensitive to MMS (Figure 3.9C). The single mutation of  
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Figure 3.9: Mutation of individual potential Mec1/Tel1 phosphorylation sites shows T90 and 
T279 to be critical sites of phosphorylation for Sae2 activity with a combination mutant of the 
other four sites also abolishing Sae2 activity. The stated potential Mec1/Tel1 phosphorylation site 
mutants were created on a centromeric Sae2-HA plasmid and transformed in sae2! cells with 
transformants selected for using hygromycin resistance. The 4A mutant consists of S73A, T90A, 
S249A and S289A.  A. YPD and YPA cultures were grown in the presence of 300 µg ml-1 hygromycin 
to maintain selection of the plasmid. B. Western blot of the Spo11-oligonucleotide membrane. 1:4000 
!-FLAG antibody (Santa Cruz) with HRP conjugate was used against the FLAG epitope tag of Spo11 
and chemiluminescence measured using an ImageQuant LAS4000 machine. C. Spot tests. All plates 
contained 300 µg ml-1 hygromycin to maintain selection of the plasmid and the MMS plate contained 
0.025% MMS. Cultures were grown overnight in YPD (with 300 µg ml-1 hygromycin) then 
transferred to fresh YPD+HYG for 4 hours. Cultures were diluted to 0.2 OD600 and a 10-fold dilution 
series spotted onto the plate down to 0.00002, plates incubated at 30 °C for 4 days and images taken 
using a Syngene InGenius bioimaging system. D. The sae2-S278A-T279A mutant was placed under 
control of a galactose inducible promoter containing a SK1-like (cryptic) ATG site and expression 
induced with the addition of 2 µM !œstradiol at 4 hours. A and D: 10 ml of cells were taken at stated 
time points from the start of meiosis. Spo11-oligos were enriched using the Spo11-oligonucleotide 
assay as stated in Materials and Methods. Samples were resolved on a 8.75% SDS-PAGE gel at 150 
V for 1 hour 30 minutes, transferred to a PVDF membrane and exposed to a phosphor screen 
overnight. Open triangles (   ) mark the long and short Spo11-oligo species generated in wild type 
cells. The open bracket (   ) marks the double-cut Spo11-oligonucleotide species seen in wild type and 
sae2!. Asterisk marks non-specific TdT band. 
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T279A prevents any Spo11-oligo formation and confers a phenotype similar to sae2∆ on MMS 
plates, suggesting that the T279 site is a critical phosphorylation site to promote both mitotic 
and meiotic DSB repair. Mutation of the T90 site to alanine caused slight hypersensitivity to 
MMS and a reduction in Spo11-oligo levels compared to wild type. The other sites (S73, S249 
and S289) had very little effect on MMS sensitivity or Spo11-oligo formation suggesting that 
T279 and T90 are the most important of all the putative Mec1/Tel1 sites for regulation of Sae2 
activity. These observations agree with a recent study that also identified T90 and T279 to be 
important during mitotic DSB repair compared to the other S/T-Q sites (Liang et al., 2015).  
To determine whether the S/T-Q sites, other than T279, might have a redundant role, a sae2-
4A mutant was generated that contained the S73A-T90A-S249A-S289A mutations. The T279A 
mutation was left out, as it was known prior to this experiment that mutating T279 prevents 
any activity of Sae2 (see above). The sae2-4A mutant was as deficient in Spo11-DSB 
processing as the sae2∆ (Figure 3.9A right hand panel). This observation suggests that either 
there is some residual function for phosphorylation on these sites that only becomes apparent 
when all four sites are mutated or that the physical nature of this many mutations of Sae2 may 
have caused improper folding, unrelated to its phosphorylation state and renders the protein 
inactive.  
3.11 Over-expression of the sae2-S278A-T279A mutant overcomes the low 
level expression defects of this mutant  
A collaboration with the Cejka lab (Zurich) has demonstrated residual stimulation of MRX 
endonuclease activity in vitro by the sae2-S278A-T279A mutant protein, suggesting that this 
mutant may be just strongly hypomorphic, rather than an inactive allele. To test this idea, the 
sae2-S278A-T279A mutant was placed downstream of the GAL1 (SK1-like) promoter (Figure 
3.9D). Expression of the sae2-S278A-T279A was induced in a meiotic culture at 4 h with β-
estradiol and Spo11-oligo production assayed as before. Upon induction, a substantial 
production of Spo11-oligos was observed (Figure 3.9D). This result indicates that whilst 
defective at low-level expression, the sae2-S278A-T279A mutant is not fully inactive – in 
agreement with observations from the Cejka laboratory. Fu et al., 2014 proposed that Sae2 
activity is regulated via phosphorylation, which alters its oligomeric state. If this idea is 
correct, over-expression of a hypomorphic allele may generate enough monomeric (active) 
protein. Unlike the S278A-T279A mutant the S267A (CDK) mutant was not rescued by over-
expression (Figure 3.8D), which suggests that even if S267 phosphorylation does affect 
oligomeric state it may also have a major role in activating the Sae2 protein biochemically. 
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3.12 Mimicking Mec1/Tel1 phosphorylation on Sae2 at different residues 
renders differing outcomes in meiotic DSB processing  
As previously discussed with CDK phosphorylation, mimicking phosphorylation on putative 
Mec1/Tel1 phosphorylation sites is also informative as to how these residues function. Such 
mutants are also useful to study the effects of mimicking phosphorylation when the kinases 
responsible for the phosphorylation are absent. Mimicking Sae2 phosphorylation at all five 
S/T-Q sites caused a higher fraction of the soluble Sae2 to be in the active monomer/dimer 
form, which is thought to be the active form (Fu et al., 2014).  
To determine the impact of mimicking phosphorylation, individual and multiple 
phosphomimicking constructs were generated by site-directed mutagenesis and cloned into the 
CEN vector (Figure 3.10). Mimicking phosphorylation at T279, a site where phosphorylation 
is important (Figure 3.9), enabled production of Spo11-oligos, although at a reduced level, 
suggesting that mutation of this site does not affect protein folding negatively and instead 
supports the requirement for Mec1/Tel1 phosphorylation. Conversely, the T90 site, seen to be 
hypomorphic when mutated to alanine, is also hypomorphic with mutation to glutamic acid, 
suggesting mutation at this site may be interfering with proper folding of Sae2 rather than the a 
putative phosphorylation event itself having an effect on Sae2 activity. The T90E mutation, 
when coupled with S73E, S249E and T279E mutants (4E mutant) to mimic phosphorylation on 
all S/T-Q sites except S289 (more detail later) resulted in no Spo11-oligos being formed 
(Figure 3.10A). This could potentially be due to mis-folding of to the T90E mutation coupled 
with three other mutations that could disrupt the 4E mutant structure, thereby preventing any 
active Sae2. Alternatively, this result may suggest that hyperphosphorylation of Sae2 may 
inhibit its activity - in contrast to Fu et al., 2014.  
Intriguingly, despite the sae2-S289A mutant being fully proficient for Spo11-oligo formation 
(Figure 3.9A) and no more sensitive to MMS than wild type cells (Figure 3.9B), mutation of 
S289 to glutamic acid (S289E) resulted in no Spo11-oligo formation in meiosis (MMS 
sensitivity was not tested) (Figure 3.10 – S289E). To further investigate this phenotype, the 
S289E mutant was compared alongside another type of phospho-mimetic mutation of the site, 
sae2-S289D. Both these mimetic mutations abolish Spo11-oligo formation (Figure 3.10C). 
These results support unpublished, collaborative work from Petr Cejka’s lab who have 
observed no stimulation of MRX endonuclease activity in vitro even with high concentrations 
of the S289E mutant protein (personal communication). One hypothesis is that hyper-
phosphorylation of Sae2 at this site switches off the protein. In this model, the initial 
phosphorylation by Tel1 (whose activity is stimulated by the unprocessed DSB and may be 
less active then Mec1) at T279 may activate Sae2 to process the DSB ends allowing 5ʹ′ to 3ʹ′  
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Figure 3.10: Mimicking phosphorylation of individual putative Mec1/Tel1 phosphorylation sites 
suggests that the T90E and 4E mutation are hypomorphic whilst S289E abolishes Sae2 activity. 
The stated putative Mec1/Tel1 phosphorylation site mutants were created on a centromeric SAE2-HA 
plasmid and transformed in sae2! cells with transformants selected using hygromycin resistance. The 
4E mutant consists of S73E, T90E, S249E and T279E. A&C. YPD and YPA cultures were grown in 
the presence of 300 µg ml-1 hygromycin to maintain selection of the plasmid. 10 ml of cells were 
taken at 4 and 6 hours from the start of meiosis. Spo11-oligos were enriched using the Spo11-
oligonucleotide assay as stated in Materials and Methods. Samples were resolved on a 8.75% SDS-
PAGE gel at 150 V for 1 hour 30 minutes, transferred to a PVDF membrane and exposed to a 
phosphor screen overnight. Open triangles (   ) mark the long and short Spo11-oligo species generated 
in wild type cells. The open bracket (   ) marks the double-cut Spo11-oligonucleotide species seen in 
wild type and sae2!. Asterisk marks non-specific TdT band. B. Western blot of the Spo11-
oligonucleotide membrane. 1:4000 !-FLAG antibody (Santa Cruz) with HRP conjugate was used 
against the FLAG epitope tag of Spo11 and chemiluminescence measured using an ImageQuant 
LAS4000 machine.  
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resection to generate long ssDNA tails. These ssDNA tails then hyper-stimulate Mec1, and/or 
Mec1 is naturally more active, resulting in phosphorylation of Sae2 on the S289 residue, 
thereby switching Sae2 activity off.  
3.13 Combining CDK phospho-mimetics with S/T-Q site phospho-mimetics of 
Sae2 reduces the production of Spo11-oligos  
Sae2 phosphorylation at S267 by CDK is critical for its activity (Huertas et al., 2008; Manfrini 
et al., 2010). This site is also the priming phosphorylation site required for subsequent 
phosphorylation by Mec1/Tel1 (Fu et al., 2014). It was therefore of interest to determine the 
impact of combining phospho-mimetics on S267 and other S/T-Q sites. As described earlier 
(Figure 3.8), the S267E mutation has a slightly hypomorphic phenotype for Spo11-oligo 
formation suggesting some potential mis-folding of the protein. Meiotic cultures were assessed 
for Spo11-oligo formation as before and when in combination with S249E and T279E, S267E 
reduces Spo11-oligo formation (Figure 3.11A). The S267E mutant does not rescue the defect 
in Spo11-DSB processing in the S289E or the 4E mutants (Figure 3.11A). These observations 
suggest that either the S267E destabilises these already hypomorphic alleles, or that the S267 
phosphorylation of Sae2 is not an over-riding activator, and instead the other phosphorylation 
sites play an important role.  
3.14 Mec1 and Tel1 are required for Spo11-DSB end processing in meiosis 
In the absence of Mec1 and Tel1 activity Spo11-DSBs accumulate, an identical phenotype to 
sae2∆ cells (Cartagena-Lirola et al., 2006). Therefore, neither kinase is required for DSB 
formation but they are for processing of Spo11-DSBs and initiation of resection. However, 
using the Spo11-oligo assay for direct analysis of Spo11-DSB processing has not been 
reported. To investigate this further, tel1∆, CLB2-MEC1 and CLB2-MEC1 tel1∆ strains were 
made and assayed for Spo11-oligo production (Figure 3.12). The CLB2 gene is switched off in 
meiosis, therefore, placing a gene under the control of the CLB2 promoter allows for a 
meiosis-specific knockdown of the protein. The CLB2-MEC1 construct allows assessment of a 
mec1-null like phenotype, whilst having no effect on the mitotic roles of Mec1. Meiotic 
cultures of the mutant strains were assessed for Spo11-oligo production as before. Spo11-oligo 
levels were slightly raised in the tel1∆ background with an increase in higher molecular weight 
bands (see Chapter 6 for more detail about these molecules).  The CLB2-MEC1 strain had a 
very low level of Spo11-oligos whereas the tel1∆ CLB2-MEC1 mutant had an even lower 
residual level of Spo11-oligos, that were just above the detection limit (Figure 3.12). These 
results support the conclusion that Mec1 and Tel1 are important for the activation of Spo11- 
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Figure 3.11: Mimicking phosphorylation of a combination of Mec1/Tel1 and/or CDK putative 
phosphorylation sites decreases the levels of Spo11-oligos.  
The stated putative Mec1/Tel1 phosphorylation site mutants were created on a centromeric SAE2-HA 
plasmid and transformed in sae2! cells with transformants selected using hygromycin resistance. The 
4E mutant consists of S73E, T90E, S249E and T279E. YPD and YPA cultures were grown in the 
presence of 300 µg ml-1 hygromycin to maintain selection of the plasmid. 10 ml of cells were taken at 
4 and 6 hours from the start of meiosis. Spo11-oligos were enriched using the Spo11-oligonucleotide 
assay as stated in Materials and Methods. Samples were resolved on a 8.75% SDS-PAGE gel at 150 
V for 1 hour 30 minutes and transferred to a PVDF membrane. A. The membrane was exposed to a 
phosphor screen overnight. B. Western blot of the Spo11-oligonucleotide membrane. 1:4000 !-FLAG 
antibody (Santa Cruz) with HRP conjugate was used against the FLAG epitope tag of Spo11 and 
chemiluminescence measured using an ImageQuant LAS4000 machine. Open triangles (   ) mark the 
long and short Spo11-oligo species generated in wild type cells. The open bracket (  ) marks the 
double-cut Spo11-oligonucleotide species seen in wild type and sae2!. Asterisk marks non-specific 
TdT band.  
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Figure 3.12: Spo11-oligonucleotide production is decreased in the absence of both Mec1 and 
Tel1 kinases.  
The centromeric SAE2-3HA plasmid was transformed into the stated Mec1/Tel1 mutant cells with 
transformants selected using hygromycin resistance. YPD and YPA cultures were grown in the 
presence of 300 µg ml-1 hygromycin to maintain selection of the plasmid. 10 ml of cells were taken at 
4 and 6 hours from the start of meiosis. Spo11-oligos were enriched using the Spo11-oligonucleotide 
assay as stated in Materials and Methods. Samples were resolved on a 8.75% SDS-PAGE gel at 150 
V for 1 hour 30 minutes, transferred to a PVDF membrane and exposed to a phosphor screen 
overnight. Open triangles (   ) mark the long and short Spo11-oligo species generated in wild type 
cells. The open bracket (   ) marks the double-cut Spo11-oligonucleotide species seen in wild type and 
sae2!. Asterisk marks non-specific TdT band.  
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DSB processing. The low residual level of Spo11-oligos seen in the double mutant may 
indicate that SAE2 can function even without Mec1/Tel1 activation. Alternatively, the residual 
Spo11-oligos formed may be due to a low level of residual Mec1 activity in the CLB2-MEC1 
strain.  
3.15 Mimicking Sae2 phosphorylation on putative Mec1/Tel1 residues cannot 
rescue the Spo11-DSB processing defect of Mec1/Tel1 deficient cells 
If Sae2 is a major regulator of end processing, controlled by phosphorylation state, then 
mimicking phosphorylation of Sae2 may rescue this end-processing defect present in the 
Mec1/Tel1 strain. Mec1 and Tel1 deficient cells were transformed with centromeric plasmids 
containing the sae2-4E(S73E-T90E-S249E-T279E), sae2-S267E and sae2-4E(S267E) mutants. 
Meiotic samples were processed for Spo11-oligos as before (Figure 3.13). In the SAE2+ 
CLB2-MEC1 tel1∆ strain, the previously observed basal level of Spo11-oligos is present 
(Figure 3.12A). Introduction of the sae2-4E mutant to the sae2∆ CLB2-MEC1 tel1∆ strain 
failed to increase Spo11-oligo formation (Figure 3.13). This negative result may be due to 
potential mis-folding of the sae2-4E mutant because the 4E mutant was defective in a wild 
type background (see Figure 3.10A). To further investigate whether mimicking 
phosphorylation on Sae2 can bypass the requirement for Mec1 and Tel1, it would be best to 
test the T279E allele alone in  CLB2-MEC1 tel1∆ background because it is still proficient in 
producing Spo11-oligos in an otherwise wild type background and looks to be the main 
phospho-site for Mec1/Tel1. Thus it is possible that the T279E allele may rescue the end-
processing defect of Mec1/Tel1 deficient cells.  
3.16 Preventing or mimicking acetylation of Sae2 has no effect on its ability to 
stimulate Spo11-DSB processing 
Sae2 is acetylated after DNA damage on sites K239 and K266 (Fu et al., 2014). This 
modification targets Sae2 for degradation by the autophagy pathway. Mutation of these 
acetylation sites to block this modification (sae2-K239R-K266R) has no effect on DNA 
damage survival however; the double mutation mimicking acetylation (sae2-K239Q-K266Q) 
causes a growth defect even in the absence of damage, correlating with a decrease in the levels 
of Sae2 protein (Fu et al., 2014). To determine whether acetylation may have a role in meiotic 
or mitotic DSB end processing, the sae2-K239R-K266R mutant was created by site-directed 
mutagenesis of the CEN vector and meiotic cultures assayed for Spo11-oligo production and 
cycling cells assessed for sensitivity to MMS. Mutation of these acetylation acceptor sites had 
no effect on Spo11-oligo production (Figure 3.14A) or sensitivity to MMS in cycling cells  
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Figure 3.13: Mimicking phosphorylation of putative Mec1/Tel1 phosphorylation sites in a 
CLB2-MEC1, tel1! background does not rescue the Spo11-oligo production deficiency of CLB2-
MEC1, tel1! cells.  
The stated potential Mec1/Tel1 and CDK phosphorylation site mutants were created on a centromeric 
SAE2-HA plasmid and transformed into sae2! or sae2!, CLB2-MEC1, tel1! cells as stated with 
transformants selected using hygromycin resistance. The 4E mutant consists of S73E, T90E, S249E 
and T279E. YPD and YPA cultures were grown in the presence of 300 µg ml-1 hygromycin to 
maintain selection of the plasmid. 10 ml of cells were taken at 4 and 6 hours from the start of meiosis. 
Spo11-oligos were enriched using the Spo11-oligonucleotide assay as stated in Materials and 
Methods. Samples were resolved on a 8.75% SDS-PAGE gel at 150 V for 1 hour 30 minutes and 
transferred to a PVDF membrane. A. The membrane was exposed to a phosphor screen overnight. B. 
Western blot of the Spo11-oligonucleotide membrane. 1:4000 !-FLAG antibody (Santa Cruz) with 
HRP conjugate was used against the FLAG epitope tag of Spo11 and chemiluminescence measured 
using an ImageQuant LAS4000 machine. Open triangles (   ) mark the long and short Spo11-oligo 
species generated in wild type cells. The open bracket (  ) marks the double-cut Spo11-
oligonucleotide species seen in wild type and sae2!. Asterisk marks non-specific TdT band.  
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Figure 3.14: Acetylation mutants and mimetics of Sae2 do not have a defect in end-processing 
and Spo11-oligo production.  
The acetylation mutants (K239R-K266R) and mimics (K239Q-K266Q) were created on a centromeric 
SAE2-HA plasmid and transformed into sae2! cells with transformants selected using hygromycin 
resistance. YPD and YPA cultures were grown in the presence of 300 µg ml-1 hygromycin to maintain 
selection of the plasmid. 10 ml of cells were taken at the time points stated from the start of meiosis. 
Spo11-oligos were enriched using the Spo11-oligonucleotide assay as stated in Materials and 
Methods. Samples were resolved on a 7.5% SDS-PAGE gel at 150 V for 1 hour 30 minutes, 
transferred to a PVDF membrane and exposed to a phosphor screen overnight. Open triangles (   ) 
mark the long and short Spo11-oligo species generated in wild type cells. The open bracket (   ) marks 
the double-cut Spo11-oligonucleotide species seen in wild type and sae2!. Asterisk marks non-
specific TdT band.  
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(Figure 3.14B). Mutation of the putative acetylation sites on Sae2 to glutamine (sae2-K239R-
K266R) mimics acetylation by neutralising the charge (Dormeyer, 2005). As reported, the 
acetylation mimic had a growth defect on MMS plates (Figure 3.14B), however, there was no 
effect on Spo11-oligo production in meiosis (Figure 3.14A). From these observations it is 
possible to conclude that whilst the acetylation pathway may have some impact on Sae2 
function, it is not relevant for Spo11-DSB processing in meiosis.  
3.17 The reported endonuclease activity of Sae2 has no role in meiosis 
Sae2 has been reported to display endonuclease activity capable of cleaving 5ʹ′ flap structures 
and single-stranded regions at the base of hairpin loops (Lengsfeld et al., 2007). It was 
postulated that this Sae2 endonuclease activity is responsible for cleaving the 5ʹ′ strand during 
DSB repair alongside, but independently of, MRX (Lengsfeld et al., 2007). A subsequent study 
determined that mutation of N123 and R127 to alanine resulted in camptothecin sensitivity and 
defective hairpin processing (Wang et al., 2014), suggesting that these residues were part of 
the Sae2 catalytic domain.  
To test the putative role of the Sae2 endonuclease during meiosis, the sae2-N123A-R127A 
mutant was generated on the CEN vector and transformed into sae2∆ cells. Meiotic cultures 
were assessed for Spo11-oligo production (Figure 3.15). This putative endonuclease mutant 
generated Spo11-oligos at levels comparable to wild type cells (Figure 3.15). This observation 
suggests that either the endonuclease activity of Sae2 plays no role in meiotic Spo11-DSB 
processing or, as reported in other labs, Sae2 does not contain endonuclease activity (Cannavo 
and Cejka, 2014; Niu et al., 2010).  
3.18 Discussion 
The precise role of Sae2 in DSB processing has been intensively studied but there are still 
questions to be answered. Sae2 has an essential role in meiosis: Spo11-DSBs accumulate in 
the absence of the protein and resection is prevented (McKee and Kleckner, 1997; Prinz et al., 
1997). In mitotic cells however, the role of Sae2 can differ depending on the type of DNA 
damage that is present. The established model for DSB repair identifies Sae2 as an essential 
component when the end(s) of DNA damage are complex, be that due to covalently bound 
proteins, adducts or chemical modifications. When the end of the damage site is clean, for 
example, due to endonuclease activity, then the requirement for Sae2 is removed. Instead, at 
clean-ended breaks, Sae2 plays a role in enhancing the repair process rather than being 
essential. Sae2 function is linked to the nuclease function of Mre11 (MRX complex),  
Chapter 3: Investigating Sae2 activity in meiotic DSB end processing 
 101 
  
Figure 3.15: The endonuclease mutant of Sae2 does not have a defect in end-processing and 
Spo11-oligo production.  
The endonuclease mutant (N123A-R127A)  was created on a centromeric SAE2-HA plasmid and 
transformed into sae2! cells with transformants selected using hygromycin resistance. YPD and YPA 
cultures were grown in the presence of 300 µg ml-1 hygromycin to maintain selection of the plasmid. 
10 ml of cells were taken at the time points stated from the start of meiosis. Spo11-oligos were 
enriched using the Spo11-oligonucleotide assay as stated in Materials and Methods. Samples were 
resolved on a 7.5% SDS-PAGE gel at 150 V for 1 hour 30 minutes, transferred to a PVDF membrane 
and exposed to a phosphor screen overnight. Open triangles (   ) mark the long and short Spo11-oligo 
species generated in wild type cells. The open bracket (  ) marks the double-cut Spo11-
oligonucleotide species seen in wild type and sae2!. Asterisk marks non-specific TdT band.  
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specifically, Sae2 stimulates the endonuclease activity of Mre11 through a direct interaction 
with members of the MRX complex (Cannavo and Cejka, 2014). However, interaction 
domains have not been identified. In other studies, Sae2 has been reported to contain an 
endonuclease which is active on hairpin structures (Lengsfeld et al., 2007; Lobachev et al., 
2002). However, the lack of a nuclease domain on Sae2 and conflicting reports from other labs 
suggest that this is not the case. In meiosis, mutation of the putative endonuclease domain has 
no effect on the ability to generate Spo11-oligos and initiate HR (Figure 3.15).  
Sae2 has also been reported to be regulated by post-translational modifications. 
Phosphorylation of Sae2 by CDK has been studied in both mitotic and meiotic cells and is 
essential for all Sae2 processes (Huertas et al., 2008; Manfrini et al., 2010). In support of these 
findings Figure 3.8 demonstrates that the S267 site, and to a lesser extent, the S134 site, are 
essential for the initiation of Spo11-DSB repair. Control by CDK links activation of the HR 
pathway (via stimulation of the Mre11 endonuclease activity by Sae2) with the cell cycle stage 
and the presence of a homologous template that HR can repair from.  
The other pathway that regulates Sae2 activity by phosphorylation is the Mec1/Tel1 pathway. 
This pathway is activated by DNA damage and when activated leads to cell cycle arrest. Sae2 
phosphorylation by these kinases has also been studied in both mitotic and meiotic cells. It has 
been previously observed that preventing phosphorylation on all five of the potential 
Mec1/Tel1 S/T-Q sites at the same time created a defect in mitotic and meiotic recombination 
and sensitivity to MMS (Baroni et al., 2004; Cartagena-Lirola et al., 2006). Here I have shown 
that mutation of four of the five S/T-Q (S73, T90, S249 and S289) sites individually has no 
effect on Spo11-DSB processing (Figure 3.9), but a combination of the four (S73A, T90A, 
S249A and S289A) completely prevents Spo11-oligo formation. In contrast, mutation of the 
fifth S/T-Q site (T279) alone prevents any Spo11-oligo formation suggesting that this site is 
the crucial phosphorylation site for Sae2 activity in meiosis. This site, alongside T90, was 
recently reported to be crucial in Sae2 activity in mitotic cells with these residues linked to 
interaction with the MRX complex through the FHA domain of Xrs2 (Liang et al., 2015). 
Consistent with this report, the T90A mutant is hypomorphic for Spo11-oligo formation in 
meiosis (Figure 3.9).  
Interestingly, the sae2-S289E mutant (Figure 3.10) has an opposite effect to that of other 
phospho-mimetics with Spo11-DSB processing completely prevented. This result has been 
replicated in the Cejka lab’s in vitro work (personal communication). An exciting possibility is 
that phosphorylation at this site may switch off Sae2 stimulation of the MRX complex. With 
this in mind, the multiple potential Mec1/Tel1 phosphorylation sites on the Sae2 protein may 
act as a molecular switch. For example, DSB formation activates Tel1, which phosphorylates a 
subset (T279) of residues on Sae2 activating the protein. The now active Sae2 stimulates DSB 
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processing and resection, enabling the generation of long ssDNA tails. These DNA structures 
may then (hyper-) activate Mec1, which in turn hyper-/further phosphorylates Sae2 on the 
S289 site switching activity off (Figure 3.16).  
Mec1/Tel1 activity are required for DSB repair in meiosis with mec1∆ tel1∆ strains 
accumulating unresected DSBs (Cartagena-Lirola et al., 2006). Consistent with this 
observation, in a background deficient for these two kinases, initiation of DSB repair/Spo11-
oligo formation is suppressed (Figure 3.12). It has been suggested that it is the phosphorylation 
of Sae2 by these kinases that prevents the initiation of resection. If phosphorylation of Sae2 on 
T279 is the only role of Mec1/Tel1 at Spo11-DSB end processing then mimicking 
phosphorylation might be expected to bypass the requirement for Mec1/Tel1. However, the 
combination of four phospho-mimetic mutations resulted in an inactive form of Sae2, and thus 
this idea remains untested (Figure 3.13). Future work to answer this question would be to 
incorporate the sae2-T279E mutation alone in this Mec1/Tel1 deficient background and 
investigate the effect on Spo11-oligo formation and subsequent resection. However, it is also 
highly likely that phosphorylation of Sae2 is not the only Mec1/Tel1-dependent 
phosphorylation event that plays a role in control of DSB resection. 
Sae2 forms a higher order oligomer, which regulates its activity in vivo (Fu et al., 2014; Kim et 
al., 2008). Conflicting reports suggest either oligomerisation is critical for Sae2 activity (Kim 
et al., 2008) or that Sae2 is inactive when restrained in an oligomer, with phosphorylation (at 
all five S/T-Q and CDK putative sites) releasing Sae2 into an active monomeric form (Fu et 
al., 2014). Therefore, in meiosis, phosphorylation of Sae2 may also regulate the protein via 
alteration of its oligomeric state. The T279A mutation is deficient for stimulation of Spo11-
oligo formation at low-level expression (natural promoter) (Figure 3.9A) but, when over-
expressed, in combination with a mutation at S278 (S278A-T279A), was proficient for 
initiation of Spo11-DSB repair (Figure 3.8D). This suggests that Mec1-Tel1-dependent 
phosphorylation of T279 may regulate its oligomeric state as previously suggested (Fu et al., 
2014), with increased expression generating an increase in the ‘free’ monomeric (active) form 
of Sae2. In contrast, over-expressing the sae2-S267A CDK mutant, could not rescue the 
Spo11-oligo formation defect seen at low expression levels (CEN plasmid) of the allele 
(Figure 3.8), suggesting CDK-dependent phosphorylation of S267 may active Sae2 in another 
manner besides regulation of oligomerisation.  
These phosphorylation sites are not the only sites on Sae2 that control the higher order 
structure of Sae2. The N-terminus of Sae2 promotes oligomerisation via the L25 residue (Kim 
et al., 2008), yet in vitro the L25P mutant is still proficient for stimulation of MRX 
endonuclease activity when assayed at high concentration (Cannavo and Cejka, 2014). 
Similarly, over-expression of N-terminal truncation mutants also allow processing of Spo11- 
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Figure 3.16: Model for Mec1/Tel1 regulation of Sae2 activity in meiosis.  
Sae2 is essential for Spo11-DSB end-processing. The MRX complex, located at the Spo11-DSB 
activates the Tel1 kinase. Tel1 phosphorylates Sae2 at T279, which, alongside phosphorylation by the 
cell-cycle regulated CDK at S267, activates Sae2. Active Sae2 stimulates the Mre11 endonuclease, 
which nucleolytically removes Spo11 bound to an oligonucleotide (Spo11-oligo). The resulting 3! 
overhang is further resected by the long-range resection enzyme, Exo1. The generation of single-
stranded DNA by MRX/Sae2 and Exo1 activates the Mec1 kinase. Mec1 (hyper-)phosphorylates Sae2 
on S289 (and possibly other S/T-Q residues) inactivating Sae2 to prevent aberrant activation of the 
Mre11 endonuclease.  
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DSBs in vivo (Figure 3.6). Together, these observations suggest self-interaction is not essential 
for Sae2 activity but that it does promote the activity of Sae2. However, neither low nor over-
expression of the L25P mutant could restore Spo11-DSB processing in vivo. This suggests that 
this site may have another function in regulation of Sae2, or that when mutated it causes 
aberrant interactions of Sae2 causing the formation of an inactive protein.  
Collectively, this investigation presented here reveals novel mechanistic insight into the 
regulation of the Sae2 protein during meiosis with a variety of Sae2 modification sites found to 
be essential for Spo11-oligo removal during meiosis. Importantly, a single Mec1/Tel1 
phosphorylation site was found to be most important for meiotic Sae2 activity compared to the 
previously reported five sites. Additionally, previously reported Sae2 endonuclease activity 
and acetylation state of the protein plays no role in Sae2 activity in meiosis.  
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Chapter 4: Investigating TDP2 biochemistry 
4.1 Introduction 
In meiosis the evolutionary conserved topoisomerase-like protein, Spo11, generates 
programmed DSBs throughout the genome from which recombination initiates (Szostak et al., 
1983). The Spo11 dimer forms these DSBs by creating a 5ʹ′ covalent linkage with either side of 
the DSB via its catalytic tyrosine residue (Bergerat et al., 1997).  The Spo11 moiety needs to 
be removed in order for the DSB to be repaired. There are two potential ways in which this 
could occur: direct hydrolysis of the covalent bond between Spo11 and the 5ʹ′-end leaving a 2 
nt 5ʹ′-overhang, or nucleolytic cleavage of the 5ʹ′ strand removing Spo11 covalently attached to 
single-stranded oligonucleotides. Current evidence indicates that Spo11-DSBs are in fact 
repaired solely via the nucleolytic pathway in S. cerevisiae via the action of the MRX complex 
and Sae2 (Neale et al., 2005). Acting together, these proteins endonucleolytically clip the 5ʹ′ 
strand adjacent to the DSB and from this nick exonucleases can further resect the 5ʹ′ strand, 
releasing Spo11 still covalently bound to single-stranded oligonucleotides of set length via the 
5ʹ′ phosphotyrosine bond (Garcia et al., 2011).  
In mitotic cells, DSBs are also generated in a programmed manner although more transiently 
through the action of Top2. Top2, in order to regulate the topological state of the DNA and 
remove catenanes, creates DSBs to allow strand passage to occur (see Figure 1.7). It does so in 
a similar manner to Spo11, creating 5ʹ′ covalent phosphotyrosine linkages with either side of 
the DSB. A slight difference between the two types of DSB is that Top2 creates a 4 nt 5ʹ′-
overhang compared to Spo11 creating a 2 nt 5ʹ′ overhang (Burden and Osheroff, 1998). These 
DSBs are usually benign because the Top2 dimer reseals the break after use. However, during 
the normal catalytic cycle of Top2 and in response to chemical poisons, Top2-DSBs can 
become stabilised resulting in a toxic lesion (Corbett and Osheroff, 1993). Unlike Spo11-DSBs 
in S. cerevisiae, in mammalian cells, TOP2-DSBs can be repaired by both nucleolytic and 
hydrolytic pathways. MRN and CtIP can act upon TOP2-DSBs to nucleolytically process them 
although in yeast the oligonucleotides covalently bound to Top2 are shorter than those created 
during Spo11-DSB processing (Hartsuiker et al., 2009; Neale et al., 2005). The direct method 
of hydrolysing the phosphotyrosyl covalent bond between TOP2 and the 5ʹ′ end is conducted 
by the recently characterised tyrosine phosphodiesterase 2 (TDP2) protein in humans (Cortes-
Ledesma et al., 2009). TDP2 cleaves the phosphotyrosyl bond after TOP2 has been 
proteolysed and can also hydrolyse an array of other phosphotyrosyl bonds (Gao et al., 2012). 
However, even though the bond between Spo11 and the 5ʹ′ end of the DSB is such a linkage 
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there have been no reports of TDP2 acting on Spo11-DSBs or that TDP2 has any role in 
meiosis at all. In S. cerevisiae, there is no known yeast TDP2 ortholog, however yeast Tdp1 
does contain some residual 5ʹ′ phosphodiesterase activity (Murai et al., 2012; Nitiss et al., 
2006), but as in humans, has not been shown to act within yeast meiosis.  
If TDP2 were able to cleave the bond between Spo11 and the DSB end, this activity could be 
utilised to monitor DSB repair in meiosis on a DSB substrate with clean ends, which are 
potentially religatable via the NHEJ pathway. Additionally, direct removal of the protein 
moiety and direct ligation of a sequencing adaptor specifically to the Spo11 break end could be 
utilised to map Spo11-DSBs with nucleotide resolution (see Chapter 5). To determine if this is 
possible, TDP2 activity on Spo11 substrates requires verification.  
4.2 Can TDP2 cleave Spo11 from the end of a single-stranded 
oligonucleotide? 
The simplest Spo11 substrate that TDP2 activity could be tested on is the Spo11-oligo 
complexes generated during meiosis by the nucleolytic action of MRX/Sae2. These single-
stranded oligonucleotides are 5ʹ′ covalently linked to Spo11 with a phosphotyrosyl bond and 
can be enriched by immunoprecipitation (see Materials and Methods, and Chapter 3). Because 
TDP2 has been reported to remove TOP2 from the end of a DSB only after TOP2 proteolysis, 
it is also possible that Spo11 may also need to be proteolysed in order for TDP2 to work. Two 
different proteases, Proteinase K (Prot K, leaving 3 amino acids attached to the DNA) and 
trypsin (leaving 12 amino acids) can be used to generate differently sized peptides attached to 
the oligos for TDP2 to act upon. A schematic of the proposed action of TDP2 on various 
Spo11-oligo substrates is presented in Figure 4.1.  
4.3 TDP2 can cleave proteolysed Spo11 from the end of a single-stranded 
oligonucleotide  
Separation of Spo11-oligo species on an SDS-PAGE gel generates two bands that correspond 
to Spo11 attached to differing lengths of single-stranded oligonucleotide (Figure 4.1). The 
actual length of the oligonucleotides attached to Spo11 can be more accurately sized using a 
denaturing urea-PAGE (sequencing) gel. These gels separate DNA species by length, however, 
protein association to DNA molecules retards migration significantly. Therefore, in order to 
size these oligonucleotides in this manner, Spo11 must first be proteolysed. Typically 
Proteinase K is used to proteolyse Spo11 resulting in a bound peptide of only three amino 
acids. This short length of peptide has only a minor effect on migration of the DNA species but 
does still lead to slightly inaccurate sizing (Neale et al., 2005). To determine whether TDP2 is 
able to remove the protein component of Spo11-oligo substrates,  
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Figure 4.1: Schematic of potential TDP2 activity on Spo11-oligos and their digested derivatives. 
10 ml of cells were taken at the stated hour from the start of meiosis and Spo11-oligos were enriched 
from wild type cells using the Spo11-oligonucleotide assay as stated in Materials and Methods. 
Samples were resolved on a 7.5% SDS-PAGE gel at 150 V for 1 hour 30 minutes, transferred to a 
PVDF membrane and exposed to a phosphor screen overnight.  Open triangles (    ) mark the long and 
short Spo11-oligo species generated in wild type cells. Asterisk marks non-specific TdT band. Tdp2 
can cleave covalently bound, proteolysed Topoisomerase-II from the 5! end of DNA. Can TDP2 
cleave 5! covalently bound Spo11, or its proteolysed forms, from the end of single-stranded 
oligonucleotides? 
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Spo11-oligos were enriched by IP from meiotic cultures at mid-meiotic prophase, end-labelled 
and reacted with increasing concentrations of TDP2 (gift from Keith Caldecott) (Figure 4.2). If 
TDP2 can act upon Spo11 substrates it was expected to be most active upon proteolysed forms 
of Spo11, as it does for Top2 in vivo (Cortes-Ledesma et al., 2009). Therefore, Spo11-oligo 
complexes were first pre-digested with either Proteinase K or trypsin before incubation with 
TDP2. Reactions were then separated on a denaturing acrylamide gel (Figure 4.2). Without 
TDP2 treatment, Proteinase K treated Spo11-oligos migrate as a heterogeneous bimodal 
distribution, ranging from 10-15 bp and 25-40 bp (Figure 4.2 – 0 nM PK lane), consistent with 
previous reports (Neale et al., 2005). Incubation with TDP2 caused this distribution to migrate 
more rapidly, equivalent to a shift of ~3 nt. For the trypsin-digested samples, digestion leaves a 
twelve amino acid peptide still bound, which severely retards migration (Figure 4.2 - 0 nM 
trypsin lane) resulting in a heterogeneous smear. Incubation of these molecules with TDP2 
caused a dramatic shift in migration pattern, which matched that of the Proteinase K/TDP2 
treated samples.  
In DSB end-processing deficient mutants, such as sae2∆, Spo11-oligonucleotides are still 
observed on SDS-PAGE gels but have much longer lengths (Chapter 3 – Figure 3.2). To 
determine whether TDP2 can also act upon these Spo11-DNA derived species, Spo11-oligos 
were purified as before and reacted with increasing concentrations of TDP2 (Figure 4.3). 
Resolution of these proteolysed species on a denaturing gel migrate with a 10 bp periodicity 
and after TDP2 treatment also migrate faster (Figure 4.3). These results are consistent with 
TDP2-dependent hydrolysis of the covalent phosphotyrosine bond between the Spo11 peptide 
and the single-stranded DNA.  
4.4 TDP2-dependent shift in the size of Spo11-derived oligonucleotides is not 
due to nuclease contamination  
It is assumed that the shift in migration of the Spo11-oigo complexes is due to the action of 
TDP2. However, a contaminant nuclease in the TDP2 preparation may also cause degradation 
and faster migration of the product. To test this, a radioactively labelled primer was reacted 
with increasing concentrations of TDP2 to observe if there was any shift in migration. No 
shift, or release of single-radioactive nucleotides, was observed with any concentration of 
TDP2 (Figure 4.3), indicating that the shift observed in TDP2 treated Spo11-oligo species is 
not due to a contaminant nuclease and instead points to TDP2 being active on the Spo11 
phosphotyrosyl bond, something that has not been previously reported.  
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Figure 4.2: TDP2 can cleave the covalent bond between proteolysed Spo11 and a single-
stranded oligonucleotide.  
Spo11-oligonucleotide detection in wild type cells during meiosis. Spo11 complexes were 3! end 
labelled using TdT and dCTP radionucleotide. Spo11-oligos were digested with Proteinase K at 
60 °C for 1 hour or with Trypsin at 37 °C for 1 hour and DNA precipitated in ethanol overnight at 
-80 °C. DNA precipitates were resuspended in TDP2 reaction buffer and reacted with stated 
concentrations of TDP2 at 37 °C for 1 hour. Species were fractionated by denaturing urea-PAGE 
(19% acrylamide). The 10 bp ladder was labelled using TdT and dCTP radionucleotide. Asterisks 
are non-specific labelled contaminants. 
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Figure 4.3: Faster migration of Spo11-oligo complexes following TDP2 treatment is not due to 
contaminating nucleases.  
A. Spo11-oligonucleotide detection in sae2! cells during meiosis. Spo11 complexes were 3! end 
labelled using TdT and dCTP radionucleotide.  Spo11-oligos were digested with Proteinase K at 
60 °C for 1 hour. Complexes were reacted with stated concentrations of TDP2 at 37 °C for 1 hour. B. 
A random 30 bp primer was labelled using TdT and dCTP radionucleotide and reacted with the stated 
concentrations of TDP2 at 37 °C for 1 hour. The 10 bp ladder was labelled using TdT and dCTP 
radionucleotide. Asterisks are non-specific labelled contaminants. All samples were fractionated by 
denaturing urea-PAGE (19% acrylamide).  
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4.5 TDP2 can cleave full-length Spo11 from the end of a single-stranded 
oligonucleotide 
TDP2 is reported to act upon proteolysed TOP2 protein, hydrolysing the phosphotyrosyl bond 
between the degraded protein and the DNA (Cortes-Ledesma et al., 2009). TDP2 cannot 
process full-length native TOP2 (Gao et al., 2012). To determine whether TDP2 can remove 
unproteolysed, full-length Spo11 from the 5ʹ′-end of the oligonucleotide, intact radiolabelled 
(denatured) Spo11-oligo species were incubated directly with increasing concentrations of 
TDP2 and the reactions resolved on a denaturing acrylamide gel (Figure 4.4). Under these 
assay conditions full-length Spo11-oligonucleotide species do not migrate on these gels and 
are frequently lost from the well during fixation (Figure 4.4, lane 0 nM of unproteolysed 
Spo11-oligos). Increasing concentrations of TDP2 resulted in radiolabelled DNA species 
entering the gel (Figure 4.4 left hand panel) with lengths indistinguishable from the TDP2-
treated samples that had first been incubated with Proteinase K (Figure 4.4 right hand panel) or 
trypsin (Figure 4.2 right hand panel). However, compared to the samples pre-treated with 
Proteinase K or trypsin, the efficiency of TDP2 against full-length Spo11-oligos was much 
lower. Spo11 is a 45 kDa protein. Thus the reduction in total oligonucleotide signal compared 
to Prot K and TDP2 treated samples is likely to be explained by the larger protein molecule 
occluding access of the catalytic site of TDP2 to the phosphotyrosyl bond. Therefore, similar 
to previous observations of TDP2 activity on Top2 substrates, proteolysis of Spo11 enhances 
the ability of TDP2 to hydrolyse the covalent bond between the 5ʹ′-end of the ssDNA species 
and the protein adduct.  
4.6 TDP2 can remove proteolysed Spo11 from the end of double-stranded 
genomic DNA to enable λ  exonuclease to resect but not Exo1 
In strains containing Spo11-DSB end processing mutants such as sae2∆, mre11-nd and 
rad50S, Spo11-DSBs accumulate. These DSBs contain Spo11 covalently bound to the 5ʹ′ end, 
preventing resection and repair. To determine whether TDP2 is able to remove such covalently 
attached Spo11 from duplex DNA a novel assay system was developed. Extracting genomic 
DNA in a proteolysing manner (with Proteinase K) from mid-meiotic prophase generates a 
population of genomic DNA fragments, some of which are derived from DSBs and thus have 
5ʹ′ ends covalently bound to a short (~3 aa) peptide. One of the most frequent Spo11-DSB sites 
in the genome is the HIS4::LEU2 meiotic recombination hotspot (Xu and Kleckner, 1995). 
This site contains two strong DSBs, that can be visualised via Southern blotting (Figure 4.5). 
In a sae2∆ mutant these two DSBs migrate as two tight bands on the gel because no in vivo  
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Figure 4.4: TDP2 can cleave the covalent bond between unproteolysed/full-length Spo11 and a 
single-stranded oligonucleotide.  
Spo11 complexes were 3! end labelled using TdT and dCTP radionucleotide.  Spo11-oligos were left 
unproteolysed or were digested with Proteinase K at 60 °C for 1 hour. Complexes were reacted with 
stated concentrations of TDP2 at 37 °C for 1 hour and fractionated by nucleotide resolution urea-
PAGE (19% acrylamide). The 10 bp ladder was labelled using TdT and dCTP radionucleotide. 
Asterisks are non-specific labelled contaminants. 
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Figure 4.5: TDP2 can remove proteolysed Spo11 from the end of double-stranded DNA to 
enable ! exonuclease, but not Exo1, to resect DSBs.  
Southern blot of DSBs at the HIS4::LEU2 meiotic hotspot. A meiotic time course was performed for 
a sae2! strain and samples taken at 6 hours. Proteolysed genomic DNA was extracted and split into 
four sub-samples. A (‘Exo1’) and C (‘!exo’) were incubated at 37 °C for 1 hour in Exo1 reaction 
buffer without the addition of TDP2 protein. B (‘TDP2 Exo1’) and D (‘TDP2 !exo’) were incubated 
at 37 °C for 1 hour in Exo1 reaction buffer with the addition of 300 nM TDP2 protein. A and B were 
then incubated at 30 °C with the addition of 20 nM Exo1 and 680 nM RPA proteins and C and D were 
supplemented with ! exonuclease buffer and 5 units of  ! exonuclease (NEB) and reacted at 37 °C. 
Time points were taken at the stated times. All reactions were stopped and DNA extracted with the 
addition of 1 volume of water and 1 volume of phenol:chloroform:isoamyl alcohol (25:24:1). DNA 
was precipitated using ethanol and digested with PstI overnight before being separated on a 0.7% 
TAE agarose gel for 18 hours at 60 V. The gel was transferred to nylon membrane under denaturing 
conditions and hybridised with a radioactive probe for the HIS4::LEU2 locus. The membrane was 
exposed to a phosphor screen and image taken using a Fuji phosphor scanner. DSBs are marked with 
an arrowhead ( > ). Dotted lines on the schematic indicate gDNA.  
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end resection has occurred. Such gDNA substrates were incubated with TDP2 under the same 
conditions that were shown to remove Spo11 from Spo11-oligo complexes (Figure 4.2). To 
determine whether Spo11 had been removed by TDP2, samples were subsequently incubated 
with lambda exonuclease (λexo). The processive 5ʹ′ to 3ʹ′ λexonuclease requires a free, 
unmodified 5ʹ′ phosphate group at the DNA end (Subramanian et al., 2003). Thus, any 5ʹ′ 
covalently bound peptide is expected to block resection by λexo, just as it blocks resection in 
vivo by 5ʹ′ to 3ʹ′ exonucleases such as Exo1. Without TDP2 treatment, λexo is unable to resect 
the Spo11-DSB molecules (Figure 4.5C). By contrast, pre-treatment of the gDNA with TDP2 
before λexo treatment enables λexo to resect both DSBs at the HIS4::LEU2 hotspot (Figure 
4.5D). Therefore, TDP2 can remove a short Spo11-derived peptide from the end of dsDNA 
even in the presence of many-fold excess competitor gDNA.  
λexo is a commercial enzyme from E. coli and thus, although it allows for a positive read out 
for TDP2 treatment on Spo11-DSBs, it has little biological context for meiosis. The main 5ʹ′ to 
3ʹ′ exonuclease in meiosis is Exo1 (Zakharyevich et al., 2010). Spo11 creates DSBs with a 2 bp 
5ʹ′-overhang but the action of the MRX complex and Sae2 in vivo generates a short 3ʹ′ ssDNA 
tail (~270 nt) onto which, Exo1 loads and catalyses further 5ʹ′ to 3ʹ′ resection (Zakharyevich et 
al., 2010). The importance of this initial end-processing and resection by MRX/Sae2 has been 
linked to the promotion of HR at the expense of NHEJ (Shibata et al., 2014).  
Therefore, it was of interest to determine whether, if Spo11 were to be removed directly 
through hydrolysis of the covalent bond by TDP2, recombinant Exo1 would be able to resect 
the resulting DNA substrate. Normally the bound Spo11 protein would be a block itself to the 
5ʹ′ to 3ʹ′ exonuclease but with TDP2 pre-treatment this would free the 5ʹ′ end, as it did for λexo, 
for the potential access to Exo1. In collaboration with Petr Cejka’s lab, recombinant Exo1 was 
purified from the baculovirus system (Cannavo et al., 2013). As expected, the Spo11 peptide 
bound to the 5ʹ′ end of the DSBs prevents any resection by Exo1 (Figure 4.5A). The question 
was then asked as to whether Exo1 could resect the DSBs once this peptide was removed. Pre-
treatment with TDP2 followed by reaction of the substrate with Exo1 for up to 15 min, 
however, still resulted in no resection by Exo1. This intriguing result suggests that even when 
the Spo11 peptide block is removed, Exo1 is still incapable of initiating resection. 
To verify these results and to further test the activity of TDP2, the experiment was conducted 
on genomic DNA from mid-meiotic prophase, extracted in the absence of proteolysis (see 
Materials and Methods). This procedure extracts gDNA and any covalently attached protein 
whilst removing all non-covalently bound proteins. Under these conditions, full-length Spo11 
will be bound to the 5ʹ′ ends of any DSB molecules rather than a short peptide. This material 
was then incubated with either λexo or Exo1 for up to 15 min with or without pre-treatment of 
Chapter 4: Investigating TDP2 biochemistry 
   117 
TDP2 (Figure 4.6). As with proteolysed gDNA substrate, λexo resects DSB molecules only 
after pre-treatment with TDP2 (Figure 4.6C&D), whilst Exo1 is unable to resect with or 
without pre-treatment with TDP2 (Figure 4.6A&B).  
4.7 Recombinant Exo1 can resect genomic DNA containing DSBs with 3ʹ′  
overhangs 
Because of the failure of Exo1 to degrade sae2∆-derived DSBs that had been deprotected by 
TDP2, it was important to validate the activity of the recombinant protein preparation. One 
possible explanation for the negative results when using Exo1 may be due to a buffer 
incompatibility. To remove any potential inhibitory effects of any of the components of the 
TDP2 buffer on Exo1 activity, TDP2 activity in the Exo1 reaction buffer was tested (Figure 
4.7). Incubation of Spo11-oligos, enriched from mid-meiotic prophase, with TDP2 in the Exo1 
reaction buffer resulted in faster migration of the oligonucleotides as before (Figure 4.7A). 
This observation indicates that TDP2 is active in the Exo1 buffer, and means that the prior 
assays can all be repeated using the Exo1 buffer, thus avoiding any buffer swaps or potential 
carry over of inhibitory components from the TDP2 reaction buffer.  
Next, genomic DNA was purified from an exo1∆ dmc∆ strain at mid-meiotic prophase. This 
strain accumulates DSBs that have been processed in vivo and potentially resected by the 
MRX complex and Sae2. The dmc1∆ mutation prevents any strand invasion and repair from 
occurring thus allowing DSBs to accumulate. The resulting DNA substrate contains DSBs 
with 3ʹ′ ssDNA tails up to 270 nt in length due to no further 5ʹ′ to 3ʹ′ resection by Exo1 (exo1∆) 
(Zakharyevich et al., 2010). This substrate is expected to be similar to the substrate that Exo1 
acts upon in vivo. Thus if resection is observed, Exo1 activity of the recombinant protein can 
be verified. Incubation of exo1∆ dmc∆ gDNA, extracted from mid-meiotic prophase, with 
recombinant Exo1 leads to resection of these 3ʹ′ overhang DSB substrates even though they are 
in the presence of excess competitor gDNA. Additionally, and importantly pre-treatment with 
TDP2 does not negatively affect Exo1 activity on this type of DNA substrate (Figure 4.7B – 
final column).  
These results confirm that despite recombinant Exo1 being active it is unable to resect a 2 nt 5ʹ′ 
overhang generated by TDP2-dependent removal of Spo11 (Figure 4.5 & 4.6). These 
observations agree with a report that in vitro, Exo1 resection has varying levels of efficiency 
depending on the composition of the DNA end (Cannavo et al., 2013).  In particular, it was 
noted that the preferred substrate of Exo1 is dsDNA with a 3ʹ′ extension, similar to that created 
by MRX/Sae2 in vivo (Garcia et al., 2011), whereas Exo1 is less efficient at resecting blunt  
Chapter 4: Investigating TDP2 biochemistry 
   118 
  
Figure 4.6: TDP2 can remove unproteolysed/full-length Spo11 from the end of double-stranded 
DNA to enable ! exonuclease, but not Exo1, to resect DSBs.  
Southern blot of DSBs at the HIS4::LEU2 meiotic hotspot. Experiments were performed identically 
to Figure 4.5, except unproteolysed genomic DNA (rather than proteolysed genomic DNA) was used 
as a substrate. DSBs are marked with an arrowhead ( > ). 
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Figure 4.7: Recombinant Exo1 can resect purified genomic DNA from an exo1! dmc1! 
background.  
A. Spo11 complexes were 3! end labelled using TdT and dCTP radionucleotide. Spo11-oligos were 
digested with Proteinase K at 60 °C for 1 hour and DNA precipitated in ethanol overnight at -80 °C. 
DNA precipitates were resuspended in Exo1 reaction buffer, reacted with stated concentrations of 
TDP2 at 37 °C for 1 hour and fractionated by nucleotide resolution urea-PAGE (19% acrylamide). 
The 10 bp ladder was labelled using TdT and dCTP radionucleotide. Asterisks are non-specific 
labelled contaminants. B. Southern blot of DSBs at the HIS4::LEU2 meiotic hotspot. A meiotic time 
course was performed for an exo1! dmc1! strain and samples taken at 6 hours. Proteolysed genomic 
DNA was extracted and split into four sub-samples. (i) and (ii) were incubated at 37 °C for 1 hour in 
TDP2/Exo1 reaction buffer without the addition of TDP2 protein. (i) was incubated at 30° C without 
the addition of Exo1 protein (‘No protein’) and (ii) with 20 nM Exo1 (‘Exo1’) and 680 nM RPA 
proteins. (iii) and (iv) were incubated at 37 ° C for 1 hour in TDP2/Exo1 reaction buffer with the 
addition of 300 nM TDP2 protein. (iii) was incubated at 30° C for the stated time without the addition 
of Exo1 protein (‘TDP2’) and (iv) with 20 nM Exo1 (‘TDP2 Exo1’) and 680 nM RPA proteins. Time 
points were taken at the stated times. All reactions were stopped and DNA extracted with the addition 
of 1 volume of water and 1 volume of phenol:chloroform:isoamyl alcohol (25:24:1). DNA was 
precipitated using ethanol and digested with PstI overnight before being resolved on a 0.7% TAE 
agarose gel for 18 hours at 60 V. The gel was transferred to nylon membrane under denaturing 
conditions and hybridised with a radioactive probe for the HIS4::LEU2 locus. The membrane was 
exposed to a phosphor screen and image taken using a Fuji phosphor scanner. DSBs are marked with 
an arrowhead (  ). 
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ended substrates and significantly impeded by dsDNA with a 5ʹ′ overhang (Cannavo et al., 
2013).  
4.8 Exo1 cannot resect DSBs with 5ʹ′  overhangs or ends blunted with Klenow 
To determine whether blunting the 2 nt 5ʹ′ overhang would be sufficient to stimulate Exo1 
activity, Klenow fragment and dNTPs were used to blunt the 2 nt 5ʹ′ overhang after TDP2 
removal of the covalently bound peptide (Figure 4.8). This genomic DNA substrate with 
blunted DSBs was reacted with Exo1 as in prior experiments. As a positive control to confirm 
that TDP2 was removing the bound peptide, parallel reactions were also incubated with λexo 
(Figure 4.8D-E). Whereas λexo was still able to resect the DSBs after TDP2 pre-treatment, 
Exo1 remained unable to initiate resection (Figure 4.8A-C). One possibility to explain the 
inability of Exo1 to initiate resection at 2 nt 5ʹ′ overhangs, or blunt ends used in this system, is 
because of the excess of competitor genomic DNA negatively affecting Exo1 compared to 
published in vitro experiments using linear plasmid substrates (Cannavo et al., 2013).  
4.9 Ectopic expression of TDP2 is unable to cleave Spo11 from DSBs in 
S. cerevisiae meiosis  
The results presented above indicate that TDP2 is capable of removing denatured, full-length 
Spo11 from the ends of DSBs in vitro. S. cerevisiae does not contain an ortholog of the human 
TDP2 protein but a previous study saw that ectopic expression of human TDP2 in yeast cells 
rescued tdp1∆ rad1∆ sensitivity to CPT  (Cortes-Ledesma et al., 2009) indicating that human 
TDP2 is active within this environment. To determine if TDP2 could perform this activity in 
vivo during meiosis the TDP2 gene was placed under the control of the GAL1 promoter on a 
centromeric plasmid and transformed into a sae2∆ strain. This strain will accumulate 
unresected DSBs during meiosis due to the sae2∆ mutant. TDP2 induction was initiated at 
4 hours after the start of meiosis and Spo11-DSBs were monitored using Southern blotting of 
the HIS4::LEU2 hotspot as in previous figures (Figure 4.9A).  However, no difference was 
observed between induced, uninduced or control (sae2∆ only) samples at any time points 
(Figure 4.9A right hand panel). DSBs accumulated in all strains with levels, or electrophoretic 
mobility of DSBs, unchanged. To test whether TDP2 was being effectively induced in these 
experiments TDP2 expression was monitored using Western blotting on whole cell lysate 
using a specific anti-TDP2 antibody (gifted from the Caldecott lab). Bands indicative of TDP2 
were present only in the induced samples. As expected, these species migrated slightly faster 
than the TDP2-His12 recombinant protein (right hand most lanes), which was used as a control 
for the specificity of the antibody.  
Figure 4.8: Exo1 cannot resect double-stranded DNA 5! overhangs or ends blunted using 
Klenow.  
Southern blot of DSBs at the HIS4::LEU2 meiotic hotspot. A meiotic time course was performed for 
a sae2! strain and samples taken at 6 hours. Proteolysed genomic DNA was extracted, split into five 
sub-samples and Exo1 reaction buffer and 66 µM dNTPs added. A (‘Exo1’) was incubated at 30 °C 
with 20 nM Exo1 and 680 nM RPA proteins. B (‘Klenow Exo1’) had 3 µl Klenow Fragment (3! ! 5! 
exo-) added and incubated at 37 °C for 30 minutes then incubated at 30 °C with 20 nM Exo1 and 
680 nM RPA proteins. C (‘TDP2 Klenow Exo1’) was incubated at 37 °C for 1 hour with the addition 
of 300 nM TDP2 protein, then incubated at 37 °C with 3 µl Klenow Fragment (3! ! 5! exo-), then 
incubated at 30 °C with 20 nM Exo1 and 680 nM RPA proteins. D (‘!exo’) was incubated at 37 °C in 
! exonuclease buffer and 5 units of  ! exonuclease (NEB). E (‘TDP2 !exo’) was incubated at 37 °C 
for 1 hour in TDP2 reaction buffer with the addition of 300 nM TDP2, supplemented with ! 
exonuclease buffer and 5 units of  ! exonuclease (NEB) and reacted at 37 °C. Time points were taken 
at the stated times. All reactions were stopped and DNA extracted with the addition of 1 volume of 
water and 1 volume of phenol:chloroform:isoamyl alcohol (25:24:1). DNA was precipitated using 
ethanol and digested with PstI overnight before being resolved on a 0.7% TAE agarose gel for 18 
hours at 60 V. The gel was transferred to nylon membrane under denaturing conditions and hybridised 
with a radioactive probe for the HIS4::LEU2 locus. The membrane was exposed to a phosphor screen 
and image taken using a Fuji phosphor scanner. DSBs are marked with an arrowhead ( > ). 
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Figure 4.9: Induction of TDP2 expression in vivo in sae2! cells has no effect on Spo11-DSBs at 
HIS4::LEU2.  
TDP2 expression was placed under the control of a galactose inducible promoter on a centromeric 
plasmid (hygromycin resistance). sae2! cells were transformed with an empty hygromycin resistance 
plasmid or the TDP2 expression plasmid. YPD and YPA cultures were grown in the presence of 
300 µg ml-1 hygromycin to maintain selection of the plasmid. 10 ml of cells were taken at stated time 
points from the start of meiosis. TDP2 expression was induced with the addition of 2 µM !œstradiol 
at 4 hours. A. DSBs were detected at the HIS4::LEU2 locus, using Southern blotting as described in 
previous figures, in the presence and absence of TDP2 induction.  B. 8 hour time points from both 
sae2! and sae2! GAL:TDP2 stains, with and without TDP2 expression, were taken and the Spo11-
DNA enrichment protocol performed. ‘–PK’ is without Proteinase K digestion, ‘+PK’ is with 
Proteinase K digestion 65 °C for 30 minutes, ‘E’ is the eluate from the column enrichment. C. 
Western blot on whole cell lysate from stated time points. 0.5 ng and 5 ng of recombinant TDP2-
His12 loaded. TDP2 was probed with anti-TDP2 antibody at 1:5000 and anti-mouse secondary 
antibody used at 1:5000.  
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If TDP2 can remove Spo11 in vivo, the outcome of the DSBs in meiosis is unknown. In 
principle, DSBs could be repaired as normal, with Exo1 able to resect the now clean end – 
however, evidence presented in Figure 4.7 would indicate this may not be possible. 
Alternatively DSBs may now be repaired by NHEJ because the clean ends would be capable 
of simple religation. Both these explanations though would be visualised on the Southern blots 
by the DSB bands at HIS4::LEU2 disappearing over time in a TDP2-dependent manner, which 
is not the case. Alternatively, TDP2 may have removed Spo11 from the DSB ends but both 
Exo1 is incapable of resecting these 5ʹ′ overhangs (as indicated by Figure 4.7) and the NHEJ 
machinery is inhibited in meiosis by factors such as CDK (Hentges et al., 2014). In this 
scenario unrepaired DSBs would accumulate and not disappear from the Southern blots even if 
TDP2 were functional. To test for this scenario, glass filter columns were used to enrich for 
protein-associated DNA molecules in samples prepared from the sae2∆ samples with and 
without induction of TDP2 (see Materials and Methods and Chapter 5 for more details). 
Protein-associated DSB eluates were then resolved on an agarose gel and visualised by 
Southern blotting (Figure 4.9B). No reduction in protein associated DNA molecules were 
observed in the TDP2-induced samples suggesting that TDP2 is not capable of removing 
Spo11 from the ends of the DSBs in meiosis.  
4.10 Constitutive expression of TDP2 cannot remove Spo11 from DSB ends 
TDP2 expression by the meiotic GAL1 induction system did not produce large amounts of 
TDP2 (Figure 4.9C), suggesting that it may have been limiting for the Spo11 removal reaction 
in vivo. As an alternative, a constitutive expression system was made by cloning TDP2 
downstream of the highly expressed, constitutive ADH1 promoter in a centromeric plasmid. 
The plasmid containing this construct was transformed into sae2∆ cells and DSB formation 
around the HIS4::LEU2 hotspot analysed as before (Figure 4.10). DSBs from strains with or 
without the TDP2 expression plasmid did not differ again suggesting that TDP2 is not capable 
of removing Spo11 in vivo. To test whether TDP2 had removed Spo11 but the DSBs were 
unrepairable, the genomic DNA from these samples were extracted and reacted with λexo. 
λexo should be able to resect the DSBs if Spo11 has been removed in vivo. However, no 
resection was observed with or without TDP2 expression in vivo (Figure 4.10B). Therefore, it 
is concluded that TDP2 cannot hydrolyse the phosphotyrosyl bond between Spo11 and the 
DSB ends in vivo, contrary to its activity in an in vitro system. 
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Figure 4.10: Constitutive expression of TDP2 cannot remove Spo11 from DSB ends.  
TDP2 expression was placed under control of the highly expressed ADH1 promoter on a multi-copy 
plasmid, marked with hygromycin resistance. sae2! cells were transformed with an empty 
hygromycin resistance plasmid or the ADH1:TDP2 plasmid and transformants selected for 
hygromycin resistance. YPD and YPA cultures were grown in the presence of 300 µg ml-1 
hygromycin to maintain selection of the plasmids. 10 ml of cells were taken at stated time points from 
the start of meiosis and genomic DNA extracted. A. Southern blot at HIS4::LEU2 hotspot. Genomic 
DNA was digested with PstI overnight before being separated on a 0.7% agarose gel for 18 hours at 
60 V. B. Genomic DNA from both strains at 10 h into meiosis were reacted with !exo at 37 °C for 
stated time to monitor potential Spo11 removal by TDP2. Reactions were stopped with addition of 
Proteinase K and incubated at 60 °C for 30 min. DNA was digested with PstI overnight before being 
separated on a 0.7% agarose gel for 18 hours at 60 V. The gels (A & B) were transferred to nylon 
membrane under denaturing conditions and hybridised with a radioactive probe for the HIS4::LEU2 
locus. The membranes were exposed to phosphor screens and images taken using a Fuji phosphor 
scanner. DSBs are marked with an arrowhead ( > ). 
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4.11 Discussion 
TDP2 has previously been shown to cleave phosphotyrosyl bonds on synthetic substrates as 
well as in vivo on proteolysed TOP2-DSB complexes (Cortes-Ledesma et al., 2009; Gao et al., 
2012). There is no yeast ortholog of human TDP2, enabling the study of its activity on Spo11-
DSBs in meiosis. Interestingly, TDP2 is expressed in mouse and human testes tissue (Pype et 
al., 2000) as well as in the C. elegans germline (Shi et al., 2012), which could indicate that 
TDP2 plays a role on a subset of Spo11-DSBs, but so far there has been no reports 
demonstrating this. Here, TDP2 is shown to act upon the phosphotyrosyl bond of Spo11 when 
bound to ssDNA oligonucleotides (Figure 4.2&4.4) or on dsDNA ends (Figure 4.5-4.6) in 
vitro. Similarly to TOP2-DSBs TDP2 is much more active when the bound protein has been 
proteolysed however, TDP2 can also act upon the bond with full-length Spo11 attached. The 
reason for reduced activity upon the full-length Spo11-DNA substrate may be because the 
catalytic site of TDP2 is buried within the core of the protein (Shi et al., 2012), which impedes 
the access of the phosphotyrosyl bond when a large protein structure is present. This may 
explain why ectopic expression of TDP2 could not act upon Spo11-DSBs in vivo in meiosis 
(Figure 4.9 and 4.10), with the large native protein blocking access. Additionally, in these in 
vitro experiments on gDNA or Spo11-oligos, even though the Spo11 protein was full-length it 
was also denatured, which may allow access of TDP2 to the phosphotyrosine bond. Spo11 
creates DSBs in meiosis as part of a 10-protein complex (Arora et al., 2004; Maleki et al., 
2007; Petrini, 1999; Uetz et al., 2000). This complex itself may also restrict access of TDP2 to 
the phosphotyrosyl bond preventing removal of Spo11. In a Spo11-DSB processing deficient 
strain, such as sae2∆, Mre11 foci accumulate at the DSB site (Usui et al., 2001). This 
accumulation may also restrict access of TDP2 to the phosphotyrosyl bond. Unfortunately, 
because the MRX complex is required for Spo11-DSB formation (reviewed in Lam and 
Keeney, 2015), deletion of MRE11, RAD50 or XRS2 to overcome this potential issue is not 
possible. However, recently two N-terminal mutants of Mre11 were reported that decreased 
binding and retention of Mre11 to DSBs in a sae2∆ background (Chen et al., 2015; Puddu et 
al., 2015). If this mutant prevents the accumulation of Mre11 at Spo11-DSBs, combining this 
mutant with a sae2∆ background and expressing TDP2 may enable TDP2 to gain access to the 
Spo11 phosphotyrosine bond. Other avenues of investigation would be to look at much later 
time points after induction of TDP2. This is because previous reports have observed a fraction 
of Spo11-DSBs behaving as if partially or fully proteolysed after prolonged meiotic arrest in a 
sae2∆ background (MJ Neale – unpublished observation).  
If TDP2 were able to remove Spo11 in vivo, the outcome of the DSBs is unknown. Potentially 
three outcomes are possible: (i) The HR machinery begins to resect the DSBs and HR 
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proceeds as normal with only a delay. (ii) With the DSB now clean-ended and initial resection 
by MRX and Sae2 absent, NHEJ is free to repair the DSBs. (iii) Neither HR or NHEJ can 
repair the DSBs leading to accumulation of DSBs. At clean-ended mitotic DSBs created by the 
HO-endonuclease, loss of Sae2 or any component of the MRX complex only slows resection 
with HR still occurring but just somewhat delayed (Mimitou and Symington, 2009). However, 
the HO-endonuclease creates 4 nt 3ʹ′ overhangs (Jin et al., 1997), which is a preferred substrate 
for Exo1 compared to the 2 nt 5ʹ′ overhang present at a clean-ended Spo11-DSB. Similar to the 
HO-DSBs, I-SceI also generates clean-ended DSBs with 3ʹ′ overhang ends (Colleaux et al., 
1988). Therefore, comparison between DSBs containing clean 3ʹ′ overhangs compared to a 
potential clean 5ʹ′ overhang generated from TDP2 activity on Spo11-DSBs may not be an 
accurate reflection due the apparent 5ʹ′ overhang impeding resection by Exo1 (Figure 4.5). 
Exo1 activity on mitotic DSBs containing 5ʹ′ overhangs has yet to be demonstrated. The other 
aspect to consider is that the Sgs1-Dna2 pathway can act as a redundant resection pathway at 
mitotic breaks, yet sgs1 mutants have no defect in resection in meiosis (Zakharyevich et al., 
2010). Therefore, comparing differences between mitotic and meiotic 5ʹ′ overhang DSBs is 
difficult because Sgs1-Dna2 may be much more proficient at resecting these types of DSB end 
than Exo1. Preliminary data in the Neale lab attempting to reconstitute Sgs1-Dna2 dependent 
resection on Spo11-DSB ends have so far suggested that Sgs1-Dna2 is unable to act upon 
these short 5ʹ′ overhang DSB ends but further clarification is required.  
Collectively, these observations point towards the essential nature of MRX and Sae2 activity 
on processing Spo11-DSBs (Figure 4.11). MRX and Sae2 activity drive repair of DSBs down 
the HR pathway by endonucleolytically cleaving off Spo11 and generating 3ʹ′ overhang DSB 
ends that are refractory to NHEJ. This is an efficient way of removing Spo11 as well as 
generating a favourable substrate for the sole meiotic resecting enzyme, Exo1, to resect 5ʹ′ to 
3ʹ′. These observations may point to an evolutionary drive towards processing Spo11-DSBs in 
this manner as if a pathway was present that simply clips off Spo11 at the phosphotyrosyl bond 
(e.g. via TDP2), this would create inefficient substrates for long-range resection to occur from, 
a process that is necessary for efficient meiotic recombination.  
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Figure 4.11: Model of DSB repair via HR or NHEJ depending on repair mechanism.  
The activity of the DSB repair mechanism may alter the outcome of DSB repair. Covalently bound 
protein at DSBs has to be removed in order for DSB repair to occur. Mre11 and Sae2 initiate repair by  
nucleolytically removing the protein bound to an oligonucleotide. This process generates a 3! ssDNA 
overhang, a substrate refractory to NHEJ and the preferred substrate for long-range resection by 
Exo1. This resection promotes homologous recombination by allowing homology search and strand 
invasion. Removal of covalently bound protein, for example, by hydrolytically cleaving the 
phoshotyrosyl bond between the protein and the 5! end of the DSB (e.g. by TDP2) generates clean, 
short 5! overhang ends. These ends are refectory to Exo1 resection, thus preventing repair by HR, but 
the complementary nature of the two ends potentially promotes repair by NHEJ, for example at Top2-
DSBs.  
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Chapter 5: Genome-wide mapping of Spo11-DSBs 
5.1 Introduction 
Genome-wide mapping of protein interactions with DNA has been conducted in a variety of 
different ways. ChIP-seq requires affinity tags or synthesis of ChIP-seq grade, protein-specific 
antibodies to identify regions of DNA a protein associates with in vivo. Specific protocols to 
enrich, and directly sequence, protein-DNA species have been developed, such as the Spo11-
oligonucleotide mapping procedure, which uses immunopreciptiation of affinity-tagged Spo11 
(see below) (Pan et al., 2011). These methods have produced a wealth of data for protein-DNA 
interactions, with the Spo11-oligo mapping data generating near nucleotide-resolution of the 
sites where Spo11 cleaves the DNA phosphate backbone to create DSBs in meiosis.  
These methods have limitations on the data they produce. ChIP-seq generates data detailing 
regions of DNA where proteins reside in vivo. However, the specific interaction/binding sites, 
within nucleotide resolution, are not achievable. Whilst this is not always necessary, 
generating sequence bias and high-resolution base pair interactions between other proteins, is 
not possible. Protocols such as the Spo11-oligonucleotide mapping assay (Pan et al., 2011) 
allows much higher resolution maps to be generated. Spo11-oligo mapping involves 
purification of Spo11 covalently bound to oligonucleotides and the ligation of an adaptor to the 
Spo11-bound end. From preparing samples in this manner Spo11-DSB sites, in a wild type 
cell, were mapped with near nucleotide resolution, the one caveat being that the rGTP-tailing 
used within this protocol generates some discrepancy with real 5ʹ′ cytosines. Mapping of 
Spo11-oligos require affinity tags to be incorporated onto the protein of interest, which, in the 
case of Spo11-HA, can alter the activity of the protein (Gray et al., 2013; Martini et al., 2006). 
For example, the Spo11-HA allele is a DSB formation hypomorph, variably reducing DSBs by 
11-50% (Martini et al., 2006). Spo11-HA may also affect DSB formation at some sites 
compared to others, altering the distribution of DSBs genome-wide (Gray et al., 2013). To 
overcome these deficiencies, more recent work utilises Spo11-FLAG or Spo11-ProtA alleles, 
which are reported to display more wild type-like activity (Mohibullah and Keeney, 2016; 
Thacker et al., 2014). However, these affinity tags may also have some influence on Spo11 
activity.  
Spo11 generates a phosphotyrosyl bond with both 5ʹ′ ends of the DSB and these species 
accumulate in Spo11 end-processing deficient backgrounds, such as rad50S, sae2∆ or mre11 -
nuclease deficient mutants. Recombinant, human TDP2 protein is capable of directly 
hydrolysing the covalent bond between Spo11 and the end of dsDNA, freeing the 5ʹ′ phosphate 
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(Chapter 4). The ability to remove Spo11 from the 5ʹ′ end without any loss of nucleotides 
enables nucleotide-resolution mapping of the precise location of Spo11-DSBs (Figure 5.1). 
Previous studies in rad50S strains mapped Spo11-DSBs in this end-processing deficient 
background using ChIP-on-ChIP (Gerton et al., 2000); however, the resolution was low in 
comparison to the Spo11-oligo mapping data (Pan et al., 2011).  
5.2 Enrichment of Spo11-bound DNA molecules using glass fibre membranes  
Before being able to map Spo11 genome-wide in this manner (Figure 5.1), a way to enrich for 
Spo11-DSBs was required. Mapping untagged Spo11 removes any possible alterations in 
Spo11 activity created by an affinity tag, as previously mentioned. A method, adapted from 
Thomas et al., 1979, that enriched for Spo11-DSBs in a rad50S background, was used to 
originally identify Spo11 as the protein responsible for generating DSB in meiosis. This 
method involved mass-spectrometry of enriched protein-bound DNA molecules from a rad50S 
strain where Spo11-DSBs accumulate (Keeney et al., 1997). A two-step purification procedure 
to isolate protein-DNA species consisted of: (i) purifying genomic DNA away from the bulk of 
cellular proteins using a caesium chloride (CsCl) gradient, whilst retaining covalently bound 
proteins, and (ii) purifying protein-DNA species away from protein-free DNA by passing the 
CsCl-purified material over a glass fibre filter, to which proteins specifically adsorb (Thomas 
et al., 1979). Free-DNA was washed away and protein-DNA species eluted using SDS. The 
eluate was treated with non-specific nucleases and the sample analysed by mass-spectrometry 
to identify Spo11 as the protein responsible for DSB formation in meiosis (Keeney et al., 
1997). To test for enrichment, gDNA was digested with the restriction enzyme PstI, the two-
step purification procedure conducted and a Southern blot used to probe the HIS4::LEU2 
hotspot. A Southern blot of HIS4::LEU2 contains a parental, unbroken band at the top with the 
two common DSB sites at HIS4::LEU2 migrating as two shorter species (Xu and Kleckner, 
1995), with the DSBs accounting for ~10% of total lane signal. After protein-DSB enrichment, 
the two bands corresponding to the two DSBs were still present, however the unbroken 
parental band was absent (Keeney et al., 1997), indicating enrichment for protein-associated 
DNA molecules.  
Before adapting this method for mapping Spo11-DSBs genome-wide, the verification of 
Spo11-DSB enrichment was required. The CsCl gradient used in the above method is 
technically time consuming and challenging. Therefore, the procedure was adapted to extract 
gDNA away from the bulk of cellular proteins (as detailed in Materials and Methods and 
schematically in Figure 5.2). A non-proteolysing phenol-chloroform gDNA preparation was  
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Figure 5.1: Schematic of Spo11 enrichment and mapping.  
A meiotic time course is performed for a sae2! strain and cells harvested at 6 hours. Unproteolysed 
genomic DNA was extracted by fixing spheroplasts in ethanol, lysing with SDS, and extracting DNA 
and protein-bound DNA using phenol:chloroform:isoamyl alcohol (25:24:1). Molecules were 
precipitated with ethanol, resuspended in 1! TE and sonicated to fragment the DNA. The sample is 
bound to the glass fibre membrane of a QIAQuick spin column, centrifuged and the flow-through 
rebound to the column and centrifuged again to increase yield. The membrane is washed using TEN 
(10 mM Tris Base!HCl pH 8.0, 1 mM EDTA, 300 mM NaCl) to remove any non-protein-bound 
DNA. Spo11-bound DNA is released from the column using two sequential elutions in 50 µl TES 
(10 mM Tris Base!HCl pH 8.0, 1 mM EDTA, 0.5% SDS). The sonicated end of the DNA fragments 
are blunted using the NEBNext Ultra II end-repair kit and Adaptor 1 ligated on before removal of 
unligated adaptors using AMPure XP beads. The fragments are then reacted with TDP2 to remove the 
Spo11 peptide covalently bound to the 5" end of the DNA before fill-in of the end that was Spo11-
bound. Adaptor 2 is then ligated onto the Spo11-derived end of the fragment, and the now polar 
molecules are amplified by PCR and 2!75 bp paired-end sequencing conducted using a Illumina 
MiSeq machine. Read1 contains the 5" base of where Spo11 cut. Read2 contains information 
regarding the sheared end of the fragment.  
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Figure 5.2: Schematic of Spo11 enrichment for Southern blotting.  
A meiotic time course is performed for a sae2! strain and cells harvested at 6 hours. Unproteolysed 
genomic DNA was extracted by fixing spheroplasts in ethanol, lysing with SDS, and extracting DNA 
and protein-bound DNA using phenol:chloroform:isoamyl alcohol (25:24:1). Molecules were 
precipitated with ethanol, resuspended in 1! TE and restriction enzyme digested with PstI for 1 h at 
37 °C to fragment the DNA. The sample is bound to the glass fibre membrane of a QIAQuick spin 
column, centrifuged and the flow-through rebound to the column and centrifuged again to increase 
yield. The membrane is washed using TEN (10 mM Tris Base!HCl pH 8.0, 1 mM EDTA, 300 mM 
NaCl) to remove any non-protein-bound DNA. Spo11-bound DNA is released from the column using 
two sequential elutions in 50 µl TES (10 mM Tris Base!HCl pH 8.0, 1 mM EDTA, 0.5% SDS). 
Eluates are Proteinase K treated at 60 °C for 1 hour and the sample separated on a 0.7% agarose gel 
for 18 hours at 60 V. The gel was transferred to nylon membrane under denaturing conditions and 
hybridised with a radioactive probe for the HIS4::LEU2 locus. The membrane was exposed to a 
phosphor screen and image taken using a Fuji phosphor scanner.  
Restriction digest!
(e.g. PstI)!
Elution!
Binding to column!
Unproteolysed gDNA 
extraction!
Washing!
Southern blot!
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conducted where gDNA partitions to the aqueous phase and proteins to the phenol/interphase. 
Proteins bound covalently to the DNA should not prevent this partitioning from occurring. 
Once extracted, the gDNA was digested with PstI to fragment the gDNA.  QIAGEN QIAprep 
2.0 Spin Columns (referred to as ‘columns’ from here), contain a glass fibre filter and, under 
conditions stated in the Materials and Methods, allow specific adsorption of proteins (DNA 
doesn’t bind). Washes with a high salt 1× TE (TEN) buffer removes unbound/free DNA whilst 
retaining protein-DNA species on the filter. Protein-DNA species are subsequently eluted 
using 1× TE containing SDS (TES buffer). Eluates were proteolysed using Proteinase K, DNA 
fragments resolved on an agarose gel and the HIS4::LEU2 hotspot probed via Southern 
blotting (Figure 5.3). Spo11-DSBs at HIS4::LEU2 were enriched, as demonstrated by the 
presence of the two DSB bands and the absence of the parental, unbroken band (Figure 5.3B 
lane 6 - ELUATE). The unbroken, non-protein bound parental fragment was observed in the 
‘wash’ fractions (Figure 5.3B lane 4 - WASH 1). Not all Spo11-DSB molecules are enriched 
on the column, - indicated by the presence of the two DSB bands in the unbound lane (Figure 
5.3B –UNBOUND), suggesting proteolysis of Spo11 in vivo or during the preparation of the 
sample, preventing DSB binding to the glass fibre filter. This hypothesis is supported by the 
presence of the two DSB bands in the non-Proteinase K sample (Figure 5.3B lane 1 - INPUT 
no PK), which was not column enriched or proteolysed with Proteinase K. Because protein 
species retard migration on agarose gels, unproteolysed/partially proteolysed Spo11-DSBs will 
not migrate, indicating that the two DSBs observed in the non-Proteinase K sample is due to 
proteolysis of some DSB molecules at HIS4::LEU2. Collectively these results suggest 
enrichment of protein-bound DSBs is achievable, with DSBs making up 99% of signal 
compared to unbroken, parental signal in the enriched eluate. Additionally, Proteinase K 
treatment of the sample before column purification resulted in no enrichment of Spo11-DSBs 
via Southern blotting or from sequencing (data not shown), indicating that the protein moiety 
is an essential factor for this enrichment process.  
5.3 Optimisation: A higher concentration of SDS in the elution buffer enriches 
more Spo11-DNA 
Enrichment of the Spo11-DSBs by the method described above, was not efficient with yield of 
the DSBs at approximately half of the total level (Figure 5.3 – compare INPUT and ELUATE 
x4). Addition of two sequential rounds of elution buffer (TES) was initially used to elute the 
Spo11-DNA species from the column. However, in order to increase the yield a series of tests 
were conducted (Figure 5.4). (i) A single volume of elution buffer was re-passed through the 
column in an attempt to solubilise more Spo11-DNA species in each subsequent flow-through.  
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Figure 5.3: Southern blot of Spo11-DSB enrichment.  
A meiotic time course is performed for a sae2! strain and cells harvested at 6 hours. Unproteolysed 
genomic DNA was extracted as described in Figure 5.2. Molecules were precipitated with ethanol, 
resuspended in 1! TE and restriction enzyme digested with PstI for 1 h at 37 °C to fragment the DNA 
(‘INPUT’). The sample is bound to the glass fibre membrane of a QIAQuick spin column and 
centrifuged. The flow-through was rebound to the column and centrifuged again to increase yield 
(second flow-through – ‘UNBOUND’). The membrane is washed using TEN (10 mM Tris Base!HCl 
pH 8.0, 1 mM EDTA, 300 mM NaCl) to remove any non-protein-bound DNA (fraction taken – 
‘WASH’). Spo11-bound DNA is released from the column using two sequential 50 µl TES buffer 
(10 mM Tris Base!HCl pH 8.0, 1 mM EDTA, 0.5% SDS) (‘ELUATE’). All samples were 
Proteinase K treated (unless stated) at 60 °C for 1 hour and the samples separated on a 0.7% agarose 
gel for 18 hours at 60 V. The gel was transferred to nylon membrane under denaturing conditions and 
hybridised with a radioactive probe for the HIS4::LEU2 locus. The membrane was exposed to a 
phosphor screen and image taken using a Fuji phosphor scanner.  
Parental!
DSB II!
DSB I!
HIS4::LEU2 DSB hotspot!
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Figure 5.4: Southern blot of Spo11-DSB enrichment elution optimisation.  
Southern blot of DSBs at the HIS4::LEU2 meiotic hotspot. A meiotic time course is performed for a 
sae2! strain and cells harvested at 6 hours. Unproteolysed genomic DNA was extracted as described 
in Figure 5.2. Molecules were precipitated with ethanol, resuspended in 1! TE and restriction enzyme 
digested with PstI for 1 h at 37 °C to fragment the DNA (‘INPUT’). The sample is bound to the glass 
fibre membrane of a QIAQuick spin column as stated in Figure 5.2 (second flow-through – 
‘UNBOUND’). The membrane is washed using TEN as stated in Figure 5.2 (fraction taken – 
‘WASH’). A. Spo11-DNA was released from the column with 1! TE containing 0.1% SDS (10 mM 
Tris Base!HCl pH 8.0, 1 mM EDTA, 0.1% SDS) (Column 1) or 1! TE containing 0.01% SDS 
(Column 2) and this eluate subsequently rebound to the column and eluted eight times. B. Spo11-
DNA was released from the column with sequential elutions of fresh 1! TE with stated concentrations 
of SDS (eluates not rebound) . All samples were Proteinase K (PK) treated (unless otherwise stated) 
before being resolved on a 0.7% TAE agarose gel for 18 hours at 60 V. The gel was transferred to 
nylon membrane under denaturing conditions and hybridised with a radioactive probe for the 
HIS4::LEU2 locus. The membrane was exposed to a phosphor screen and image taken using a Fuji 
phosphor scanner.  
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Eluted with 0.1% SDS!
Column 2 !
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This was to check if more Spo11-DNA could be eluted and, if it could, could it be 
concentrated into a small volume. However, eight passages through the column did not 
increase the signal in the eluate compared to one passage (Figure 5.4A left hand panel), 
suggesting that either all the Spo11-DNA had been removed in the first passage or a saturation 
point had been reached in this volume of elution buffer. (ii) The presence of SDS in the elution 
buffer may be carried over into subsequent steps and inhibit any reactions required for 
mapping Spo11-DSBs. Therefore, a lower concentration of SDS was initially tested (0.1% 
reduced to 0.01%). Using this lower concentration of SDS resulted in a lower yield of Spo11-
DNA (Figure 5.4A right hand panel). A subsequent elution with 0.1% SDS (TES) buffer on 
the same column eluted a large fraction of Spo11-DNA similar to what was eluted in previous 
elution attempts with 0.1% SDS, suggesting that there is a solubilisation limit of Spo11-DNA, 
which is dependent on the concentration of SDS. (iii) Subsequent elutions, all on the same 
column, with multiple increasing concentrations of SDS (0.01%, 0.03%, 0.1% and 0.5%) was 
conducted (i.e. one column was eluted ten times) (Figure 5.4B). Spo11-DSBs were observed 
from every elution. Subsequent elutions with the same concentration of SDS yielded 
progressively less Spo11-DSBs (except for 0.01%). A subsequent elution with a higher SDS 
percentage eluted more Spo11-DSBs than the last elution with a lower percentage, suggesting 
a saturation point for Spo11-DNA elution, dependent on SDS concentration. Additionally, 
there is a fraction of Spo11-DSB molecules that can only be eluted with a higher SDS 
concentration, suggesting that there may be protein aggregates. The final elution with 0.5% 
SDS, after the first 0.5% elution, had a low level of Spo11-DSBs, suggesting that the prior 
elution with 0.5% SDS stripped the glass fibre filter of the majority of Spo11-DSBs. For 
subsequent steps of the protocol, enriched Spo11-DSBs need to be in a small volume. 
Therefore, these multiple elutions steps are not possible to enrich for all available Spo11-
DSBs. However, using 0.5% SDS in the elution buffer should allow for high percentage of the 
species to be eluted for mapping and will be used for future experiments.  
5.4 Sonication of Spo11-bound genomic DNA generates an unbiased average 
fragment length for sequencing  
In the experiments described so far, genomic DNA was fragmented using the PstI restriction 
enzyme, which enables specific loci (HIS4::LEU2) to be probed to estimate Spo11-DSB 
enrichment (Figure 5.3-5.4). Restriction enzyme-mediated fragmentation could also be used 
for generating a genome-wide sequencing library, however, there will be areas of the genome 
where Spo11 creates DSBs close to, or far from, PstI cut sites. This size bias of specific 
fragments of the genome may result in loss of information from mapping Spo11 cut sits due to 
too small, or too large fragment size. To avoid this, a different fragmentation strategy was 
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required. Sonication of gDNA allows the generation of a heterogeneous size range of DNA 
molecule, with little or no bias towards certain areas of the genome. This size range can be 
controlled by sonication time length, with a target size of DNA molecule needed for efficient 
PCR amplification and mapping being ~500 bp. To optimise the sonication step, a sonication 
time course was conducted with samples taken at stated time points (Figure 5.5). Sonication up 
to 24 min decreased the average DNA molecule size in an exponential manner. 24 min 
sonication resulted in a 500 bp average size of DNA molecule, and will be used for subsequent 
column enrichments.  
5.5 Retaining polarity of the fragmented DNA to distinguish the Spo11-bound 
end from the sonicated end  
Using restriction digest to fragment the genome enables the Spo11-bound end of the fragment 
to be distinguished from the other, due to the known consensus site for a restriction enzyme. 
To retain this knowledge of polarity of the molecules, the activity of recombinant TDP2 can be 
utilised. The first adaptor is ligated to the sheared end with excess adaptor washed away. This 
adaptor cannot be ligated to the Spo11-end of the fragment due to the presence of the bound 
Spo11 protein. Removal of Spo11 by TDP2 allows a second adaptor, with a different DNA 
sequence, to be selectively ligated to the Spo11-end, without loss of nucleotides, generating 
polarity of the molecules. However, proteolysed Spo11-DNA is a more efficient substrate for 
TDP2 cleavage compared to full-length Spo11 (Figure 4.4), with the remaining ~3 amino acid 
peptide, from proteolysis by Proteinase K, still blocking resection by λexo (Figure 4.5). 
Therefore, once Spo11-DNA has been enriched and eluted from the column, the large Spo11 
moiety is now unnecessary and Proteinase K digestion of the eluate can be performed. 
Ligation of unique adaptors onto each end permits paired-end sequencing and enables single-
base pair resolution of where Spo11 cleaves the DNA by bioinformatically extracting the 5ʹ′ 
end of the first read pair (Read1) generated from the Illumina MiSeq machine (Figure 5.1 right 
hand column). When these dual-adaptor ligated molecules are PCR amplified, they are also 
barcoded with unique sequences. This barcoding enables multiple samples to be multiplexed in 
the same sequencing run.  
5.6 AMPure XP beads allows size-selection of DNA fragments for optimal 
library construction  
To prepare the Spo11-DNA for sequencing the NEBNext Ultra II Library Prep Kit was used, 
as described in Materials and Methods. The two main alterations to the protocol included: (i) 
two custom adaptors (described above) used for ligation to generate polarity of the molecules,  
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Figure 5.5: Agarose gel of sonicated genomic DNA.  
Unproteolysed genomic DNA was extracted from 50 ml sae2! cells 6 hours into meiosis, dissolved in 
1 ml of TE, and sonicated in a Covaris M220 machine. 5 µl was taken at the stated time points and 
11.7 µl double-distilled water, 3.3 µl 6! purple loading dye (NEB) added to each. 10 µl was loaded on 
a 1! TAE agarose gel containing 50 µg ml-1 ethidium bromide alongside a 2-log ladder (NEB) and 
separated for 40 minutes at 100 V. Gels were imaged using a Syngene InGenius bioimaging system.  
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Figure 5.6: Bioanalyser traces to show contaminating small and large fragments compared to 
ideal size distribution.  
Spo11-DNA libraries were diluted 1 in 10 with double-distilled water and 1 µl loaded on an Agilent 
High Sensitivity chip. Lower marker peak at 35 bp (*). Large marker peak at 10380 bp (**). A. 
Figure shows large DNA fragments that have been amplified by PCR co-migrating with the large 
marker peak (i). B. Figure shows contaminating adaptor dimer peak at approximately 150 bp (ii). C. 
Trace shows an ideal size distribution of DNA (~400 bp, (iii)) with no large or small contaminating 
peaks. 
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and (ii) size-selection of molecules was performed after PCR amplification rather than before 
due to the low concentration of input DNA enriched from the column. Size-selection was 
carried out using AMPure XP beads. This is a necessary step to remove amplified large 
molecules and adaptor dimers, both of which negatively affect mapping quality. Figure 5.6 
demonstrates a set of example bioanalyser traces from samples where large fragments have 
been amplified that co-migrate with the large (10380 bp) marker (Figure 5.6A), samples that 
are contaminated by adaptor dimers, sharp peak at ~150 bp (Figure 5.6B), and a sample, which 
following AMPure size selection has the desired size range of amplified molecules ready for 
sequencing (Figure 5.6C).  
5.7 The Illumina MiSeq allows multiple samples to be multiplexed, generating 
3-7.5 million reads per sample 
As described above, fragments have adaptors ligated and are PCR amplified, which also 
incorporates unique indexes. Double-stranded DNA fragments from different samples are 
mixed together, denatured and loaded onto a flow-cell for paired-end (2 x 75 bp) sequencing 
with an Illumina MiSeq machine. Sequencing generates .FASTQ output files containing 
specific base composition of the paired-end reads – Read1 (from Spo11-end) and Read2 (from 
sheared end). The individual strain sequences are demultiplexed within BaseSpace (Illumina) 
generating a pair of unique FASTQ files for each sample. Typically, sequencing libraries on 
the Illumina MiSeq generates 20-30 million reads per run. Mulitplexing with barcoded 
samples allows the mixing of 4-6 different samples, each generating 3-7.5 million reads per 
sample. 
5.8 Sequencing reads are aligned to the S288C genome and the location of 
the 5ʹ′- Spo11-bound ends are extracted  
Using bowtie2 the demulitplexed sequencing reads are aligned end-to-end to a custom version 
of the S. cerevisiae S288C published genome, that contains the HIS4::LEU2 and LEU2::HISG 
regions incorporated (‘Cer3H4L2’) (‘Spo11Align.command’ – Appendix 10.1). The resulting 
.SAM files contain the globally aligned read coordinates, chromosome number, if they are 
Watson or Crick and their read quality. Using perl, correctly aligned 5ʹ′ ends of Read1 (the 
Spo11 end) are extracted. Reads containing ambiguous 5ʹ′ ends are filtered out, whilst reads 
with an unmapped mate (either Read1 or Read2) are further processed to trim non-5ʹ′ ends to 
attempt re-mapping. Any resulting mapped reads from the trimmed files are combined with the 
originally mapped reads. The output file (.txt) contains the 5ʹ′ co-ordinates of the Read1  
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sequences, and indicate the chromosome number and whether they come from the Watson or 
Crick strand (‘Spo11Extract.pl’ – Appendix 10.2). 
5.9 5ʹ′  Spo11 ends are converted into a histogram for analysis  
To convert the aligned reads into useful data for analysis, the single nucleotide position of the 
Spo11 5ʹ′ end is aggregated into a 1 bp histogram using R Studio to calculate the number of 
times a certain base in the genome was broken by Spo11 (‘Creating 1bp histograms v03 
(H4L2).R’ – Appendix 10.3). These histograms are utilised for analysis of the data and the file 
names annotated as follows: StrainNumber_Genotype_BiologicalRepeatNumber_ 
TechnicalRepeatLetter_TimePointFromMeiosis. Also note, the ‘wild type (WT)’ annotation 
refers to sae2∆ because all strains from this mapping procedure contain sae2∆.  For example, a 
sae2∆ strain (strain number MJ315) from a second biological repeat (‘2’) taken at six hours 
into meiosis (‘6h’), from the first attempt at mapping from this material (‘A’) reads as follows: 
MJ315_WT_2A_6h.  
5.10 Calculating background reads allows for correction and correlation 
between datasets 
Any enrichment method will contain a certain level of contaminating non-specific DNA that 
may map to the reference genome. These contaminating/background reads need to be 
controlled for because variation in the background levels may have an effect on real signal 
levels (a decrease in the signal:noise ratio). Thus, adjusting for background reads enables a 
more accurate comparison between data sets. Background reads were calculated using any 
annotated gene ORF over 5.5 kb in length and calculating the hit rate per million reads per 
base pair (‘Calculating background reads v03.R’ – Appendix 10.4). ORFs of this length have 
been reported to contain very few Spo11-DSB sites (Pan et al., 2011); therefore the majority of 
hits in these regions are expected to be background. The TEL1 ORF is one such gene greater 
than 5.5 kb in length, however, as future mapping studies involve TEL1 mutants, this gene was 
excluded from the list. ORFs NUM1, YRF1-7, YRF1-6, YRF1-3, URA2 and TOR2 were 
empirically determined to be outliers (Figure 5.7A vs. 5.8B) and also removed, leaving 47 
genes >5.5 kb used to estimate background (as seen in the list in Figure 5.7B). Excluding 1 kb 
proximal and terminal of the ORF (‘Core’) lowers the standard deviation (see Table 5.1), 
suggesting some real DSB hits reside in these regions (Figure 5 left hand columns) and thus, 
using the ‘Core’ is likely to generate a more accurate determination of background.  
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Figure 5.7: Background levels are calculated from the number of hits occurring in the core 
region of 47 of the largest ORFs.  
The R script ‘Calculating background reads v03.R’ was used to calculate the level of background 
(putative non-specific reads) from individual samples. Any annotated gene greater then 5.5 kb in 
length was subset and the number of hits per million reads per base pair within these regions was 
calculated (left hand panels). Hits within 1 kb proximal and terminal of these ORFs were excluded 
(right hand panels). A. All 54 genes greater than 5.5 kb were used to calculate the background reads. 
B. TEL1 was excluded from the calculation because the Tel1 protein function will be studied using 
this method and is not present in all strains sequenced. NUM1, YRF1-7, YRF1-6, YRF1-3, URA2 and 
TOR2 were empirically determined to be outliers and excluded. Overall estimated background reads 
(‘Mean’ or ‘MeanCore’) was calculated from the average number of total hits per million reads per 
base pair from each stated ORF. 
A. All ORFs >5.5 kb!
B. ORFs >5.5 kb with exclusions!
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Table 5.1 Background reads from wild type (sae2∆), spo11-YF and Spo11-oligo data (Pan_HA) 
Strain Mean	  (hits/bp/MReads) S.D.	  (hits/bp/MReads) 
Mean	  
Core	  (hits/bp/MReads) 
S.D.	  
Core	  (hits/bp/MReads) 
All	  genes	  >5.5	  kb	  	  
MJ315_WT_2A_6h 0.01098 0.0073 0.00940 0.00296 
MJ319_Y135F_1_6h 0.07431 0.0090 0.07391 0.00829 
Pan_HA_1_4h 0.00489 0.0101 0.00363 0.00316 
After	  removal	  of	  outliers	  
MJ315_WT_2A_6h 0.00961 0.0012 0.00865 0.00060 
MJ319_Y135F_1_6h 0.07664 0.0021 0.07610 0.00273 
Pan_HA_1_4h 0.00364 0.0011 0.00331 0.00092 
 
Calculating the background reads between sae2∆ (WT) and spo11-Y135F (catalytic dead) 
indicates the majority of hits in the spo11-YF mutant are non-specific background (0.07610 
hits/bp/MReads*12.5 Mb (size of S. cerevisiae genome)/1,000,000 reads = 95% of reads are 
background – as expected). This figure, compared to the 12% generated from sae2∆ (WT), 
indicates the real signal to noise ratio is much higher in wild type Spo11 strains. Comparing 
the sae2∆ (WT) background to the Spo11-oligo mapping data (Pan_HA) (Pan et al., 2011), 
which has 4% background hits, suggests that the Spo11-oligo mapping data is more specific 
for real Spo11-DSB signal. Alternatively, ‘real’ hits in the long ORFs are not mapped in the 
Pan_HA data but are in the sae2∆. From calculating the background reads, hits at specific 
locations can be corrected to visualise a more quantitative image of DSB frequency between 
strains/mapping procedure.  
5.11 Reducing the amount of phenol used to extract gDNA and decreasing the 
sonication amount reduces the apparent background levels 
Background in sae2∆ is relatively low (and not too different from the Spo11-oligo mapping 
data), however, during protocol development it was found that background levels in other 
strains varied dramatically (data not shown). In order to improve the signal:noise ratio, and to 
try and improve reproducibility, numerous steps were altered to try and optimise the method 
and decrease apparent background levels. Contaminating reads, or loss of real signal, could 
derive from a number of different steps each looked at in detail below.  
Phenol 
The separation of proteins from DNA by phenol works as follows: Phenol and water are 
immiscible, therefore when the two solutions are mixed two phases form: an aqueous phase 
(water) and a phenol phase, sometimes with a large interphase between the two. Thorough 
mixing of a sample with phenol forces the phenol to mix with the water, forming an emulsion 
of droplets throughout. Phenol denatures any proteins solubilised in the aqueous (water) phase 
and this partitions them into the phenol. DNA however, stays soluble in the aqueous phase. 
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Molecules of DNA with Spo11 covalently bound will be partitioned to either phase depending 
on the length of the DNA and the strength of the solvent (water/phenol). If DNA molecules are 
short, the protein being pulled into the phenol phase may overcome the nature of the DNA 
molecules to partition into the aqueous phase, therefore, these molecules would be lost (as the 
aqueous phase is taken and used for subsequent steps of the library preparation). Phenol 
extraction of DNA is conducted prior to fragmentation and therefore, in general, the length of 
DNA bound to Spo11 is sufficient to partition Spo11-bound DNA molecules to the aqueous 
phase (as shown by the enrichment at the HIS4::LEU2 DSB hotspot – Figure 5.3). However, it 
was considered that lowering the volume of phenol added to the lysed cells may reduce the 
amount of Spo11-DNA molecules lost to the phenol phase. There is a balance between 
extracting all DNA with protein covalently attached (desired) and extracting DNA with 
potentially loosely bound proteins, or even some completely unbound proteins. The latter is 
not so much of an issue as the only negative effect it may cause is blocking the glass fibre 
filter and lowering the binding capacity of the column to real protein-bound DNA molecules. 
The extraction of non-covalently bound proteins that are loosely attached may be more of an 
issue as these may be retained on the column through the wash cycle and eluted off with non-
specific DNA still attached. These DNA molecules would then pass through to the end-
preparation and sequencing steps, generating background reads.  
Therefore, to determine the effect phenol has on enrichment of Spo11-DNA (and subsequent 
background levels) a test was conducted using a range of saturated phenol volumes during 
gDNA extraction (Table 5.2). A decrease in the volume of phenol used decreased the apparent 
background observed (an increase in the signal to noise ratio) down to 100 µl of phenol (Table 
5.2 – ‘Mean Core’: 0.05779 (250 µl) down to 0.01545 (100 µl) hits/bp/MReads). At 50 µl (a 
tenth of the aqueous volume), the apparent background increased (0.02549 hits/bp/MReads). 
This latter result may be due to the low volume of phenol increasing the difficulty of taking 
solely aqueous phase at the DNA extraction step.  
Table 5.2: Effect of phenol volume on background reads 
Strain Mean (hits/bp/MReads) S.D. (hits/bp/MReads) 
Mean 
Core (hits/bp/MReads) 
S.D. 
Core (hits/bp/MReads) 
MJ315_WT 
250 µl 0.05947 0.0056 0.05779 0.00542 
MJ315_WT 
175 µl 0.01589 0.0017 0.01496 0.00179 
MJ315_WT 
100 µl 0.01645 0.0012 0.01545 0.00142 
MJ315_WT 
50 µl 0.02631 0.0021 0.02549 0.00224 
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Sonication 
To determine the effect varied sonication has on apparent background levels different times of 
sonication were tested (Table 5.3). An increase in sonication time increased apparent 
background reads (8 min sonication – 0.0501 hits/bp/MReads to 24 min sonication – 0.0659 
hits/bp/MReads), suggesting that less sonication may be more favourable to lower background 
reads. This may be due to increased sonication generating more non-protein bound fragments 
(and adaptor ligatable ends) that are retained and eluted from the column and now sequenced.  
Table 5.3: Effect of sonication amount on background reads 
Strain Mean (hits/bp/MReads) S.D. (hits/bp/MReads) 
Mean 
Core (hits/bp/MReads) 
S.D. 
Core (hits/bp/MReads) 
MJ315_WT 
8 min sonication 0.0514 0.0024 0.0501 0.0023 
MJ315_WT 
12 min sonication 0.0602 0.0019 0.0594 0.0023 
MJ315_WT 
16 min sonication 0.0652 0.0026 0.0648 0.0031 
MJ315_WT 
24 min sonication 0.0659 0.0024 0.0659 0.0026 
 
Due to the above findings (Table 5.2 and 5.3), the final protocol involves using a lower 
volume of phenol compared to the 1:1 ratio of soluble extract:phenol used initially. Less 
sonication also appears to be more favourable to decrease the apparent background and will be 
utilised for mapping Spo11-DSBs in future strains.  
5.12 Mapping Spo11-DSBs using the sae2∆ DSB-enrichment procedure agrees 
with the Spo11-oligonucleotide mapping data  
Deep sequencing sae2∆ strains generated between 2-5 million reads that were mapped to the 
genome of the S288C S. cerevisiae strain. Approximately 95% of total read pairs mapped to 
the S288C genome and of these total mapped pairs, 98.5% generated unambiguous (valid) 5ʹ′ 
hits. Using the 1 bp histogram file, which contains all 5ʹ′ hits for the Spo11-DSBs, the entire 
length of each chromosome was plotted (‘Spo11 mapping v09 MC’ – Appendix 10.5). 
Chromosome 1 and chromosome 7 were visualised to compare the Spo11-oligo map (Pan et 
al., 2011), the new sae2∆ data, and newly mapped data from a spo11-Y135F (catalytic dead) 
mutant as a control (Figure 5.8). Strong peaks from both the Spo11-oligo data and the sae2∆ 
are present in the same locations. The spo11-YF mutant fails to show significant enrichment at 
any position in the genome on a chromosome wide (Figure 5.8), local chromosome region 
(Figure 5.9) or at DSB hotspots on a fine scale (Figure 5.10). Rather, all the reads from the 
spo11-YF mutant average evenly across every bp of the genome, strongly supporting the view 
that enrichment of Spo11-DSBs at hotspots in the sae2∆ data is, as expected, dependent on the 
catalytic activity of Spo11.  
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Figure 5.8: New sae2! genome-wide Spo11-DSB mapping reveals hotspots are located at similar 
positions to that characterised in Spo11-oligo map.  
Spo11-DSBs were mapped in a sae2! background and compared to Spo11-oligo maps generated by 
Pan et al., 2011. Sequencing reads generated from a sae2! strains enriched for Spo11-DSBs were 
aligned against the S. cerevisiae S288C genome with 5! Spo11 ends used to generate a 1 bp 
histogram. Chromosome 1 (A) and Chromosome 7 (B) were plotted with hits on the Watson strand 
(red), Crick strand (blue) and total hits (grey) indicated. Background reads were calculated for all 
strains and used to normalise signal intensity (‘Spo11 Mapping v09 MC.R’ – Appendix 10.5).  
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5.13 Spo11-DSBs are enriched at promoter regions and a 2 bp Watson/Crick 
offset is observed at the majority of sites  
The Pan et al., 2011 data set, and studies prior to this (Baudat and Nicolas, 1997), observed 
that the majority of Spo11-DSBs form in intergenic regions containing promoters. To 
determine whether Spo11-DSBs from the sae2∆ DSB-enrichment procedure agree with these 
studies, a narrow 40 kb region of the genome was visualised for Spo11-DSB hits (Figure 
5.9A)(‘Spo11 mapping 09 MC’ – Appendix 10.5). In agreement with previous studies, Spo11-
DSBs from the sae2∆ dataset are observed enriched at promoter regions (Figure 5.9A). This 
corroborates the view that an open chromatin structure is necessary for Spo11 to access the 
DNA. Both promoter and terminator regions are nucleosome-depleted (Fan et al., 2010; 
Lantermann et al., 2010), therefore if an open chromatin structure is all that is required then 
promoter and terminator regions should both contain Spo11-DSBs. To further determine 
whether the presence of a promoter, or just an open chromatin structure, increases the 
enrichment of Spo11-DSBs in an intergenic region, Spo11-DSBs were subset into intergenic 
region type (tandem (two promoters), convergent (two terminators), and divergent (two 
promoters) – as visualised in Figure 5.9B) and numbers aggregated (Figure 5.9B). Spo11-
DSBs are enriched at tandem and divergent intergenic regions – regions that contain 
promoters, with divergent regions having increased Spo11-DSB hits compared to tandem 
regions. At convergent regions, Spo11-DSB levels are very low, indicating that Spo11-DSBs 
rarely form in terminator regions, even if these regions are nucleosome-depleted. At a closer 
high-resolution scale of visualisation, a 2 bp offset between the Watson and Crick strands is 
observed (Figure 5.9C), which correlates with the expected 2 bp overhang the Spo11 dimer 
generates when creating a DSB (Liu et al., 1995). 
The sites where Spo11 generates DSBs in the genome have been previously mapped by 
sequencing the Spo11-oligonucleotide products formed from the initial processing of the 
Spo11-DSB end by the MRX complex and Sae2 (Pan et al., 2011). The Spo11-oligo mapping 
data identified and annotated DSB hotspots, areas of the genome where Spo11-oligos/DSBs 
clustered (Pan et al., 2011). 3599 hotspots were called from the Spo11-oligo data. Of these 
3599 hotspots, the new sae2∆ mapping detects 3576 hotspots (99.4%) that are >2-fold over 
background and 3384 (94%) >5-fold over background, suggesting that these two methods 
correlate well. 
5.14 Spo11-DSBs mapped via the new sae2∆ method enrich at known hotspots 
Historically, directly observing Spo11-DSBs at specific places in the genome is conducted via 
Southern blotting or pulse-field gel electrophoresis. These assays are limited to studying one to  
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Figure 5.9: Spo11-DSBs are enriched at promoter regions and create a 2 bp 5! overhang.  
Spo11-DSBs were mapped in a sae2! background and compared to Spo11-oligo maps generated by 
Pan et al., 2011. Sequencing reads generated from a sae2! strains enriched for Spo11-DSBs were 
aligned against the S. cerevisiae S288C genome with 5! Spo11 ends used to generate a 1 bp 
histogram. A. A 40 kb interval on chromosome 2 was visualised for Spo11-DSB hits. B. Spo11-DSB 
hits were subset into intergenic region type and aggregated. C. A 200 bp interval was plotted from 
Chromosome 1 with each base pair represented as a single line with Watson strand (red) hits, Crick 
strand (blue) and total (grey) hits indicated. Estimated background reads were calculated for all 
strains and used to normalise signal intensity (‘Spo11 Mapping v09 MC.R’ – Appendix 10.5).  
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a few hotspots at any one time due to the technical limitations. Utilising the new sae2∆ 
mapping procedure, once the strain has been sequenced, any given site of the genome can be 
visualised for Spo11-DSBs simultaneously. Because the procedure takes a similar time frame 
to conducting a Southern blot this method is beneficial for studying Spo11 hotspots genome-
wide. Two hotspots (ERG25 and ARE1) were chosen for visualisation (Figure 5.10), with the 
strong HIS4::LEU2 hotspot not chosen due to the strains used for Spo11-oligo mapping not 
containing this strong artificial hotspot (Pan et al., 2011) (‘Spo11 mapping v09 MC’ – 
Appendix 10.5). These two hotspots are both enriched for Spo11-DSBs in both the wild type 
(Pan et al., 2011) data and the new sae2∆ mapping method. The peaks are similar between the 
Spo11-oligo data and the sae2∆ data, however differences can be noted with more defined 
peaks observed in the Spo11-oligo data, whereas the sae2∆ contains a more broad range of 
signal throughout the hotspot. This may be due to a sae2∆-specific phenotype or due to the 
Spo11-oligo data only mapping the long oligonucleotide produced, thus losing signal that may 
have been contained within these hotspots. In both studies, signal is restricted mainly within 
the promoter region, as previously characterised (Pan et al., 2011), and described (Figure 5.9).  
5.15 The measured strength of each hotspot is reproducible across multiple 
sae2∆ repeats and correlates with the Spo11-oligo hotspot data  
The sae2∆ strain was mapped multiple times from biological duplicates (originating from 
separate colonies/cultures). To determine how reproducible these repeats were the strength of 
each annotated hotspot was compared. This comparison can also be made between the sae2∆ 
data sets and the Spo11-oligo data set. Hits per million reads, that have been normalised to the 
level of background observed (HpMNorm), were calculated for each hotspot (‘Hotspot totals 
v09 MC.R’ - Appendix 10.6). The fraction of hits per hotspot out of the total number of reads 
from all the hotspots (after background subtraction and filtering) were multiplied by 1 million 
(to generate an easy to use number scale) and plotted against each other (Figure 5.11) 
(‘Plotting hotspot tables v03.R’ – Appendix 10.7).  
Comparison of the biological replicates of the sae2∆ maps generated an r2 value between 0.93 
and 0.99 indicating that the sae2∆ repeats are highly reproducible (Figure 5.11A). The data 
points between sae2∆ repeats correlate even at low hit strength hotspots (HpMNorm), 
producing signal above background level at these weak sites, indicating a high dynamic range. 
Therefore, these sae2∆ repeats were combined and averaged for comparison against the 
Spo11-oligo data (Figure 5.11B). When comparing an averaged dataset for five sae2∆ strains,  
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Figure 5.10: Spo11-DSB hits from sae2! mapping reside within promoter regions at known 
hotspots.  
Spo11-DSBs were mapped in a sae2! background and compared to Spo11-oligo maps generated by 
Pan et al., 2011. Sequencing reads generated from a sae2! strains enriched for Spo11-DSBs were 
aligned against the S. cerevisiae S288C genome with 5! Spo11 ends used to generate a 1 bp 
histogram. Hits on the Watson strand (red), Crick strand (blue) and total hits (grey) are indicated. 
Background reads were calculated for all strains and used to normalised signal intensity (‘Spo11 
Mapping v09 MC.R’ – Appendix 10.5). A. ERG25 hotspot. B. ARE1 hotspot.  
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Figure 5.11: Multiple repeats of the wild type (sae2!) strain have highly correlated hotspot 
strengths. Correlation between wild type (sae2!) and the Spo11-oligo dataset is also observed. 
A. Quantitative reproducibility. Comparisons are shown for pairs of biological replicates (WT_1, 
WT_2A, WT_3, WT_5) and against an averaged data set (WT_Average). Total Spo11-DSB hits were 
summed up for all annotated hotspots from Pan et al., 2011 and the hotspot strengths (hits per million 
mapped reads (HpM)) compared between data sets (A.) and between an averaged sae2! data set and 
the Spo11-oligo data set (B.). Pearson’s r2 for pairwise comparisons ranged from 0.939-0.994 for all 
biological replicates and against the averaged data set. Pearson’s r2 for pairwise comparison between 
the averaged sae2! and the Spo11-oligo data set was calculated as 0.713. Script (‘Plotting hotspot 
tables v03.R’ – Appendix 10.7).  
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against the Spo11-oligo (Pan) data, there is strong correlation (r2 value ~0.68). However, the 
correlation between sae2∆ data was much stronger compared to between the sae2∆ and the 
Spo11-oligo dataset, suggesting that there is a real biological difference between wild type and 
sae2∆ strains. This can be observed at medium strength hotspots (100-1000 HpMNorm) that 
are 10-fold greater in the Spo11-oligo data. There is however some major differences in the 
comparison between sae2∆ and the Spo11-oligo data at weak hotspots with a skew occurring 
at this lower end (Figure 5.11B). For the calling of hotspots in the Spo11-oligo dataset, a cut-
off was used of 25 total mapped Spo11-oligos (Pan et al., 2011). Therefore, no hotspots were 
called below this threshold. By contrast, the sae2∆ dataset had no cut-off applied, apart from 
the correction for background levels. This may cause the skew of the data at the weak hotspots 
because at these designated sites the sae2∆ data could record less than the 25 hit cut-off, 
whereas all the Spo11-oligo hotspots at this weaker end would be 25 hits and above.  
5.16 Chromosome size-correlated variation in DSB frequencies  
The Spo11-oligo data (Pan et al., 2011), and older mapping studies (Blitzblau et al., 2007; 
Gerton et al., 2000; Martini et al., 2006), observed a negative correlation between chromosome 
size and hit density, potentially due to chromosome synapsis-dependent, Zip3-mediated shut-
off of DSB formation (Thacker et al., 2014). For chromosomes to synapse DSB resection, 
ssDNA-dependent homology search and strand invasion is essential. Larger chromosomes 
have an increased chance for homolog engagement due to more DSBs forming on these 
chromosomes (Thacker et al., 2014). In a DSB processing mutant, such as sae2∆, DSB 
resection, and therefore synapsis-dependent shut-off of DSB formation, does not occur. First, 
to determine whether Spo11-DSBs numbers increase with chromosome length in the sae2∆ 
data set, as seen in the Spo11-oligo data, chromosome length was plotted against total 
chromosome hits per million (HpM) (Figure 5.12A). As in the Spo11-oligo data, a positive 
linear correlation (r2 = 0.88) is observed between chromosome length and numbers of Spo11-
DSB hits. For unknown reasons, chromosome 12, is an outlier in this data, forming fewer 
DSBs relative to its size.  
To determine whether homolog synapsis in a wild type background does cause larger 
chromosomes to contain a lower DSB density, the hit density of the sae2∆ data set was 
calculated (total Spo11 hits per million per bp) and plotted against chromosome length (Figure 
5.12B). The sae2∆ data set also contains a negative correlation between hit density and 
chromosome length however, the r2 value was much lower than the wild type data (r2 = 0.061 
in sae2∆ compared to r2 = 0.43 in the Spo11-oligo data). This suggests that larger  
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Figure 5.12: Spo11 DSBs increase with chromosome length but larger chromosomes contain a 
lower density of Spo11-DSBs, potentially due to synaptic shut-off.  
A. Total chromosome hits per million reads (MReads) was calculated and plotted against the 
chromosome size (kb). The correlation between total chromosomal Spo11 hits per million reads and 
chromosome length was calculated and displayed on the graph (r2). B. The Spo11 hit density (total 
chromosome hits per million reads per base pair) was calculated and plotted against chromosome size 
(kb). The correlation between hit density and chromosome size was calculated and displayed on the 
graph (r2).  
sae2!!
 Spo11-oligo!
!"#$#%&'(')*#
!"#$#%&%+,%-#
%#
%&%)#
%&%'#
%&%+#
%&%.#
%&,#
%&,)#
%# -%%# ,%%%# ,-%%#
!"
#$%
&'
("
#)
$*!
+,
-.
+/
$
0123"4&$*5./$
!"#$#%&%+,%-#
!"#$#%&%%,*)#
%#
%&%)#
%&%'#
%&%+#
%&%.#
%&,#
%&,)#
%# -%%# ,%%%# ,-%%#
!"
#$%
&'
("
#)
$*!
+,
-.
+/
$
0123"4&$*5./$
!"#$#%&/*+-,#
!"#$#%&..%-'#
%#
)#
'#
+#
.#
,%#
,)#
,'#
,+#
%# -%%# ,%%%# ,-%%#67
#8
9$1
"#(
-0
12
7:
(7
:
&-
,
2&
8%
($;
<=
>$
0123"4&$*5./$
!"#$#%&..-%.#
!"#$#%&..%-'#
%#
)#
'#
+#
.#
,%#
,)#
,'#
,+#
%# -%%# ,%%%# ,-%%#6
7#
89
$1
"#(
-0
12
7:
(7
:
&-
,
2&
8%
($;
<=
> $
0123"4&$*5./$
sae2! ndt80!!
A!
B!
sae2!!
Chapter 5: Genome-wide mapping of Spo11-DSBs 
 155 
chromosomes in sae2∆ contain Spo11-DSBs more similar to smaller chromosomes, supporting 
the hypothesis that DSB formation is repressed by synapsis-dependent shut-off. In the sae2∆ 
data set small chromosomes still have a higher hit density to larger chromosomes, therefore, 
another potential factor is active that is suppressing DSB formation on larger chromosomes. 
One hypothesis is that sae2∆ cells have a shorter prophase due to a weakened prophase 
checkpoint response. This shortened prophase would decrease the time for larger 
chromosomes to form DSBs. Therefore, to determine whether prevention of prophase exit, 
through an ndt80∆ mutation, has an effect on DSB hit density, the sae2∆ hit density was 
compared to sae2∆ ndt80∆ (Figure 5.12B – right hand panel). The hit density of the sae2∆ 
ndt80∆ mutant was similar across all chromosome sizes (r2 = 0.0017), suggesting that length of 
prophase has an effect on DSB formation on larger chromosomes in a sae2∆ background. In 
order to distinguish whether DSB formation suppression on larger chromosomes is synapsis-
dependent or due to prophase timing, the Spo11-oligo mapping procedure would need to be 
conducted on wild type cells in an ndt80∆ background.  
Potentially the shortened length of prophase in a sae2∆ mutant could cause chromosome 12 to 
display fewer Spo11 hits than expected for its size. To test the hypothesis, the total number of 
hits on chromosome 12 was calculated for a sae2∆ ndt80∆ mutant (Figure 5.12A – right hand 
size). However, preventing exit from prophase did not affect the number of hits on 
chromosome 12, suggesting that this factor is not the cause for chromosome 12 being an 
outlier.  
5.17 Spo11 contains a weak sequence bias for cleavage  
The Spo11-oligo mapping study determined that there is a weak sequence bias for Spo11 
cleavage (Pan et al., 2011). However, due to the ambiguity of 5ʹ′ C residues (due to the rGTP-
tailing conducted to generate sequenceable molecules), and this procedure only mapping the 
long Spo11-oligo produced, an incomplete picture was formed. Using the nucleotide-
resolution sae2∆ mapping data, a more accurate sequence bias can be obtained that contains no 
ambiguity for the 5ʹ′ end, with both sides of the DSB enriched for (assuming the shorter Spo11-
oligo that was unmapped arises from asymmetric processing of the Spo11-DSB) (Figure 5.13). 
To determine whether Spo11 displays a sequence bias for cleavage, the 5ʹ′ (Spo11) ends +-
35 bp were aggregated, with any single 5ʹ′ site that occurred greater than five times (to remove 
any potential background effect) used to generate a sequence bias profile (Figure 5.13). This 
consensus sequence for Spo11 cleavage at DSB sites consists of biases of A at positions +10, 
G at positions +2 and +13, and T at positions +1, +4, +5 and +11. These biases are palindromic 
and therefore contain the complementary purine/pyrimidine on the opposing strand (negative  
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Figure 5.13: Spo11 cleavage sites genome-wide contain a sequence bias.  
Sequences derived from the sae2!, Spo11 enrichment protocol were aligned to the S. cerevisiae 
S288C genome using bowtie2. 5! Read1 (Spo11) ends were extracted and converted into a 1 bp 
histogram using R Studio. The sequence of each 5! read +/- 35 bp were aggregated for sites where 
Spo11-DSBs were at least 5 to reduce the influence of non-specific signal. The sequence bias was 
plotted for A/T and G/C pairs, which are expected to show rotational symmetry consistent with Spo11 
cleaving DNA as a dimer.  
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values). Notably, some positions were depleted below the average occupancy: A at +1, C at 
+2, and G at +5. Overall, a weak (palindromic) consensus for Spo11-DSBs can be read as 
AAGC*A|TGCTT (top-strand displayed only, dyad axis (|) indicated, Spo11 cleavage site (*) 
would be reciprocated on the right hand side of the axis, bottom strand). The palindromic 
nature and rotational symmetry of the bias is indicative of a Spo11 dimer cleaving the dsDNA, 
comparable with previous reports (Sasanuma et al., 2007).  
5.18 Discussion 
The mapping procedure detailed in this chapter is able to generate a single-nucleotide 
resolution genome-wide map of Spo11-DSBs in a sae2∆ (Spo11-end processing deficient) 
background, improving on the previous low-resolution rad50S mapping data (Gerton et al., 
2000). In comparison to the Spo11-oligo mapping (Pan et al., 2011), this high resolution map 
also observed Spo11-DSB accumulation at the majority of the previously annotated hotspots. 
These hotspots reside in nucleosome-depleted regions at promoters (Figure 5.9-5.11). As 
expected from the Spo11-oligo data (Pan et al., 2011), the number of DSBs per chromosome 
increase with the length of chromosome (Figure 5.12A). The Spo11-oligo data set observed a 
slight negative correlation of DSB density with chromosome length attributed to synapsis-
dependent shut-off of DSB formation, which, due to increased numbers of DSBs on larger 
chromosomes would decrease the DSB density the larger a chromosome is (Thacker et al., 
2014). DSB resection-defective mutants (e.g. sae2∆) do not permit homolog synapsis and the 
sae2∆ data set observes a more even DSB density between short and long chromosomes 
(Figure 5.12B). However, increasing the length of prophase using an ndt80∆ mutant resulted in 
short and long chromosomes containing almost identical DSB density, suggesting that 
synapsis-dependent regulation of DSBs on large chromosomes may not be the only factor 
involved in a sae2∆ background, and that length in prophase is also important.  
A weak Spo11 sequence bias was previously observed, however an ambiguity for 5ʹ′ C 
molecules due to technical limitations skewed the data slightly (Pan et al., 2011). Using the 
sae2∆ data set that contains no ambiguity for the 5ʹ′ end of molecules, a more accurate 
consensus sequence could be generated (Figure 5.13). Potentially, the bias arises due to DNA 
properties that affect Spo11 binding or cleavage of the DNA. The enrichment or depletion of 
each base reflects that observed previously (Pan et al., 2011) and thus supports the hypothesis 
that whilst Spo11 is directed to specific regions of the genome, for example at nucleosome-
depleted regions,  it also is slightly directed to specific regions due to base composition.  
This sae2∆, Spo11-DSB mapping procedure involved the enrichment of Spo11-DNA 
molecules by utilising the covalently bound protein moiety as a substrate for specific 
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enrichment on glass fibre columns. This enables genome-wide DSB maps of untagged Spo11, 
avoiding any potential effects affinity tags have on Spo11 function. This is in contrast to the 
Spo11-oligo mapping data, which initially relied on HA-tagged Spo11 for enrichment (Pan et 
al., 2011). A caveat to this new method of enrichment is that any protein-bound molecules 
could potentially be enriched and thus, the signal observed in the sae2∆ maps could actually be 
due to another DNA-bound protein. However, sequencing of a catalytic dead Spo11 mutant 
(spo11-Y135F) mutant indicates that the signal observed is Spo11-DSB dependent because no 
specific signal was observed in this strain (Figure 5.8-5.11).  
In principle, this procedure is not S. cerevisiae specific because all that is required is the 
presence of the protein covalently bound to the 5ʹ′ end of the DNA. The lack of requirement for 
an affinity tag has the advantage of removing any potential effect affinity tags have on protein 
activity and also aids in mapping in other organisms where incorporating a tagged form of a 
protein is technically difficult. Additionally, TDP2 shows no specificity to proteins (Chapter 
4), rather it is capable of cleaving any 5ʹ′ phosphotyrosine covalent bond. Therefore, there is 
the potential to utilise this procedure to map Top2, which, like Spo11, generates a 5ʹ′ 
phosphotyrosyl bond at DSBs. In situations where the covalently bound protein is 3ʹ′ linked, 
such as Top1, other hydrolytic proteins, such as Tdp1, which cleaves 3ʹ′ phosphotyrosyl bonds, 
could be utilised to map these proteins. Thus, the protocol developed in this chapter has the 
potential to be used to create high-resolution, genome-wide maps of a variety of covalently-
attached proteins in a range of organisms.  
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Chapter 6: The role of Tel1 kinase activity on DSB formation  
6.1 Introduction 
Spo11-DSBs are essential for initiation of meiotic recombination (Szostak et al., 1983), 
however, they are still lesions that have the potential to be detrimental to genomic stability if 
not repaired correctly. In S. cerevisiae there are ~3600 hotspots, regions that are enriched for 
Spo11-DSBs. However, within a single cell only 150-200 DSBs form per meiosis. Therefore, 
meiotic cells must have evolved pathways that limit the number and distribution of DSBs 
(reviewed in Cooper et al., 2014; Keeney et al., 2014).  
Two proteins have been implicated in the negative regulation of DSB formation in meiosis; the 
serine/threonine kinases Tel1ATM and Mec1ATR. Both proteins are involved in trans inhibition, a 
process that prevents DSBs from forming on the same location on sister chromatids and 
homologous chromosomes once a DSB has formed at the corresponding locus (Fukuda et al., 
2008; Rocco and Nicolas, 1996; Xu and Kleckner, 1995; Zhang et al., 2011). DSB events 
along chromatids also exhibit non-random patterns via a process known as DSB interference 
(Garcia et al., 2015). Tel1 controls DSB interference, with coincident formation of DSBs 
adjacent to each other occurring less often than by chance. In meiosis, sister chromatids 
condense by being organised into protruding loops, attached to a proteinaceous axis. DSB 
hotspots predominantly occur within these loops, however many of the proteins responsible for 
the activation and regulation of Spo11-induced DSBs reside at the axis (Blat et al., 2002; 
Borde and de Massy, 2013; Kleckner, 2006). The tethered-loop axis model suggests that DSBs 
forming primarily on loops are tethered to the axis to initiate the DSB (Sommermeyer et al., 
2013). In tel1∆ strains, a loss of interference occurs whereby DSBs form independently of one 
another but also now form more closely spaced than by chance (Garcia et al., 2015). This 
concerted DSB activity is restricted to ~15 kb windows that correlate with the location of 
singular meiotic loop domains. The data suggest that Tel1 is responsible for limiting a loop to 
contain a single DSB whilst also suppressing adjacent sites in the surrounding regions (Garcia 
et al., 2015). However, it is unknown whether the kinase activity of Tel1 is responsible for this 
action and if it is, what the relevant target(s) is.  
Mutation to the kinase domain of Tel1 results in a loss of in vitro kinase activity and in vivo 
phenotypes associated with tel1∆ (Mallory and Petes, 2000). However, a more recent study 
identified Tel1-kinase independent functions in telomere maintenance, suggesting that Tel1 
has two separate functions and that the Xrs2-dependent recruitment and association of Tel1 to 
telomeres plays an important role, independent of its kinase activity (Ma and Greider, 2009). 
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Therefore it was of interest to determine whether Tel1 kinase activity is required for DSB 
interference.  
6.2 In a sae2∆ background the tel1-kinase dead mutant causes DSB signal to 
smear on Southern blots 
Loss of TEL1 causes loss of DSB interference (Garcia et al., 2015). To determine whether the 
kinase activity of Tel1 was responsible for meiotic DSB interference, the tel1-kinase dead 
mutant (D2612A-N2617A-D2631A) (Ma and Greider, 2009) (tel1kd) was generated in the SK1 
background (V.Garcia). Genomic DNA extracted from meiotic cultures were assayed for DSB 
formation via Southern blotting. These experiments were conducted in a sae2∆ background to 
prevent resection and inhibit DSB repair, which otherwise causes heterogeneous migration of 
the DSBs and makes quantification challenging (Figure 6.1). At the HIS4::LEU2 hotspot, two 
DSBs form (Xu and Kleckner, 1995) and, in a TEL1+, sae2∆ background, migrate as two tight 
bands (Figure 6.1A). In sae2∆ tel1∆ strains, migration of these two bands does not differ from 
sae2∆ (Figure 6.1B). However, in sae2∆ tel1kd the two DSBs form but now two sub-
populations are visualised for each DSB site. The two tight DSBs bands are present alongside 
a heterogeneous, faster migrating, smear down the gel (initially observed by V.Garcia – 
unpublished work, replicated in Figure 6.1C), similar to that seen at resected DSBs.  
In a sae2∆ background, unresected DSBs accumulate with Spo11 covalently bound to the 5ʹ′ 
ends, preventing any resection/repair from occurring (de Massy et al., 1995; Keeney et al., 
1997; Keeney and Kleckner, 1995; Liu et al., 1995). Due to the resection-like smear observed 
(Figure 6.1C), it was hypothesised that the tel1kd mutant was somehow bypassing the Spo11-
block to resection. However, subsequent experiments by Valerie Garcia have confirmed these 
smears are resistant to S1 nuclease, indicating the smear is not due to ssDNA being present 
(i.e. from resection). Additionally, the Spo11-DSB enrichment procedure (detailed in Figure 
5.3) is able to confirm that the smear is covalently bound Spo11-DNA (V.Garcia – data not 
shown). Both these results indicate that the smear is not due to resection of the DSB. The 
smear increases in length over time and intriguingly only extends in the direction of 
transcription at HIS4::LEU2 (V.Garcia – unpublished observation and Figure 6.1C).  
6.3 Genome-wide, nucleotide-resolution mapping supports the spreading of 
DSBs in the direction of transcription in the tel1kd mutant 
In order to determine whether the tel1kd mutant causes DSB spreading at all DSB hotspots, the 
sae2∆ Spo11 mapping protocol (developed in Chapter 5) was utilised. As before,  
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Figure 6.1: At the HIS4::LEU2 hotspot the tel1kd mutant causes a heterogeneous smear 
of DSB signal in the direction of transcription.  
Southern blot of DSBs at the HIS4::LEU2 hotspot. A meiotic time course was performed for 
sae2! (A), tel1! (B) and te1kd (C), and samples taken at the indicated time points after the 
start of meiosis. Proteolysed genomic DNA was extracted from each time point and digested 
with PstI overnight before being resolved on a 0.7% TAE agarose gel for 18 hours at 60 V. 
The gel was transferred to nylon membrane under denaturing conditions and hybridised with 
a radioactive probe for the HIS4::LEU2 locus. The membrane was exposed to a phosphor 
screen overnight and an image taken using a Fuji phosphor scanner. DSBs are marked with 
an arrowhead (>). Annotated gene array (right hand side) indicates positions and orientations 
of genes and the locations of the two DSBs at the HIS4::LEU2 locus.  
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unproteolysed genomic DNA was extracted from meiotic cultures at mid-meiotic prophase 
from sae2∆, sae2∆ tel1∆ and sae2∆ tel1kd strains. DNA was fragmented to ~500 bp using 
sonication and protein-associated molecules enriched on a glass fibre column. Free DNA 
molecules were removed using high salt washes and Spo11-DNA molecules eluted using SDS. 
Sonicated ends of molecules had Adaptor 1 (Read2) ligated on with free adaptor subsequently 
removed. Molecules were incubated with human TDP2 protein to hydrolytically remove 
Spo11 from the other 5ʹ′ end without any loss of nucleotides, which allowed specific ligation of 
Adaptor 2 (Read1) to the Spo11 bound end. Molecules were PCR amplified and sequences 
read on an Illumina MiSeq. Sequences were aligned to the S. cerevisiae S288C genome and 
the 5ʹ′ ends from Read1 (i.e. the 5ʹ′ base where Spo11 cut) sorted into a histogram for each 
specific base pair in the genome.  
To determine whether the spreading observed via Southern blotting (Figure 6.1C) was visible 
in the mapping data, the specific sites of the genome (HIS4::LEU2 and ERG25) were plotted 
(Figure 6.2) (‘Spo11 mapping v09 MC.R’ – Appendix 10.5). In sae2∆, sae2∆ tel1∆ and sae2∆ 
tel1kd, the majority of the signal observed at these sites resides in the promoter regions of 
these genes. However, the tel1kd mutant also contains signal spreading from the promoter 
region into the 5ʹ′ end of the ORF in the direction of transcription at the ERG25 locus (Figure 
6.2A) and at both DSB sites of HIS4::LEU2 (Figure 6.2B). The amount of spreading observed 
at HIS4::LEU2 in the mapping data agrees with the Southern blots of the same locus, where 
the spreading at DSB-I is stronger than that observed at DSB-II (Figure 6.2B). At sites of the 
genome where hotspots aggregate in close proximity, such as ARE1, the tel1-kd mutant causes 
spreading of the hotspot DSB to overlap (Figure 6.2C). The spreading phenotype observed at 
these specific hotspots in the tel1kd mutant is also slightly present in in tel1∆ strains in 
comparison to wild type (sae2∆) strains (Figure 6.2). By contrast, Southern blotting of the 
tel1∆ strain displays no indication of spreading at ERG25 (data not shown) or HIS4::LEU2 
(Figure 6.1B), suggesting the Southern blotting detection level is too low to observe this subtle 
spreading phenotype in tel1∆.  
6.4 Spreading of DSB signal in tel1kd and tel1∆ mutants occurs genome-wide  
This spreading phenomenon may be distinct to the ERG25 and HIS4::LEU2 loci. Therefore, to 
determine whether spreading of DSB signal into ORFs occurs across the genome, the promoter 
regions of all genes, centred on the translation start site (TSS), were piled-up for each strain 
(‘Pileups around TSS v02.R’ - Appendix 10.8). The orientations of genes located on the Crick 
strand were reversed to match the direction of the Watson genes for visualisation purposes  
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sae2!"
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Figure 6.2: DSB signal spreads in the direction of transcription at various Spo11-DSB hotspots 
in TEL1 mutants.  
Unproteolysed genomic DNA was extracted from meiotic cultures at mid-meiotic prophase from 
sae2!, sae2! tel1! and sae2! tel1kd strains. DNA was fragmented using sonication and protein-
associated molecules enriched on a glass fibre column. Samples were processed for next-generation 
sequencing as described in Chapter 4. Sequences were aligned to the S. cerevisiae S288C genome and 
the 5! ends from Read1 (i.e. the 5! base where Spo11 cut) sorted into a histogram for each specific 
base pair in the genome. Regions indicated were visualised in R Studio (‘Spo11 Mapping v09 MC.R’ 
– Appendix 10.5). Highlighted region indicates region of spread signal. A. ERG25 locus. B. 
HIS4::LEU2 locus. C. ARE1 locus.  
C. ARE1 locus:!
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(Figure 6.3). As previously observed at ERG25 and HIS4::LEU2, the majority of signal resides 
in the promoter region adjacent to the ORF. Spreading of Spo11-DSB signal into the ORF is 
observed slightly in all strains, however, the tel1kd mutant displays a vastly heightened signal 
spreading into the ORF from the promoter region for ~500 bp (Figure 6.3C), suggesting that 
this spreading phenotype is a genome-wide phenomena. The small amount of spreading seen at 
ERG25 and HIS4::LEU2 in the tel1∆ mutant (Figure 6.2B), compared to wild type (Figure 
6.2A), is replicated in the genome-wide TSS pile-up data (Figure 6.3B). This suggests that the 
prevention of extensive DSB spreading in wild type cells is Tel1-kinase dependent, but yet 
independently, the Tel1 protein itself actually promotes DSB spreading via interaction with an 
unknown factor. Alternatively, the catalytically-dead Tel1 protein is obstructing a redundant 
pathway from compensating for the lack of Tel1 kinase activity.  
6.5 Spo11-DSB sites in tel1 mutants spread in the direction of the ORF 
To further test the hypothesis that DSB signal spreads in the direction of the ORF, DSB 
hotspots were subset into tandem (one promoter, one terminator), divergent (two promoters) 
and convergent (two terminators) hotspot regions (as depicted in Figure 6.4), and Spo11-DSB 
signal piled-up for each individual hotspot type centred on the DSB hotspot (‘Pileups around 
TSS v03 Gene expression’ – Appendix 10.9). At tandem hotspots, the tel1kd mutant Spo11-
DSB signal spreads only in the direction of the ORF (i.e. not backwards into the 3ʹ′ terminal 
end of the adjacent ORF) (Figure 6.4 - Tandem). At divergent hotspots, DSB signal spreads in 
both directions into both 5ʹ′ ends of the two adjacent ORFs (Figure 6.4 - Divergent). There are 
very few hotspots at converging genes, therefore the total hits found at these types is very low. 
For hotspots that are contained at convergent gene sites, spreading is minimal (Figure 6.4 – 
Convergent). These results suggest that a factor associated with the start of ORFs at promoter 
regions is a target for the Tel1 kinase with phosphorylation of this target suppressing hyper-
localised coincident Spo11-DSB formation.   
6.6 Spo11-DSB spreading correlates with disparity in recovery of 
Watson/Crick hits 
From visualising specific hotspots in tel1kd, such as ERG25 and HIS4::LEU2 (Figure 6.2), it 
became clear that directional spreading was strongly correlated with disparity in recovery of 
Watson or Crick ends, depending on the direction of the ORF.  For example, at the ERG25 
locus, the gene is encoded on the Watson strand, with the spread DSB signal enriched on the 
Watson strand with very little recovery of any spread DSB signal on the Crick strand (Figure 
6.2A). This disparity can be explained by a second/coincident cleavage of Spo11 adjacent to  
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Figure 6.3: Spo11-DSB signal spreads from the NDR region into the ORF in the direction of 
transcription occurs genome-wide tel1 mutants.  
Unproteolysed genomic DNA was extracted from meiotic cultures at mid-meiotic prophase from 
sae2! (A), sae2! tel1! (B) and sae2! tel1kd (C) strains. DNA was fragmented using sonication and 
protein-associated molecules enriched on a glass fibre column. Samples were processed for next-
generation sequencing as described in Chapter 4. Sequences were aligned to the S. cerevisiae S288C 
genome and the 5! ends from Read1 (i.e. the 5! base where Spo11 cut) sorted into a histogram for 
each specific base pair in the genome. 5! Spo11-hits were piled-up centred on the translation start site 
(TSS) and visualised using R Studio (‘Pileups around TSS v02.R’ – Appendix 10.8). Highlighted 
region indicates spread region.   
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Figure 6.4: Spo11-DSB signal spreads from the NDR region into the ORF in the direction of 
transcription genome-wide in tel1 mutants.  
Unproteolysed genomic DNA was extracted from meiotic cultures at mid-meiotic prophase from 
sae2!, sae2! tel1! and sae2! tel1kd strains. DNA was fragmented using sonication and protein-
associated molecules enriched on a glass fibre column. Samples were processed for next-generation 
sequencing as described in Chapter 4. Sequences were aligned to the S. cerevisiae S288C genome and 
the 5! ends from Read1 (i.e. the 5! base where Spo11 cut) sorted into a histogram for each specific 
base pair in the genome. 5! Spo11-hits on Watson (red) and Crick (blue) strands at annotated hotspots 
(Pan et al., 2011) were subset into hotspots located at tandem, divergent and convergent genes and 
hits piled-up centred on the DSB hotspot and  and visualised using R Studio (‘Pileups around TSS 
v03 Gene expression.R’ – Appendix 10.9).  
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an initial Spo11-DSB being formed (Figure 6.5A). This coincident cleavage creates hyper-
localised ‘double-cut’ events. Coincident cutting would result in Spo11 bound to either end of 
a short fragment of dsDNA. In Spo11 end-processing mutants, such as sae2∆, oligonucleotide 
species longer than the Spo11-oligos formed from normal Spo11-DSB end-processing are 
observed via the Spo11-oligo assay (Figure 3.2A – middle panel). These Spo11-oligo species 
are estimated to be 35 bp in length and increase in size with a 10 bp periodicity. The levels of 
these larger species increase in TEL1 mutants (Mohibullah and Keeney, 2016), therefore, they 
could be attributable to Spo11 double-cuts. When duplex DNA is wrapped around 
nucleosomes, every 10.5 bp an exposed, DNase sensitive, region is displayed (Brogaard et al., 
2012; Cockell et al., 1983) (Figure 6.5B). This exposed site may also be more liable for Spo11 
cleavage generating this 10 bp periodicity observed. Therefore, if Spo11 mainly forms a DSB 
juxtaposed to the +1 nucleosome at a promoter, a 10 bp periodicity would be observed if 
Spo11 cleaved at positions where it could access (every 10 bp). For technical reasons, these 
double-cut molecules are unlikely to enter the sequencing library (Figure 6.5C) resulting in 
only the most distal Watson hit being recovered. Consistent with this hypothesis, direct 
physical analysis of hotspots via Southern blotting has revealed that spreading is only visible 
towards where the probe is located - but could not be detected distal to the location of the 
canonical DSB site (Valerie Garcia - data not shown).  
6.7 Whole-genome mapping of Spo11 double-cut molecules reveals opposing 
disparity in Watson/Crick signal to single-cut libraries  
To determine whether the disparity observed in the Watson/Crick hits in the spread signal is 
due to coincident cleavage by Spo11 of the same DNA molecule in close proximity, the sae2∆ 
Spo11-DSB mapping protocol was modified in order to enrich for DNA molecules where 
Spo11 was stably bound to both ends (schematic in Figure 6.6).  The Spo11 moiety on the 5ʹ′ 
ends of the DSBs prevent degradation by λexo nuclease (Figure 4.5C). Therefore, λexo 
nuclease treatment of Spo11-DNA fragments eluted from the column enrichment procedure 
should degrade any molecules with a free 5ʹ′ end, i.e. any contaminating free DNA molecules 
and any single-cut Spo11-DNA molecules (molecules with Spo11 bound one end and a shear 
point at the other). Thus, this treatment will selectively degrade all non-double-cut molecules. 
TDP2 was utilised to hydrolyse Spo11 from both ends of the double-cut molecules and NEB 
(polar) adaptors were ligated simultaneously to both Spo11-derived ends. Double-cuts were 
PCR amplified and sequenced as before. Both 5ʹ′ ends (Read1 and Read2) are extracted from 
the sequencing data (‘Spo11ExtractDC’ – Appendix 10.10) and a 1 bp histogram made of the 
specific Spo11-cut sites in the genome (‘Creating 1bp histograms v03 (H4L2).R’ –  
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Figure 6.5: Hyperlocalised double-cutting of Spo11.  
Model of proposed Spo11-double cutting mechanism. A. Spo11 generates multiple DSBs on the same 
molecule in a hyper-local area (within a hotspot) with a 10 bp periodicity, a phenotype exacerbated in 
a TEL1 mutant backgrounds. B. Each helical turn of nucleosome bound duplex DNA contains a 
DNase-sensitive region 10.5 bp in periodicity (Brogaard et al., 2012; Cockell et al., 1983), 
comparable to the 10 bp periodicity observed in double-cut molecule size. C. For a DNA fragment to 
be sequenced it must contain polar adaptors to enter the MiSeq library. Using TDP2 to remove Spo11, 
two unique adaptors can be specifically ligated to the sonicated or Spo11 end generating a polar 
molecule with the Spo11-end distinguishable. These polar molecules can be sequenced via the paired-
end Illumina MiSeq and enter the library for analysis. A molecule with Spo11 bound both ends does 
not have Adaptor 1 ligated due to Spo11 blocking access. Therefore, TDP2 removal of Spo11 
generates a DNA fragment with two free ends that both have Adaptor 2 ligated to. These molecules 
with Adaptor 2 ligated to both ends are not sequencable by the Illumina MiSeq and are not present in 
the library. 
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Figure 6.6: Schematic of Spo11 double-cut enrichment and mapping.  
A meiotic time course is performed for a sae2! strain and cells harvested at 6 hours. Unproteolysed 
genomic DNA was extracted by fixing spheroplasts in ethanol, lysing with SDS, and extracting DNA 
and protein-bound DNA using phenol:chloroform:isoamyl alcohol (25:24:1). Molecules were 
precipitated with ethanol, resuspended in 1! TE and sonicated to fragment the DNA. The sample is 
bound to the glass fibre membrane of a QIAQuick spin column, centrifuged and the flow-through 
rebound to the column and centrifuged again to increase yield. The membrane is washed using TEN 
(10 mM Tris Base!HCl pH 8.0, 1 mM EDTA, 300 mM NaCl) to remove any non-protein-bound 
DNA. Spo11-bound DNA is released from the column using two sequential elutions in 50 µl TES 
(10 mM Tris Base!HCl pH 8.0, 1 mM EDTA, 0.5% SDS). Eluates are ethanol precipitated overnight 
and resuspended in 1x TE. Free-DNA and Spo11 single-cut molecules are degraded with lambda 
exonuclease followed by heat denaturation and AMPure XP beads clean-up. The fragments are 
reacted with TDP2 to remove the peptide covalently bound to the 5" ends of the DNA before end-
repair and ligation of NEBNext polar adaptors. The molecules are amplified by PCR and 2!75 bp 
paired-end sequencing conducted using a Illumina MiSeq machine. 
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Appendix 10.3). First, to determine whether these double-cut molecules were enriched at 
Spo11-hotspots, the ERG25 hotspot was visualised for Spo11-DSB signal (Figure 6.7). At 
ERG25 the Spo11-DSB signal spread into the ORF as before, but the disparity between 
Watson and Crick strand hits was reversed with Crick hits now predominating (Figure 6.7). 
These double-cut molecules also exist in sae2∆ (Figure 6.7 – sae2∆) and tel1∆ (Figure 6.7 – 
sae2∆ tel1∆), but are exacerbated in tel1kd (Figure 6.7 – sae2∆ tel1kd). However, in sae2∆ 
these double-cut molecules reside within the characterised hotspot (the NDR promoter region) 
and not into the ORF (Figure 6.7 – sae2∆), unlike tel1kd whose signal again spreads into the 
ORF in the direction of transcription.  
6.8 A 10 bp periodicity of Spo11 double-cut molecule lengths is observed in 
tel1 mutants, correlating with large Spo11-oligonucleotide lengths 
observed in sae2∆ cells 
To determine whether these double-cut molecules have a set length or periodicity (as 
hypothesised – Figure 6.5), the length of double-molecule was tallied and the abundance of 
each length of molecule compared to the length (Figure 6.8A) (lengths of molecule calculated 
as part of ‘Spo11ExtractDC’ script). To smooth noise in the data, a 3-point moving average 
was calculated and plotted (Figure 6.8A) and molecules between 0-200 bp zoomed in to 
observe these smaller sized molecules (Figure 6.8B). Tallying the lengths of double-cuts, 
enriched in the modified Spo11-DSB mapping protocol, rendered a 10 bp periodicity starting 
at 100 bp up to 400 bp (Figure 6.8A).  
6.9 Larger Spo11-oligonucleotide species increase in tel1 mutants with a 
10 bp periodicity  
Cells deficient in TEL1 generate longer Spo11-oligonucleotides when assessed via the Spo11-
oligo assay (Mohibullah and Keeney, 2016). It was of interest to further characterise these 
larger species and determine the effect these tel1 mutations had in a sae2∆ background (Figure 
6.9). Following the Spo11-oligo assay as before, Spo11-oligo species enriched from wild type, 
tel1∆ and tel1kd (+-sae2∆) meiotic cultures were end labelled with dCTP, then proteolysed 
with Proteinase K. In order to correctly size DNA species, TDP2 was used to remove the 
covalently bound peptide left after proteolysis. DNA species were resolved on a 19% 
denaturing urea-PAGE (sequencing) gel to resolve species from 5 nt to 100 nt (Figure 6.9A). 
The larger (>30 nt) species can be observed in all lanes, with and without sae2∆, with a 10 nt 
periodicity. The precise sizes of the observable molecules are: 32 nt, 42 nt, 52nt, 62 nt, 72 nt, 
82 nt, 92 nt and 102 nt. The abundance of these larger species increase in a sae∆ background  
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Figure 6.7: Mapping Spo11-double-cut molecules at specific hotspots.  
Double-cut Spo11-DSB molecules were mapped in a sae2! background in the stated strains using the 
double-cut method described in Figure 6.6. Sequencing reads were generated from the stated strains 
enriched for Spo11-DSBs and aligned against the S. cerevisiae S288C genome with both 5! Spo11 
ends used to generate a 1 bp histogram. Hits on the Watson (red) and Crick (blue) strands are 
indicated. Putative background reads were calculated for all strains and used to normalise signal 
intensity. The ERG25 locus is visualised as an example of the distribution of Spo11 double-cut 
molecules (‘Spo11 Mapping v09 MC.R’ – Appendix 10.5). Highlighted region indicates double-cut 
area.  
ERG25 locus:!
sae2!"
Watson"
Crick"
sae2! tel1!"
sae2! tel1-kd"
Watson"
Crick"
Watson"
Crick"
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Figure 6.8: Analysing the length of the double-cut molecules reveals a 10 bp periodicity. 
Double-cut Spo11-DSB molecules were mapped in a sae2! tel1! and in a sae2! tel1-kd 
background. Sequencing reads generated from the double-cut enrichment strategy (Figure 
6.6 and 6.7) were aligned against the S. cerevisiae S288C genome. A. A 3-point moving 
average was calculated and plotted for the distance between the two 5! ends (size of double-
cut) against the number of hits for each given length (frequency). B. To visualise short 
molecules, the axis were scaled to observe molecules less than 200 bp in length.  
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Figure 6.9: In both wild type and sae2! cells a 10 bp periodicity of species is observed from 
35 bp. These species are exacerbated in TEL1 mutants.  
Spo11 oligonucleotides were enriched and 3! end labelled using TdT and dCTP radionucleotide from 
stated mutants. Spo11-oligos were digested with Proteinase K at 60 °C for 1 hour and DNA 
precipitated overnight at -80 °C using 100% ethanol. Precipitate was resuspended in TDP2 reaction 
buffer and TDP2 protein added (unless otherwise stated) and incubated at 37 °C for 1 hour. The 10 bp 
ladder was labelled using TdT and dCTP radionucleotide. A. Spo11-oligos from 6 hours into meiosis 
were treated with and without TDP2 to accurately size Spo11-oligos from the stated mutants. Samples 
were separated on a 19% denaturing urea-PAGE gel. Putative Spo11 double-cut molecules are 
observed in sae2! (and wild type SAE2) with a 10 bp periodicity starting at 35 bp.  B. Spo11 oligos 
from stated time points in meiosis were separated on a 10% denaturing urea-PAGE gel. Putative 
Spo11 double-cut molecules with a 10 bp periodicity are observed up to 150 bp in tel1kd. Asterisks 
indicate non-specific contaminants.   
B!
Chapter 6: The role of Tel1 kinase activity on DSB formation 
 176 
(Figure 6.9A right hand panel) and further increase in the tel1kd mutant. In both tel1 mutants a 
smear is present at ~150 nt in tel1∆ and at 150 to 400 nt in tel1kd. The 10 bp periodicity 
observed when analysing the Spo11 double-cut molecule lengths from the genome-wide data 
(Figure 6.8A) started at 100 bp up to 400 bp, suggesting this smear observed could be the same 
double-cut molecules (as hypothesised – Figure 6.5).  
To try and further resolve these molecules, Spo11-derived DNA molecules from sae2∆, sae2∆ 
tel1∆ and sae2∆ te1kd cells were resolved on a 10% denaturing urea-PAGE gel (Figure 6.9B). 
The 10 bp periodicity of Spo11-DNA molecules can be observed up to 250 bp in length in the 
tel1kd strain with the smeared signal extending further but unable to be resolved into a ladder 
at longer lengths (Figure 6.9B left hand panel). This periodicity thus appears to directly 
correlate with the periodicity observed from the genome-wide mapping data (Figure 6.8A). 
This periodicity cannot be observed in the tel1∆ or TEL1+ strains above 80 bp (Figure 6.9B 
middle and right hand panels) potentially due to either low abundance or absence, supported 
by the lack of visible spreading in these strains (Figure 6.3).  
6.10 Discussion 
Tel1 is responsible for DSB interference in cis during meiosis (Garcia et al., 2015). To 
determine whether Tel1 kinase activity was required for DSB interference a kinase deficient 
mutant of Tel1 (tel1kd) was generated. Unexpectedly, the tel1kd mutant causes a smearing 
phenotype of DSB signal via Southern blotting (Figure 6.1C), preventing accurate 
determination of DSB interference in this strain. However, this phenotype was intriguing as 
this smearing of the DSB sites was not due to resection (VG – unpublished work). Utilising the 
sae2∆ Spo11-DSB mapping procedure developed in Chapter 5, genome-wide mapping of 
Spo11-DSBs in the tel1kd background was performed. The tel1kd mutant caused genome-wide 
spreading of DSBs from promoter regions into the ORFs of the downstream genes, in the 
direction of transcription (Figure 6.4). A disparity between Watson and Crick strand signal 
was noted in the spread region (Figure 6.2). This disparity was attributed to coincident 
cleavage of the same DNA molecule by Spo11, generating a double-cut Spo11 molecule (a 
molecule with Spo11 covalently bound to both 5ʹ′ ends – Figure 6.5). By altering the sae2∆ 
Spo11 mapping procedure, these double-cut molecules were enriched and mapped as before 
(Figure 6.6), generating maps with the opposing disparity between Watson and Crick signal, 
supporting the view these molecules are double-cut molecules.  
Analysis of the lengths of these double-cut molecules revealed a 10 bp periodicity ranging 
from 100-400 bp in length (Figure 6.8A). This 10 bp periodicity correlated with a 10 bp 
periodicity of Spo11-oligonucleotides observed via the Spo11-oligo assay (Figure 3.2 and 
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Figure 6.9). This 10 bp periodicity ranged from 32 to 102 nt (Figure 6.9) and these larger 
Spo11-DNA molecules were observed to increase in tel1∆ and tel1kd mutants (Mohibullah and 
Keeney, 2016). Using denaturing urea-PAGE, the 10 bp periodicity of these Spo11-derived 
DNA molecules was further characterised (Figure 6.9). These species ranged from 32 nt to 
202 nt in tel1∆ strains and from 32 nt to 402 nt in tel1kd (Figure 6.9B) agreeing with sae2∆ 
mapping data of Spo11 double-cut lengths (Figure 6.8A). However, molecules shorter than 
100 bp in the sae2∆ mapping data are not detected via this procedure, potentially due to the 
size-selection steps required for efficient mapping (to remove contaminant adaptors). 
Therefore, whilst the molecules below 100 bp also display a 10 bp periodicity via urea-PAGE 
gels (Figure 6.9), the mapping data has yet to detect these very short double-cut molecules. 
The 10 bp periodicity observed could be attributed to exposed/DNase sensitive sites of 
nucleosomal duplex DNA that occur every 10.5 bp (Brogaard et al., 2012a; Cockell et al., 
1983) (Figure 6.5B), as these exposed regions may also be more liable for Spo11 cleavage. 
Therefore, if Spo11 mainly forms a DSB juxtaposed to a nucleosome, a 10 bp periodicity 
would be observed if Spo11 cleaved at positions where it could access (sites with 10 bp 
increments). 
The increased hyper-localised DSBs may occur as a consequence of aberrant control of DSB 
numbers, due to the tel1 mutation, with multiple DSBs occurring within the same hotspot. The 
10 bp periodicity observed within this localised region could be due to the cleavage of Spo11 
on one side/turn of the DNA duplex potentially due to DNA-binding proteins. More 
intriguingly it could be due to adjacent nucleosomes. DNA duplexes wrap around nucleosomes 
and have an exposed site every 10 bp, observed via MNase hyper-sensitivity (Brogaard et al., 
2012; Cockell et al., 1983). Therefore these sites may also be more favourable to Spo11-
cleavage.  
To account for the differences in spreading observed between the tel1∆ and tel1kd mutants it is 
possible that the presence of the Tel1 protein in the tel1kd mutant is blocking a redundant 
pathway from preventing hyper-localised spreading. This redundant pathway could potentially 
be Mec1 due to the similar substrates that both Mec1 and Tel1 phosphorylate (Baldo et al., 
2008; Ritchie et al., 1999). Preliminary work in the Neale lab has observed in a mec1-kinase 
dead mutant, a reduction in Spo11-DSB spreading into the ORF compared to wild type strains 
(DJ/MJN – unpublished data). However, the target for phosphorylation by Tel1/Mec1 is still 
unknown. 
One potential target for this spreading phenotype is the MRX complex. The MRX complex is 
essential not only for DSB end processing and resection (Mimitou and Symington, 2008; Zhu 
et al., 2008b), but the components are also members of the Spo11 complex and are required for 
DSB formation in meiosis (reviewed in Keeney, 2008). In Spo11 end processing mutants such 
Chapter 6: The role of Tel1 kinase activity on DSB formation 
 178 
as sae2∆, rad50S and mre11 nuclease mutants, Mre11 proteins accumulate at the DSB site 
(Usui et al., 2001). Two Mre11 N-terminal mutations, H33R and P110L decrease both Mre11 
binding and retention to DSBs in a sae2∆ background and suppress sae2∆ CPT sensitivity 
(Chen et al., 2015; Puddu et al., 2015). TEL1 inactivation does not suppress the DNA damage 
hypersensitivity of sae2∆ but does reduce the ability of the mre11-H37R mutant to suppress 
sae2∆ CPT hypersensitivity. In TEL1 deficient cells the mre11-H37R mutant now forms foci 
suggesting Tel1 cooperates with Sae2 to promote the removal of Mre11 from DSBs (Puddu et 
al., 2015). Hyper-phosphorylation of the mammalian MRX complex (MRN) by ATM (Tel1) 
leads to dissociation of the MRN complex from the DSB site. Therefore, if the tel1kd protein 
stabilised the MRX complex at the DSB but failed to phosphorylate it (and/or prevented Mec1 
from phosphorylating it) then this may lead to increased DSB formation locally within the 
hotspot.  
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Chapter 7: Genome-wide mapping of Top2-DSBs 
7.1 Introduction 
The topoisomerase II (Top2) dimer introduces transient DSBs, with 4 bp overhangs, 
throughout the genome to allow strand passage and relaxation of superhelical tension (Burden 
and Osheroff, 1998; Nitiss, 2009; Schoeffler and Berger, 2005), issues generated during the 
normal cellular processes of DNA replication, transcription and chromatin remodelling 
(Bermejo et al., 2007; Fachinetti et al., 2010). The transient Top2-DSBs are formed through a 
similar mechanism to Spo11-DSBs. The catalytic tyrosine residue attacks the DNA phosphate 
backbone to create a covalent bond to the 5ʹ′ ends, either side of the DSB. Strand passage 
occurs through this gap and the Top2 dimer reseals the DSB once this is complete (Deweese 
and Osheroff, 2009; McClendon and Osheroff, 2007; Nitiss, 2009; Pommier et al., 2010b; 
Schoeffler and Berger, 2008; Schoeffler and Berger, 2005; Wang, 2002).  
The DSBs generated by Top2 can become stabilised during its normal catalytic cycle or in 
response to poisons, resulting in a toxic lesion (Corbett and Osheroff, 1993). Etoposide binds 
the protein-DNA interface, misaligning the two DNA strands, resulting in prevention of 
religation and trapping of the Top2 dimer at the DSB site (Pommier and Marchand, 2011; Wu 
et al., 2011). These Top2-DSBs can be repaired by either the NHEJ or HR pathways, but first 
the 5ʹ′ adducts need to be removed (Cruz-García et al., 2014; Gómez-Herreros et al., 2013).  
Two pathways contribute to the processing of Top2-DSBs: (i) In mammalian, but not yeast 
cells, the TDP2 pathway can directly hydrolyse the phosphotyrosine bond between the 5ʹ′ 
linked adduct and the DNA (Cortes-Ledesma et al., 2009; Gao et al., 2014). (ii) In yeast and 
mammalian cells, the Sae2 (CtIP) and Mre11 pathway endonucleolytically processes Top2-
DSBs (Aparicio et al., 2016; Hartsuiker et al., 2009b; Nakamura et al., 2010). S. cerevisiae do 
not contain an ortholog of mammalian TDP2 but do contain Tdp1, an ortholog of mammalian 
3ʹ′-tyrosyl-DNA-phosphodiesterase (TDP1), which cleaves 3ʹ′ phosphotyrosyl bonds and has 
shown residual in vitro activity on 5ʹ′ phosphotyrosyl bonds (Murai et al., 2012; Nitiss et al., 
2006).  
Genome-wide mapping of stalled Top2 complexes in mammalian cells has been conducted at 
low resolution (Baranello et al., 2014). Single-stranded (SSBs) and double-stranded (DSBs) 
breaks were both labelled and enriched for from cells exposed to etoposide. Supporting earlier 
studies, etoposide was found to generate mostly SSBs over DSBs, potentially due to etoposide 
inhibiting the religation of each broken strand by the two Top2 monomers independently 
(Bromberg et al., 2003). Top2 lesions are enriched at promoter regions, with an anti-
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correlation to nucleosome occupancy, compared to the rest of the genome (Baranello et al., 
2014; Sperling et al., 2011) and this was positively correlated with the high levels of 
transcription (Baranello et al., 2014). Nucleotide-resolution mapping of Top2 lesions has yet to 
be conducted.  
7.2 Deletion of PDR1 allows exposure and sensitivity of S. cerevisiae cells to 
etoposide in liquid culture  
Wild type S. cerevisiae are not sensitive to low doses of etoposide due to an array of drug 
extrusion pumps that are involved in actively pumping out these compounds, preventing toxic 
build-up (Balzi et al., 1987; Balzi and Goffeau, 1991; Stepanov et al., 2008). These pumps are 
encoded for by the Pleiotropic Drug Resistance (PDR) network of genes. This network 
consists of four transcriptional regulators (PDR1, PDR3, PDR7 and PDR9), which regulate 
gene expression of the membrane drug extrusion pump PDR5 (Balzi et al., 1994). The PDR1 
transcriptional regulator is also involved in regulation of other membrane pumps, which may 
be involved in multidrug resistance (Balzi and Goffeau, 1991). A sensitivity cassette has been 
created that fuses the potent transcriptional repressor CYC8p to Pdr1p (Stepanov et al., 2008). 
To determine whether the CYC8-PDR1 cassette confers etoposide sensitivity to wild type, 
sae2∆ and mre11∆ cells spot tests were conducted (Figure 7.1, conducted by Holly Thomas 
(HT), MSc student). Serial 10-fold dilutions of exponentially growing cells were spotted onto 
YPD plates containing various concentrations of etoposide for each strain and grown for 3 
days. Wild type cells that did not contain the sensitivity cassette were resistant to all 
concentrations of etoposide (Figure 7.1A). The sensitivity cassette, incorporated into a wild 
type strain (pdr1∆) resulted in sensitivity to etoposide at 0.3 µM and 1.0 µM etoposide 
concentrations, whilst the sae2∆ and mre11∆ strains were sensitive at all concentrations. 
Therefore, this sensitivity cassette can be used to render S. cerevisiae sensitive to 
topoisomerase poisons under chronic exposure.  
To determine the effects of the sensitivity cassette on acute exposure to etoposide, overnight 
cells (sae2∆ and mre11∆ both containing the sensitivity cassette) were diluted to an OD600 of 
0.5 in fresh YPD and grown to an OD600 of 2.0 (Figure 7.1B, conducted by HT). Cells were 
taken, serially diluted and spotted (t0). The remaining culture had 1 µM etoposide or 
equivalent volume of DMSO added and left to incubate at 30°C. Cells were taken after 1, 2, 4 
and 24 hours, serially diluted and spotted onto YPD plates and grown for 3 days. Both mre11∆ 
and sae2∆ strains displayed very little etoposide sensitivity after 1 h acute exposure. 2-24 h 
etoposide exposure caused increased sensitivity in both sae2∆ and mre11∆ strains, with  
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Figure 7.1: A sensitivity cassette renders wild type, sae2! and mre11! cells sensitive to chronic 
and acute etoposide exposure.  
Serial spot dilution assays of sensitivity to etoposide of stated S. cerevisiae mutants. The sensitivity 
cassette (‘PDR1’) consists of a deletion of the PDR1 gene and a fusion of the transcriptional repressor 
CYC8p to the DNA binding domain of Pdr1p. A&C. Cells were grown overnight at 30 °C, diluted to 
an OD600 of 0.5 in fresh YPD and grown to an OD600 of 2.0. A serial 10-fold dilution series, starting at 
OD600 2.0, were spotted onto YPD plates containing the stated final concentration of etoposide (A) or 
DMSO (C) and grown at 30 °C for 3 days.  B. Overnight cells were diluted to an OD600 of 0.5, grown 
to an OD600 of 2.0 and the culture split into four. Cells were taken at time 0 (‘t0’) and a serial dilution 
series was spotted. 1 µM Etoposide or DMSO was added and incubated for the stated exposure time. 
A serial 10-fold dilution series was spotted and cells grown at 30 °C for 3 days. Images were taken 
using a Syngene InGenius bioimaging system. Experiment was performed by Holly Thomas.   
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mre11∆ having very little cell grow at all time points from 2 h. The mre11∆ cells had reduced 
growth not only to the DMSO control (growth defect) but also to t0 suggesting cell death had 
occurred for 2-24 h. The sae2∆ cells had a similar phenotype at 4-24 h (Figure 7.1B). 
Etoposide is poorly soluble in aqueous solution and was therefore dissolved in DMSO. To 
determine whether the DMSO solvent affects cell growth, wild type, sae2∆ and mre11∆ strains 
were spotted on YPD plates containing varying levels of DMSO. All three strains observed no 
growth defect to DMSO solvent controls (Figure 7.1C), suggesting effects observed with 
etoposide exposure are due to the compound itself.  
Collectively these results from Figure 7.1 suggest the sensitivity cassette incorporated into 
S. cerevisiae render the cells sensitive to 1 µM etoposide exposure for 4 h in liquid culture. 
These conditions were used for acute exposure of strains to etoposide in liquid culture to 
accumulate Top2-DSBs on a large scale.  
7.3 Exposure to etoposide generates Top2 hotspots spread across the entire 
genome 
Genome-wide mapping of meiotic Spo11-DSBs from sae2∆ cells utilised the covalently bound 
Spo11-protein to enrich for protein-linked DNA molecules (Chapter 5). TDP2, a human 
protein that in vivo cleaves the phosphotyrosine bond between proteolysed Top2 and the 5ʹ′ end 
of DNA was also capable of removing Spo11 (Chapter 4). Exposure of cycling cells to 
etoposide (Figure 7.1) causes accumulation of Top2-DSBs, complexes that consist of Top2 
covalently bound to the 5ʹ′ end either side of the DSB, a situation similar to Spo11-DSBs. 
Therefore, the sae2∆ mapping procedure (Chapter 5) could potentially be utilised for mapping 
of Top2-DSBs genome-wide with nucleotide resolution (as depicted in Figure 7.2).  
To determine whether Top2-DSBs could be mapped genome-wide in this manner, haploid 
wild type, sae2∆ and mre11∆ strains, all containing the sensitivity cassette, were grown 
overnight in YPD (Figure 7.3, conducted alongside HT). Cultures were diluted to an OD600 of 
0.5 in 100 ml YPD and grown to an OD600 of 2.0. Cultures were split into 2 × 50 ml and a final 
concentration of 1 µM etoposide (‘E’ – etoposide), or an equivalent volume of DMSO for a 
control (‘U’ – untreated), was added and cultures grown for a further 4 h. Cells were pelleted 
and unproteolysed genomic DNA extracted. DNA was fragmented to an average size of 
500 bp and protein-DNA species enriched for on a glass fibre filter.  The sonicated ends of the 
fragments were end-repaired and Adaptor 1 (Read2) ligated. Samples were incubated with 
TDP2 to remove the covalently bound Top2 protein, a second round of end-repaired conducted 
and Adaptor 2 (Read1) ligated onto the Top2-bound ends. Samples were PCR amplified and  
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Figure 7.2: Schematic of Top2 enrichment and mapping.  
Overnight YPD cultures were diluted to an OD600 of 0.5 in 50 ml YPD, in duplicate, and grown to an 
OD600 of 2.0. A final concentration of 1 µM etoposide (‘E’ – etoposide), or an equivalent volume of 
DMSO for a control (‘U’ – untreated), was added and cultures grown for a further 4 h and cells 
pelleted. Unproteolysed genomic DNA was extracted by fixing spheroplasts in ethanol, lysing with 
SDS, and extracting DNA and protein-bound DNA using phenol:chloroform:isoamyl alcohol 
(25:24:1). Molecules were precipitated with ethanol, resuspended in 1! TE and sonicated to fragment 
the DNA. The sample is bound to the glass fibre membrane of a QIAQuick spin column, centrifuged 
and the flow-through rebound to the column and centrifuged again to increase yield. The membrane is 
washed using TEN (10 mM Tris Base!HCl pH 8.0, 1 mM EDTA, 300 mM NaCl) to remove any non-
protein-bound DNA. Top2-bound DNA is released from the column using two sequential elutions in 
50 µl TES (10 mM Tris Base!HCl pH 8.0, 1 mM EDTA, 0.5% SDS). The sonicated end of the DNA 
fragments are blunted using the NEBNext Ultra II end-repair kit and Adaptor 1 ligated on before 
removal of unligated adaptors using AMPure XP beads. The fragments are then reacted with TDP2 to 
remove the Top2 peptide covalently bound to the 5" end of the DNA before fill-in of the end that was 
Top2-bound. Adaptor 2 is then ligated onto the Top2-derived end of the fragment, and the now polar 
molecules are amplified by PCR and 2!75 bp paired-end sequencing conducted using a Illumina 
MiSeq machine. Read1 contains the 5" base of where Top2 cut. Read2 contains information regarding 
the sheared end of the fragment.  
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Figure 7.3: Genome-wide mapping of Top2 lesions and the Top2 hit density per chromosome. 
Haploid wild type, sae2! and mre11! strains were grown overnight in YPD. Cultures were diluted to 
an OD600 of 0.5 and grown to an OD600 of 2.0. Cells were split into two 50 ml cultures and 1 µM 
etoposide (‘etoposide’) or equivalent volume of DMSO (‘untreated’) added. Cells were incubated for 
an additional 4 h and cells harvested by centrifugation. Next-generation sequencing libraries were 
prepared as stated in Figure 7.2. Sequences were aligned to the S. cerevisiae S288C genome using 
bowtie2. 5! Read1 (Top2) ends were extracted an converted into a 1 bp histogram using R Studio. 
Top2 hits along Chromosome 2 (A) and Chromosome 1 (B) were compared between strains and 
between treatments using R Studio (‘Topo mapping v01.R’ – Appendix 10.11). Top2 hits were also 
compared against Spo11 hits on Chromosome 1 (B). C. The hit density (hits per million reads (HpM) 
per base pair) was calculated and compared for each chromosome and between mre11! and sae2! 
strains.  
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uniquely barcoded, enabling mixing/multiplexing of the samples. Samples were sequenced on 
an Illumina MiSeq, demultiplexed and aligned to the S. cerevisiae S288C genome using 
bowtie2 (‘Spo11Align.command’ – Appendix 10.1). 5ʹ′ Read1 reads (Top2 end) were extracted 
(‘Spo11Extract.pl’ – Appendix 10.2) and converted into a 1 bp histogram using R Studio 
(‘Creating 1 bp histograms v03.R’ – Appendix 10.3). Top2 hits were compared between wild 
type, sae2∆ and mre11∆ (untreated or +etoposide) and plotted for chromosome 2 with Watson 
and Crick hits differentiated (Figure 7.3A) (‘topo mapping v01 mc.R’ – Appendix 10.11). All 
untreated samples have no distinct peaks at this range with even coverage across the whole 
length of chromosome 2, suggesting this is background/non-specific hits. Treatment with 
etoposide in all three strains studied generated a large increase in signal with defined peaks. 
The etoposide treated wild type cells had less signal compared to the sae2∆ and mre11∆ 
mutants suggesting that Sae2 and Mre11 are both responsible for the repair of etoposide-
induced Top2-DSBs. The mre11∆ strain had higher signal compared to sae2∆, suggesting that 
Mre11 is more important for the repair of Top2-DSBs than Sae2. These results correlate with 
the sensitivity to etoposide via spot testing (Figure 7.1). Chromosome 1 was also visualised for 
Top2-DSBs, in untreated and etoposide treated, sae2∆ and mre11∆ cells and was compared 
against the Spo11-DSB hits over the same region (Figure 7.3B). Top2-DSBs are much more 
frequent than Spo11-DSBs with a broad coverage across most NDRs throughout the entire 
genome. In comparison Spo11-DSBs reside in much more defined regions (hotspots), mainly 
in promoters (Pan et al., 2011; Chapter 5). This suggests that Spo11 has a much tighter 
regulation for DSB formation than Top2 does, with factors restricting Spo11-DSB numbers 
and their location.   
To determine whether the length of the chromosome has an effect on Top2-DSB formation the 
hit density between chromosomes, or between the mre11∆ and sae2∆ strains, was analysed 
(Figure 7.3C). Hit density (hits per kb) was unchanged across chromosomes, except for 
chromosome 12. This can be accounted to the rDNA that resides on chromosome 12. The 
rDNA consists of repetitive DNA, whose repeat number can differ between strains, normally 
between 100-200 repeats (Petes, 1979). The published S. cerevisiae S288C genome only 
contains two copies of the repeat and therefore, this site has amplified signal due to multiple 
hits in the repetitive region all aggregating at one site. Finally, the peaks between all three 
etoposide treated strains are in similar positions, indicating some specificity as to where Top2 
is generating DSBs in the genome. 
Chapter 7: Genome-wide mapping of Top2-DSBs 
 188 
7.4 Top2-DSBs accumulate in NDRs with a 4 bp overhang observable 
The Top2 dimer, when generating DSBs, does so with a 4 bp overhang (Dong and Berger, 
2007). Spo11 generates similar DSBs to Top2 except with a 2 bp overhang (Liu et al., 1995), 
which can be visualised from the sae2∆ mapping (Figure 5.10). To determine whether the 
Top2 4 bp overhang could be observed, a 300 bp region was studied (Figure 7.4A). The 4 bp 
offset can be observed in the etoposide treated sae2∆ cells and in both the untreated and 
etoposide treated mre11∆ cells, suggesting that both sides of the Top2-DSBs are enriched from 
these DSBs.  
At this scale, Top2-DSBs are observed enriched at nucleosome-depleted regions (NDRs), 
although there are hits within genic regions (Figure 7.4B). Top2 activity is positively 
correlated with actively transcribed regions, potentially due to an increase in transcription-
generated torsional stress which requires increased action of Top2 (Baranello et al., 2014). An 
array of genes can be orientated in three different manners (as depicted in Figure 7.4C). 
Tandem genes are adjacent genes on the same strand with the intergenic region containing a 
terminator from the first gene and a promoter from the second gene. Divergent genes are genes 
on opposing strands with the intergenic region containing both gene promoters. Convergent 
genes are genes on opposing strands with the intergenic region containing both terminators. 
Therefore, to determine whether the orientation of genes, and thus promoter containing 
regions, affects the level of Top2-DSBs, the mean Top2 signal per kb was plotted for NDRs 
(split tandem, convergent and divergent gene regions) and genic regions (Figure 7.4B).  Only 
10% of Top2-DSBs occur within genic regions, suggesting that Top2-DSBs favourably form 
within intergenic/NDR regions. Top2 hits within NDRs form more favourably in tandem and 
divergent regions compared to convergent regions (Figure 7.4B), suggesting that Top2 is more 
active at promoter regions compared to terminator regions. This is observed in both mre11∆ 
and sae2∆ strains. 
7.5 Top2-DSBs accumulate in NDRs but also occur in genic regions with an 
anti-correlation to nucleosome occupancy  
Top2-DSBs form more in promoter regions than terminator regions (Figure 7.4B), suggesting 
a link between transcription initiation and Top2 activity. To determine whether there is any 
pattern of Top2-DSBs forming within the promoter region and the start of the transcribing 
gene/ORF, pile-ups of the 5ʹ′ Top2 hits in promoter regions, centred on the translation start site 
(TSS) and stretching 500 bp into the ORF, were made for wild type, sae2∆ and mre11∆ cells 
untreated and with etoposide (Figure 7.5A) (‘Pileups around TSS Topo stratify by 
transcription v02’ – Appendix 10.12). Top2 hits forming mainly within the promoter regions at  
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Figure 7.4: Top2-DSBs preferentially form within intergenic regions and display a 4 bp offset.  
Haploid wild type, sae2! and mre11! strains were grown overnight in YPD. Cultures were diluted to 
an OD600 of 0.5 and grown to an OD600 of 2.0. Cells were split into two 50 ml cultures and 1 µM 
etoposide (‘etoposide’) or equivalent volume of DMSO (‘untreated’) added. Cells were incubated for 
an additional 4 h and cells harvested by centrifugation. Next-generation sequencing libraries were 
prepared as stated in Figure 7.2. Sequences were aligned to the S. cerevisiae S288C genome using 
bowtie2. 5! Read1 (Top2) ends were extracted an converted into a 1 bp histogram using R Studio. A. 
A 200 bp region from chromosome 8 was visualised to observed a 4 bp offset between Watson (red) 
and Crick (blue) Top2 hits. B. A 40 kb region was visualised to observed Top2-DSBs enriching at 
intergenic region with Watson hits (red), Crick hits (blue) and total hits (grey) displayed. C. The mean 
Top2 signal per kb was calculated for intergenic (split tandem, convergent and divergent) and genic 
regions of the genome and mre11! and sae2! data plotted. Script for mapping ‘Topo mapping v01.R’ 
– Appendix 10.11.  
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Figure 7.5: Top2-DSBs accumulate in NDRs, but also within genic regions, with an anti-
correlation to nucleosome occupancy.  
Next-generation sequencing libraries for wild type, sae2! and mre11! strains were prepared as stated 
in Figure 7.2. Sequences were aligned to the S. cerevisiae S288C genome using bowtie2. 5! Read1 
(Top2) ends were extracted an converted into a 1 bp histogram using R Studio. A. Top2 hits were 
piled up centred on the translation start site (TSS, at 0) +-1000 bp with Watson (red), Crick (blue) and 
averaged (black) hits annotated. B. Top2 hits were piled up centred on the translation stop site (at 0) 
+-1000 bp. C. Top2 hits were piled-up centred around every nucleosome in the genome +-600 bp. R 
Studio scripts: ‘Pileups around TSS Topo stratify by transcription v02.R’ – Appendix 10.12. 
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the TSS can be observed in wild type, sae2∆ and mre11∆ cells treated with etoposide. 
Enrichment at promoter regions can also be observed in mre11∆ untreated cells, suggesting 
that this observation is not an etoposide-dependent process but is amplified when Top2-
complexes are poisoned. However, in wild type and sae2∆ untreated cells there is no 
enrichment, suggesting these lesions are not common, or are efficiently repaired in wild type 
cells by Mre11. These observations suggest that the role of Sae2 is not as important as Mre11 
for Top2-DSB processing. To determine whether Top2-DSB enrichment is also observed 
around the translation stop sites, pile-ups were created at the terminal region of all the ORFs in 
wild type, sae2∆ and mre11∆ cells (Figure 7.5B). Enrichment of Top2 hits was seen at the 
terminal region in both sae2∆ and mre11∆ etoposide treated cells, but only observed in 
mre11∆ untreated cells - a similar situation to the TSS (Figure 7.5A). Both these observations 
suggest that Top2-DSBs are not common in wild type cells and only accumulate when DSB 
repair by Mre11 is abrogated (mre11∆).  
Intriguingly, in etoposide treated sae2∆ and mre11∆ cells repeating peaks with ~150 bp 
periodicity were observed stretching into the ORF/genic region from the TSS (Figure 7.5A). 
This 150 bp periodicity is reminiscent of MNase sensitive linker regions between nucleosomal 
DNA (Axel, 1975; Clark and Felsenfeld, 1971). To determine whether this periodicity 
observed is due to nucleosome free regions, smoothed pile-ups of Top2 hits were centred 
around every nucleosome location in the genome (Brogaard et al., 2012b) for wild type, sae2∆ 
and mre11∆ cells both untreated and etoposide treated (Figure 7.5C). An anti-correlation of 
Top2 hits with nucleosome position is observed in all strains. Untreated cells had a less of an 
anti-correlation but the repeating pattern is still observed, suggesting that even though anti-
correlation was not observable for wild type and untreated cells in the TSS pile-up data, 
genome-wide Top2 hits generally form in linker regions and NDRs.  
7.6 Top2 displays a sequence bias for generating DSBs 
Mapping Top2-DSBs in the manner described generates nucleotide resolution maps of where 
Top2 cuts throughout the genome. To determine whether Top2 displays a sequence bias for 
cleavage, the 5ʹ′ (Top2) ends +-20 bp were aggregated, with any single 5ʹ′ site that occurred 
greater than five times (to remove any potential background effect) used to generate a 
sequence bias profile (Figure 7.6A). Recovery of both sides of a Top2-DSB only occurred in 
10% of cases and produces a rotationally symmetrical cleavage sequence bias due to the Top2 
dimer cleaving both the Watson and Crick strand. This consensus sequence for Top2 cleavage 
at DSB sites consist of biases of A at positions +8, +9 and +10, C at positions +1 and +2, G at 
position +3, and T at positions +4, +5 and +6. These biases are palindromic and therefore  
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Figure 7.6: Top2 displays a sequence bias for generating DSBs.  
Next-generation sequencing libraries were prepared as stated in Figure 7.2. Sequences were aligned 
to the S. cerevisiae S288C genome using bowtie2. 5! Read1 (Top2) ends were extracted and converted 
into a 1 bp histogram using R Studio. The sequence of each 5! read +/- 20 bp were aggregated for 
sites where Top2-DSBs were at least 5 to reduce the influence of non-specific signal. The sequence 
bias was plotted for A/T and G/C pairs, which are expected to show rotational symmetry consistent 
with Top2 cleaving DNA as a dimer. Top2 hits that contained a cognate pair (hit site on opposing 
strand 4 bp offset) were subset into DSBs. Top2 hits without a cognate pair were subset into SSBs.  
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contain the complementary purine/pyrimidine on the opposing strand (negative values). 
Overall, a weak palindromic consensus for Top2-DSBs can be read as GAAC*GG|CCGTTC 
(top-strand displayed only, dyad axis (|) indicated, Top2 cleavage site (*) would be 
reciprocated on the right hand side of the axis, bottom strand). In the other 90% of cases, only 
one side of the Top2-DSB is recovered and the rotational symmetry and palindromic sequence 
bias, is lost. This is indicative of single-stranded breaks (SSBs) occurring instead of DSBs. 
The high proportion of SSBs to DSBs agrees with previous mapping studies who attributed 
this observation to an etoposide-concentration dependent mechanism (Baranello et al., 2014). 
Etoposide acts by intercalating into the DNA within the cut site of the Top2 monomer and 
preventing religation (Pommier and Marchand, 2011; Wu et al., 2011). Etoposide acts 
independently on either Top2 monomer, suggesting a low concentration of etoposide would be 
more likely to only prevent religation of one monomer of Top2 and not both. Although this 
may account for these observations made (Figure 7.6B), a high concentration of etoposide was 
used (1 µM). Therefore, an alternative explanation may be that, due to DNA sequence 
preference, only one Top2 monomer of the dimer was able to cleave, with the preferred 
sequence not present on the other strand. This would result in only one monomer cleaving and 
therefore, when etoposide binds, only the one strand is blocked from religation and a SSB is 
formed.  
7.7 Discussion 
S. cerevisiae is not sensitive to low levels of etoposide due to active removal of the compound 
from the cell by the PDR network (Stepanov et al., 2008). Insertion of a sensitivity cassette, 
which removes PDR1 activity and deletes PDR1 itself, causes etoposide sensitivity of wild 
type cells (Figure 7.1). This construct has enabled the study of Top2 poisoning by etoposide 
and has enabled the enrichment of Top2-DSB fragments and nucleotide resolution, genome-
wide mapping of Top2 cut sites via the methods established in Chapter 6.  
In wild type cells without etoposide treatment very few Top2-DSBs are observed (Figure 7.3). 
Addition of etoposide causes an accumulation and amplification of Top2-DSB signal genome-
wide (Figure 7.3). Deficiency in MRE11 or SAE2 causes an increase in Top2 signal with 
mre11∆ causing the most Top2 hits overall, suggesting that MRE11 and SAE2 are involved in 
the repair of etoposide-induced Top2-lesions. MRE11 deficiency also causes an increase in 
Top2 hits at NDRs, in the absence of etoposide, however wild type and sae2∆ cells do not 
show this. This suggests that Top2-lesions occur in wild type cells and that Mre11 (and in part, 
Sae2) actively repairs any Top2-DSBs generated under normal conditions, preventing their 
accumulation and thus enrichment via this protocol. The locations of Top2 sites in untreated 
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and etoposide treated cells are consistent, although the levels are amplified with etoposide. 
This indicates that etoposide may simply be stabilising Top2-DSB complexes in locations it 
frequently cuts.  Top2 displays a sequence bias for where it cleaves in the genome, however, 
even though Top2 acts as a dimer, symmetrically cleaved sites only account for 10% of all 
Top2 hits (Figure 7.6). The remainder are incidences where only one side of the DSB is 
recovered, suggesting this site is a single-stranded break (SSB). This high occurrence of SSBs 
could be etoposide-concentration dependent, inhibiting only one monomer as previously 
hypothesised (Baranello et al., 2014). By contrast, this high occurrence of SSBs could also be 
due to Top2 cutting a preferred DNA sequence that is only present on one strand at the 
majority of locations.  
The majority of Top2 hits reside in nucleosome-depleted regions (NDRs) (Figure 7.3C). From 
these NDRs, a greater proportion of Top2 hits are located in promoter regions compared to 
terminator sites (Figure 7.3C), indicated by a large number occurring in tandem (one 
promoter) and divergent (two promoters) regions compared to convergent regions. For 
efficient transcription elongation to occur positive supercoils ahead of RNA polymerase and 
negative supercoils behind it need to be relaxed by topoisomerases (Pedersen et al., 2012; 
Sperling et al., 2011). Cells deficient in Top1 and Top2 have a global down-regulation of gene 
expression (Pedersen et al., 2012), suggesting Top2 plays an important role in promoting 
transcription. Additionally, the increased supercoiling generated by the transcriptional 
machinery may require relaxation by topoisomerases within the ORF of a transcribing gene. 
An access point for Top2 may therefore be at linker regions between nucleosomes generating 
the 150 bp wave observed when aggregating Top2 hits (Figure 7.5A).  
Genome-wide mapping of S. cerevisiae nucleosomes demonstrates that promoters and sites of 
transcription termination are depleted in nucleosomes (Fan et al., 2010; Lantermann et al., 
2010). Top2 hits were enriched at terminator regions (Figure 7.5B), supporting the link 
between NDRs and Top2 activity. However, terminator regions were less enriched than 
promoter regions (Figure 7.5). This could be linked to the requirement for topoisomerases to 
regulate supercoiling at promoter regions to aid transcription initiation (Pedersen et al., 2012). 
However, it may be due to nucleosome occupancy at these sites. Unlike promoter regions, 
nucleosome occupancy at terminator regions is strongly linked to growth conditions, with a 
reduction in transcription increasing the nucleosome occupancy (Fan et al., 2010). If the 
cycling cells mapped were nutrient-limited, then terminator regions would increase in 
nucleosome occupancy and thus decrease Top2 cleavage at these sites. Alternatively, a 
decrease in transcription in these cells decreases the supercoiling generated at the end of the 
ORF and the need for Top2 activity at terminator regions.  
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This work has confirmed that the procedure for genome-wide, high resolution mapping of 
Spo11 in a sae2∆ background can also be applied to map Top2-lesions in cycling cells. This 
suggests a wide potential for further investigation of Top2 function and other covalently bound 
proteins in S. cerevisiae and other organisms. 
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Chapter 8: Discussion 
8.1 Summary 
In this thesis I have presented work investigating the mechanisms that regulate the formation 
and repair of the protein-linked DSBs created by Spo11 and topoisomerase II (Top2). I have 
characterised the phenotype of Sae2 proteins mutated at putative CDK and Mec1/Tel1 
phosphorylation sites (Chapter 3), showed TDP2 is active upon the phosphotyrosine bond 
between Spo11 and DNA in vitro (Chapter 4), and that removal of Spo11 in this manner 
permits resection by lambda exonuclease but no resection by the sole meiotic 5ʹ′ to 3ʹ′ 
exonuclease, Exo1 in vitro. Utilising TDP2 activity, I have developed a novel method to map 
Spo11-DSBs genome-wide with single nucleotide resolution (Chapter 5) and I used this 
procedure to further elucidate the regulation of Spo11 DSB formation by Tel1 (Chapter 6), 
and also to map Top2 cleavage sites genome-wide (Chapter 7).  
8.2 Evolutionary pressures upon the use of the MRX complex and Sae2 for 
Spo11-DSB processing 
The DSBs Spo11 generates throughout the genome during meiosis are utilised for homologue 
pairing via the homologous recombination repair pathway (Szostak et al., 1983). In 
S. cerevisiae, the initiation of Spo11-DSB repair is coordinated by the MRX complex (MRN in 
mammalian cells) and the Sae2 protein (CtIP in mammalian cells) (Mimitou and Symington, 
2009; Pueyo et al., 1993). These two proteins nucleolytically process the Spo11-DSB end, 
clipping the 5ʹ′ strand adjacent to the DSB generating Spo11 covalently bound to the 5ʹ′ end of 
short oligonucleotides (Garcia et al., 2011; Neale et al., 2005). This process generates a short 
3ʹ′ ssDNA overhang, a substrate favourable for Exo1 to bind to and further resect from in a 5ʹ′ 
to 3ʹ′ direction (Cannavo et al., 2013; Krogh and Symington, 2004). These long ssDNA tracts 
are important for efficient homology search and strand invasion, an essential step in the pairing 
of homologs during meiosis (San Filippo et al., 2008). Theoretically, Spo11 could also be 
removed via a different mechanism to the nucleolytic method. Directly hydrolysing the 
covalent bond formed between the Spo11 protein and the 5ʹ′ end of the DSB would remove the 
protein block, potentially permitting resection and thus homolog search. One such protein 
identified in humans, TDP2 (Cortes-Ledesma et al., 2009), contains a tyrosine 
phosphodiesterase capable of cleaving a range of 5ʹ′ phospho-tyrosine bonds in vitro (Gao et 
al., 2012), including the bond between Spo11 and the 5ʹ′ end of DSBs (Figures 4.3-4.8). 
However, here I have shown that in vitro removal of Spo11 in this manner does not permit 
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Exo1 resection of DSBs (Figures 4.5-4.8). These findings suggest that the mechanism for 
Spo11 removal by the MRX complex and Sae2, rather than a TDP2-like mechanism, has 
evolved to permit Exo1 resection and thus efficient HR to allow crossing over of homologues 
to enable gamete production and to produce genetic diversity. Another issue that may have 
arisen with a TDP2-like removal of Spo11 is the potential for repair via NHEJ. End-resection 
by the MRX complex and Sae2 promote HR and inhibit NHEJ through the production of 
ssDNA (Shibata et al., 2014). By contrast, repair by hydrolytic removal of Spo11 from the 
DSB end would generate a substrate capable of repair by NHEJ. This sort of repair is not 
proficient for the pairing homologs and thus needs to be avoided during meiosis. Although 
TDP2 is expressed in mouse and human testes tissue (Pype et al., 2000), as well as in the C. 
elegans germline (Shi et al., 2012), no role for TDP2 has been found during meiosis (Keith 
Caldecott – personal communication). Here, I have shown that expression of TDP2 during 
S. cerevisiae meiosis was not capable of removing Spo11 from the ends of DSBs in vivo 
(Figures 4.9-4.10), suggesting that TDP2 may not act during meiosis in any organism due to 
the evolutionary pressures for repair via the MRX/Sae2 pathway. In support of this conclusion, 
loss or mutation of MRN or CtIP in mammalian and C. elegans cells leads to unviable 
offspring even though, in C. elegans, a COM-1CtIP mutant is capable of repair of meiotic DSBs 
via the NHEJ pathway (Lemmens et al., 2013). This suggests that there is no redundant 
pathway that can compensate for the Spo11-removal and HR promoting role of MRN/CtIP 
during meiosis (Buis et al., 2008; Chen et al., 2005).  
Due to the importance of Sae2CtIP during meiotic recombination there are numerous regulatory 
pathways that control activity. Sae2CtIP is phosphorylated by CDK, a modification essential for 
Sae2 activity (Huertas et al., 2008; Wang et al., 2013). This phosphorylation event is regarded 
as the switch between HR and NHEJ in mitotic cells, with activation of Sae2 stimulating 
Mre11 endonuclease activity (Shibata et al., 2014). This nucleolytic event promotes HR and 
prevents NHEJ through generation of ssDNA (Shibata et al., 2014). Because CDK activity is 
linked to DNA replication, this ensures HR is only active when a sister chromatid template is 
available for repair (Aylon et al., 2004; Caspari et al., 2002; Esashi et al., 2005; Grzegorz et 
al., 2004). In meiosis, CDK is also active and therefore promotes HR through phosphorylation 
of Sae2 (Huertas et al., 2008; Marston and Amon, 2004). This is therefore another way by 
which the cell promotes HR repair of DSBs during meiosis to ensure efficient homolog 
pairing, and the formation of genetic variation.  
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8.3 Development of the protein-linked DNA mapping procedure (sae2∆ 
Spo11-DSB) has the potential for a wide range of other applications  
The development of a nucleotide resolution mapping procedure for Spo11 not only improved 
our understanding of S. cerevisiae meiotic recombination but it has the potential to further our 
understanding of a variety of different pathways in multiple organisms. This procedure only 
requires the presence of a covalently bound protein to map where this protein forms this bond 
with the DNA in vivo. Therefore, this procedure cannot only be used to map Spo11 but as 
shown in Chapter 7, has the flexibility to map other covalently bound proteins such as 
topoisomerase-II. One caveat with mapping Spo11 in other species is that a sae2CtIP∆ mutation, 
or another end-processing mutant such as a nuclease dead form of Mre11, is required to 
stabilise Spo11 at the 5ʹ′ ends of the DSB. Covalent Spo11-DSBs are transient complexes that 
are processed almost simultaneously with Spo11-DSB formation (Neale et al., 2005). Whilst, 
there is potential to identify stable Spo11-DSB complexes in a wild type background, this has 
yet to be conducted. This procedure can be utilised to map Spo11Rec12 in other organisms, such 
as S. pombe, where only oligonucleotides produced from end-processing by Mre11 and Ctp1 
greater than 15 nucleotides in length could be mapped (Fowler et al., 2014). Creating a ctp1∆ 
or a mre11-nd mutation within this species would enable the mapping of Spo11Rec12 at 
nucleotide resolution, generating a map that would retain all the information about where 
Rec12 generated DSBs throughout the genome without the loss of information at the short 
oligonucleotide locations.  
In the case of Top2, no mutation is required to stabilise the Top2-DNA complex. Instead, these 
complexes can be poisoned by drugs such as etoposide (Baldwin and Osheroff, 2005) (Figure 
7.3). Although mutation of MRE11 and SAE2 further enriched for Top2-DSB complexes, 
mapping was possible in a wild type background with no affinity tags required, providing 
information on the function of Top2 without the potential disruption to its activity by affinity 
tags or mutations to downstream pathways (Chapter 7).  Etoposide could be utilised to map 
Top2-DSB complexes within nucleotide resolution in a wide variety or organisms, including 
human cells. By monitoring where etoposide affects Top2 in humans, there is the potential to 
develop new drugs that may affect Top2 via different mechanisms, which may aid in the 
selective poisoning of Top2 in human cancer cells.  
The procedure described in Chapter 5, relied on the human TDP2 protein to hydrolytically 
cleave the phospho-tyrosine bond to prevent any loss of nucleotides. Therefore, proteins that 
covalently link to the 3ʹ′ end of the DNA, such as Top1 (Chen et al. 2013), are not expected to 
be mapped by this method. However, TDP2 may contain some residual 3ʹ′ phosphodiesterase 
activity (Zeng et al., 2012). Alternatively, the S. cerevisiae Tdp1 protein, which contains 3ʹ′ 
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and residual 5ʹ′ phosphodiesterase activity (Nitiss et al., 2006) or the human TDP1 3ʹ′ 
phosphodiesterase protein (Yang et al., 1996) could be utilised to map Top1 genome-wide 
within nucleotide resolution. Mutations in proteases, such as Wss1SPARTAN, that degrade 
proteins covalently bound to the DNA (Stingele et al., 2015), could also be investigated for 
their effects on covalent DNA-protein binding genome-wide. Therefore, as long as there is a 
mechanism for the removal of the covalently bound protein from the DNA, this procedure has 
the ability to map numerous proteins in a wide-range of organisms without the requirement for 
affinity tags.  
8.4 Tel1 kinase activity is responsible for hyper-localised repression of DSB 
formation  
The Tel1 protein is responsible for DSB interference, a process of inhibiting DSBs on the same 
molecule in close proximity once a DSB is first formed (Garcia et al., 2015). To determine 
whether the Tel1 kinase activity was responsible for this action, a TEL1 mutant was made that 
abolished the kinase activity of the protein. Whilst determination of DSB interference was not 
possible in the tel1-kd mutant, an interesting phenotype was observed. Spo11-DSB signal 
spread from the promoter hotspot in the direction of transcription (Figure 6.1). This spreading 
signal is attributed to a hyper-local loss of repression of DBS formation. This loss of 
repression resulted in the same molecule of DNA being cut multiple times by Spo11 within a 
small region (Figure 6.5), generating double-cut molecules, which are relatively short dsDNA 
molecules that contain Spo11 covalently bound to both 5ʹ′ ends. These molecules arose with a 
10 bp periodicity (Figure 6.8), comparable to the 10 bp periodicity observed via the Spo11-
oligo assay in Spo11 end-processing mutants such as sae2∆ (Figure 6.9). This periodicity may 
arise due to the structure of nucleosomal duplex DNA containing a DNase sensitive region 
every helical turn (10.5 nt), which is also potentially susceptible to cleavage by Spo11 (Figure 
6.5). Studying the function of TEL1 in S. cerevisiae may lead to further understanding of how 
the human ortholog ATM may function. Understanding the role of ATM is important due to its 
numerous roles in the cell. In particular, because mutation of ATM is linked to a variety of 
different disease states (van Os et al., 2016), understanding how it functions in the cell, both in 
mitotic and meiotic cells, may be important for the development of new therapeutics.  
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Appendix 
10.1 Spo11Align.command (created by Tim Cooper) 
#!/usr/bin/env bash 
#Version: 1.5 
######################################################################################################## 
# Author(s): T.J.Cooper 
# Updated: 13/9/2016 
# Automates batch-processing of FASTQ/SAM files for genome-wide mapping 
######################################################################################################## 
DIR=$( cd "$( dirname "${BASH_SOURCE[0]}" )" && pwd ) 
cd "$DIR" || exit 
source "./Spo11Extract.config" || exit 
if [[ ! -f $PERLDIR || ! -d $GENOMEDIR || -z $GENOMENAME || -z $READ1_EXT || -z $READ2_EXT || -z $TRIM || -z $TRIMLEN ]]; then 
    printf "\nError: User parameters are missing and/or incorrectly specified.\n\n"; exit -1 
fi 
mkdir -p "./Logs" 
printf %b "\n\n\n\n--------------------------------------------\n" 
printf "FASTQ Alignment (1 of 2) (Paired End-To-End)\n" 
printf %b "--------------------------------------------\n" 
printf "Currently aligning:\n" 
declare -A STR 
for file in *$READ1_EXT.*; do 
   STR["${file%*$READ1_EXT.*}"]=1 
done 
for i in "${!STR[@]}"; do 
   printf "%s\n" "$i" 
   printf "%s\n%s\n%s\n%s\n" "$i" "-----------------------" "GLOBAL" "-----------------------" > "$DIR/Logs/$i.txt" 
   bowtie2 -X 1000 --end-to-end --dovetail --no-discordant --very-sensitive --mp 5,1 --rg-id 1 --rg PU:1 --rg LB:1 --rg SM:1 --rg PL:1 -p 4 -x 
$GENOMEDIR/$GENOMENAME -1 $i$READ1_EXT.fastq -2 $i$READ2_EXT.fastq -S $i"_Global".SAM 2>> "$DIR/Logs/$i.txt" 
done 
perl "$PERLDIR" "Global.SAM" $TRIM $TRIMLEN $READ1_EXT $READ2_EXT 
if [ $TRIM = Y ]; then 
   printf %b "\n\n------------------------------------------\n" 
   printf "FASTQ Alignment (2 of 2) (Trimmed Local)\n" 
   printf %b "------------------------------------------\n" 
   printf "Currently realigning:\n" 
   for n in "${!STR[@]}"; do 
      printf "%s\n" "${n}" 
      printf "\n%s\n%s\n%s\n" "-----------------------" "TRIMMED" "-----------------------" >> "$DIR/Logs/${n}.txt" 
      bowtie2 -X 1000 --local --dovetail --no-discordant --very-sensitive --mp 5,1 --rg-id 1 --rg PU:1 --rg LB:1 --rg SM:1 --rg PL:1 -p 4 -x 
$GENOMEDIR/$GENOMENAME -1 ${n}$READ1_EXT"_unmapped_trimmed.fastq" -2 ${n}$READ2_EXT"_unmapped_trimmed.fastq" -S 
$n"_Trimmed".SAM 2>> "$DIR/Logs/${n}.txt" 
   done 
   perl "$PERLDIR" "Trimmed.SAM" 
fi 
printf %b "\n------------------------------------------\n" 
printf "Generating logs & cleaning directory....\n" 
printf %b "------------------------------------------\n\n" 
mkdir -p "./FASTQ" 
mkdir -p "./SAM" 
mv *.fastq ./FASTQ 
mv *.SAM ./SAM 
cd "$DIR/Coordinates" || exit 
printf "%s\t%s\t%s\t%s\t%s\t%s\t%s\t%s\t%s\t%s\n" "Strain" "Total Read Pairs (A)" "Total Mapped Pairs (B)" "% of (A)" "Multimapping Pairs" "% 
of (B)" "Valid 5' Hits" "% of (B)" "Ambiguous 5' Hits" "% of (B)" > "$DIR/Logs/LogSummary.txt" 
for k in "${!STR[@]}"; do 
   printf "\n%s\n%s\n%s\n" "-----------------------" "CALL STATS" "-----------------------" >> "$DIR/Logs/${k}.txt" 
   TotalRead=$(awk '/reads/ && ! seen {print $1; seen=1}' < "$DIR/Logs/${k}.txt") 
   MultiMap=$(awk '/concordantly >1/ {sum+=$1} END{print sum}' < "$DIR/Logs/${k}.txt") 
   MappedRead=$(($(awk '/concordantly exactly/ {sum+=$1} END{print sum}' < "$DIR/Logs/${k}.txt") + $MultiMap)) 
   Ambig=$(($(wc -l < ${k}_Ambiguous.txt)-1)) 
   Global=$(($(wc -l < ${k}_Global.txt)-1)) 
   if [ $TRIM = Y ]; then 
      Trimmed=$(($(wc -l < ${k}_Trimmed.txt)-1)) 
      ValidHits=$(($Global + $Trimmed)) 
      printf "%s\t%d\n%s\n%s\t%d\n%11s\t%d\n%11s\t%d\n%s\n%s\t%d\n" "Total Hits:" "$(($Global + $Trimmed + $Ambig))" "-----------------------
" "Valid Hits:" "$ValidHits" "Global:" "$Global" "Trimmed:" "$Trimmed" "-----------------------" "Ambig Hits:" "$Ambig" >> "$DIR/Logs/${k}.txt" 
      awk 'FNR==1 && NR!=1{next;}{print}' ${k}_Global.txt ${k}_Trimmed.txt > ${k}_Combined.txt 
   elif [ $TRIM = N ]; then 
      ValidHits=$Global 
      printf "%s\t%d\n%11s\t%d\n%s\n%s\t%d\n" "Total Hits:" "$(($Global + $Ambig))" "Valid Hits:" "$Global" "-----------------------" "Ambig Hits:" 
"$Ambig" >> "$DIR/Logs/${k}.txt" 
   fi 
   printf "%s\t%d\t%d\t%.3f\t%d\t%.3f\t%d\t%.3f\t%d\t%.3f\n" "${k}" "$TotalRead" "$MappedRead" "$(bc -l <<< 
"($MappedRead/$TotalRead)*100")" "$MultiMap" "$(bc -l <<< "($MultiMap/$MappedRead)*100")" "$ValidHits" "$(bc -l <<< 
"($ValidHits/$MappedRead)*100")" "$Ambig" "$(bc -l <<< "($Ambig/$MappedRead)*100")" >> "$DIR/Logs/LogSummary.txt" 
done 
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10.2 Spo11Extract.pl (created by Tim Cooper) 
#!/usr/bin/env perl 
#Version: 1.5 
 
####################################################################################################################### 
# Author(s): T.J.Cooper 
# Updated: 13/9/2016 
# Processes paired-end .SAM files, extracting Watson + Crick coordinate information for single-cut Spo11 and Topo-II libraries 
# Quality-control and filtering (atypical read-orientation, dubious ends) 
# Two-step alignment (unmapped mate read-trimming, --local alignment) 
####################################################################################################################### 
 
use strict; 
use warnings; 
use Cwd; 
use List::Util qw(first); 
my $outext = '.txt'; #Output .file-extension 
my $inext = $ARGV[0]; #Input .file-extension 
my @files = glob("*$inext"); 
my $chk = scalar(@files); 
print "\nFailed to detect any .SAM files within the current directory.\n\n" if $chk == 0; 
exit if $chk == 0; #Stop script if no .SAM files are found 
my $sub = cwd()."/Coordinates"; 
mkdir("$sub") unless $chk == 0; 
my $trimmode = $ARGV[1]; 
my $trimlength = $ARGV[2]; 
print "-------------------------------------"; 
print "\nCalculating Coordinates....\n"; 
print "-------------------------------------\n"; 
print "Currently processing:\n"; 
for my $file (@files) {   #For-each input file 
open my $IN, '<', $file or die "$!"; #Open and read input .SAM file(s) 
(my $strain = $file) =~ s/_[^_]+$//; #Strain-name 
(my $mode = $ARGV[0]) =~ s/\.SAM//;  #Alignment-mode 
print "$strain\n"; 
my $outfile = $strain."_".$mode.$outext;  #Output files 
my $outfile2 = $strain."_Ambiguous".$outext; 
my ($OUT,$OUT2,$OUT3, $OUT4); 
open $OUT, '>', "$sub/$outfile" or die "$!"; 
open $OUT2, '>>', "$sub/$outfile2" or die "$!"; 
print $OUT "Strand\tChr\tPos\tReadLength\tCIGAR\tAdjustment\n"; 
if ($inext eq "Global.SAM" && $trimmode eq "Y")  { 
 print $OUT2 "Strand\tChr\tPos\tReadLength\tCIGAR\tAdjustment\tMD-Tag\n"; 
 my $outfile3 = $strain.$ARGV[3]."_unmapped_trimmed.fastq"; #Unmapped R1 FASTQ file 
 my $outfile4 = $strain.$ARGV[4]."_unmapped_trimmed.fastq"; #Unmapped R2 FASTQ file 
 open $OUT3, '>', "$outfile3" or die "$!"; 
 open $OUT4, '>', "$outfile4" or die "$!"; 
} 
while (<$IN>) { #For-each .SAM record 
 chomp $_; 
 next if /^\s*@/; #Skip .SAM headerlines 
 my @F = split("\t", $_); #Split each tab-delimited field 
 my $orientation = $F[3]-$F[7]; #Discard atypical read-orientations 
 if ($F[1] == 99 && $orientation > 0 || $F[1] == 83 && $orientation < 0) { 
  my $skipline = <$IN>; 
  next; 
 } 
 if ($inext eq "Global.SAM" && $trimmode eq "Y") { #Populate unmapped R1/R2 FASTQ files mapped-unmapped pairs 
  if (grep {$_ == $F[1]} 73,137) { 
   print $OUT3 "\@$F[0] 1:N:0:1\n$F[9]\n+\n$F[10]\n" if $F[1] == 73; 
   print $OUT4 "\@$F[0] 1:N:0:1\n$F[9]\n+\n$F[10]\n" if $F[1] == 137; 
  } 
  if (grep {$_ == $F[1]} 89,153) { 
   $F[9] =~ tr/GATC/CTAG/; 
   my $revseq = reverse($F[9]); 
   my $revqual = reverse($F[10]); 
   print $OUT3 "\@$F[0] 1:N:0:1\n$revseq\n+\n$revqual\n" if $F[1] == 89; 
   print $OUT4 "\@$F[0] 1:N:0:1\n$revseq\n+\n$revqual\n" if $F[1] == 153; 
  } 
  if (grep {$_ == $F[1]} 69,133) { 
   my $trimseq = substr($F[9],0,$trimlength); 
   my $trimqual = substr($F[10],0,$trimlength); 
   print $OUT3 "\@$F[0] 1:N:0:1\n$trimseq\n+\n$trimqual\n" if $F[1] == 69; 
   print $OUT4 "\@$F[0] 1:N:0:1\n$trimseq\n+\n$trimqual\n" if $F[1] == 133; 
  } 
 } 
 if (grep {$_ == $F[1]} 99,83) { 
  my $index = first{/MD:Z/} @F;   #Obtain variable-column MD:Z: tag 
  my @MDtag = $index =~ /\d+/g;  #Remove non-numeric characters 
  my @revMDtag = reverse(@MDtag); 
  my %rules = (M => 1,D => 1,I => 0,S => 1); #Rules to handle insertion/deletions/matches/soft-clipping 
  my ($s,$LS,$RS) = (0)x3; 
  while ($F[5] =~ /(\d+)([MDIS])/g) {   #Parse and interpret CIGAR code 
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   my ($n,$op)  = ($1,$2); 
   $s += $n * $rules{$op} unless $op eq 'S';   #Calculate POS adjustment (insertions/deletions) 
   $LS += $n * $rules{$op} if $op eq 'S' && $-[0]==0;   #(upstream soft-clip) 
   $RS += $n * $rules{$op} if $op eq 'S' && $+[0]==length($F[5]);   #(downstream soft-clip) 
  } 
 my $l = length($F[9]); #Read-length 
 my $wp = $F[3]-$LS;  #Adjusted 5' coordinate (Watson strand) 
 my $cp = $F[3]+($RS+$s)-1;  #Adjusted 5' coordinate (Crick strand) 
 if ($MDtag[0] == 0 && $MDtag[1] == 0 && $F[1] == 99 || $LS >1 && $F[1] == 99) {  #Detect ambigious ends (Watson 
strand) 
  printf($OUT2 "%s\t%d\t%d\t%d\t%s\t%d\t%s\n", "w",$F[2],$wp,$l,$F[5],0-$LS,$index); 
 } elsif ($F[1] == 99 && $wp > 0) { 
  printf($OUT "%s\t%d\t%d\t%d\t%s\t%d\n", "w",$F[2],$wp,$l,$F[5],0-$LS); 
 } 
 if ($revMDtag[0] == 0 && $revMDtag[1] == 0 && $F[1] == 83 || $RS >1 && $F[1] == 83) { #Detect ambigious ends (Crick 
strand) 
  printf($OUT2 "%s\t%d\t%d\t%d\t%s\t%d\t%s\n", "c",$F[2],$cp,$l,$F[5],$RS+$s-1,$index); 
 } elsif ($F[1] == 83 && $cp >0) { 
  printf($OUT "%s\t%d\t%d\t%d\t%s\t%d\n", "c",$F[2],$cp,$l,$F[5],$RS+$s-1); 
 } 
} 
} 
} 
my $run_time = time() - $^T; 
print "-------------------------------------"; 
print "\nRun Completed\n"; 
print "Processing Runtime: $run_time Seconds\n"; 
print "-------------------------------------\n\n"; 
10.3 Creating 1bp histograms v03 (H4L2).R (created by Matt Neale) 
# Create new empty master dataframe 
master=NULL 
data=NULL 
require(stringr) 
 
# Sequentially imports each _Global.txt read file from working directory 
 
files = list.files(pattern="*_Combined.txt") # import files names with ""*_Global.txt" string into variable "files"  
files1 = length(files) # Count number of files 
files2 = read.table(text = files, sep = "_", as.is = TRUE) #Split file names by "_" separator and create table "files2" 
 
 
# Create 1bp histogram of data for each chromosome 
ChrSize = c(230218,813184,320870,1531933,576874,270161,1090940,562643,439888,745751,666816,1078177,924431,784333,1091291,948066) 
# Note not sure if these are correct since some reads more distal than expected 
ChrSize=ChrSize+100 # Add padding at right end in case of mismapped 5' ends due to CIGAR encoding and repeats 
master=NULL #create empty dataframe 
master2=NULL #create empty dataframe 
binsize=1 
 
for (i in 1:files1){ 
  data=NULL 
  master=NULL #create empty dataframe 
  master2=NULL #create empty dataframe 
  master_c=NULL #create empty dataframe 
  data <- read.table(files[i], sep = "\t", header=TRUE) #Import datatable from files number 1 to j 
   
  for (j in 1:16){ 
    chrlen=ChrSize[j] 
    temp=subset(data, Chr==j & Strand=="w" & Pos>=0) 
    w=hist((temp$Pos),breaks=seq(0,chrlen,l=chrlen+1), plot=F) #watson 
    temp=subset(data, Chr==j & Strand=="c" & Pos>=0) 
    c=hist((temp$Pos),breaks=seq(0,chrlen,l=chrlen+1), plot=F) #crick 
    pos = w$mids+0.5 
     
    #Create new table containing the histogram data for Watson, Crick and Total. Each in separate columns 
    master2=data.frame(Chr=j, Pos = pos, Watson=w$counts, Crick=c$counts) 
    master <- rbind(master, master2) # Combine data into master table 
  } 
   
  master_c=subset(master, Watson!=0 | Crick!=0) # Creates compressed version of data histogram discarding all zeros 
   
  #Write out master files EDIT NAME OF STRING! 
  wd = getwd() 
  #out = paste(wd,"/","FullMap.Cer3H4L2_",files2[i,1],"_",files2[i,2],"_",files2[i,3],"_",files2[i,4],".txt", sep="") 
  #write.table(master, out, col.names =TRUE, row.names = FALSE, quote = FALSE, sep="\t", append=F) 
  out = paste(wd,"/","FullMap.Cer3H4L2_",files2[i,1],"_",files2[i,2],"_",files2[i,3],"_",files2[i,4],"_c.txt", sep="") 
  write.table(master_c, out, col.names =TRUE, row.names = FALSE, quote = FALSE, sep="\t", append=F) 
   
  } 
   
####################################################################################################################### 
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10.4 Calculating background reads v03.R (created by Matt Neale) 
require("e1071") # This pacakge permits smoothing functions (used later) 
  require(stringr) 
  options(scipen=999) #Suppresses scientific notation appearing in plots/graphs etc 
  require(doParallel) 
  require(plyr)   
####################################################################################################################### 
  # Import histogram FullMap files for each strain in working directory and tally up the total number of Million mapped reads 
  Mreads=NULL; DSBList=list();DSBListNames=NULL 
   
  library(doParallel) 
  cl <- makeCluster(8) 
  registerDoParallel(cl) 
  #files=c("FullMap.sae2.S288C_MJ315_WT_1_6h_c.txt") 
   
  #Read in all tables with string "Full.Map." 
  files = list.files(pattern="FullMap.") # import files names with "FullMap." string into variable "files"  
  DSBListNames = substr(files, 9, nchar(files)-6) # Shorten filename by 8 characters from beginning and 6 characters form end (i.e. remove 
"FullMap." and "_c.txt") 
  nfiles = length(files) # Count number of files 
   
  DSBList=foreach (k = 1:nfiles) %dopar% { DSBList[[k]] = read.table(files[k], sep = "\t", header=TRUE) } #Import datatable 
  #dflist=s 
  stopCluster(cl) 
   
  AllElementsDUB = read.table("AllElementsDUB_H4L2_2016.08.11b.txt", sep = "\t", header=TRUE) #Import datatable 
  for (i in 1:nfiles){Mreads[i]=sum(DSBList[[i]]$Watson+DSBList[[i]]$Crick)/1000000} # Calculate Million reads per sample for conveting to HpM 
   
  Pan = read.table("Pan.Hotspots.IGR.SacCer3_H4L2_2016.08.10a.txt", sep = "\t", header=TRUE) #Import hotspot datatable 
   
####################################################################################################################### 
############ START HERE ONCE DATAFRAMES ARE LOADED ###################### 
####################################################################################################################### 
# New loop to plot multiple comparisions 
strains=c(nfiles) # Analyse these numbered dataframes from the dflist 
strains=1:nfiles 
####################################################################################################################### 
# MODULE for pulling out largest genes 
AllElementsDUB$length=AllElementsDUB$stop-AllElementsDUB$start # Add length of feature column 
genes=AllElementsDUB #First make a copy of the ALLElements table 
genes=subset(genes, type=="gene" & genename!="Dubious_ORF" & chr !="chrmt") 
genes=subset(genes, !genes$genename %in% c("TEL1","NUM1","YRF1-7","YRF1-6","YRF1-3","URA2","TOR2")) # Exclude these genes 
(emprically determined to be outliers) 
genes=subset(genes, length>=5500) 
at=sum(genes$length) 
genes$start2=genes$start+1000 
genes$stop2=genes$stop-1000 
genes$length2=genes$stop2-genes$start2 
at2=sum(genes$length2) 
#genes=genes[1:5,] 
####################################################################################################################### 
bg=list() # list of tables containing info on the backgrounds for each gene for each strain 
library(doParallel) 
cl <- makeCluster(8) 
registerDoParallel(cl) 
 
#writeLines(c(""), "log.txt") 
 
r=NULL 
r=foreach (k = strains) %dopar% { #step through sequentially each dataframe/strain. r collects within it a list of the foreach loops 
  bg[[k]]=data.frame(NULL) 
  bg[[k]][1:nrow(genes),"Genename"]=genes$genename 
  #sink("log.txt", append=TRUE) # Send console output to text file to monitor run 
  #print(dflistNames[k]) 
   
for (i in 1:nrow(genes)) { 
  #cat("\r", i, "of", nrow(genes)); flush.console() # Keep track of progress. cat "\r" overprints to same line of console 
   
  temp=subset(DSBList[[k]], Chr==(genes[i,"chr"]) & Pos>=(genes[i,"start"]) & Pos<=(genes[i,"stop"])) # Create temp vector with DSB hits across 
each gene in the table 
  bg[[k]][i,"Total"]=sum(temp$Watson+temp$Crick) # Calculate sum of hits within this region 
  bg[[k]][i,"Density"]=bg[[k]][i,"Total"]/Mreads[k]/genes[i,"length"] # Calculate density/bp of hits within this region 
   
  temp2=subset(DSBList[[k]], Chr==(genes[i,"chr"]) & Pos>=(genes[i,"start2"]) & Pos<=(genes[i,"stop2"])) # Create temp vector with DSB hits 
across each gene in the table for "core" region 
  bg[[k]][i,"TotalCore"]=sum(temp2$Watson+temp2$Crick) # Calculate sum of hits within this region 
  bg[[k]][i,"DensityCore"]=bg[[k]][i,"TotalCore"]/Mreads[k]/genes[i,"length2"] # Calculate density/bp of hits within this region 
} 
  bg[[k]][1:5]=bg[[k]][1:5] # This line is essential in multicore loops for some reason 
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  #cat("\r", "Job", k, dflistNames[k], "COMPLETED"); flush.console() # Keep track of progress. cat "\r" overprints to same line of console 
   
} 
bg=r # Collect the foreach loop 
stopCluster(cl) 
 
###################################################################### 
########## Drawing DotPlots of background counts #################### 
###################################################################### 
 
wd = getwd(); out = paste(wd,"/","Output_Files","/","BackgroundReads",Sys.time(),".pdf",sep=""); pdf(file=out, width=15,height=9); 
layout(matrix(c(1,2), 1, 2, byrow = T)) 
for (k in strains) { #step through sequentially each dataframe/strain 
#dotchart(bg[[k]]$Total, labels=bg[[k]]$Genename, main=dflistNames[k], xlim=c(0,max(bg[[k]]$Total))) 
dotchart(bg[[k]]$Density, labels=bg[[k]]$Genename, main=DSBListNames[k], xlim=c(0,max(bg[[k]]$Density)), xlab="Total hits per Million reads 
per bp") 
dotchart(bg[[k]]$DensityCore, labels=bg[[k]]$Genename, main=paste(c(DSBListNames[k],"Core")), xlim=c(0,max(bg[[k]]$DensityCore)), 
xlab="Total hits per Million reads per bp") 
} 
dev.off() 
 
###################################################################### 
########## Making background coutn table "BGreads" #################### 
###################################################################### 
 
BG=data.frame(NULL) 
for (k in strains) { 
BG[k,"Strain"]=DSBListNames[k] 
BG[k,"Mean"]=mean(bg[[k]]$Density) 
BG[k,"StDev"]=sd(bg[[k]]$Density) 
BG[k,"StDev%"]=sd(bg[[k]]$Density)/BG[k,"Mean"]*100 
BG[k,"MeanCore"]=mean(bg[[k]]$DensityCore) 
BG[k,"StDevCore"]=sd(bg[[k]]$DensityCore) 
BG[k,"StDevCore%"]=sd(bg[[k]]$DensityCore)/BG[k,"MeanCore"]*100 
BG[k,"Mreads"]=Mreads[k] 
BG[k,"BGreads"]=(BG[k,"MeanCore"]*12.071326*Mreads[k]) #Calculate TOTAL reads that are background. 12.071326=Mbp of genome 
BG[k,"BGreadspM"]=(BG[k,"MeanCore"]*12.071326) #Calculate FRACTION of million reads that are background. 12.071326=Mbp of genome 
BG[k,"Mreads_BGreads"]=Mreads[k]-BG[k,"BGreads"] #Calculate TOTAL reads that are NOT background. 12.071326=Mbp of genome 
} 
BG[2:11]=signif(BG[2:11], digits=4) 
#Write out master files EDIT NAME OF STRING! 
wd = getwd() 
out = paste(wd,"/","BGreads6.txt", sep="") 
write.table(BG, out, col.names =TRUE, row.names = FALSE, quote = FALSE, sep="\t", append=F) 
10.5 Spo11 Mapping v09 MC.R (created by Matt Neale) 
require("e1071") # This pacakge permits smoothing functions (used later) 
require(stringr) 
options(scipen=999) #Suppresses scientific notation appearing in plots/graphs etc 
require(doParallel) 
require(plyr)  
####################################################################################################################### 
# Import histogram FullMap files for each strain in working directory and tally up the total number of Million mapped reads 
Mreads=NULL; DSBList=list();DSBListNames=NULL 
 
library(doParallel) 
cl <- makeCluster(8) 
registerDoParallel(cl) 
#files=c("FullMap.sae2.S288C_MJ315_WT_1_6h_c.txt") 
 
#Read in all tables with string "Full.Map." 
files = list.files(pattern="FullMap.") # import files names with "FullMap." string into variable "files"  
DSBListNames = substr(files, 9, nchar(files)-6) # Shorten filename by 8 characters from beginning and 6 characters form end (i.e. remove 
"FullMap." and "_c.txt") 
nfiles = length(files) # Count number of files 
 
DSBList=foreach (k = 1:nfiles) %dopar% { DSBList[[k]] = read.table(files[k], sep = "\t", header=TRUE) } #Import datatable 
#DSBList=s 
stopCluster(cl) 
 
for (i in 1:nfiles){Mreads[i]=sum(DSBList[[i]]$Watson+DSBList[[i]]$Crick)/1000000} # Calculate Million reads per sample for conveting to HpM 
 
AllElementsDUB = read.table("AllElementsDUB_H4L2_2016.08.11b.txt", sep = "\t", header=TRUE) #Import datatable 
BG = read.table("BGreads6.txt", sep = "\t", header=TRUE) #Import hotspot datatable 
BGmean=NULL; for (i in 1:nfiles){BGmean[i]=unlist(subset(BG, Strain==DSBListNames[i], MeanCore))} # Ensure that background vector 
BGmean is using same indexe numbering as hit data  
Nfactor=(1-(BGmean*12.01)) # Normalisation factor: based on number of reads that appear NOT to be background 
 
#######################################################################################################################
######################## 
############ START HERE ONCE DATAFRAMES ARE LOADED ###################### 
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#######################################################################################################################
######################## 
# MODULE for pulling out specific locus of interest 
orf="7" 
genes=AllElementsDUB #First make a copy of the ALLElements table 
upstream=1600; downstream=100 # bp to extend by in either direction of ORF 
genes=subset(genes, genename==orf | sysname==orf) 
xl1=genes$start-upstream 
xl2=genes$stop+downstream 
chrom=genes$chr 
 
####################################################################################################################### 
# MODULE for manually specifying chromosome and location 
#chrom=8; xl1=400000; window.w=100000; xl2=xl1+window.w; #Plot range minimum (bp); # Plot range width (bp); #Plot range maximum (bp) 
 
####################################################################################################################### 
# New loop to plot multiple comparisions 
strains=c(8,9,3,5,1) # Plot these numbered dataframes from the DSBList 
scalar.u=c(1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1) # Unique scaling factor for each strain in the DSBList (default =1 is identical scaling) 
scalar.u=1/Nfactor # Override scaling factor and use apparent hit reads instead 
 
####################################################################################################################### 
#Plotting: first set up how the plots are organised. How many panes per image for example using the layout command 
plotnumber=length(strains) # Number from 1 to 5 
if (plotnumber==1) {layout(matrix(c(1,1,1,2,2),5, 1, byrow = T))} 
if (plotnumber==2) {layout(matrix(c(1,1,1,2,2,2,3,3), 8, 1, byrow = T))} 
if (plotnumber==3) {layout(matrix(c(1,1,1,2,2,2,3,3,3,4,4),11, 1, byrow = T))} 
if (plotnumber==4) {layout(matrix(c(1,1,1,2,2,2,3,3,3,4,4,4,5,5),14, 1, byrow = T))} 
if (plotnumber==5) {layout(matrix(c(1,1,1,2,2,2,3,3,3,4,4,4,5,5,5,6,6),17, 1, byrow = T))} 
 
par(mar=c(1,5,1,0),oma = c(0, 1, 1, 1),las=1) # Sets margins per graph and outside margins per grouped set (order is bottom, left, top, right) 
layout.show((length(strains)+1)) 
 
for (k in strains){ #step through sequentially each dataframe/strain 
   
#Subset for region of interest 
sae2.0=subset(DSBList[[k]], Chr==chrom & Pos>=xl1 & Pos <=xl2) #Make a sub-table of the sae2-DSB data that only contains those rows where 
chr = 1 in range of interest 
 
####################################################################################################################### 
#Decompression code here 
sae2.1 <- data.frame(Chr=chrom, Pos=(xl1:xl2)) # Creates expanded empty dataframe with Chr and Pos locations 
sae2.1 <- merge(sae2.1,sae2.0, all=TRUE) # Merge expanded empty dataframe with compressed sae2.1 dataframe 
sae2.1[is.na(sae2.1)] <- 0 # Convert all NA values to zero 
sae2.1$Total=sae2.1$Watson+sae2.1$Crick 
 
####################################################################################################################### 
# Smoothing function #### temp and smooth are just two temporary vectors. New version creates two smoothed plots for each profile for overlaying 
win=1 # hanning window size [1] 
win2=101 # hanning window size [2] for overlay 
scalar=15 #scalar [1] 
scalar2=2 # scalar [2] for overlay 
sae2scalar=scalar.u[k]*scalar # adjust this if needed when adjusting hann window smoothing 
sae2scalar2=scalar.u[k]*scalar2 # adjust this if needed when adjusting hann window smoothing 
hw=hanning.window(win) #create hanning window (require package e1071 to be loaded) 
hw2=hanning.window(win2) #create hanning window (require package e1071 to be loaded) 
 
####################################################################################################################### 
temp=NULL 
for (j in 3:5){ 
temp=c(rep(0,win),sae2.1[1:nrow(sae2.1),j], rep(0,win)) # Create vector length of chromosome and extend by the length of the slidign window with 
zeros at both ends 
smooth=filter(temp,hw) # smooth the temp vector using the hann window 
smooth=smooth[(win+1):(length(smooth)-win)] # trim smooth to correct lengthsmooth2=smooth2[(win2+1):(length(smooth2)-win2)] # trim smooth 
to correct length 
sae2.1[j+3]=smooth 
} 
temp2=NULL 
for (j in 3:5){ 
  temp2=c(rep(0,win2),sae2.1[1:nrow(sae2.1),j], rep(0,win2)) # Create vector length of chromosome and extend by the length of the slidign window 
with zeros at both ends 
  smooth2=filter(temp2,hw2) # smooth the temp vector using the hann window 
  smooth2=smooth2[(win2+1):(length(smooth2)-win2)] # trim smooth to correct length 
  sae2.1[j+6]=smooth2 
} 
 
colnames(sae2.1)=c("Chr", "Pos", "Watson", "Crick", "Total", "watson.s", "crick.s", "total.s","watson.s2", "crick.s2", "total.s2") 
 
####################################################################################################################### 
# Plot boundaries: 
plot(sae2.1$Pos,sae2.1$total.s/Mreads[k], type="n", xlim=c(xl1,xl2), ylim=c(-1600,1000), ylab=paste(c(DSBListNames[k]," / Scalar 
",round(scalar.u[k],digits=2)), collapse="")) #plot the start histogram 
# Broad Overlays: 
lines(sae2.1$Pos,sae2.1$watson.s2*sae2scalar2/Mreads[k], type="h", xlim=c(xl1,xl2), col="lightcoral") #plot the start histogram 
lines(sae2.1$Pos,-sae2.1$crick.s2*sae2scalar2/Mreads[k], type="h", xlim=c(xl1,xl2), col="lightblue") #plot the start histogram 
lines(sae2.1$Pos,0.5*sae2.1$total.s2*sae2scalar2/Mreads[k]-1500, type="l", xlim=c(xl1,xl2), col="grey") #plot the start histogram 
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#hi-res smoothed data: 
lines(sae2.1$Pos,sae2.1$watson.s*sae2scalar/Mreads[k], type="h", xlim=c(xl1,xl2), col="red") #plot the start histogram 
lines(sae2.1$Pos,-sae2.1$crick.s*sae2scalar/Mreads[k], type="h", xlim=c(xl1,xl2), col="blue") #plot the start histogram 
lines(sae2.1$Pos,0.5*sae2.1$total.s*sae2scalar/Mreads[k]-1500, type="l", xlim=c(xl1,xl2), col="grey") #plot the start histogram 
# overlay of smoothed W/C ratio : 
#lines(sae2.1$Pos,100*log2((sae2.1$watson.s2*sae2scalar2/Mreads[k])/(sae2.1$crick.s2*sae2scalar2/Mreads[k])), type="l", xlim=c(xl1,xl2), 
col="black") #plot the ratio 
} 
####################################################################################################################### 
#Now plot the gene datatrack 
#First subset the relevant data 
genes=AllElementsDUB #First make a copy of the ALLElements table 
genes=subset(genes,chr==chrom & start>(xl1-10000) & stop<(xl2+10000)) #Make a sub-table of ALLElements where chr = 1 and has limits just 
beyond plot range 
genes=subset(genes,type=="gene") #Make a sub-table of ALLElements 
#Now perform the plot 
plot(sae2.1$range,sae2.1$filtered, xaxt="n",yaxt="n",type="n", ylab=paste("Genes"),cex.lab=1.5,font=2, xlim=c(xl1,xl2), ylim=c(-100,120),axes=F) 
#set up empty plot 
text((xl1+xl2)/2,-80, labels=paste("Chromosome",chrom, "/",orf,"/ Range",xl1,"to",xl2,"bp / Hann", win, "/ Y-Scalar",scalar), cex.lab=1.4) 
####################################################################################################################### 
########### STOP HERE IF YOU ARE PLOTTING WHOLE CHROMOSOMES!!! ############# 
####################################################################################################################### 
# Following module draws arrows for each element 
xrange=xl2-xl1 
ahead=xrange/25 #make arrowhead length proportional to plot range 
ahead[(ahead>500)]=500 #limit max length to 500 
av=75 #arrow vertical location relative to plot dimensions 
ahw=15 #arrow/head width 
genesW=subset(genes,genename !="Dubious_ORF" & orientation =="+") #Make a sub-table of ALLElements 
for (i in 1:nrow(genesW)){ 
   polygon(c(genesW[i,"start"], genesW[i,"stop"]-ahead, genesW[i,"stop"]-ahead,genesW[i,"stop"], genesW[i,"stop"]-ahead, genesW[i,"stop"]-ahead, 
genesW[i,"start"]),c(av+ahw,av+ahw,av+ahw+ahw,av,av-ahw-ahw,av-ahw, av-ahw), col="wheat", border="wheat4") 
  text((genesW[i,"start"]+genesW[i,"stop"])/2,av, font=3, genesW[i,"genename"], cex=0.9) } 
genesW=subset(genes,genename=="Dubious_ORF" & orientation =="+") #Make a sub-table of ALLElements 
for (i in 1:nrow(genesW)){ 
  polygon(c(genesW[i,"start"], genesW[i,"stop"]-ahead, genesW[i,"stop"]-ahead,genesW[i,"stop"], genesW[i,"stop"]-ahead, genesW[i,"stop"]-ahead, 
genesW[i,"start"]),c(av+ahw,av+ahw,av+ahw+ahw,av,av-ahw-ahw,av-ahw, av-ahw), col="wheat", border="wheat4", lty=2) 
  text((genesW[i,"start"]+genesW[i,"stop"])/2,av, font=3, genesW[i,"sysname"], cex=0.9) } 
 
av=25 #arrow vertical location for Crick genes relative to plot dimensions 
genesC=subset(genes,genename !="Dubious_ORF" & orientation =="-") #Make a sub-table of ALLElements 
for (i in 1:nrow(genesC)){ 
  polygon(c(genesC[i,"stop"], genesC[i,"start"]+ahead, genesC[i,"start"]+ahead,genesC[i,"start"], genesC[i,"start"]+ahead, genesC[i,"start"]+ahead, 
genesC[i,"stop"]),c(av+ahw,av+ahw,av+ahw+ahw,av,av-ahw-ahw,av-ahw, av-ahw), col="thistle", border ="thistle4") 
  text((genesC[i,"start"]+genesC[i,"stop"])/2,av, font=3, genesC[i,"genename"], cex=0.9) } 
genesC=subset(genes,genename=="Dubious_ORF" & orientation =="-") #Make a sub-table of ALLElements 
for (i in 1:nrow(genesC)){ 
  polygon(c(genesC[i,"stop"], genesC[i,"start"]+ahead, genesC[i,"start"]+ahead,genesC[i,"start"], genesC[i,"start"]+ahead, genesC[i,"start"]+ahead, 
genesC[i,"stop"]),c(av+ahw,av+ahw,av+ahw+ahw,av,av-ahw-ahw,av-ahw, av-ahw), col="thistle", border ="thistle4", lty=2) 
  text((genesC[i,"start"]+genesC[i,"stop"])/2,av, font=3, genesC[i,"sysname"], cex=0.9) } 
####################################################################################################################### 
10.6 Hotspot totals v09 MC.R (created by Matt Neale) 
####################################################################################################################### 
require("e1071") # This pacakge permits smoothing functions (used later) 
require(stringr) 
options(scipen=999) #Suppresses scientific notation appearing in plots/graphs etc 
require(doParallel) 
library(doParallel) 
require(plyr) 
####################################################################################################################### 
 
# YOU MUST CHANGE TO WORKING DIRECTORY CONTAINING THE INPUT and DATA MAPS 
 
# First load required dataset files: 
setwd("~/Dropbox/Documents/Work Docs/Research/Lab Notebooks/Computer scripting/R scripts/R datasets/Cer3H4L2") 
AllElementsDUB = read.table("AllElementsDUB_H4L2_Brar_2016.08.16.txt", sep = "\t", header=TRUE) #Import datatable 
Pan = read.table("Pan.Hotspots.IGR.SacCer3_H4L2_2016.08.10a.txt", sep = "\t", header=TRUE) #Import hotspot datatable 
names(Pan) <- c("Chr","Start","End","Length","PanHits","Feature_name","Name","Midpoint", "Type","Direction","IGR","IGR.start","IGR.end") 
Pan <- Pan[c("Chr","Start","End","Length","Midpoint","PanHits","Feature_name","Name","Type","Direction","IGR","IGR.start","IGR.end")] # 
reorder 
 
# Now point at the data to be processed: 
setwd("~/Dropbox/Aligned Files/Spo11 H4L2/Temp") 
 
# Import histogram FullMap files for each strain in working directory and tally up the total number of Million mapped reads 
Mreads=NULL; DSBList=list();dflistNames=NULL 
 
#Read in all tables with string "Full.Map." 
files = list.files(pattern="FullMap.Cer3H4L2") # import files names with "FullMap." string into variable "files"  
dflistNames = substr(files, 9, nchar(files)-6) # Shorten filename by 8 characters from beginning and 6 characters form end (i.e. remove "FullMap." 
and "_c.txt") 
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nfiles = length(files) # Count number of files 
 
BG = read.table("BGreads8Average.txt", sep = "\t", header=TRUE) #Import background datatable 
BGmean=NULL; for (i in 1:nfiles){BGmean[i]=unlist(subset(BG, Strain==dflistNames[i], MeanCore))} # Ensure that background vector BGmean 
is using same indexe numbering as hit data  
 
####################################################################################################################### 
############ START HERE ONCE DATAFRAMES ARE LOADED ###################### 
####################################################################################################################### 
#num=1 
strains=c(1:nfiles) # Process these numbered dataframes from the DSBList 
#strains=c(1:2) # Process these numbered dataframes from the DSBList 
hotspots=Pan 
extend=300 
hs=list() # list of tables containing info on the hotspots for each gene for each strain 
 
cl <- makeCluster(8) 
registerDoParallel(cl) 
 
writeLines(c(""), "log.txt") 
hs=NULL 
r=NULL 
r=foreach (k = strains) %dopar% { #step through sequentially each dataframe/strain 
  DSBList=NULL; Mreads=NULL 
  # DSB map files now loaded in within each loop/instance 
  DSBList = read.table(files[k], sep = "\t", header=TRUE) #Import datatable 
  Mreads=sum(DSBList$Watson+DSBList$Crick)/1000000 # Calculate Million reads per sample for conveting to HpM 
   
  hs[[k]]=Pan[c("Chr","Start","End","Length","Midpoint","PanHits","Feature_name","Name","Type","Direction")] 
  hs[[k]]=hs[[k]][NULL,] 
  row=1 
  sink("log.txt", append=TRUE) # Send console output to text file to monitor run 
   
  for (j in 1:16){ 
    hs1=NULL 
    hs1=data.frame(subset(Pan[1:10], Chr==j)) # subsetting the datatables first by chromosome massively speeds the script up! 
    hs1[,c("WatsonHpM","CrickHpM","TotalHpM","BGHpM","Total-
BGHpM","WatsonHpM300","CrickHpM300","TotalHpM300","BGHpM300","Total-
BGHpM300","NormHpM","NormHpM300","NormHpChr")]=NA #Fill in missing columns before rbind call 
    temp1=subset(DSBList, Chr==j) # subsetting the datatables first by chromosome massively speeds the script up! I am sure this is most important 
for the large DSBList tables! 
    hs[[k]]=rbind(hs[[k]],hs1) 
    cat("\r", "Job", k, dflistNames[k], "Chromosome", j, "Hotspot", row, "of", nrow(hotspots)); flush.console() # Keep track of progress. cat "\r" 
overprints to same line of console 
     
    for (i in 1:nrow(hs1)) { 
      temp=subset(temp1, Pos>=(hs1[i,"Start"]) & Pos<=(hs1[i,"End"])) # Create temp vector with DSB hits across each hotspot in the table 
      hs[[k]][row,"WatsonHpM"]=sum(temp$Watson)/Mreads # Calculate sum of hits within this region/Mreads[k] 
      hs[[k]][row,"CrickHpM"]=sum(temp$Crick)/Mreads # Calculate sum of hits within this region/Mreads[k] 
       
      temp=subset(temp1, Pos>=((hs1[i,"Start"])-extend) & Pos<=((hs1[i,"End"])+extend)) # Create temp vector with DSB hits across hotspot in table 
+/-300bp 
      hs[[k]][row,"WatsonHpM300"]=sum(temp$Watson)/Mreads # Calculate sum of hits within this region/Mreads[k] 
      hs[[k]][row,"CrickHpM300"]=sum(temp$Crick)/Mreads # Calculate sum of hits within this region/Mreads[k] 
   
      row=row+1 # Increment counter 
    } 
  } 
   
  # Vectorised math: 
  hs[[k]][1:nrow(hs[[k]]),"TotalHpM"]=hs[[k]][1:nrow(hs[[k]]),"WatsonHpM"]+hs[[k]][1:nrow(hs[[k]]),"CrickHpM"] 
   
  hs[[k]][1:nrow(hs[[k]]),"TotalHpM300"]=hs[[k]][1:nrow(hs[[k]]),"WatsonHpM300"]+hs[[k]][1:nrow(hs[[k]]),"CrickHpM300"] 
   
  hs[[k]][1:nrow(hs[[k]]),"BGHpM"]=BGmean[k]*hs[[k]][1:nrow(hs[[k]]),"Length"] 
  hs[[k]][1:nrow(hs[[k]]),"BGHpM300"]=BGmean[k]*(hs[[k]][1:nrow(hs[[k]]),"Length"]+(extend*2)) 
   
  hs[[k]][1:nrow(hs[[k]]),"Total-BGHpM"]=hs[[k]][1:nrow(hs[[k]]),"TotalHpM"]-hs[[k]][1:nrow(hs[[k]]),"BGHpM"] 
  hs[[k]][1:nrow(hs[[k]]),"Total-BGHpM300"]=hs[[k]][1:nrow(hs[[k]]),"TotalHpM300"]-hs[[k]][1:nrow(hs[[k]]),"BGHpM300"] 
   
  hs[[k]][1:nrow(hs[[k]]),"NormHpM"]=hs[[k]][1:nrow(hs[[k]]),"Total-BGHpM"] 
  hs[[k]][1:nrow(hs[[k]]),"NormHpM"][hs[[k]][1:nrow(hs[[k]]),"NormHpM"] < 0] = 0 # Convert all -ve values to zero 
  FinalSum=sum(hs[[k]][1:nrow(hs[[k]]),"NormHpM"]) 
  hs[[k]][1:nrow(hs[[k]]),"NormHpM"]=hs[[k]][1:nrow(hs[[k]]),"NormHpM"]/FinalSum*1000000 
   
  hs[[k]][1:nrow(hs[[k]]),"NormHpM300"]=hs[[k]][1:nrow(hs[[k]]),"Total-BGHpM300"] 
  hs[[k]][1:nrow(hs[[k]]),"NormHpM300"][hs[[k]][1:nrow(hs[[k]]),"NormHpM300"] < 0] = 0 # Convert all -ve values to zero 
  FinalSum=sum(hs[[k]][1:nrow(hs[[k]]),"NormHpM300"]) 
  hs[[k]][1:nrow(hs[[k]]),"NormHpM300"]=hs[[k]][1:nrow(hs[[k]]),"NormHpM300"]/FinalSum*1000000 
   
  #Loop to calculate NormHpChr 
   
  rowA=0 
  for (i in 1:16){ 
    aChr=subset(hs[[k]],Chr==i) 
    aChrDSBs=nrow(aChr) # Number of hotspots per chromosome (rows) 
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    aChrTotal=sum(aChr[1:aChrDSBs,"NormHpM"]) 
    hs[[k]][(rowA+1):(aChrDSBs+rowA),"NormHpChr"]=aChr[1:aChrDSBs,"NormHpM"]/aChrTotal*1000000 
    rowA=rowA+aChrDSBs 
  } 
   
  #hs[[k]][1:nrow(hs[[k]]),"Total-BG"]=hs[[k]][1:nrow(hs[[k]]),"Watson"]+hs[[k]][1:nrow(hs[[k]]),"Crick"]-hs[[k]][1:nrow(hs[[k]]),"BGhits"] 
  #hs[[k]][1:nrow(hs[[k]]),"Total300-BG"]=hs[[k]][1:nrow(hs[[k]]),"Watson300"]+hs[[k]][1:nrow(hs[[k]]),"Crick300"]-
hs[[k]][1:nrow(hs[[k]]),"BGhits300"] 
   
  #hs[[k]][1:nrow(hs[[k]]),"Hit.Increase"]=hs[[k]][1:nrow(hs[[k]]),"Total300-BG"]-hs[[k]][1:nrow(hs[[k]]),"Total-BG"] 
  #hs[[k]][1:nrow(hs[[k]]),"Fold.Increase"]=hs[[k]][1:nrow(hs[[k]]),"Total300-BG"]/hs[[k]][1:nrow(hs[[k]]),"Total-BG"] 
   
  #hs[[k]][1:nrow(hs[[k]]),"WC.ratio"]=hs[[k]][1:nrow(hs[[k]]),"Watson"]/hs[[k]][1:nrow(hs[[k]]),"Crick"] 
  #hs[[k]][1:nrow(hs[[k]]),"WC.ratio300"]=hs[[k]][1:nrow(hs[[k]]),"Watson300"]/hs[[k]][1:nrow(hs[[k]]),"Crick300"] 
   
  cat("\r", "Job", k, "COMPLETED", dflistNames[k], "Chromosome", j, "Hotspot", row-1, "of", nrow(hotspots)); flush.console() 
  hs[[k]][1:23]=hs[[k]][1:23] # For unknown reasons this code is ESSENTIAL to get the script to populate hs[[k]] with anything. Otherwise it returns 
"NULL"  
  hs[[k]][11:23]=round(hs[[k]][11:23], digits=2) 
   
  ######### Write tables to text file ---- Now part of loop ########## 
  wd = getwd() 
  out = paste(wd,"/","Hotspot.Table.",dflistNames[k],".txt", sep="") 
  write.table(hs[[k]], out, col.names =TRUE, row.names = FALSE, quote = FALSE, sep="\t", append=F) 
 
  } 
stopCluster(cl) 
 
sink() 
 
#a=hs[[3]] 
 
#hs=r 
 
#for (i in 1:nfiles) { hs[[i]][11:20]=round(hs[[i]][11:20], digits=2); hs[[i]][1:15,] } 
 
####################################################################################################################### 
STOP HERE 
####################################################################################################################### 
######### Write tables to text file #################### 
 
#for (i in 1:nfiles){ 
#wd = getwd() 
#out = paste(wd,"/","Hotspot.Table.",dflistNames[i],".txt", sep="") 
#write.table(hs[[i]], out, col.names =TRUE, row.names = FALSE, quote = FALSE, sep="\t", append=F) 
#} 
 
############## 
 
#layout(matrix(c(1,2), 1, 2, byrow = T)) 
#for (k in strains) { #step through sequentially each dataframe/strain 
   
  #dotchart(bg[[k]]$Total, labels=bg[[k]]$Genename, main=dflistNames[k], xlim=c(0,max(bg[[k]]$Total))) 
  #dotchart(bg[[k]]$Density, labels=bg[[k]]$Genename, main=dflistNames[k], xlim=c(0,max(bg[[k]]$Density)), xlab="Total hits per Million reads 
per bp") 
  #dotchart(bg[[k]]$DensityCore, labels=bg[[k]]$Genename, main=paste(c(dflistNames[k],"Core")), xlim=c(0,max(bg[[k]]$DensityCore)), 
xlab="Total hits per Million reads per bp") 
#} 
10.7 Plotting hotspot tables v03.R (created by Matt Neale) 
setwd("~/Dropbox/Aligned Files/Spo11 H4L2/Temp") 
options(scipen=999) #Suppresses scientific notation appearing in plots/graphs etc 
  
#Read in all tables with string "Hotspot.Table." 
files = list.files(pattern="Hotspot.Table.") # import files names with ""Hotspot.Table." string into variable "files"  
#files1 = substr(files, 1, nchar(files)-4) # SHorten filename by 4 characters (i.e. remove ".txt") 
nfiles = length(files) # Count number of files 
#files2 = read.table(text = files1, sep = "_", as.is = TRUE) #Split file names by "_" separator and create table "files2" 
hs=list() # Initialise empty list 
hsListNames=NULL # Initialise hsListNames 
Nfactor = NULL 
for (j in 1:nfiles) { 
  hs[[j]] <- read.table(files[j], sep = "\t", header=TRUE) # Import datatable from files number 1 to j into hs[[X]] 
  #hsListNames[j]=paste(files2[j,2],files2[j,3],files2[j,4],files2[j,5], sep="_")} # Extract identifiers from filename 
 hsListNames[j] = substr(files[j], 15, nchar(files[j])-4) # Shorten filename by 14 characters from beginning and 6 characters form end (i.e. remove 
"Hotspot.Table." and ".txt") 
} 
 
#BG = read.table("BGreads8.txt", sep = "\t", header=TRUE) #Import background datatable 
 
#BGmean=NULL; for (i in 1:nfiles){BGmean[i]=unlist(subset(BG, Strain==hsListNames[i], MeanCore)) # Ensure that background vector BGmean 
is using same indexe numbering as hit data  
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#  Nfactor[i]=(1-(BGmean[i]*12.01))} # Normalisation factor: based on number of reads that appear NOT to be background           
 
# Other data: 
CEN=c(151523.5, 238265, 114443, 449766,152045.5, 148568.5, 496979,105644.5, 355687, 436366,440187.5, 150887.5, 268090, 628816.5, 
326643, 556015) # CENtromere positions 
#RMM = read.table("RMMSubSamp_simple.txt", sep = "\t", header=TRUE) #Import RMM datatable 
#RMM1=RMM[seq(1, NROW(RMM), by = 100),] # Subsample every 10th row to reduce resoltuion of RMM plot 
 
####################################################################################################################### 
#####Data-manipulation 
####################################################################################################################### 
 
# Create "averaged" WT 
#i=nfiles+1 # Index of additional table 
#hs[[i]]=hs[[7]] # EDIT! table 7 is currently Kayleigh's WT data 
#hs[[i]][11:20]=round((hs[[7]][11:20]+hs[[10]][11:20]+hs[[11]][11:20])/3,digits=2) # EDIT! Tables 7,10,11 are currently the WT repeats 
#hs[[i]][1:100,] 
#BGmean[i]=mean(BGmean[c(7,10,11)]) 
#Nfactor[i]=(1-(BGmean[i]*12.01)) # Normalisation factor: based on number of reads that appear NOT to be background 
#hsListNames[i]="WT1.3.4.average" 
 
   
# Correlation plots 
plots=c(2,1) 
nplots=length(plots) 
wd = getwd(); out = paste(wd,"/","Output_Files","/","HotspotCorrelations",Sys.time(),".pdf",sep=""); pdf(file=out, width=4*nplots,height=4*nplots); 
par(mar=c(4,4,1,1),oma = c(1, 1, 1, 1),las=1) # Sets margins per graph and outside margins per grouped set (order is bottom, left, top, 
right)plots=nfiles 
layout(matrix(c(1:nplots^2),nplots, nplots, byrow = T)) 
#layout.show(nplots^2) 
for (n in plots){ 
  for (m in plots){ 
    y=subset(hs[[n]],Chr %in% (1:16)) # Subset data for particular chromosomes if desired 
    y=y[,"NormHpM"] 
    x=subset(hs[[m]],Chr %in% (1:16)) # Subset data for particular chromosomes if desired 
    x=x[,"NormHpM"] 
    #model1=lm(log2(y)~log2(x)) 
    model2=lm(y~x) 
     
    #plot(log2(x),log2(y), xlim=c(log2(0.1),log2(10000)), ylim=c(log2(.1),log2(10000)),xlab=hsListNames[m],ylab=hsListNames[n], 
col=rgb(0,0,0,0.2), 
    #     text(log2(100),log2(0.1),paste(c("r^2 =", signif(summary(model1)$r.squared)),collapse="")), cex=0.5) 
    #abline(lm(log2(y)~log2(x))) 
     
    plot(x,y, log="xy", xlim=c(1,10000), ylim=c(1,10000),xlab=hsListNames[m],ylab=hsListNames[n], col=rgb(0,0,0,0.2), 
         text(100,1,paste(c("r^2 =", signif(summary(model2)$r.squared)),collapse="")), cex=0.5) 
    abline(0,1) 
} 
} 
 
dev.off() 
 
10.8 Pileups around TSS v02.R (created by Matt Neale) 
setwd("~/Dropbox/Aligned Files/Spo11 H4L2/Temp") 
DUB = read.table("AllElementsDUB_H4L2_Brar_2016.08.16.txt", sep = "\t", header=TRUE) #Import datatable 
####################################################################################################################### 
require("e1071") # This package permits smoothing functions (used later) 
require(stringr) 
options(scipen=999) #Suppresses scientific notation appearing in plots/graphs etc 
require(doParallel) 
library(doParallel) 
require(plyr) 
####################################################################################################################### 
# Import histogram FullMap files for each strain in working directory and tally up the total number of Million mapped reads 
Mreads=NULL; dflist=list();dflistNames=NULL 
 
#Read in all tables with string "Full.Map." 
files = list.files(pattern="FullMap.Cer3H4L2") # import files names with "FullMap.Cer3H4L2" string into variable "files" 
dflistNames = substr(files, 9, nchar(files)-6) # Shorten filename by 8 characters from beginning and 6 characters form end (i.e. remove "FullMap." 
and "_c.txt") 
nfiles = length(files) # Count number of files 
 
cl <- makeCluster(8) 
registerDoParallel(cl) 
 
dflist=foreach (k = 1:nfiles) %dopar% { dflist[[k]] = read.table(files[k], sep = "\t", header=TRUE) } #Import datatable 
stopCluster(cl) 
 
####################################################################################################################### 
 
BG = read.table("BGreads8Average.txt", sep = "\t", header=TRUE) #Import background datatable 
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BGmean=NULL; for (i in 1:nfiles){BGmean[i]=unlist(subset(BG, Strain==dflistNames[i], MeanCore))} # Ensure that background vector BGmean 
is using same indexe numbering as hit data 
 
# Calculate Mreads for each datatable 
for (i in 1:nfiles){Mreads[i]=sum(dflist[[i]]$Watson+dflist[[i]]$Crick)/1000000} 
 
####################################################################################################################### 
############ START HERE ONCE DATAFRAMES ARE LOADED ###################### 
#######################################################################################################################
################################### 
# New loop to plot multiple comparisions 
strains=c(11,12,17,18,19,20,1,2,5,6,3,4,21,22,13,14,15,16,9,10,7,8) # Plot these numbered dataframes from the dflist (MAXIMUM of FIVE!) 
columns=2 # How many columns for data output? 
scalar.u=c(1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1) # Unique scaling factor for each strain in the dflist (default =1 is 
identical scaling) 
#scalar.u=1/Nfactor # Override unique caling factor and instead use apparnt non-background-read normalisation factor 
#ymin=c(0,145,0,0,0) 
#ymax=c(250,160,250,250,400) 
####################################################################################################################### 
# Send output to PDF: height of page scales with number of plots 
wd = getwd(); out = paste(wd,"/","Output_Files","/","TSSPileup_",Sys.time(),".pdf",sep=""); pdf(file=out, 
width=columns*4,height=((length(strains)/columns*3)+3)); 
#Plotting: first set up how the plots are organised. How many panes per image for example using the layout command 
plotnumber=length(strains) # Number from 1 to 16 
#layout(matrix(c(1:(plotnumber+length(quantiles))),(length(strains)+1), length(quantiles), byrow = T)) 
layout(matrix(c(1:plotnumber,rep((plotnumber+1),columns)),((length(strains)/columns)+1), columns, byrow = T)) 
#if (plotnumber>0) {layout(matrix(c(1,2,1,2,3,3),3, 2, byrow = T))} 
#if (plotnumber>2) {layout(matrix(c(1,2,1,2,3,4,3,4,5,5), 5, 2, byrow = T))} 
#if (plotnumber>4) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,7),7, 2, byrow = T))} 
#if (plotnumber>6) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,8,7,8,9,9),9, 2, byrow = T))} 
#if (plotnumber>8) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,8,7,8,9,10,9,10,11,11),11, 2, byrow = T))} 
#if (plotnumber>10) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,8,7,8,9,10,9,10,11,12,11,12,13,13),13, 2, byrow = T))} 
#if (plotnumber>12) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,8,7,8,9,10,9,10,11,12,11,12,13,14,13,14,15,15),15, 2, byrow = T))} 
#if (plotnumber>14) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,8,7,8,9,10,9,10,11,12,11,12,13,14,13,14,15,16,15,16,17,17),17, 2, byrow = T))} 
par(mar=c(1,4,1,2),oma = c(1, 1, 1, 1),las=1) # Sets margins per graph and outside margins per grouped set (order is bottom, left, top, right) 
#layout.show((length(strains))+1) 
####################################################################################################################### 
# MODULE for pulling out specific locus of interest 
genes=DUB #First make a copy of the ALLElements table 
genes=subset(genes, type=="gene" & genename!="Dubious_ORF") #ONly look at genes and exlcude dubious orfs 
genesW=subset(genes, orientation=="+") # genesW = Watson strand genes 
genesC=subset(genes, orientation=="-") # genesC = Crick strand genes 
 
############################################## Start of Strain Loop ############################################ 
 
for (k in strains) { #step through sequentially each dataframe/strain 
 
width1=1000 # bp upstream and downstream of TSS to retrieve 
padding=500 
width=width1+padding 
 
#Zero out TSS dataframe - ONLY DO THIS FOR EACH STRAIN! - This must be outside of chromosome loop! 
TSS=data.frame(NULL) 
TSS[1:((width*2)+1),"Pos"]=(1:((2*width)+1)) 
 
TSS$WatsonW=0 # Watson genes watson hits 
TSS$CrickW=0 # Watson genes crick hits 
TSS$WatsonC=0 # Crick genes watson hits 
TSS$CrickC=0 # Crick genes crick hits 
 
temp=NULL 
#chroms=c(1:16) 
#chroms=c(1:2,4:16) # Specify the chromosomes you want to plot 
chroms=c(2,4,5,7:16) # Or just a single chromoosme. Hash this line out if you wnat to plot all of them specified above. 
 
############################################## Start of Chromosome Loop ############################################ 
for (chrom in chroms) { #Specify which chromosomes to process 
df.1=subset(dflist[[k]],Chr==chrom) # Make copy of the datatable 
 
genesW1=subset(genesW, chr==chrom) 
genesC1=subset(genesC, chr==chrom) 
 
#Watson genes 
for (i in 1:nrow(genesW1)) { 
    temp=subset(df.1[2:4], Pos>=(genesW1[i,"start"]-width) & Pos<=(genesW1[i,"start"]+width)) # Create temp matrix with DSB hits in this region 
    temp$Pos=temp$Pos-genesW1[i,"start"]+width+1 
    TSS[temp$Pos,"WatsonW"]=TSS[temp$Pos,"WatsonW"]+temp[,"Watson"] 
    TSS[temp$Pos,"CrickW"]=TSS[temp$Pos,"CrickW"]+temp[,"Crick"] 
} 
#Crick genes 
for (i in 1:nrow(genesC1)) { #NOTE: TSS is at the stop location in the table 
  temp=subset(df.1[2:4], Pos>=(genesC1[i,"stop"]-width) & Pos<=(genesC1[i,"stop"]+width)) # Create temp matrix with DSB hits in this region 
  temp$Pos=temp$Pos-genesC1[i,"stop"]+width+1 
  TSS[temp$Pos,"WatsonC"]=TSS[temp$Pos,"WatsonC"]+temp[,"Watson"] 
  TSS[temp$Pos,"CrickC"]=TSS[temp$Pos,"CrickC"]+temp[,"Crick"] 
} 
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} # Repeat for each chromosome 
 
# This section combines the Watson and Crick hits, reversing the order of the crick gene hits and adding the Watsons to the Crick hits and Crick to 
Watsons 
# (i.e. reverse complements the data for the Crick genes). 
# This allows both to be combined in the plot 
TSS$revWc=rev(TSS$WatsonC) #Crick genes with Watson hits 
TSS$revCc=rev(TSS$CrickC) #Crick genes with Crick hits 
TSS$WatsonTotal=TSS$WatsonW+TSS$revCc # Add WatsonW hits to reversed CrickC hits 
TSS$CrickTotal=TSS$CrickW+TSS$revWc # Add CrickW hits to reversed WatsonC hits 
TSS$WCTotal=(TSS$WatsonTotal+TSS$CrickTotal)/2 #Create total column and halve it 
 
####################################################################################################################### 
# Smoothing function #### temp and smooth are just two temporary vectors 
win=151 # hanning window size 
scalar=.1 
sae2scalar=scalar.u[k]*scalar # adjust this if needed when adjusting hann window smoothing 
hw=hanning.window(win) #create hanning window (require package e1071 to be loaded) 
 
temp=NULL 
for (j in 8:10){ #Smooth columns 8 to 10 in the TSS table 
  temp=c(rep(0,win),TSS[1:nrow(TSS),j], rep(0,win)) # Create vector length of chromosome and extend by the length of the slidign window with 
zeros at both ends 
  smooth=filter(temp,hw) # smooth the temp vector using the hann window 
  smooth=smooth[(win+1):(length(smooth)-win)] # trim smooth to correct length 
  TSS[j+3]=smooth 
} 
colnames(TSS)=c("Pos", "WatsonW", "CrickW", "WatsonC", "CrickC", "revWc", "revCc", "WatsonTotal", "CrickTotal", "WCTotal", 
"WatsonTotalS", "CrickTotalS","WCTotalS") 
TSS=TSS[padding:(padding+width1+width1),] 
#Unsmoothed data: 
#plot(TSS$Pos-width, TSS$WCTotal*sae2scalar/Mreads[k], type="l", ylab=dflistNames[k], xlim=c(-width1,width1)) 
#lines(TSS$Pos-width, TSS$WatsonTotal*sae2scalar/Mreads[k], type="l", ylab=dflistNames[k], col="red") 
#lines(TSS$Pos-width, TSS$CrickTotal*sae2scalar/Mreads[k], type="l", ylab=dflistNames[k], col="blue") 
#Smoothed data: 
plot(TSS$Pos-width, TSS$WCTotalS*sae2scalar/Mreads[k], type="l", ylab=c(dflistNames[k])) 
lines(TSS$Pos-width, TSS$WatsonTotalS*sae2scalar/Mreads[k], type="l", col="red") 
lines(TSS$Pos-width, TSS$CrickTotalS*sae2scalar/Mreads[k], type="l", col="blue") 
 
####################################################################################################################### 
 
} # Strain loop 
plot(TSS$Pos-width, TSS$WCTotal, xaxt="n",yaxt="n", type="n", ylab="", ylim=c(-100,120), axes=F) 
text(0,0, font=3, labels=paste("Chromosome",toString(chroms), "/ Hann", win, "/ Y-Scalar",scalar)) 
 
dev.off() 
10.9 Pileups around TSS v03 Gene expression.R (created by Matt Neale) 
setwd("~/Dropbox/Aligned Files/Spo11 H4L2/Temp") 
DUB = read.table("AllElementsDUB_H4L2_Brar_2016.08.16.txt", sep = "\t", header=TRUE) #Import datatable 
DUB[is.na(DUB)]=0 # Convert all NA values to zero 
####################################################################################################################### 
require("e1071") # This pacakge permits smoothing functions (used later) 
require(stringr) 
options(scipen=999) #Suppresses scientific notation appearing in plots/graphs etc 
require(doParallel) 
library(doParallel) 
require(plyr) 
####################################################################################################################### 
# Import histogram FullMap files for each strain in working directory and tally up the total number of Million mapped reads 
Mreads=NULL; dflist=list();dflistNames=NULL 
 
#Read in all tables with string "Full.Map." 
files = list.files(pattern="FullMap.Cer3H4L2") # import files names with "FullMap.Cer3H4L2" string into variable "files" 
dflistNames = substr(files, 9, nchar(files)-6) # Shorten filename by 8 characters from beginning and 6 characters form end (i.e. remove "FullMap." 
and "_c.txt") 
nfiles = length(files) # Count number of files 
 
cl <- makeCluster(8) 
registerDoParallel(cl) 
 
dflist=foreach (k = 1:nfiles) %dopar% { dflist[[k]] = read.table(files[k], sep = "\t", header=TRUE) } #Import datatable 
stopCluster(cl) 
 
####################################################################################################################### 
 
BG = read.table("BGreads8.txt", sep = "\t", header=TRUE) #Import background datatable 
BGmean=NULL; for (i in 1:nfiles){BGmean[i]=unlist(subset(BG, Strain==dflistNames[i], MeanCore))} # Ensure that background vector BGmean 
is using same indexe numbering as hit data 
 
# Calculate Mreads for each datatable 
for (i in 1:nfiles){Mreads[i]=sum(dflist[[i]]$Watson+dflist[[i]]$Crick)/1000000} 
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####################################################################################################################### 
############ START HERE ONCE DATAFRAMES ARE LOADED ###################### 
####################################################################################################################### 
# New loop to plot multiple comparisions 
strains=c(1,7,12) # Plot these numbered dataframes from the dflist (MAXIMUM of FIVE!) 
quantiles=c(1:5) # Split the data up into this many fractions (Syntax is (1:5) or (1:10) etc) 
scalar.u=c(1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1) # Unique scaling factor for each strain in the dflist (default =1 is identical scaling) 
#scalar.u=1/Nfactor # Override unique caling factor and instead use apparnt non-background-read normalisation factor 
#ymin=c(0,145,0,0,0) 
#ymax=c(250,160,250,250,400) 
####################################################################################################################### 
# Send output to PDF: height of page scales with number of plots 
wd = getwd(); out = paste(wd,"/","Output_Files","/","TSSPileup_",Sys.time(),".pdf",sep=""); pdf(file=out, 
width=length(quantiles)*4,height=(length(strains)*3+3)); 
#Plotting: first set up how the plots are organised. How many panes per image for example using the layout command 
plotnumber=length(strains)*length(quantiles) # Number from 1 to 16 
#layout(matrix(c(1:(plotnumber+length(quantiles))),(length(strains)+1), length(quantiles), byrow = T)) 
layout(matrix(c(1:plotnumber,rep((plotnumber+1),length(quantiles))),(length(strains)+1), length(quantiles), byrow = T)) 
#if (plotnumber>0) {layout(matrix(c(1,2,1,2,3,3),3, 2, byrow = T))} 
#if (plotnumber>2) {layout(matrix(c(1,2,1,2,3,4,3,4,5,5), 5, 2, byrow = T))} 
#if (plotnumber>4) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,7),7, 2, byrow = T))} 
#if (plotnumber>6) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,8,7,8,9,9),9, 2, byrow = T))} 
#if (plotnumber>8) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,8,7,8,9,10,9,10,11,11),11, 2, byrow = T))} 
#if (plotnumber>10) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,8,7,8,9,10,9,10,11,12,11,12,13,13),13, 2, byrow = T))} 
#if (plotnumber>12) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,8,7,8,9,10,9,10,11,12,11,12,13,14,13,14,15,15),15, 2, byrow = T))} 
#if (plotnumber>14) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,8,7,8,9,10,9,10,11,12,11,12,13,14,13,14,15,16,15,16,17,17),17, 2, byrow = T))} 
par(mar=c(1,4,1,2),oma = c(1, 1, 1, 1),las=1) # Sets margins per graph and outside margins per grouped set (order is bottom, left, top, right) 
#layout.show((plotnumber+length(quantiles))) 
 
####################################################################################################################### 
# MODULE for pulling out specific locus of interest 
genes=DUB #First make a copy of the ALLElements table 
genes=subset(genes, type=="gene" & genename!="Dubious_ORF") #ONly look at genes and exlcude dubious orfs 
genes=genes[order(genes$RNAseq_Brar_00_EXP),] ## Order datatable by relevant Brar expression column 
genesW=subset(genes, orientation=="+") # genesW = Watson strand genes 
genesC=subset(genes, orientation=="-") # genesC = Crick strand genes 
 
############################################## Start of Strain Loop ############################################ 
for (k in strains) { #step through sequentially each dataframe/strain 
  width1=1000 # bp upstream and downstream of TSS to retrieve 
  padding=500 
  width=width1+padding 
 
  ############################################## Start of Quantile Loop ############################################ 
  quantE=nrow(genes)/max(quantiles) # calculate the range of each quantile 
  quantE1=c(1,quantiles*quantE) 
  for (kk in quantiles){ 
    genesQ=genes[quantE1[kk]:quantE1[kk+1],] #subset DUB table by expression quantile 
    genesW=subset(genesQ, orientation=="+") 
    genesC=subset(genesQ, orientation=="-") 
    kkTotal=sum(genesQ$RNAseq_Brar_00_EXP) # Add up all the expression data for this quartile and store in variable - will be added to plot. 
 
    #Zero out TSS dataframe - ONLY DO THIS FOR EACH STRAIN! - This must be outside of chromosome loop! 
    TSS=data.frame(NULL) 
    TSS[1:((width*2)+1),"Pos"]=(1:((2*width)+1)) 
    TSS$WatsonW=0 # Watson genes watson hits 
    TSS$CrickW=0 # Watson genes crick hits 
    TSS$WatsonC=0 # Crick genes watson hits 
    TSS$CrickC=0 # Crick genes crick hits 
 
    temp=NULL 
    chroms=c(1:16) # Or just a single chromosome. 
 
    ############################################## Start of Chromosome Loop ############################################ 
    for (chrom in chroms) { #Specify which chromosomes to process 
      df.1=subset(dflist[[k]],Chr==chrom) # Make copy of the datatable 
 
      genesW1=subset(genesW, chr==chrom) #Subset for Watson genes 
      genesC1=subset(genesC, chr==chrom) #Subset for Crick genes 
 
      #Watson genes 
      for (i in 1:nrow(genesW1)) { 
        temp=subset(df.1[2:4], Pos>=(genesW1[i,"start"]-width) & Pos<=(genesW1[i,"start"]+width)) # Create temp matrix with DSB hits in this 
region 
        temp$Pos=temp$Pos-genesW1[i,"start"]+width+1 
        TSS[temp$Pos,"WatsonW"]=TSS[temp$Pos,"WatsonW"]+temp[,"Watson"] 
        TSS[temp$Pos,"CrickW"]=TSS[temp$Pos,"CrickW"]+temp[,"Crick"] 
      } 
      #Crick genes 
      for (i in 1:nrow(genesC1)) { #NOTE: TSS is at the stop location in the table 
        temp=subset(df.1[2:4], Pos>=(genesC1[i,"stop"]-width) & Pos<=(genesC1[i,"stop"]+width)) # Create temp matrix with DSB hits in this region 
        temp$Pos=temp$Pos-genesC1[i,"stop"]+width+1 
        TSS[temp$Pos,"WatsonC"]=TSS[temp$Pos,"WatsonC"]+temp[,"Watson"] 
        TSS[temp$Pos,"CrickC"]=TSS[temp$Pos,"CrickC"]+temp[,"Crick"] 
      } 
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    } # Repeat for each chromosome 
 
    # This section combines the Watson and Crick hits, reversing the order of the crick gene hits and adding the Watsons to the Crick hits and Crick to 
Watsons 
    # (i.e. reverse complements the data for the Crick genes). 
    # This allows both to be combined in the plot 
    TSS$revWc=rev(TSS$WatsonC) #Crick genes with Watson hits 
    TSS$revCc=rev(TSS$CrickC) #Crick genes with Crick hits 
    TSS$WatsonTotal=TSS$WatsonW+TSS$revCc # Add WatsonW hits to reversed CrickC hits 
    TSS$CrickTotal=TSS$CrickW+TSS$revWc # Add CrickW hits to reversed WatsonC hits 
    TSS$WCTotal=(TSS$WatsonTotal+TSS$CrickTotal)/2 #Create total column and halve it 
 
    
####################################################################################################################### 
    # Smoothing function #### temp and smooth are just two temporary vectors 
    win=151 # hanning window size 
    scalar=.1 
    sae2scalar=scalar.u[k]*scalar # adjust this if needed when adjusting hann window smoothing 
    hw=hanning.window(win) #create hanning window (require package e1071 to be loaded) 
 
    temp=NULL 
    for (j in 8:10){ #Smooth columns 8 to 10 in the TSS table 
      temp=c(rep(0,win),TSS[1:nrow(TSS),j], rep(0,win)) # Create vector length of chromosome and extend by the length of the slidign window with 
zeros at both ends 
      smooth=filter(temp,hw) # smooth the temp vector using the hann window 
      smooth=smooth[(win+1):(length(smooth)-win)] # trim smooth to correct length 
      TSS[j+3]=smooth 
    } 
    colnames(TSS)=c("Pos", "WatsonW", "CrickW", "WatsonC", "CrickC", "revWc", "revCc", "WatsonTotal", "CrickTotal", "WCTotal", 
"WatsonTotalS", "CrickTotalS","WCTotalS") 
    TSS=TSS[padding:(padding+width1+width1),] 
    #Unsmoothed data: 
    #plot(TSS$Pos-width, TSS$WCTotal*sae2scalar/Mreads[k], type="l", ylab=dflistNames[k], xlim=c(-width1,width1)) 
    #lines(TSS$Pos-width, TSS$WatsonTotal*sae2scalar/Mreads[k], type="l", ylab=dflistNames[k], col="red") 
    #lines(TSS$Pos-width, TSS$CrickTotal*sae2scalar/Mreads[k], type="l", ylab=dflistNames[k], col="blue") 
    #Smoothed data: 
    plot(TSS$Pos-width, TSS$WCTotalS*sae2scalar/Mreads[k], type="l", ylab=c(dflistNames[k],paste("Quantile=",kk,"of",length(quantiles),"/ 
Total=",kkTotal))) 
    lines(TSS$Pos-width, TSS$WatsonTotalS*sae2scalar/Mreads[k], type="l", col="red") 
    lines(TSS$Pos-width, TSS$CrickTotalS*sae2scalar/Mreads[k], type="l", col="blue") 
 
    
####################################################################################################################### 
 
  } # quantile loop 
} # Strain loop 
plot(TSS$Pos-width, TSS$WCTotal, xaxt="n",yaxt="n", type="n", ylab="", ylim=c(-100,120), axes=F) 
text(0,0, font=3, labels=paste("Chromosome",toString(chroms), "/ Hann", win, "/ Y-Scalar",scalar,"/ Quantiles are : RNAseq_Brar_00_EXP")) 
 
dev.off() 
10.10  Spo11ExtractDC.pl (created by Tim Cooper) 
#!/usr/bin/env perl 
#Version: 1.5 
 
################################################################################################################## 
# Author(s): T.J.Cooper 
# Updated: 13/9/2016 
# Processes paired-end .SAM files, extracting Watson + Crick coordinate information for double-cut Spo11 libraries 
# Quality-control and filtering (atypical read-orientation, dubious ends) 
# Two-step alignment (unmapped mate read-trimming, --local alignment) 
# Calculates inter-event distances (between double-cut DSBs) and tallies instances of specific double-cuts 
################################################################################################################## 
 
use strict; 
use warnings; 
use Cwd; 
use List::Util qw(first); 
my $outext = '.txt'; #Output .file-extension 
my $inext = $ARGV[0]; #Input .file-extension 
my @files = glob("*$inext"); 
my $chk = scalar(@files); 
print "\nFailed to detect any .SAM files within the current directory.\n\n" if $chk == 0; 
exit if $chk == 0; #Stop script if no .SAM files are found 
my $sub = cwd()."/Coordinates"; 
mkdir("$sub") unless $chk == 0; 
my $sub2 = cwd()."/Analysis"; 
mkdir("$sub2") unless $chk == 0; 
my $trimmode = $ARGV[1]; 
my $trimlength = $ARGV[2]; 
print "-------------------------------------"; 
print "\nCalculating Coordinates....\n"; 
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print "-------------------------------------\n"; 
print "Currently processing:\n"; 
for my $file (@files) {   #For-each input file 
 open my $IN, '<', $file or die "$!"; #Open and read input .SAM file(s) 
 (my $strain = $file) =~ s/_[^_]+$//; #Strain-name 
 (my $mode = $ARGV[0]) =~ s/\.SAM//;  #Alignment-mode 
 print "$strain\n"; 
 my $outfile = $strain."_".$mode.$outext; #Output files 
 my $outfile2 = $strain."_Ambiguous".$outext; 
 my ($OUT, $OUT2, $OUT3, $OUT4); 
 open $OUT, '>', "$sub/$outfile" or die "$!"; 
 open $OUT2, '>>', "$sub/$outfile2" or die "$!"; 
 print $OUT "PairID\tStrand\tChr\tPos\tReadLength\tCIGAR\tAdjustment\n"; 
 if ($inext eq "Global.SAM" && $trimmode eq "Y") { 
  print $OUT2 "Strand\tChr\tPos\tReadLength\tCIGAR\tAdjustment\tMD-Tag\n"; 
  my $outfile3 = $strain.$ARGV[3]."_unmapped_trimmed.fastq"; #Unmapped R1 FASTQ file 
  my $outfile4 = $strain.$ARGV[4]."_unmapped_trimmed.fastq"; #Unmapped R2 FASTQ file 
  open $OUT3, '>', "$outfile3" or die "$!"; 
  open $OUT4, '>', "$outfile4" or die "$!"; 
 } 
 my ($ID,$A,$B,$R1var,$R2var); 
 while (<$IN>) { #For-each .SAM record 
  chomp $_; 
  next if /^\s*@/; #Skip .SAM headerlines 
  my @F = split("\t", $_); #Split each tab-delimited field 
  my $orientation = $F[3]-$F[7]; #Discard atypical read-orientations 
  if ($F[1] == 99 && $orientation > 0 || $F[1] == 83 && $orientation < 0) { 
   my $skipline = <$IN>; 
   next; 
  } 
  if ($inext eq "Global.SAM" && $trimmode eq "Y") { #Populate unmapped R1/R2 FASTQ files mapped-
unmapped pairs 
   if (grep {$_ == $F[1]} 73,137) { 
    print $OUT3 "\@$F[0] 1:N:0:1\n$F[9]\n+\n$F[10]\n" if $F[1] == 73; 
    print $OUT4 "\@$F[0] 1:N:0:1\n$F[9]\n+\n$F[10]\n" if $F[1] == 137; 
   } 
   if (grep {$_ == $F[1]} 89,153) { 
    $F[9] =~ tr/GATC/CTAG/; 
    my $revseq = reverse($F[9]); 
    my $revqual = reverse($F[10]); 
    print $OUT3 "\@$F[0] 1:N:0:1\n$revseq\n+\n$revqual\n" if $F[1] == 89; 
    print $OUT4 "\@$F[0] 1:N:0:1\n$revseq\n+\n$revqual\n" if $F[1] == 153; 
   } 
   if (grep {$_ == $F[1]} 69,133) { 
    my $trimseq = substr($F[9],0,$trimlength); 
    my $trimqual = substr($F[10],0,$trimlength); 
    print $OUT3 "\@$F[0] 1:N:0:1\n$trimseq\n+\n$trimqual\n" if $F[1] == 69; 
    print $OUT4 "\@$F[0] 1:N:0:1\n$trimseq\n+\n$trimqual\n" if $F[1] == 133; 
   } 
  } 
  sub parseSAM {  #Subroutine to interpret SAM-field data 
   my @rcd = @_; 
   my @read; 
   my $index = first{/MD:Z/} @rcd; #Obtain variable-column MD:Z tag 
   my @MDtag = $index =~ /\d+/g;  #Remove non-numeric characters 
   my %rules = (M => 1,D => 1,I => 0,S => 1); #Rules to handle insertion/deletions/matches/soft-clipping 
   my ($s,$LS,$RS) = (0)x3; 
   while ($rcd[5] =~ /(\d+)([MDIS])/g) {  #Parse and interpret CIGAR code 
    my ($n,$op)  = ($1,$2); 
    $s += $n * $rules{$op} unless $op eq 'S';  #Calculate POS adjustment 
(insertions/deletions) 
    $LS += $n * $rules{$op} if $op eq 'S' && $-[0]==0;  #(upstream soft-clip) 
    $RS += $n * $rules{$op} if $op eq 'S' && $+[0]==length($rcd[5]);  #(downstream soft-
clip) 
   } 
   my $l = length($rcd[9]); #Read-length 
   my $wp = $rcd[3]-$LS;  #Adjusted 5' coordinate (Watson strand) 
   my $cp = $rcd[3]+($RS+$s)-1;  #Adjusted 5' coordinate (Crick strand) 
   push(@read, $rcd[2],$wp,$cp,$l,$rcd[5],$s,$LS,$RS,$index); 
   return(\@read, \@MDtag); 
  } 
  if (grep {$_ == $F[1]} 99,83) { #For 99/147 or 83/163 read-pairs 
   my $partner = <$IN>; 
   my @F2 = split("\t", $partner); #Split each tab-delimited field 
   if ($F[1] == 99) { 
    ($A, $R1var) = parseSAM(@F); ($B, $R2var) = parseSAM(@F2); 
   } else { 
    ($A, $R1var) = parseSAM(@F2); ($B, $R2var) = parseSAM(@F); 
   } 
   my @revMDtag = reverse(@{$R2var}); 
   my @Wat = @{$A}; my @Cri = @{$B}; 
   my ($chr, $pos, $rl, $cigar, $Lclip, $vtag) = @Wat[0,1,3,4,6,8]; 
   my ($chrp, $posp, $rlp, $cigarp, $cc, $Rclip, $vtagp) = @Cri[0,2,3,4,5,7,8]; 
   if ($R1var->[0] == 0 && $R1var->[1] == 0 && $pos > 0 || $revMDtag[0] == 0 && $revMDtag[1] == 0 && 
$pos > 0 || $Lclip > 1 && $pos > 0 || $Rclip > 1 && $pos > 0) { #Detect ambigious ends (99/147 or 83/163 pairs) 
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    printf($OUT2 "%s\t%d\t%d\t%d\t%s\t%d\t%s\n%s\t%d\t%d\t%d\t%s\t%d\t%s\n", 
"w",$chr,$pos,$rl,$cigar,0-$Lclip,$vtag,"c",$chrp,$posp,$rlp,$cigarp,$Rclip+$cc-1,$vtagp); 
   } else { 
    $ID++; 
    printf($OUT "%d\t%s\t%d\t%d\t%d\t%s\t%d\n%d\t%s\t%d\t%d\t%d\t%s\t%d\n", 
$ID,"w",$chr,$pos,$rl,$cigar,0-$Lclip,$ID,"c",$chrp,$posp,$rlp,$cigarp,$Rclip+$cc-1); 
   } 
  } 
 } 
 close $IN; 
 close $OUT; 
 close $OUT2; 
 if ($ARGV[0] eq "Global.SAM") { 
  open my $IN2, '<', "$sub/$outfile" or die "$!"; 
  my $outfile5 = $file."_Distances".$outext; 
  my $outfile6 = $file."_DoubleCuts".$outext; 
  open my $OUT5, '>', "$sub2/$outfile5" or die "$!"; 
  open my $OUT6, '>', "$sub2/$outfile6" or die "$!"; 
  <$IN2> for (1..1); 
  my (%IED, %DoubleCut); 
  while (<$IN2>) { 
   chomp $_; 
   next if eof; 
   my @F2 = split("\t", $_); #Split each tab-delimited field 
   my $partner = <$IN2>; 
   chomp $partner; 
   my @F3 = split("\t", $partner); #Split each tab-delimited field 
   $IED{(abs($F2[3]-$F3[3])+1)}++; #Calculates and tallies IEDs 
   ($F2[3], $F3[3]) = ($F3[3], $F2[3]) if $F2[3] > $F3[3]; 
   $DoubleCut{$F2[2]}{$F2[3]}{$F3[3]}++; #Tallies double-cut molecules 
  } 
  print $OUT5 "IED\tFreq\n"; 
  print $OUT6 "Chr\tCoord-A\tCoord-B\tFreq\n"; 
  foreach my $key (sort {$a <=> $b} keys %IED) { 
   print $OUT5 "$key\t$IED{$key}\n"; 
  } 
  foreach my $chr (sort {$a <=> $b} keys %DoubleCut) { 
   foreach my $coord1 (sort {$a <=> $b} keys %{$DoubleCut{$chr}}) { 
    foreach my $coord2 (sort {$a <=> $b} keys %{$DoubleCut{$chr}{$coord1}}) { 
     print $OUT6 "$chr\t$coord1\t$coord2\t$DoubleCut{$chr}{$coord1}{$coord2}\n" 
    } 
   } 
  } 
 } 
} 
my $run_time = time() - $^T; 
print "-------------------------------------"; 
print "\nRun Completed\n"; 
print "Processing Runtime: $run_time Seconds\n"; 
print "-------------------------------------\n\n"; 
10.11 Topo mapping v01 mc.R (created by Matt Neale) 
setwd("~/Dropbox/Documents/Work Docs/People/Holly Thomas/Top2/Top2_R_scripts") 
 
####################################################################################################################### 
require("e1071") # This pacakge permits smoothing functions (used later) 
require(stringr) 
options(scipen=999) #Suppresses scientific notation appearing in plots/graphs etc 
require(doParallel) 
require(plyr) 
####################################################################################################################### 
# Import histogram FullMap files for each strain in working directory and tally up the total number of Million mapped reads 
Mreads=NULL; dflist=list() 
library(doParallel) 
cl <- makeCluster(8) 
registerDoParallel(cl) 
files=c("FullMap.sae2.S288C_MJ475_1U_SAE2_c.txt", 
        "FullMap.sae2.S288C_MJ475_1E_SAE2_c.txt", 
        "FullMap.sae2.S288C_MJ551_1U_MRE11_c.txt", 
        "FullMap.sae2.S288C_MJ551_1E_MRE11_c.txt", 
        "FullMap.sae2.S288C_MJ319_1_c.txt") 
num=length(files) # Number of files to load 
 
s=foreach (k = 1:num) %dopar% { dflist[[k]] = read.table(files[k], sep = "\t", header=TRUE) } #Import datatable 
dflist=s 
stopCluster(cl) 
 
AllElementsDUB = read.table("AllElementsDUB.txt", sep = "\t", header=TRUE) #Import datatable 
for (i in 1:num){Mreads[i]=sum(dflist[[i]]$Watson+dflist[[i]]$Crick)/1000000} # Calculate Million reads per sample for conveting to HpM 
dflistNames=c("MJ475_1U_sae2D", 
              "MJ475_1E_sae2D", 
              "MJ551_1U_mre11D", 
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              "MJ551_1E_mre11D", 
              "MJ319_Y135F_1") 
 
BG = read.table("BGreads5.txt", sep = "\t", header=TRUE) #Import hotspot datatable 
BGmean=NULL; for (i in 1:num){BGmean[i]=unlist(subset(BG, Strain==dflistNames[i], MeanCore))} # Ensure that background vector BGmean is 
using same indexe numbering as hit data  
#BGmean=Mreads/12.01/Mreads*0.8 
Nfactor=(1-(BGmean*12.01)) # Normalisation factor: based on number of reads that appear NOT to be background 
Nfactor=Mreads #Supercede previous calculation and just plot everythign based on fraction of million reads per library 
Nfactor=BGmean 
 
####################################################################################################################### 
############ START HERE ONCE DATAFRAMES ARE LOADED ###################### 
####################################################################################################################### 
# MODULE for pulling out specific locus of interest 
orf="12" 
genes=AllElementsDUB #First make a copy of the ALLElements table 
upstream=500; downstream=000 # bp to extend by in either direction of ORF 
genes=subset(genes, genename==orf | sysname==orf) 
xl1=genes$start-upstream 
xl2=genes$stop+downstream 
chrom=genes$chr 
 
####################################################################################################################### 
# MODULEor manually specifiying chromosome and location 
chrom=12; xl1=460400; window.w=400; xl2=xl1+window.w; #Plot range minimum (bp); # Plot range width (bp); #Plot range maximum (bp) 
 
####################################################################################################################### 
# New loop to plot multiple comparisions 
strains=c(1:5) # Plot these numbered dataframes from the dflist 
scalar.u=c(1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1) # Unique scaling factor for each strain in the dflist (default =1 is identical scaling) 
scalar.u=1/Nfactor/Mreads # Override scaling factor and use apparent hit reads instead 
 
####################################################################################################################### 
#Plotting: first set up how the plots are organised. How many panes per image for example using the layout command 
plotnumber=length(strains) # Number from 1 to 5 
if (plotnumber==1) {layout(matrix(c(1,1,1,2,2),5, 1, byrow = T))} 
if (plotnumber==2) {layout(matrix(c(1,1,1,2,2,2,3,3), 8, 1, byrow = T))} 
if (plotnumber==3) {layout(matrix(c(1,1,1,2,2,2,3,3,3,4,4),11, 1, byrow = T))} 
if (plotnumber==4) {layout(matrix(c(1,1,1,2,2,2,3,3,3,4,4,4,5,5),14, 1, byrow = T))} 
if (plotnumber==5) {layout(matrix(c(1,1,1,2,2,2,3,3,3,4,4,4,5,5,5,6,6),17, 1, byrow = T))} 
 
par(mar=c(1,5,1,0),oma = c(0, 1, 1, 1),las=1) # Sets margins per graph and outside margins per grouped set (order is bottom, left, top, right) 
layout.show((length(strains)+1)) 
 
for (k in strains){ #step through sequentially each dataframe/strain 
   
#Subset for region of interest 
sae2.0=subset(dflist[[k]], Chr==chrom & Pos>=xl1 & Pos <=xl2) #Make a sub-table of the sae2-DSB data that only contains those rows where chr = 
1 in range of interest 
 
####################################################################################################################### 
#Decompression code here 
sae2.1 <- data.frame(Chr=chrom, Pos=(xl1:xl2)) # Creates expanded empty dataframe with Chr and Pos locations 
sae2.1 <- merge(sae2.1,sae2.0, all=TRUE) # Merge expanded empty dataframe with compressed sae2.1 dataframe 
sae2.1[is.na(sae2.1)] <- 0 # Convert all NA values to zero 
sae2.1$Total=sae2.1$Watson+sae2.1$Crick 
 
####################################################################################################################### 
# Smoothing function #### temp and smooth are just two temporary vectors. New version creates two smoothed plots for each profile for overlaying 
masterscalar=.2 
win=1 # hanning window size [1] 
win2=1 # hanning window size [2] for overlay 
scalar=1*masterscalar #scalar [1] 
scalar2=.25*masterscalar # scalar [2] for overlay 
sae2scalar=scalar.u[k]*scalar # adjust this if needed when adjusting hann window smoothing 
sae2scalar2=scalar.u[k]*scalar2 # adjust this if needed when adjusting hann window smoothing 
hw=hanning.window(win) #create hanning window (require package e1071 to be loaded) 
hw2=hanning.window(win2) #create hanning window (require package e1071 to be loaded) 
 
####################################################################################################################### 
temp=NULL 
for (j in 3:5){ 
temp=c(rep(0,win),sae2.1[1:nrow(sae2.1),j], rep(0,win)) # Create vector length of chromosome and extend by the length of the slidign window with 
zeros at both ends 
smooth=filter(temp,hw) # smooth the temp vector using the hann window 
smooth=smooth[(win+1):(length(smooth)-win)] # trim smooth to correct lengthsmooth2=smooth2[(win2+1):(length(smooth2)-win2)] # trim smooth 
to correct length 
sae2.1[j+3]=smooth 
} 
temp2=NULL 
for (j in 3:5){ 
  temp2=c(rep(0,win2),sae2.1[1:nrow(sae2.1),j], rep(0,win2)) # Create vector length of chromosome and extend by the length of the slidign window 
with zeros at both ends 
  smooth2=filter(temp2,hw2) # smooth the temp vector using the hann window 
  smooth2=smooth2[(win2+1):(length(smooth2)-win2)] # trim smooth to correct length 
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  sae2.1[j+6]=smooth2 
} 
 
colnames(sae2.1)=c("Chr", "Pos", "Watson", "Crick", "Total", "watson.s", "crick.s", "total.s","watson.s2", "crick.s2", "total.s2") 
 
####################################################################################################################### 
# Plot boundaries: 
plot(sae2.1$Pos,sae2.1$total.s/Mreads[k], type="n", xlim=c(xl1,xl2), ylim=c(-160,100), ylab=paste(c(dflistNames[k]," / Scalar 
",round(scalar.u[k],digits=2)), collapse="")) #plot the start histogram 
# Broad Overlays: 
#lines(sae2.1$Pos,sae2.1$watson.s2*sae2scalar2/Mreads[k], type="h", xlim=c(xl1,xl2), col="lightcoral") #plot the start histogram 
#lines(sae2.1$Pos,-sae2.1$crick.s2*sae2scalar2/Mreads[k], type="h", xlim=c(xl1,xl2), col="lightblue") #plot the start histogram 
#lines(sae2.1$Pos,0.5*sae2.1$total.s2*sae2scalar2/Mreads[k]-150, type="l", xlim=c(xl1,xl2), col="grey") #plot the start histogram 
#hi-res smoothed data: 
lines(sae2.1$Pos,sae2.1$watson.s*sae2scalar/Mreads[k], type="h", xlim=c(xl1,xl2), col="red") #plot the start histogram 
lines(sae2.1$Pos,-sae2.1$crick.s*sae2scalar/Mreads[k], type="h", xlim=c(xl1,xl2), col="blue") #plot the start histogram 
lines(sae2.1$Pos,0.5*sae2.1$total.s*sae2scalar/Mreads[k]-150, type="l", xlim=c(xl1,xl2), col="grey") #plot the start histogram 
# overlay of smoothed W/C ratio : 
#lines(sae2.1$Pos,100*log2((sae2.1$watson.s2*sae2scalar2/Mreads[k])/(sae2.1$crick.s2*sae2scalar2/Mreads[k])), type="l", xlim=c(xl1,xl2), 
col="black") #plot the ratio 
} 
####################################################################################################################### 
#Now plot the gene datatrack 
#First subset the relevant data 
genes=AllElementsDUB #First make a copy of the ALLElements table 
genes=subset(genes,chr==chrom & start>(xl1-10000) & stop<(xl2+10000)) #Make a sub-table of ALLElements where chr = 1 and has limits just 
beyond plot range 
genes=subset(genes,type==!"CDS") #Make a sub-table of ALLElements ********* Hash out if you want to plot all elements! ******** 
genes=subset(genes,type=="rRNA_gene") #Make a sub-table of ALLElements ********* Hash out if you want to plot all elements! ******** 
#genes=subset(genes,type=="gene") #Make a sub-table of ALLElements ********* Hash out if you want to plot all elements! ******** 
#Now perform the plot 
plot(sae2.1$range,sae2.1$filtered, xaxt="n",yaxt="n",type="n", ylab=paste("Genes"),cex.lab=1.5,font=2, xlim=c(xl1,xl2), ylim=c(-100,120),axes=F) 
#set up empty plot 
text((xl1+xl2)/2,-80, labels=paste("Chromosome",chrom, "/",orf,"/ Range",xl1,"to",xl2,"bp / Hann", win, "/ Y-Scalar",scalar), cex.lab=1.4) 
####################################################################################################################### 
########### STOP HERE IF YOU ARE PLOTTING WHOLE CHROMOSOMES!!! ############# 
####################################################################################################################### 
# Following module draws arrows for each element 
xrange=xl2-xl1 
ahead=xrange/25 #make arrowhead length proportional to plot range 
ahead[(ahead>500)]=500 #limit max length to 500 
av=75 #arrow vertical location relative to plot dimensions 
ahw=15 #arrow/head width 
genesW=subset(genes,genename !="Dubious_ORF" & orientation =="+") #Make a sub-table of ALLElements 
for (i in 1:nrow(genesW)){ 
   polygon(c(genesW[i,"start"], genesW[i,"stop"]-ahead, genesW[i,"stop"]-ahead,genesW[i,"stop"], genesW[i,"stop"]-ahead, genesW[i,"stop"]-ahead, 
genesW[i,"start"]),c(av+ahw,av+ahw,av+ahw+ahw,av,av-ahw-ahw,av-ahw, av-ahw), col="wheat", border="wheat4") 
  text((genesW[i,"start"]+genesW[i,"stop"])/2,av, font=3, genesW[i,"genename"], cex=0.9) } 
genesW=subset(genes,genename=="Dubious_ORF" & orientation =="+") #Make a sub-table of ALLElements 
for (i in 1:nrow(genesW)){ 
  polygon(c(genesW[i,"start"], genesW[i,"stop"]-ahead, genesW[i,"stop"]-ahead,genesW[i,"stop"], genesW[i,"stop"]-ahead, genesW[i,"stop"]-ahead, 
genesW[i,"start"]),c(av+ahw,av+ahw,av+ahw+ahw,av,av-ahw-ahw,av-ahw, av-ahw), col="wheat", border="wheat4", lty=2) 
  text((genesW[i,"start"]+genesW[i,"stop"])/2,av, font=3, genesW[i,"sysname"], cex=0.9) } 
 
av=25 #arrow vertical location for Crick genes relative to plot dimensions 
genesC=subset(genes,genename !="Dubious_ORF" & orientation =="-") #Make a sub-table of ALLElements 
for (i in 1:nrow(genesC)){ 
  polygon(c(genesC[i,"stop"], genesC[i,"start"]+ahead, genesC[i,"start"]+ahead,genesC[i,"start"], genesC[i,"start"]+ahead, genesC[i,"start"]+ahead, 
genesC[i,"stop"]),c(av+ahw,av+ahw,av+ahw+ahw,av,av-ahw-ahw,av-ahw, av-ahw), col="thistle", border ="thistle4") 
  text((genesC[i,"start"]+genesC[i,"stop"])/2,av, font=3, genesC[i,"genename"], cex=0.9) } 
genesC=subset(genes,genename=="Dubious_ORF" & orientation =="-") #Make a sub-table of ALLElements 
for (i in 1:nrow(genesC)){ 
  polygon(c(genesC[i,"stop"], genesC[i,"start"]+ahead, genesC[i,"start"]+ahead,genesC[i,"start"], genesC[i,"start"]+ahead, genesC[i,"start"]+ahead, 
genesC[i,"stop"]),c(av+ahw,av+ahw,av+ahw+ahw,av,av-ahw-ahw,av-ahw, av-ahw), col="thistle", border ="thistle4", lty=2) 
  text((genesC[i,"start"]+genesC[i,"stop"])/2,av, font=3, genesC[i,"sysname"], cex=0.9) } 
10.12  Pileups around TSS Topo stratify by transcription v02.R (created by Matt 
Neale) 
# Load secondary datasets: 
setwd("~/Dropbox/Documents/Work Docs/Research/Lab Notebooks/Computer scripting/R scripts/R datasets/Cer3") 
 
DUB = read.table("AllElementsDUB_Brar_2016.08.16.txt", sep = "\t", header=TRUE) #Import datatable 
#Pan = read.table("Pan.Hotspots.IGR.SacCer3_H4L2_2016.08.10a.txt", sep = "\t", header=TRUE) #Import hotspot datatable 
 
#names(Pan) <- c("Chr","Start","End","Length","PanHits","Feature_name","Name","Midpoint", "Type","Direction","IGR","IGR.start","IGR.end") 
#Pan <- Pan[c("Chr","Start","End","Length","Midpoint","PanHits","Feature_name","Name","Type","Direction","IGR","IGR.start","IGR.end")] # 
reorder 
 
 
####################################################################################################################### 
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# YOU MUST CHANGE TO WORKING DIRECTORY CONTAINING THE INPUT DATA MAPS 
# Use a temporary directory that just contains COPIES of the files of interest: 
setwd("~/Dropbox/Aligned Files/Top2 NEW/Temp") 
 
####################################################################################################################### 
require("e1071") # This pacakge permits smoothing functions (used later) 
require(stringr) 
options(scipen=999) #Suppresses scientific notation appearing in plots/graphs etc 
require(doParallel) 
library(doParallel) 
require(plyr) 
####################################################################################################################### 
# Import histogram FullMap files for each strain in working directory and tally up the total number of Million mapped reads 
Mreads=NULL; dflist=list();dflistNames=NULL 
 
#Read in all tables with string "Full.Map." 
files = list.files(pattern="FullMap.Cer3") # import files names with "FullMap.Cer32" string into variable "files"  
dflistNames = substr(files, 9, nchar(files)-6) # Shorten filename by 8 characters from beginning and 6 characters form end (i.e. remove "FullMap." 
and "_c.txt") 
nfiles = length(files) # Count number of files 
 
cl <- makeCluster(8) 
registerDoParallel(cl) 
 
dflist=foreach (k = 1:nfiles) %dopar% { dflist[[k]] = read.table(files[k], sep = "\t", header=TRUE) } #Import datatable 
stopCluster(cl) 
 
####################################################################################################################### 
 
BG = read.table("BGreadsTopo1.txt", sep = "\t", header=TRUE) #Import background datatable 
BGmean=NULL; for (i in 1:nfiles){BGmean[i]=unlist(subset(BG, Strain==dflistNames[i], MeanCore))} # Ensure that background vector BGmean 
is using same indexe numbering as hit data  
 
# Calculate Mreads for each datatable 
for (i in 1:nfiles){Mreads[i]=sum(dflist[[i]]$Watson+dflist[[i]]$Crick)/1000000}  
 
####################################################################################################################### 
############ START HERE ONCE DATAFRAMES ARE LOADED ###################### 
####################################################################################################################### 
# Send output to PDF: 
wd = getwd(); out = paste(wd,"/","Output_Files","/","TSSPileup_",Sys.time(),".pdf",sep=""); pdf(file=out, width=16,height=16); 
 
# New loop to plot multiple comparisions 
strains=c(1,2,3,4,5,6) # Plot these numbered dataframes from the dflist (MAXIMUM of SIX!) 
scalar.u=c(1,1,1,1,1,1) # Unique scaling factor for each strain in the dflist (default =1 is identical scaling) 
#scalar.u=1/Nfactor # Override unique caling factor and instead use apparnt non-background-read normalisation factor 
#ymin=c(0,145,0,0,0) 
#ymax=c(250,160,250,250,400) 
####################################################################################################################### 
#Plotting: first set up how the plots are organised. How many panes per image for example using the layout command 
plotnumber=length(strains) # Number from 1 to 5 
if (plotnumber==1) {layout(matrix(c(1,2,1,2,3,3),3, 2, byrow = T))} 
if (plotnumber==2) {layout(matrix(c(1,2,1,2,3,4,3,4,5,5), 5, 2, byrow = T))} 
if (plotnumber==3) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,7),7, 2, byrow = T))} 
if (plotnumber==4) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,8,7,8,9,9),9, 2, byrow = T))} 
if (plotnumber==5) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,8,7,8,9,10,9,10,11,11),11, 2, byrow = T))} 
if (plotnumber==6) {layout(matrix(c(1,2,1,2,3,4,3,4,5,6,5,6,7,8,7,8,9,10,9,10,11,12,11,12,13,13),13, 2, byrow = T))} 
par(mar=c(1,4,1,2),oma = c(1, 1, 1, 1),las=1) # Sets margins per graph and outside margins per grouped set (order is bottom, left, top, right) 
#layout.show((length(strains)*2)+1) 
 
####################################################################################################################### 
# MODULE for pulling out specific locus of interest 
genes=DUB #First make a copy of the ALLElements table 
genes=subset(genes, type=="gene" & genename!="Dubious_ORF") 
genesW=subset(genes, orientation=="+") 
genesC=subset(genes, orientation=="-") 
####################################################################################################################### 
k=1 
for (k in strains) { #step through sequentially each dataframe/strain 
temp=NULL 
chroms=c(1:16) 
#chroms=c(1:2,4:16) # Specify the chromosomes you want to plot 
#chroms=c(2) # Or just a single chromosome. Hash this line out if you want to plot all of them specified above. 
 
width1=1000 # bp upstream and downstream of TSS to retrieve 
padding=500 
width=width1+padding 
 
#Initialise TSS dataframe 
TSS=data.frame(NULL) 
TSS[1:((width*2)+1),"Pos"]=(1:((2*width)+1)) 
TSS$WatsonW=0 # Watson genes watson hits 
TSS$CrickW=0 # Watson genes crick hits 
TSS$WatsonC=0 # Crick genes watson hits 
TSS$CrickC=0 # Crick genes crick hits 
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#### Start of Chromosome loop 
for (chrom in chroms) { #Specify which chromosomes to process 
df.1=subset(dflist[[k]],Chr==chrom) # Make copy of the datatable 
#sae2.1=sae2.0 #Second copy (no longer any need to decompress datatables) 
#sae2.1$Total=sae2.1$Watson+sae2.1$Crick 
 
temp=NULL 
 
genesW1=subset(genesW, chr==chrom) #Subset for Watson genes 
genesC1=subset(genesC, chr==chrom) #Subset for Crick genes 
 
# The following lines superced the preceding ones in order to first subtract a mean level of background from the zeroed out array based on number of 
genes to be piled-up and BGmean 
#TSS1500[1:((width1*2)+1),"WatsonW"]=0-(BGmean[k]/2*nrow(genesW1)) #TSS1500[1:((width1*2)+1),"CrickW"]=0-
(BGmean[k]/2*nrow(genesW1)) #TSS1500[1:((width1*2)+1),"TotalW"]=0-(BGmean[k]*nrow(genesW1)) 
#i=1 
 
for (i in 1:nrow(genesW1)) { 
    temp=subset(df.1[2:4], Pos>=(genesW1[i,"start"]-width) & Pos<=(genesW1[i,"start"]+width)) # Create temp matrix with DSB hits in this region 
    temp$Pos=temp$Pos-genesW1[i,"start"]+width+1 
    TSS[temp$Pos,"WatsonW"]=TSS[temp$Pos,"WatsonW"]+temp[,"Watson"] 
    TSS[temp$Pos,"CrickW"]=TSS[temp$Pos,"CrickW"]+temp[,"Crick"] 
} 
for (i in 1:nrow(genesC1)) { #NOTE: TSS is at the stop location in the table 
  temp=subset(df.1[2:4], Pos>=(genesC1[i,"stop"]-width) & Pos<=(genesC1[i,"stop"]+width)) # Create temp matrix with DSB hits in this region 
  temp$Pos=temp$Pos-genesC1[i,"stop"]+width+1 
  TSS[temp$Pos,"WatsonC"]=TSS[temp$Pos,"WatsonC"]+temp[,"Watson"] 
  TSS[temp$Pos,"CrickC"]=TSS[temp$Pos,"CrickC"]+temp[,"Crick"] 
} 
 
} # Repeat for each chromosome 
 
# This section combines the Watson and Crick hits, reversing the order of the crick gene hits and adding the Watsons to the Crick hits and Crick to 
Watsons (i.e. reverse complements the data for the Crick genes). 
# This allows both to be combined in the plot 
TSS$revWc=rev(TSS$WatsonC) #Crick genes with Watson hits 
TSS$revCc=rev(TSS$CrickC) #Crick genes with Crick hits 
TSS$WatsonTotal=TSS$WatsonW+TSS$revWc 
TSS$CrickTotal=TSS$CrickW+TSS$revCc 
TSS$WCTotal=(TSS$WatsonTotal+TSS$CrickTotal)/2 #Create total column and halve it 
 
####################################################################################################################### 
# Smoothing function #### temp and smooth are just two temporary vectors 
win=151 # hanning window size 
scalar=.1 
sae2scalar=scalar.u[k]*scalar # adjust this if needed when adjusting hann window smoothing 
hw=hanning.window(win) #create hanning window (require package e1071 to be loaded) 
 
temp=NULL 
for (j in 8:10){ #Smooth columns 8 to 10 in the TSS table 
  temp=c(rep(0,win),TSS[1:nrow(TSS),j], rep(0,win)) # Create vector length of chromosome and extend by the length of the slidign window with 
zeros at both ends 
  smooth=filter(temp,hw) # smooth the temp vector using the hann window 
  smooth=smooth[(win+1):(length(smooth)-win)] # trim smooth to correct length 
  TSS[j+3]=smooth 
} 
colnames(TSS)=c("Pos", "WatsonW", "CrickW", "WatsonC", "CrickC", "revWc", "revCc", "WatsonTotal", "CrickTotal", "WCTotal", 
"WatsonTotalS", "CrickTotalS","WCTotalS") 
TSS=TSS[padding:(padding+width1+width1),] 
#Unsmoothed data: 
#plot(TSS$Pos-width, TSS$WCTotal*sae2scalar/Mreads[k], type="l", ylab=dflistNames[k], xlim=c(-width1,width1)) 
#lines(TSS$Pos-width, TSS$WatsonTotal*sae2scalar/Mreads[k], type="l", ylab=dflistNames[k], col="red") 
#lines(TSS$Pos-width, TSS$CrickTotal*sae2scalar/Mreads[k], type="l", ylab=dflistNames[k], col="blue") 
#Smoothed data: 
plot(TSS$Pos-width, TSS$WCTotalS*sae2scalar/Mreads[k], type="l", ylab=dflistNames[k], ylim=c(1200,2700)) 
lines(TSS$Pos-width, TSS$WatsonTotalS*sae2scalar/Mreads[k], type="l", ylab=dflistNames[k], col="red") 
lines(TSS$Pos-width, TSS$CrickTotalS*sae2scalar/Mreads[k], type="l", ylab=dflistNames[k], col="blue") 
 
####################################################################################################################### 
##TSS1500=subset(TSS1500, Pos>=padding & Pos <=(width*2)+padding) 
#plot(TSS1500$Pos-width1, TSS1500$TotalWS*sae2scalar/Mreads[k], type="l", ylab=dflistNames[k], ylim=c(ymin[k],ymax[k])) 
#lines(TSS1500$Pos-width1, TSS1500$WatsonWS*sae2scalar/Mreads[k]*2, type="l", ylab=dflistNames[k], col="red") 
#lines(TSS1500$Pos-width1, TSS1500$CrickWS*sae2scalar/Mreads[k]*2, type="l", ylab=dflistNames[k], col="blue") 
 
#plot(TSS1500$Pos-width1, TSS1500$TotalCS*sae2scalar/Mreads[k], type="l", ylab=paste(c("Watson", "\n", "Crick")), yaxt="n", 
ylim=c(ymin[k],ymax[k])) 
#axis(4) 
#lines(TSS1500$Pos-width1, TSS1500$WatsonCS*sae2scalar/Mreads[k]*2, type="l", ylab=dflistNames[k], col="red") 
#lines(TSS1500$Pos-width1, TSS1500$CrickCS*sae2scalar/Mreads[k]*2, type="l", ylab=dflistNames[k], col="blue") 
} 
 
plot(TSS$Pos-width, TSS$WCTotal*sae2scalar/Mreads[k], xaxt="n",yaxt="n", type="n", ylab="", ylim=c(-100,120), axes=F) 
text(0,0, font=3, labels=paste("Chromosome",toString(chroms), "/ Hann", win, "/ Y-Scalar",scalar)) 
 
dev.off() 
